<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://pubmeddy.com/stocks/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/2.9.1" --><!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.1.4" --><!-- generated-on="March 11, 2010 5:05 pm" --><!-- Debug: Total comment count: 0 --><urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://pubmeddy.com/stocks/</loc>
		<lastmod>2010-03-12T00:03:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
<!-- Debug: Start Postings --><!-- Debug: Priority report of postID 9233: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-comments-on-fda-joint-advisory-committee-meeting-on-post-marketing-safety-studies-for-the-use-of-labas-in-asthma/2010/</loc>
		<lastmod>2010-03-12T00:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9236: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-discontinues-a-phase-3-study-of-figitumumab-in-previously-treated-patients-with-advanced-non-small-cell-lung-cancer/2010/</loc>
		<lastmod>2010-03-12T00:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9237: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/two-phase-3-trials-of-sunitinib-with-commonly-used-chemotherapies-in-advanced-breast-cancer-did-not-meet-the-primary-endpoint/2010/</loc>
		<lastmod>2010-03-12T00:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9241: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-anti-dennis-kozlowski/2010/</loc>
		<lastmod>2010-03-11T23:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9231: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-seeks-fda-approval-of-a-new-six-month-45-mg-formulation-of-lupronr-depot-for-the-palliative-treatment-of-advanced-prostate-cancer/2010/</loc>
		<lastmod>2010-03-11T22:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9214: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-manage-gains/2010/</loc>
		<lastmod>2010-03-11T21:22:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9215: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-inches-higher/2010/</loc>
		<lastmod>2010-03-11T21:02:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9238: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-medivation-a-buy/2010/</loc>
		<lastmod>2010-03-11T20:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9239: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-medivation-a-buy/2010/</loc>
		<lastmod>2010-03-11T20:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9230: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-next-big-opportunity-for-big-pharma-is-bric/2010/</loc>
		<lastmod>2010-03-11T20:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9242: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/investments-to-fight-inflation-2/2010/</loc>
		<lastmod>2010-03-11T20:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9243: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-still-has-a-bone-to-pick-with-these-drugmakers/2010/</loc>
		<lastmod>2010-03-11T20:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9244: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dont-invest-another-penny-3/2010/</loc>
		<lastmod>2010-03-11T20:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9219: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/long-term-debt-prices-rise-after-auction/2010/</loc>
		<lastmod>2010-03-11T19:47:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9216: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pharma-firms-set-to-regain-their-health/2010/</loc>
		<lastmod>2010-03-11T19:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9225: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/preview-devices-to-take-center-stage-at-acc-heart-meeting/2010/</loc>
		<lastmod>2010-03-11T19:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9220: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-mixed-after-jobs-trade-data/2010/</loc>
		<lastmod>2010-03-11T18:38:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9217: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/corrected-update-2-fda-rules-out-bisphosphonate-thigh-fracture-link/2010/</loc>
		<lastmod>2010-03-11T18:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9226: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/have-stocks-dethroned-cash/2010/</loc>
		<lastmod>2010-03-11T17:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9206: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-exact-sciences-corp-issued-by-investorsoup-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-03-11T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9211: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-could-be-the-biggest-mistake-youll-ever-make-2/2010/</loc>
		<lastmod>2010-03-11T11:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9205: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-poised-for-weak-open/2010/</loc>
		<lastmod>2010-03-11T10:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9213: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-to-pay-450-million-for-facet-biotech-lake-county-news-sun/2010/</loc>
		<lastmod>2010-03-11T10:02:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9210: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-agrees-generics-deal-with-torrent/2010/</loc>
		<lastmod>2010-03-11T09:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9199: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-recap-the-banks-are-back-final/2010/</loc>
		<lastmod>2010-03-11T02:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9200: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/billionaire-owned-stocks-to-avoid/2010/</loc>
		<lastmod>2010-03-11T02:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9196: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbotts-high-stakes-weekend/2010/</loc>
		<lastmod>2010-03-11T00:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9151: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nasdaq-leads-market-higher/2010/</loc>
		<lastmod>2010-03-10T23:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9204: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-tucks-in-facet-biotech/2010/</loc>
		<lastmod>2010-03-10T23:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9192: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-fda-rules-out-bisphosphonate-thigh-fracture-link/2010/</loc>
		<lastmod>2010-03-10T22:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9161: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/financials-lead-stocks-higher/2010/</loc>
		<lastmod>2010-03-10T22:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9183: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/obamacare-who-cares-there-are-drug-deals-to-do/2010/</loc>
		<lastmod>2010-03-10T22:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9139: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-post-modest-gains/2010/</loc>
		<lastmod>2010-03-10T21:54:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9156: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rises-after-inventory-report/2010/</loc>
		<lastmod>2010-03-10T21:35:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9185: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/new-securities-issues/2010/</loc>
		<lastmod>2010-03-10T20:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8829: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sp-gains-as-financials-outlook-improves/2010/</loc>
		<lastmod>2010-03-10T20:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9240: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-adds-facet-biotech-to-its-test-tube-2/2010/</loc>
		<lastmod>2010-03-10T19:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9184: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/up-160-with-room-to-run/2010/</loc>
		<lastmod>2010-03-10T19:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9247: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/you-paid-how-much-for-that/2010/</loc>
		<lastmod>2010-03-10T19:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9165: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramer-abbotts-a-growth-stock/2010/</loc>
		<lastmod>2010-03-10T19:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9181: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/airline-stocks-take-off/2010/</loc>
		<lastmod>2010-03-10T19:13:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9154: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-dip-as-21b-auction-sees-big-demand/2010/</loc>
		<lastmod>2010-03-10T19:05:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9158: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-facet-brings-to-abbott/2010/</loc>
		<lastmod>2010-03-10T18:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9159: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotechs-jump-on-facet-intermune-deal/2010/</loc>
		<lastmod>2010-03-10T18:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9162: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-stocks-rise-helped-by-inventory-data/2010/</loc>
		<lastmod>2010-03-10T18:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9169: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/citi-aig-fannie-and-freddie-the-not-fab-4/2010/</loc>
		<lastmod>2010-03-10T17:53:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9170: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/citi-aig-fannie-and-freddie-the-not-fab-4/2010/</loc>
		<lastmod>2010-03-10T17:53:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9176: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/one-reason-stocks-may-stall/2010/</loc>
		<lastmod>2010-03-10T17:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9232: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/secrets-of-the-worlds-wealthiest-people/2010/</loc>
		<lastmod>2010-03-10T17:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9142: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-bids-66-premium-for-facets-drugs/2010/</loc>
		<lastmod>2010-03-10T17:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9152: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-higher-despite-inventories-dip/2010/</loc>
		<lastmod>2010-03-10T17:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9167: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-key-representative-weighs-in-on-financial-reform-and-health-care/2010/</loc>
		<lastmod>2010-03-10T16:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9141: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-merck-hartford-financial-services-human-genome-sciences-toll-brothers-and-verifone-released-by-seven-summits-research/2010/</loc>
		<lastmod>2010-03-10T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9227: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-stocks-futures-point-to-flat-open-as-ma-heats-up/2010/</loc>
		<lastmod>2010-03-10T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9207: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-intermune-lead-biotech-stocks-north-fox-news/2010/</loc>
		<lastmod>2010-03-10T15:52:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9135: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/citigroup-wednesdays-headlines/2010/</loc>
		<lastmod>2010-03-10T15:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9155: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-seesaws/2010/</loc>
		<lastmod>2010-03-10T14:54:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9140: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-post-modest-gains-at-open/2010/</loc>
		<lastmod>2010-03-10T14:43:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9137: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-stocks-futures-little-changed-after-china-data-deals/2010/</loc>
		<lastmod>2010-03-10T14:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9208: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-futures-point-to-flat-open-as-ma-heats-up-reuters-via-yahoo-news/2010/</loc>
		<lastmod>2010-03-10T14:02:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9168: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/an-80-chance-youll-fail/2010/</loc>
		<lastmod>2010-03-10T14:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9209: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-futures-little-changed-after-china-data-deals-reuters-via-yahoo-news/2010/</loc>
		<lastmod>2010-03-10T12:45:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9118: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-leaning-toward-gains/2010/</loc>
		<lastmod>2010-03-10T12:23:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9212: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-stock-index-futures-little-changed-facet-citigroup-rise-bloomberg/2010/</loc>
		<lastmod>2010-03-10T12:22:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9121: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/four-etf-plays-for-biotech-thestreet-com/2010/</loc>
		<lastmod>2010-03-10T11:16:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9120: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-stock-index-futures-fluctuate-facet-citigroup-advance-bloomberg/2010/</loc>
		<lastmod>2010-03-10T10:52:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9124: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-futures-signal-higher-open-facet-eyed-reuters-via-yahoo-news/2010/</loc>
		<lastmod>2010-03-10T10:14:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9117: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ford-shares-buy-or-sell/2010/</loc>
		<lastmod>2010-03-10T09:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9123: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-bests-biogen-with-27-a-share-bid-for-facet-biotech-bloomberg/2010/</loc>
		<lastmod>2010-03-10T06:07:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9112: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-next-moves/2010/</loc>
		<lastmod>2010-03-10T03:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9110: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-recap-the-dogs-of-the-dow-final/2010/</loc>
		<lastmod>2010-03-10T02:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9125: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-agrees-to-buy-facet-biotech-for-450-million-update2-bloomberg/2010/</loc>
		<lastmod>2010-03-10T02:07:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9122: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-to-pay-450-million-for-facet-biotech-ap-via-yahoo-news/2010/</loc>
		<lastmod>2010-03-10T00:46:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9102: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-to-buy-facet-biotech/2010/</loc>
		<lastmod>2010-03-10T00:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9103: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-labs-to-buy-facet-biotech-for-722-million/2010/</loc>
		<lastmod>2010-03-10T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9119: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotech-stock-soars-on-abbott-bid-thestreet-com/2010/</loc>
		<lastmod>2010-03-10T00:00:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9104: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-enhances-pharmaceutical-pipeline-with-acquisition-of-facet-biotech/2010/</loc>
		<lastmod>2010-03-09T23:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9126: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-agrees-to-buy-facet-biotech-for-450-million-update1-bloomberg/2010/</loc>
		<lastmod>2010-03-09T23:41:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9094: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-close-modestly-higher/2010/</loc>
		<lastmod>2010-03-09T23:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9095: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-roiled-by-cisco-banks/2010/</loc>
		<lastmod>2010-03-09T23:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9105: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-you-need-to-know-about-fish-oil/2010/</loc>
		<lastmod>2010-03-09T23:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9106: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/in-pictures-10-things-you-need-to-know-about-fish-oil/2010/</loc>
		<lastmod>2010-03-09T23:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9081: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-inch-up-amid-strong-demand-for-3-year-notes/2010/</loc>
		<lastmod>2010-03-09T23:04:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9127: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-to-pay-450-million-for-facet-biotech-abc-news/2010/</loc>
		<lastmod>2010-03-09T22:46:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9080: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/high-grade-bond-sales-pick-up/2010/</loc>
		<lastmod>2010-03-09T22:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9128: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-labs-to-buy-facet-biotech-for-722-million-fox-news/2010/</loc>
		<lastmod>2010-03-09T22:23:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9077: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-muster-gains-nasdaq-at-18-month-high/2010/</loc>
		<lastmod>2010-03-09T21:31:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9091: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-eye-fresh-highs-on-anniversary-of-lift-off/2010/</loc>
		<lastmod>2010-03-09T21:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9090: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/animal-health-the-profits-hidden-inside-the-barn/2010/</loc>
		<lastmod>2010-03-09T20:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9096: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/are-billions-of-dollars-in-revenue-at-risk/2010/</loc>
		<lastmod>2010-03-09T19:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9092: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-big-upgrade-for-sciclone-pharmaceuticals/2010/</loc>
		<lastmod>2010-03-09T18:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9089: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-falls-as-the-dollar-firms/2010/</loc>
		<lastmod>2010-03-09T18:28:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9086: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-dows-best-performer-is/2010/</loc>
		<lastmod>2010-03-09T17:50:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9087: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-opportunity-that-wasnt/2010/</loc>
		<lastmod>2010-03-09T17:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9075: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-myers-squibb-and-astrazeneca-announce-the-commencement-of-the-saxagliptin-assessment-of-vascular-outcomes-recorded-in-patients-with-diabetes-mellitus-trial-savor-timi-53/2010/</loc>
		<lastmod>2010-03-09T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9071: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/trendspotting-the-boomer-consumer/2010/</loc>
		<lastmod>2010-03-09T15:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9078: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-mixed-in-quiet-trading-3/2010/</loc>
		<lastmod>2010-03-09T14:34:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9069: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-sanofi-herd-animal-health-businesses-into-one-corral/2010/</loc>
		<lastmod>2010-03-09T14:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9070: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-folly/2010/</loc>
		<lastmod>2010-03-09T13:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9066: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-opening-drop/2010/</loc>
		<lastmod>2010-03-09T13:06:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9059: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-sanofi-create-animal-health-giant/2010/</loc>
		<lastmod>2010-03-09T09:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9067: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/citigroup-shares-no-longer-toxic/2010/</loc>
		<lastmod>2010-03-09T09:35:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9068: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sanofi-aventis-merck-form-animal-health-venture/2010/</loc>
		<lastmod>2010-03-09T09:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9060: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sanofi-aventis-and-merck-to-create-a-global-leader-in-animal-health/2010/</loc>
		<lastmod>2010-03-09T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9061: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-market-investors-claw-their-way-back-san-francisco-chronicle/2010/</loc>
		<lastmod>2010-03-09T08:45:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9028: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ciscos-gains-lift-tech-sector/2010/</loc>
		<lastmod>2010-03-08T23:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9018: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nasdaq-at-18-month-highs/2010/</loc>
		<lastmod>2010-03-08T21:15:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9062: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pacific-biomarkers-inc-common-stock-now-trading-under-new-symbol-pbmc-pr-newswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-03-08T20:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9033: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ftse-hits-18-month-closing-high-led-by-commods/2010/</loc>
		<lastmod>2010-03-08T19:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9057: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/buy-these-stocks-before-the-trend-reverses/2010/</loc>
		<lastmod>2010-03-08T19:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9058: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/buy-these-stocks-before-the-trend-reverses/2010/</loc>
		<lastmod>2010-03-08T19:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9034: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/roche-biogen-idec-end-drug-trial/2010/</loc>
		<lastmod>2010-03-08T19:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9035: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/european-shares-fall-weak-drugmakers-outpace-oils/2010/</loc>
		<lastmod>2010-03-08T18:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9052: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-still-dealing-with-antitrust-issues/2010/</loc>
		<lastmod>2010-03-08T18:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9053: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/really-a-59-share-price-jump-for-that/2010/</loc>
		<lastmod>2010-03-08T18:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9020: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-us-court-to-decide-if-vaccine-makers-can-be-sued/2010/</loc>
		<lastmod>2010-03-08T18:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9039: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/no-lost-decade-for-these-techs/2010/</loc>
		<lastmod>2010-03-08T18:01:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9040: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/no-lost-decade-for-these-techs/2010/</loc>
		<lastmod>2010-03-08T18:01:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9029: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-stocks-hold-steady-2/2010/</loc>
		<lastmod>2010-03-08T17:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9065: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lexicon-poniard-lead-decliners-malaysianews-net/2010/</loc>
		<lastmod>2010-03-08T17:45:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9063: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/media-internet-companies-get-spotlight-at-roth-capital-partners-22nd-annual-oc-growth-stock-conference-march-15-17-business-wire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-03-08T17:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9046: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-retreat-in-wake-of-supply-wave/2010/</loc>
		<lastmod>2010-03-08T17:02:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9026: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-lexicon-poniard-weigh-on-drug-stocks-market-watch/2010/</loc>
		<lastmod>2010-03-08T16:15:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9032: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-edges-higher-on-upbeat-sentiment/2010/</loc>
		<lastmod>2010-03-08T15:44:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9030: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/must-read-mutual-fund-news-2/2010/</loc>
		<lastmod>2010-03-08T14:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9031: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/must-read-mutual-fund-news-2/2010/</loc>
		<lastmod>2010-03-08T14:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9027: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/israel-stocks-israel-stocks-slip-citi-warns-on-reclassification-market-watch/2010/</loc>
		<lastmod>2010-03-08T14:15:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9019: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-slides-versus-euro/2010/</loc>
		<lastmod>2010-03-08T14:07:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9013: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-positive-open/2010/</loc>
		<lastmod>2010-03-08T13:50:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9024: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-keryx-biopharmaceuticals-inc-issued-by-investorsoup-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-03-08T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9025: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-keryx-biopharmaceuticals-inc-issued-by-investorsoup-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-03-08T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9014: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/an-easy-fix-for-a-tricky-securities-problem/2010/</loc>
		<lastmod>2010-03-08T10:51:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9012: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-recentin-not-better-vs-rival-in-trial/2010/</loc>
		<lastmod>2010-03-08T09:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9011: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/volatility-alert-fear-indices-fall-sharply-as-stocks-rally-optionetics-com-via-yahoo-finance/2010/</loc>
		<lastmod>2010-03-07T21:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9003: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medivations-next-moves/2010/</loc>
		<lastmod>2010-03-07T19:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9004: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biopharma-stock-alert-for-pfizer-inc-issued-by-beacon-equity/2010/</loc>
		<lastmod>2010-03-07T18:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9010: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/positive-u-s-jobs-data-could-translate-into-gains-on-stock-markets-this-week-canoe-money/2010/</loc>
		<lastmod>2010-03-07T18:26:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9005: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-woos-ratiopharm-with-ramp-up-pledge-sources/2010/</loc>
		<lastmod>2010-03-07T18:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 9002: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bears-vs-bulls-as-anniversary-looms/2010/</loc>
		<lastmod>2010-03-07T17:35:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8997: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dividends-for-100-years-3/2010/</loc>
		<lastmod>2010-03-07T12:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8989: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/happy-anniversary-investors/2010/</loc>
		<lastmod>2010-03-06T14:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8990: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/an-upbeat-market-shrugs-off-jobs-data/2010/</loc>
		<lastmod>2010-03-06T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8974: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-raises-ratiopharm-bid/2010/</loc>
		<lastmod>2010-03-06T13:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8977: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/street-cheers-prospects-for-intermune-drug/2010/</loc>
		<lastmod>2010-03-05T23:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8987: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amag-anemia-drug-eyes-growing-market-investors-business-daily-inc-via-yahoo-finance/2010/</loc>
		<lastmod>2010-03-05T23:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8978: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/intermune-curries-favor-with-fda-investors/2010/</loc>
		<lastmod>2010-03-05T21:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8956: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nasdaq-at-18-month-high/2010/</loc>
		<lastmod>2010-03-05T21:21:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8979: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/former-peninsula-manager-starts-his-own-charity-fund/2010/</loc>
		<lastmod>2010-03-05T20:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8986: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/investment-bank-ups-agilent-stock-rating-price-target-genomeweb-news/2010/</loc>
		<lastmod>2010-03-05T20:45:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8953: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-jumps-to-2-month-high-on-jobs-report/2010/</loc>
		<lastmod>2010-03-05T20:41:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8969: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/good-news-about-jobs-bad-for-bonds/2010/</loc>
		<lastmod>2010-03-05T17:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8957: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/an-allergy-shot-in-a-pill/2010/</loc>
		<lastmod>2010-03-05T17:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8958: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/unemployment-rate-holds-steady-at-9-7/2010/</loc>
		<lastmod>2010-03-05T17:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8966: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/economic-snow-job/2010/</loc>
		<lastmod>2010-03-05T17:11:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8948: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-soars-on-yen-after-jobs-data/2010/</loc>
		<lastmod>2010-03-05T17:10:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8985: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/intermune-pushes-biotech-index-north-fox-news/2010/</loc>
		<lastmod>2010-03-05T16:05:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8960: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ibm-reinventing-the-wheel-at-the-speed-of-light/2010/</loc>
		<lastmod>2010-03-05T15:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8963: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-to-buy-when-nothings-cheap/2010/</loc>
		<lastmod>2010-03-05T15:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8959: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-to-replace-6-1-billion-in-lost-revenue/2010/</loc>
		<lastmod>2010-03-05T14:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8955: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-for-the-next-decade/2010/</loc>
		<lastmod>2010-03-05T13:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8942: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-rally-at-open/2010/</loc>
		<lastmod>2010-03-05T13:44:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8952: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/judge-holds-merck-liable/2010/</loc>
		<lastmod>2010-03-05T12:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8949: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dendreon-biotech-stock-mailbag-thestreet-com/2010/</loc>
		<lastmod>2010-03-05T12:15:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8947: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bourbon-suez-environnement-veolia-french-equity-preview-bloomberg/2010/</loc>
		<lastmod>2010-03-05T08:01:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8940: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-statement-on-vioxx%c2%ae-judgment-in-australia/2010/</loc>
		<lastmod>2010-03-05T03:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8984: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-pfe-8/2010/</loc>
		<lastmod>2010-03-05T01:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8936: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/advance-2-study-results-demonstrate-investigational-anticoagulant-apixaban-was-statistically-superior-to-enoxaparin-in-the-prevention-of-venous-thromboembolism-following-knee-replacement-surgery/2010/</loc>
		<lastmod>2010-03-05T01:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8939: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stopping-the-killer/2010/</loc>
		<lastmod>2010-03-05T01:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8938: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-bull-and-bear-of-the-day-highlights-microsoft-corp-western-union-pozen-astrazeneca-and-glaxosmithkline/2010/</loc>
		<lastmod>2010-03-05T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8920: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-finish-higher-jobs-report-on-tap/2010/</loc>
		<lastmod>2010-03-04T23:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8903: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-returns-to-black-for-2010/2010/</loc>
		<lastmod>2010-03-04T23:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8929: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/saving-big-bucks-on-prescription-drugs/2010/</loc>
		<lastmod>2010-03-04T23:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8930: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eight-ways-to-save-big-on-prescription-drugs/2010/</loc>
		<lastmod>2010-03-04T23:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8895: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rises-sharply/2010/</loc>
		<lastmod>2010-03-04T22:55:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8946: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/growth-stock-swing-option-march-4-2010-optionetics-com-via-yahoo-finance/2010/</loc>
		<lastmod>2010-03-04T21:46:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8907: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-positive-for-2010/2010/</loc>
		<lastmod>2010-03-04T21:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8931: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fridays-labor-report-a-snow-job/2010/</loc>
		<lastmod>2010-03-04T21:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8932: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-only-way-to-profit-in-2010-2/2010/</loc>
		<lastmod>2010-03-04T20:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8921: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-ray-of-hope-for-medivation/2010/</loc>
		<lastmod>2010-03-04T20:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8901: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-closes-lower/2010/</loc>
		<lastmod>2010-03-04T20:10:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8914: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bmy-forecasts-profit-above-estimates-sees-5-new-drugs-in-2012/2010/</loc>
		<lastmod>2010-03-04T19:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8922: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/you-cant-afford-to-skip-this-question/2010/</loc>
		<lastmod>2010-03-04T18:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8919: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-ahead-of-jobs-report/2010/</loc>
		<lastmod>2010-03-04T18:34:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8927: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-upbeat-on-crestor-patent-as-trial-ends/2010/</loc>
		<lastmod>2010-03-04T18:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8917: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fear-1-year-later-greed-10-years-gone/2010/</loc>
		<lastmod>2010-03-04T17:45:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8915: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-painless-drug-deal/2010/</loc>
		<lastmod>2010-03-04T17:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8912: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/initial-jobless-claims-decline/2010/</loc>
		<lastmod>2010-03-04T17:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8973: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-to-find-good-stocks-cheap/2010/</loc>
		<lastmod>2010-03-04T16:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8943: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-combinatorx-rebounds-drug-indexes-flat-market-watch/2010/</loc>
		<lastmod>2010-03-04T16:15:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8909: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-expects-impact-from-plavix-patent-loss/2010/</loc>
		<lastmod>2010-03-04T15:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8904: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-sets-baseline-for-profits-post-plavix/2010/</loc>
		<lastmod>2010-03-04T15:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8908: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/your-portfolios-riskier-than-you-think/2010/</loc>
		<lastmod>2010-03-04T15:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8944: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-advanced-cell-technology-inc-issued-by-investorsoup-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-03-04T14:01:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8945: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gse-to-present-at-the-roth-capital-partners-22nd-annual-oc-growth-stock-conference-business-wire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-03-04T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8902: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fidelity-fund-gets-top-rating-bets-on-u-s/2010/</loc>
		<lastmod>2010-03-04T13:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8883: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mixed-open-seen-for-stocks/2010/</loc>
		<lastmod>2010-03-04T13:44:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8905: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-under-5-three-earnings-plays/2010/</loc>
		<lastmod>2010-03-04T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8897: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-market-watch-for-sequenom-inc-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-03-04T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8935: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-best-yields-for-the-next-10-years-2/2010/</loc>
		<lastmod>2010-03-04T11:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8896: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/press-release-bb-biotech-ag-publishes-its-2009-annual-report-financial-de/2010/</loc>
		<lastmod>2010-03-04T07:10:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8892: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-political-gridlock/2010/</loc>
		<lastmod>2010-03-04T02:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8881: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-pharma-should-avoid-course-in-medivation/2010/</loc>
		<lastmod>2010-03-04T00:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8870: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-in-the-spotlight-wednesday-3/2010/</loc>
		<lastmod>2010-03-04T00:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8894: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-bull-and-bear-of-the-day-highlights-skyworks-solutions-tetra-tech-bristol-myers-squibb-co-abbott-laboratories-and-novartis/2010/</loc>
		<lastmod>2010-03-04T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8898: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-millipore-corporation-merck-company-general-dynamics-lockheed-martin-corp-and-raytheon-co/2010/</loc>
		<lastmod>2010-03-04T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8875: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/beige-book-paints-gray-picture-of-economy/2010/</loc>
		<lastmod>2010-03-03T23:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8878: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-wrap-the-real-story-march-3/2010/</loc>
		<lastmod>2010-03-03T23:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8867: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-close-flat-after-obama-beige-book/2010/</loc>
		<lastmod>2010-03-03T23:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8835: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-st-flat-as-white-house-pushes-regulation/2010/</loc>
		<lastmod>2010-03-03T22:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8826: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-stocks-fall-hurting-dow/2010/</loc>
		<lastmod>2010-03-03T21:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8857: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/staying-rational-on-ratiopharm/2010/</loc>
		<lastmod>2010-03-03T21:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8831: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-struggle-ahead-of-jobs-reports/2010/</loc>
		<lastmod>2010-03-03T21:14:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8889: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/san-diego-states-clinical-lab-sciences-program-will-dip-into-5m-govt-biotech-revival-grant-genomeweb-news/2010/</loc>
		<lastmod>2010-03-03T21:05:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8851: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-backed-experimental-drug-for-alzheimers-fails-in-trial/2010/</loc>
		<lastmod>2010-03-03T20:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8888: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-outlook-stock-review-zacks-com-via-yahoo-finance/2010/</loc>
		<lastmod>2010-03-03T20:47:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8824: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-crosses-80/2010/</loc>
		<lastmod>2010-03-03T20:31:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8853: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-100-best-corporate-citizens/2010/</loc>
		<lastmod>2010-03-03T20:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8855: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-abt-14/2010/</loc>
		<lastmod>2010-03-03T19:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8879: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-to-collaborate-with-gsk-on-molecular-diagnostic-test-to-select-candidate-patients-for-future-skin-cancer-immunotherapy/2010/</loc>
		<lastmod>2010-03-03T19:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8841: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-readies-ratiopharm-bid/2010/</loc>
		<lastmod>2010-03-03T18:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8842: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medivation-biotech-stock-mailbag/2010/</loc>
		<lastmod>2010-03-03T18:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8923: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-deflation-back-on-the-table/2010/</loc>
		<lastmod>2010-03-03T18:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8890: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/china-kangtai-cactus-biotech-announces-preliminary-fy-2009-results-malaysianews-net/2010/</loc>
		<lastmod>2010-03-03T17:50:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8847: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bulls-are-back-send-in-the-bears/2010/</loc>
		<lastmod>2010-03-03T17:39:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8836: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bmy-sinks-as-strategist-cornelius-walks/2010/</loc>
		<lastmod>2010-03-03T17:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8848: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/judges-ruling-has-brand-and-generic-drugmakers-smiling/2010/</loc>
		<lastmod>2010-03-03T17:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8846: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-fall-on-greece-plan-economic-data/2010/</loc>
		<lastmod>2010-03-03T17:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8837: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-climb-on-jobs-data/2010/</loc>
		<lastmod>2010-03-03T17:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8884: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medivation-biotech-stock-mailbag-thestreet-com/2010/</loc>
		<lastmod>2010-03-03T16:45:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8885: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonus-biotech-stock-mailbag-medivation-thestreet-com/2010/</loc>
		<lastmod>2010-03-03T16:31:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8849: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-5-underdogs-are-no-dogs-2/2010/</loc>
		<lastmod>2010-03-03T16:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8916: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/adp-report-wednesdays-headlines-2/2010/</loc>
		<lastmod>2010-03-03T16:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8827: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-medivation-alzheimers-drug-fails/2010/</loc>
		<lastmod>2010-03-03T15:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8828: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medivation-alzheimers-drug-fails-pivotal-study/2010/</loc>
		<lastmod>2010-03-03T15:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8839: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-unloved-stocks-are-the-best-buys/2010/</loc>
		<lastmod>2010-03-03T14:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8910: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-medivation-disappointed-with-dimebon-trial/2010/</loc>
		<lastmod>2010-03-03T14:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8834: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/job-cuts-fall-in-february-to-lowest-since-2006/2010/</loc>
		<lastmod>2010-03-03T14:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8830: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-and-medivation-announce-results-from-two-phase-3-studies-in-dimebon-latrepirdine-alzheimer%e2%80%99s-disease-clinical-development-program/2010/</loc>
		<lastmod>2010-03-03T14:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8886: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/china-kangtai-cactus-biotech-announces-preliminary-fy-2009-results-and-forecasts-fy-2010-guidance-business-wire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-03-03T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8823: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-slides-on-greece-budget-package/2010/</loc>
		<lastmod>2010-03-03T12:32:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8819: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-headed-for-flat-open/2010/</loc>
		<lastmod>2010-03-03T12:17:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8906: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/top-bonds-for-rising-rates-analysts-toolkit/2010/</loc>
		<lastmod>2010-03-03T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8820: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-reportedly-to-offer-4-1-bln-for-ratiopharm/2010/</loc>
		<lastmod>2010-03-03T11:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8818: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-diversification-will-work-again/2010/</loc>
		<lastmod>2010-03-03T09:50:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8891: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/china-on-way-to-self-sufficiency-in-rice-corn-manila-bulletin/2010/</loc>
		<lastmod>2010-03-03T08:03:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8817: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristols-accidental-revolutionary/2010/</loc>
		<lastmod>2010-03-03T05:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8812: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-to-outline-ratiopharm-offer-this-week/2010/</loc>
		<lastmod>2010-03-03T03:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8825: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/japan-shares-near-flat-as-drug-makers-weaken/2010/</loc>
		<lastmod>2010-03-03T02:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8821: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-set-to-join-bidding-for-ratiopharm-bloomberg/2010/</loc>
		<lastmod>2010-03-03T02:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8811: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-going-for-generic-crown-report/2010/</loc>
		<lastmod>2010-03-03T00:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8805: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/teva-gets-180-day-headstart-to-sell-generics-of-2-merck-drugs/2010/</loc>
		<lastmod>2010-03-02T23:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8781: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-eke-out-gains/2010/</loc>
		<lastmod>2010-03-02T23:02:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8806: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-reports-results-of-phase-iii-study-of-investigational-oral-allergy-immunotherapy-tablet-ait-in-patients-ages-5-17-with-grass-pollen-allergy/2010/</loc>
		<lastmod>2010-03-02T23:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8792: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-loses-steam-on-greece-hopes/2010/</loc>
		<lastmod>2010-03-02T22:56:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8804: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-fall-on-fed-officials-comments/2010/</loc>
		<lastmod>2010-03-02T21:08:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8796: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-prices-rise-on-weaker-dollar/2010/</loc>
		<lastmod>2010-03-02T20:13:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8808: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-best-investor-youve-never-heard-of/2010/</loc>
		<lastmod>2010-03-02T19:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8911: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-details-rd-overhaul/2010/</loc>
		<lastmod>2010-03-02T19:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8801: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-poised-for-growth-and-eager-to-go/2010/</loc>
		<lastmod>2010-03-02T19:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8793: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rpt-update-1-astrazeneca-drops-psychiatric-other-drug-research/2010/</loc>
		<lastmod>2010-03-02T18:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8794: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rpt-update-1-astrazeneca-drops-psychiatric-other-drug-research/2010/</loc>
		<lastmod>2010-03-02T18:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8791: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/foreign-companies-buy-american/2010/</loc>
		<lastmod>2010-03-02T17:46:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8850: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-21/2010/</loc>
		<lastmod>2010-03-02T17:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8803: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/data-from-two-phase-iii-studies-of-merck%e2%80%99s-investigational-asthma-drug-presented-at-american-academy-of-allergy-asthma-immunology-aaaai-annual-meeting/2010/</loc>
		<lastmod>2010-03-02T17:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8802: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-invites-public-to-view-and-listen-to-webcast-of-investor-breakfast-at-healthcare-conference/2010/</loc>
		<lastmod>2010-03-02T17:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8787: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/osip-fight-is-on-as-astellas-tenders/2010/</loc>
		<lastmod>2010-03-02T16:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8843: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-abt-13/2010/</loc>
		<lastmod>2010-03-02T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8844: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-abt-13/2010/</loc>
		<lastmod>2010-03-02T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8782: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-and-enanta-announce-advancement-of-hepatitis-c-collaboration/2010/</loc>
		<lastmod>2010-03-02T16:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8887: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-sequenom-combinatorx-lead-drug-stocks-north-market-watch/2010/</loc>
		<lastmod>2010-03-02T16:00:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8783: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/twenty-five-years-of-hiv-blood-testing-helped-to-positively-transform-global-health-crisis/2010/</loc>
		<lastmod>2010-03-02T14:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8789: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/top-dow-dividend-stocks-part-2/2010/</loc>
		<lastmod>2010-03-02T12:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8773: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-higher-open-3/2010/</loc>
		<lastmod>2010-03-02T12:58:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8788: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/terrible-advice-you-should-ignore-2/2010/</loc>
		<lastmod>2010-03-02T11:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8774: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/osip-soars-52-seems-a-higher-bid-must-be-near/2010/</loc>
		<lastmod>2010-03-02T00:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8759: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-in-the-spotlight-monday-3/2010/</loc>
		<lastmod>2010-03-01T23:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8758: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/data-deal-talk-rally-stocks/2010/</loc>
		<lastmod>2010-03-01T23:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8756: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-toyota-may-cause-higher-interest-rates/2010/</loc>
		<lastmod>2010-03-01T21:33:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8744: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-choppy-as-greece-news-boosts-stocks/2010/</loc>
		<lastmod>2010-03-01T21:30:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8727: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nasdaq-sp-turn-positive-for-2010/2010/</loc>
		<lastmod>2010-03-01T21:23:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8740: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/three-biotech-bets-worth-making/2010/</loc>
		<lastmod>2010-03-01T20:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8761: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-new-global-investing-hot-spot/2010/</loc>
		<lastmod>2010-03-01T19:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8778: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/you-seriously-think-stocks-are-risky/2010/</loc>
		<lastmod>2010-03-01T19:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8741: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/manufacturing-grows-at-a-slower-pace/2010/</loc>
		<lastmod>2010-03-01T18:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8743: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/spending-more-saving-less-uh-oh/2010/</loc>
		<lastmod>2010-03-01T18:26:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8739: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-prices-lose-traction/2010/</loc>
		<lastmod>2010-03-01T18:23:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8748: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-treaty-of-versailles-redressed/2010/</loc>
		<lastmod>2010-03-01T17:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8749: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-treaty-of-versailles-redressed/2010/</loc>
		<lastmod>2010-03-01T17:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8734: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-pfe-7/2010/</loc>
		<lastmod>2010-03-01T17:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8767: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-to-pay-us7-2b-for-us-biotech-firm-business-times-malaysia/2010/</loc>
		<lastmod>2010-03-01T16:52:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8729: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-pfizer-travelers-goldcorp-delta-air-lines-and-rambus-released-by-seven-summits-research/2010/</loc>
		<lastmod>2010-03-01T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8730: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/millipore-up-11-as-germanys-merck-pays-7-2b/2010/</loc>
		<lastmod>2010-03-01T15:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8736: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-warren-buffett-experiment/2010/</loc>
		<lastmod>2010-03-01T15:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8723: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/two-ways-to-play-merck-and-millipore-kick-off-ma-monday/2010/</loc>
		<lastmod>2010-03-01T15:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8724: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-20/2010/</loc>
		<lastmod>2010-03-01T15:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8725: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-announces-robust-integrated-pipeline-with-more-than-20-medicines-and-vaccines-in-late-stage-development/2010/</loc>
		<lastmod>2010-03-01T15:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8786: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biomed-realty-trust-acquires-two-life-science-buildings-totaling-82400-square-feet-in-gaithersburg-maryland/2010/</loc>
		<lastmod>2010-03-01T15:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8722: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-new-option-for-portfolio-management/2010/</loc>
		<lastmod>2010-03-01T15:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8732: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-price-you-pay-for-frothy-assets/2010/</loc>
		<lastmod>2010-03-01T15:14:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8726: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-exercises-option-to-acquire-mercks-interest-in-partnership-products/2010/</loc>
		<lastmod>2010-03-01T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8768: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-stock-futures-rise-as-aig-unit-to-be-sold-malaysianews-net/2010/</loc>
		<lastmod>2010-03-01T13:24:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8720: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/copper-spikes-after-chile-quake/2010/</loc>
		<lastmod>2010-03-01T13:15:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8765: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-futures-higher-on-aig-deal-reuters-via-yahoo-news/2010/</loc>
		<lastmod>2010-03-01T13:03:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8721: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-firms-against-other-currencies/2010/</loc>
		<lastmod>2010-03-01T13:02:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8717: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-headed-for-a-rally/2010/</loc>
		<lastmod>2010-03-01T12:28:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8719: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mutual-funds-are-recuperating-from-reforms/2010/</loc>
		<lastmod>2010-03-01T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8716: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/indications-u-s-stock-futures-maintain-gains-after-data-market-watch/2010/</loc>
		<lastmod>2010-03-01T11:30:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8712: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/can-vanguard-wellington-keep-running/2010/</loc>
		<lastmod>2010-03-01T10:14:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8714: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/clal-biotech-buys-biomedical-investments-globes-online/2010/</loc>
		<lastmod>2010-03-01T10:12:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8708: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-buys-biotech-co-millipore-for-6b-malaysianews-net/2010/</loc>
		<lastmod>2010-03-01T07:42:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8707: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-buys-biotech-co-millipore-for-6b-cbs-news/2010/</loc>
		<lastmod>2010-03-01T03:08:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8706: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/german-drug-maker-merck-kgaa-to-buy-us-biotech-equipment-maker-millipore-for-6b-plus-debt-malaysianews-net/2010/</loc>
		<lastmod>2010-03-01T01:28:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8709: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/germanys-merck-buying-millipore-for-6b-plus-debt-ap-via-yahoo-news/2010/</loc>
		<lastmod>2010-03-01T01:02:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8705: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/german-drug-maker-merck-kgaa-to-buy-us-biotech-equipment-maker-millipore-for-6b-plus-debt-minneapolis-st-paul-star-tribune/2010/</loc>
		<lastmod>2010-03-01T00:04:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8710: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/report-germanys-merck-buying-millipore-for-7-2b-ap-via-yahoo-news/2010/</loc>
		<lastmod>2010-02-28T23:57:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8718: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/daiichi-sankyo-unit-to-sell-generic-drugs/2010/</loc>
		<lastmod>2010-02-28T17:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8698: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/all-eyes-on-the-job-market/2010/</loc>
		<lastmod>2010-02-28T13:17:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8697: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ipo-activity-poised-to-pop-with-anthera-aveo-and-trius-on-deck-bioworld/2010/</loc>
		<lastmod>2010-02-27T16:18:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8713: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/back-in-business/2010/</loc>
		<lastmod>2010-02-27T13:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8699: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-close-higher-on-light-volume/2010/</loc>
		<lastmod>2010-02-27T02:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8694: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-weekly-layoff-report-midwinter-blues/2010/</loc>
		<lastmod>2010-02-27T01:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8700: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/betting-on-botox/2010/</loc>
		<lastmod>2010-02-27T00:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8690: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/3-reasons-this-rally-is-doomed/2010/</loc>
		<lastmod>2010-02-26T11:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8689: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/3-ways-to-find-value-in-a-pricey-market/2010/</loc>
		<lastmod>2010-02-26T09:28:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8686: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sector-review-new-2010-targets-for-pharmaceutical-stocks-bmy-abt-mrk-pfe-lly/2010/</loc>
		<lastmod>2010-02-25T23:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8693: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/funds-spot-winners-amid-greek-debris/2010/</loc>
		<lastmod>2010-02-25T23:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8692: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merger-for-them-less-money-for-you/2010/</loc>
		<lastmod>2010-02-25T23:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8681: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/william-ringo-pfizer%e2%80%99s-senior-vice-president-worldwide-business-development-strategy-and-innovation-to-retire/2010/</loc>
		<lastmod>2010-02-25T22:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8649: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rises-against-euro-on-greece-debt-woes/2010/</loc>
		<lastmod>2010-02-25T21:31:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8658: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-lose-big-early-then-cut-losses/2010/</loc>
		<lastmod>2010-02-25T21:21:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8682: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/an-untouched-market-waiting-to-be-captured/2010/</loc>
		<lastmod>2010-02-25T20:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8683: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/transplanting-future-revenue/2010/</loc>
		<lastmod>2010-02-25T20:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8651: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-slides-on-negative-jobs-report/2010/</loc>
		<lastmod>2010-02-25T20:45:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8676: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-that-guy-on-tv-touting-lipitor-could-be-your-neighbor/2010/</loc>
		<lastmod>2010-02-25T19:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8677: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-that-guy-on-tv-touting-lipitor-could-be-your-neighbor-2/2010/</loc>
		<lastmod>2010-02-25T19:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8678: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/leveraging-industrial-recovery/2010/</loc>
		<lastmod>2010-02-25T19:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8670: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-experimental-bone-drug-shows-mixed-results-in-study/2010/</loc>
		<lastmod>2010-02-25T18:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8661: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-first-diagnosis-by-dna-2/2010/</loc>
		<lastmod>2010-02-25T18:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8662: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/makers-breakers/2010/</loc>
		<lastmod>2010-02-25T18:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8672: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/initial-claims-up-22000-to-496000/2010/</loc>
		<lastmod>2010-02-25T17:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8668: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-speaks-health-reform-doesnt-matter/2010/</loc>
		<lastmod>2010-02-25T17:42:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8669: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-speaks-health-reform-doesnt-matter/2010/</loc>
		<lastmod>2010-02-25T17:42:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8684: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-apple-prudential-abbott-labs-ca-and-terex-released-by-seven-summits-research/2010/</loc>
		<lastmod>2010-02-25T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8665: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-is-sequenom-motley-fools-darling-here-are-three-reasons-genomeweb-news/2010/</loc>
		<lastmod>2010-02-25T16:15:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8663: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-analysts-upgrades-downgrades-2/2010/</loc>
		<lastmod>2010-02-25T16:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8660: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/palm-stock-tumbles-20/2010/</loc>
		<lastmod>2010-02-25T15:56:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8664: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-retreat-mylan-gains-market-watch/2010/</loc>
		<lastmod>2010-02-25T15:55:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8659: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-gain-on-flight-to-safety/2010/</loc>
		<lastmod>2010-02-25T15:40:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8656: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/prescription-for-pfizer/2010/</loc>
		<lastmod>2010-02-25T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8654: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-rexahn-pharma-thestreet-com/2010/</loc>
		<lastmod>2010-02-25T14:30:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8655: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-rexahn-pharma-thestreet-com/2010/</loc>
		<lastmod>2010-02-25T14:25:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8666: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-stocks-are-gifts-that-will-keep-on-giving/2010/</loc>
		<lastmod>2010-02-25T14:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8653: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/positives-make-it-tough-to-see-too-much-downside/2010/</loc>
		<lastmod>2010-02-25T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8652: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drug-companies-disappoint-me-again/2010/</loc>
		<lastmod>2010-02-25T13:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8646: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-tumble-2/2010/</loc>
		<lastmod>2010-02-25T10:06:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8647: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-has-toyota-bottomed/2010/</loc>
		<lastmod>2010-02-25T02:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8648: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-gets-some-wyeth-payback-as-fda-approves-vaccine/2010/</loc>
		<lastmod>2010-02-25T00:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8639: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-ride-rate-wave-to-higher-close/2010/</loc>
		<lastmod>2010-02-24T23:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8620: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-fall-after-bernanke/2010/</loc>
		<lastmod>2010-02-24T23:36:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8643: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-profitable-one-drug-wonder/2010/</loc>
		<lastmod>2010-02-24T23:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8611: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-surge-on-renewed-optimism/2010/</loc>
		<lastmod>2010-02-24T21:19:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8635: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-next-top-seller/2010/</loc>
		<lastmod>2010-02-24T21:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8636: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cdc%e2%80%99s-advisory-committee-on-immunization-practices-recommends-pfizer%e2%80%99s-prevnar-13%e2%84%a2-vaccine-for-the-prevention-of-invasive-pneumococcal-disease-in-infants-and-young-children-in/2010/</loc>
		<lastmod>2010-02-24T20:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8637: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-winners-for-small-investors-5/2010/</loc>
		<lastmod>2010-02-24T19:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8638: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dear-president-obama-per-your-request/2010/</loc>
		<lastmod>2010-02-24T19:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8685: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medtronic-needs-to-regrow-a-spine/2010/</loc>
		<lastmod>2010-02-24T19:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8622: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/young-kids-should-get-new-prevnar-us-experts-say/2010/</loc>
		<lastmod>2010-02-24T18:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8624: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-approves-pfizers-prevnar-13-vaccine/2010/</loc>
		<lastmod>2010-02-24T18:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8626: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-committe-recommends-pfizer-new-prevnar-vaccine/2010/</loc>
		<lastmod>2010-02-24T18:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8645: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2010-02-24-1805-update-1-anthera-pharmaceuticals-ipo-postponed-interactive-investor/2010/</loc>
		<lastmod>2010-02-24T18:28:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8613: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-receives-fda-approval-for-prevnar-13%e2%84%a2-for-the-prevention-of-invasive-pneumococcal-disease-in-infants-and-young-children/2010/</loc>
		<lastmod>2010-02-24T18:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8627: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/approval-of-new-version-of-prevnar-lifts-pfizer/2010/</loc>
		<lastmod>2010-02-24T18:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8628: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/approval-of-new-version-of-prevnar-lifts-pfizer/2010/</loc>
		<lastmod>2010-02-24T18:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8667: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-tobacco-plants-have-to-do-with-swine-flu-vaccine/2010/</loc>
		<lastmod>2010-02-24T18:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8633: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/build-your-fortune-with-these-winners/2010/</loc>
		<lastmod>2010-02-24T18:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8632: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bofa-no-longer-hated-on-wall-street/2010/</loc>
		<lastmod>2010-02-24T18:15:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8614: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-pfizer-wins-us-approval-for-pneumonia-vaccine/2010/</loc>
		<lastmod>2010-02-24T17:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8615: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-wins-us-approval-for-pneumonia-vaccine/2010/</loc>
		<lastmod>2010-02-24T17:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8618: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-slides-on-bernankes-testimony/2010/</loc>
		<lastmod>2010-02-24T16:28:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8634: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-to-present-at-cowen-and-company-annual-health-care-conference/2010/</loc>
		<lastmod>2010-02-24T16:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8619: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-next-financial-disaster/2010/</loc>
		<lastmod>2010-02-24T15:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8609: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/have-cash-must-shop-deals-are-back/2010/</loc>
		<lastmod>2010-02-24T09:10:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8608: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/australian-company-plans-to-buy-ga-biotech-firm-rome-news-tribune/2010/</loc>
		<lastmod>2010-02-24T06:28:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8612: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/broker-free-yield-stocks/2010/</loc>
		<lastmod>2010-02-24T01:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8610: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medco-doles-out-higher-profits/2010/</loc>
		<lastmod>2010-02-23T23:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8657: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-sees-bearish-move/2010/</loc>
		<lastmod>2010-02-23T23:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8604: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medco-scores-new-clients-profits-roll-in/2010/</loc>
		<lastmod>2010-02-23T22:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8616: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gail-boudreauxs-got-game/2010/</loc>
		<lastmod>2010-02-23T22:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8603: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/first-solar-burns-out-bears-taste-blood/2010/</loc>
		<lastmod>2010-02-23T21:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8607: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotech-reports-fourth-quarter-and-full-year-2009-financial-results-marketwire/2010/</loc>
		<lastmod>2010-02-23T21:21:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8606: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotech-reports-fourth-quarter-and-full-year-2009-financial-results-marketwire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-23T21:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8600: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-announces-second-quarter-2010-dividends/2010/</loc>
		<lastmod>2010-02-23T20:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8593: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medco-jacks-up-prices-profits-roll-in/2010/</loc>
		<lastmod>2010-02-23T20:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8570: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-hit-as-confidence-slips/2010/</loc>
		<lastmod>2010-02-23T20:19:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8602: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-one-that-didnt-get-away/2010/</loc>
		<lastmod>2010-02-23T20:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8594: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jobs-stimulus-debate-rolls-on/2010/</loc>
		<lastmod>2010-02-23T19:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8605: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-flags-risks-for-hiv-drugs/2010/</loc>
		<lastmod>2010-02-23T19:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8601: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/triple-teaming-cancer-for-fun-and-profit/2010/</loc>
		<lastmod>2010-02-23T19:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8591: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-us-fda-warns-of-heart-problem-with-hiv-drug-combo/2010/</loc>
		<lastmod>2010-02-23T19:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8597: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-end-of-a-swine-flu-era/2010/</loc>
		<lastmod>2010-02-23T19:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8598: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-settles-u-k-dispute/2010/</loc>
		<lastmod>2010-02-23T18:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8596: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-rise-on-consumer-data-auction/2010/</loc>
		<lastmod>2010-02-23T18:53:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8583: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/daily-dividend-report-abbott-increases-kellogg-stands-pat/2010/</loc>
		<lastmod>2010-02-23T18:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8595: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-bonuses-still-flow-on-street/2010/</loc>
		<lastmod>2010-02-23T18:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8587: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-mixed-on-downbeat-consumer-confidence/2010/</loc>
		<lastmod>2010-02-23T18:01:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8584: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-new-approach-to-assessing-mutual-funds/2010/</loc>
		<lastmod>2010-02-23T17:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8588: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/can-wal-mart-beat-the-tech-giants-no/2010/</loc>
		<lastmod>2010-02-23T17:37:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8571: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/in-vaccines-ma-may-be-the-only-way-to-compete/2010/</loc>
		<lastmod>2010-02-23T17:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8592: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/great-companies-waiting-for-you/2010/</loc>
		<lastmod>2010-02-23T17:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8580: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dividend-stocks-with-a-healthy-outlook/2010/</loc>
		<lastmod>2010-02-23T17:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8582: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-dips-on-consumer-confidence-drop/2010/</loc>
		<lastmod>2010-02-23T17:06:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8581: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-this-toyotas-smoking-gun/2010/</loc>
		<lastmod>2010-02-23T16:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8576: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/top-car-models-of-the-year/2010/</loc>
		<lastmod>2010-02-23T16:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8575: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/australian-company-plans-to-buy-ga-biotech-firm-fox-24-macon/2010/</loc>
		<lastmod>2010-02-23T15:54:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8574: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/australian-company-to-buy-ga-biotech-firm-41-nbc-macon/2010/</loc>
		<lastmod>2010-02-23T13:30:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8569: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dutch-find-no-link-between-infant-deaths-and-vaccine/2010/</loc>
		<lastmod>2010-02-23T13:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8561: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-first-diagnosis-by-dna/2010/</loc>
		<lastmod>2010-02-23T13:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8563: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drugmakers-form-asian-cancer-research-firm/2010/</loc>
		<lastmod>2010-02-23T12:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8558: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-stumble/2010/</loc>
		<lastmod>2010-02-23T11:57:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8562: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-genta-inc-issued-by-investorsoup-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-23T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8559: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/speedy-prototype-gene-decoders-sold/2010/</loc>
		<lastmod>2010-02-23T11:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8564: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-settles-tax-dispute-lifts-10-outlook/2010/</loc>
		<lastmod>2010-02-23T09:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8565: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lilly-merck-and-pfizer-join-forces-to-accelerate-research-and-improve-treatment-of-lung-and-gastric-cancers-in-asia/2010/</loc>
		<lastmod>2010-02-23T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8530: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-winning-streak-ends-djia-down-18-97/2010/</loc>
		<lastmod>2010-02-23T00:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8551: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/potential-avandia-lawsuits-threaten-glaxosmithclines-gsk-bottom-line/2010/</loc>
		<lastmod>2010-02-22T23:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8544: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-wrap-the-real-story-february-22/2010/</loc>
		<lastmod>2010-02-22T23:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8553: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/xenoport-4q-loss-narrows-more-than-expected-ap-via-yahoo-news/2010/</loc>
		<lastmod>2010-02-22T23:43:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8572: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/no-more-pandemic-hysterics/2010/</loc>
		<lastmod>2010-02-22T23:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8545: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/double-short-pfizer-and-merck/2010/</loc>
		<lastmod>2010-02-22T23:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8541: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/endo-smokin-after-surprising-earnings/2010/</loc>
		<lastmod>2010-02-22T22:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8542: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-panel-recommends-single-flu-vaccine/2010/</loc>
		<lastmod>2010-02-22T21:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8534: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-begins-court-fight-over-crestor-patent/2010/</loc>
		<lastmod>2010-02-22T21:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8509: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-end-volatile-session-lower/2010/</loc>
		<lastmod>2010-02-22T21:11:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8555: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/thermo-fisher-in-6-billion-bid-for-millipore-source-reuters-via-yahoo-news/2010/</loc>
		<lastmod>2010-02-22T20:30:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8538: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gilead-sciences-pipeline-could-choke/2010/</loc>
		<lastmod>2010-02-22T20:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8522: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/long-term-treasurys-under-pressure/2010/</loc>
		<lastmod>2010-02-22T20:10:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8539: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-huge-business-wrapped-up-in-tiny-packages/2010/</loc>
		<lastmod>2010-02-22T20:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8540: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/warning-avandia-could-cause-drool-among-trial-lawyers/2010/</loc>
		<lastmod>2010-02-22T19:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8560: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/daily-dividend-report-abt-k-jwn-ceg-joyg/2010/</loc>
		<lastmod>2010-02-22T19:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8529: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-great-weekend/2010/</loc>
		<lastmod>2010-02-22T18:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8554: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sebi-cracks-the-whip-on-price-rigging-business-standard-india/2010/</loc>
		<lastmod>2010-02-22T18:40:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8511: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/endo-pharma-gains-on-2010-outlook/2010/</loc>
		<lastmod>2010-02-22T18:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8528: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-boy-who-cried-housing-recovery/2010/</loc>
		<lastmod>2010-02-22T17:30:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8526: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-mixed-in-quiet-trading-2/2010/</loc>
		<lastmod>2010-02-22T17:26:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8527: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-mixed-in-quiet-trading-2/2010/</loc>
		<lastmod>2010-02-22T17:26:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8512: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/glaxo-off-2-as-senators-slam-avandia-another-vioxx/2010/</loc>
		<lastmod>2010-02-22T17:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8524: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/does-fda-need-more-power/2010/</loc>
		<lastmod>2010-02-22T16:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8520: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-business-summary-washington-post-3/2010/</loc>
		<lastmod>2010-02-22T16:03:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8518: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sebi-cracks-the-whip-on-price-rigging-central-chronicle/2010/</loc>
		<lastmod>2010-02-22T15:41:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8521: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-nvs-20/2010/</loc>
		<lastmod>2010-02-22T14:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8513: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/viiv-healthcare-presents-new-data-from-hivaids-portfolio-demonstrating-research-advances-and-commitment-to-patient-care-at-conference-on-retroviruses-and-opportunistic-infections/2010/</loc>
		<lastmod>2010-02-22T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8516: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/hearusa-to-present-at-the-roth-capital-partners-22nd-annual-oc-growth-stock-conference-marketwire/2010/</loc>
		<lastmod>2010-02-22T13:20:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8505: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-worlds-most-expensive-drugs/2010/</loc>
		<lastmod>2010-02-22T13:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8510: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/get-briefed-joseph-stiglitz/2010/</loc>
		<lastmod>2010-02-22T13:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8517: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/hearusa-to-present-at-the-roth-capital-partners-22nd-annual-oc-growth-stock-conference-marketwire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-22T13:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8506: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-hovers-near-80/2010/</loc>
		<lastmod>2010-02-22T12:44:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8500: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/downside-is-containable/2010/</loc>
		<lastmod>2010-02-22T12:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8514: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-molecular-insight-pharmaceuticals-inc-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-22T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8501: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-gene-factory-revs-up/2010/</loc>
		<lastmod>2010-02-22T11:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8502: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-gene-factory-revs-up/2010/</loc>
		<lastmod>2010-02-22T11:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8515: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-executives-talk-about-mergers-at-entrepreneur-conference-winston-salem-journal/2010/</loc>
		<lastmod>2010-02-22T11:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8498: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-early-gains-5/2010/</loc>
		<lastmod>2010-02-22T10:23:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8491: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-insiders-talk-mergers-at-nc-conference-nbc-17-raleigh/2010/</loc>
		<lastmod>2010-02-22T09:43:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8493: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-insiders-talk-mergers-at-nc-conference-mync-com/2010/</loc>
		<lastmod>2010-02-22T09:40:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8496: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/time-to-buy-a-slice-of-buffett/2010/</loc>
		<lastmod>2010-02-22T09:38:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8504: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-gets-fda-approval-for-menveo/2010/</loc>
		<lastmod>2010-02-22T09:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8492: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-wish-list-for-2010-and-beyond-the-edge/2010/</loc>
		<lastmod>2010-02-22T07:50:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8495: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/exclusive-genzyme-in-icahns-sights-thestreet-com/2010/</loc>
		<lastmod>2010-02-22T07:15:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8490: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-paradox-of-a-giving-government/2010/</loc>
		<lastmod>2010-02-22T07:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8494: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/organizers-hope-1300-will-attend-biotech-2010-the-news-observer/2010/</loc>
		<lastmod>2010-02-22T05:11:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8484: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/overnight-marketwatch-money-management/2010/</loc>
		<lastmod>2010-02-22T01:34:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8480: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/israel-stocks-teva-leads-israeli-stocks-higher-market-watch/2010/</loc>
		<lastmod>2010-02-21T16:45:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8478: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-streets-big-week-ahead/2010/</loc>
		<lastmod>2010-02-21T13:05:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8479: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/analysts-are-wrong-about-this-stock/2010/</loc>
		<lastmod>2010-02-21T10:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8467: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/seeking-stocks-with-the-smart-money-2/2010/</loc>
		<lastmod>2010-02-20T13:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8486: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/despite-rising-rates-stocks-march-higher/2010/</loc>
		<lastmod>2010-02-20T13:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8523: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/who-needs-health-care-reform/2010/</loc>
		<lastmod>2010-02-20T13:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8470: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-motley-fools-weekly-editors-picks-2/2010/</loc>
		<lastmod>2010-02-20T12:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8472: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/my-big-fat-dividends/2010/</loc>
		<lastmod>2010-02-20T12:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8468: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-follow-up-feb-19/2010/</loc>
		<lastmod>2010-02-20T01:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8469: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-follow-up-feb-19/2010/</loc>
		<lastmod>2010-02-20T01:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8462: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/robs-wrap-cogt-iyt-pfe/2010/</loc>
		<lastmod>2010-02-19T23:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8464: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/making-all-the-reit-moves-investors-business-daily-via-yahoo-news/2010/</loc>
		<lastmod>2010-02-19T23:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8456: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-edge-up-day-after-fed-move/2010/</loc>
		<lastmod>2010-02-19T23:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8438: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-post-4th-day-of-gains/2010/</loc>
		<lastmod>2010-02-19T23:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8432: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-turns-mixed/2010/</loc>
		<lastmod>2010-02-19T21:58:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8473: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fed-move-subdues-asian-stocks-nestl-stirs-europe/2010/</loc>
		<lastmod>2010-02-19T21:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8434: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-make-it-4-for-4/2010/</loc>
		<lastmod>2010-02-19T21:11:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8431: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-prices-gain-3-6-for-the-week/2010/</loc>
		<lastmod>2010-02-19T20:39:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8448: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/attention-deficit-drug-maker-shire-up-5-on-blow-out-q4-outlook-in-line/2010/</loc>
		<lastmod>2010-02-19T20:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8458: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/whos-right-on-gold-soros-or-central-bankers/2010/</loc>
		<lastmod>2010-02-19T20:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8460: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/retire-happy-even-without-a-401k/2010/</loc>
		<lastmod>2010-02-19T20:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8450: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/european-stocks-gain-for-fifth-day/2010/</loc>
		<lastmod>2010-02-19T20:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8441: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/two-big-pharma-stocks-to-short/2010/</loc>
		<lastmod>2010-02-19T19:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8442: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-sex-addiction-real/2010/</loc>
		<lastmod>2010-02-19T19:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8452: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/breathe-deep-it-might-not-be-that-bad/2010/</loc>
		<lastmod>2010-02-19T19:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8453: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/breathe-deep-it-might-not-be-that-bad/2010/</loc>
		<lastmod>2010-02-19T19:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8454: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-5-underdogs-are-no-dogs/2010/</loc>
		<lastmod>2010-02-19T18:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8447: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-labs-hikes-quarterly-dividend-by-10/2010/</loc>
		<lastmod>2010-02-19T18:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8437: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-announces-10-percent-increase-in-quarterly-dividend/2010/</loc>
		<lastmod>2010-02-19T18:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8444: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-flat-weighing-fed-rate-hike/2010/</loc>
		<lastmod>2010-02-19T18:02:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8455: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-is-googles-nightmare-scenario/2010/</loc>
		<lastmod>2010-02-19T17:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8435: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nestl-s-full-year-net-falls/2010/</loc>
		<lastmod>2010-02-19T17:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8445: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dont-discount-feds-rate-hike/2010/</loc>
		<lastmod>2010-02-19T17:17:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8446: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wal-mart-slips-on-u-s-dip/2010/</loc>
		<lastmod>2010-02-19T16:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8439: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/five-dumbest-things-on-wall-street-feb-19/2010/</loc>
		<lastmod>2010-02-19T15:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8425: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-poised-for-early-drop/2010/</loc>
		<lastmod>2010-02-19T12:27:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8428: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-dara-biosciences-inc-issued-by-stockpreacher-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-19T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8426: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/berkshires-big-day-24-billion-in-trading/2010/</loc>
		<lastmod>2010-02-19T08:53:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8433: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-nvs-19/2010/</loc>
		<lastmod>2010-02-19T08:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8424: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stalking-the-ten-bagger-brisbane-times/2010/</loc>
		<lastmod>2010-02-19T02:23:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8419: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stalking-the-ten-bagger-sydney-morning-herald/2010/</loc>
		<lastmod>2010-02-19T02:17:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8422: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/asthma-drugs-get-stiff-new-warnings/2010/</loc>
		<lastmod>2010-02-19T01:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8423: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/asthma-drugs-get-stiff-new-warnings-2/2010/</loc>
		<lastmod>2010-02-19T01:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8416: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-close-higher-before-fed-move/2010/</loc>
		<lastmod>2010-02-19T00:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8413: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-vale-money-flow-leaders-mrk-vale/2010/</loc>
		<lastmod>2010-02-18T23:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8411: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-pare-losses/2010/</loc>
		<lastmod>2010-02-18T22:57:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8389: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-firms-on-fed-action/2010/</loc>
		<lastmod>2010-02-18T22:35:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8410: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tougher-labels-for-asthma-drugs/2010/</loc>
		<lastmod>2010-02-18T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8400: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-discourages-use-of-some-asthma-drugs-after-years-of-review/2010/</loc>
		<lastmod>2010-02-18T21:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8388: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-rally-three-days-and-counting/2010/</loc>
		<lastmod>2010-02-18T21:31:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8396: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mercks-pipeline-carries-promise/2010/</loc>
		<lastmod>2010-02-18T21:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8382: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-climbs-above-79/2010/</loc>
		<lastmod>2010-02-18T20:58:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8399: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/go-for-the-pin-action/2010/</loc>
		<lastmod>2010-02-18T20:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8401: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/still-restless-for-an-approval/2010/</loc>
		<lastmod>2010-02-18T20:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8404: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-recap-retail-conundrum/2010/</loc>
		<lastmod>2010-02-18T20:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8391: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/xenoport-shareholders-run-their-restless-legs/2010/</loc>
		<lastmod>2010-02-18T19:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8405: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gilead-shareholders-are-whistling-a-happy-tune/2010/</loc>
		<lastmod>2010-02-18T19:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8418: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genesis-research-and-development-proposes-stock-purchase-plan-to-fund-ssrnai-subsidiary-genomeweb-news/2010/</loc>
		<lastmod>2010-02-18T19:00:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8393: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sirius-xm-above-1-again-now-what/2010/</loc>
		<lastmod>2010-02-18T17:45:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8395: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ronald-a-cass-does-india-want-drug-innovation-or-not/2010/</loc>
		<lastmod>2010-02-18T17:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8406: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/adverse-reaction-to-astrazenecas-rigel-deal-is-justified/2010/</loc>
		<lastmod>2010-02-18T17:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8392: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/your-best-shot-at-a-10-bagger/2010/</loc>
		<lastmod>2010-02-18T16:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8417: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-xenoport-crushed-depomed-battered-by-fda-news-market-watch/2010/</loc>
		<lastmod>2010-02-18T16:11:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8394: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/even-me-too-drugs-get-the-blues/2010/</loc>
		<lastmod>2010-02-18T15:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8379: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lower-start-seen-for-stocks/2010/</loc>
		<lastmod>2010-02-18T14:01:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8387: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-portfolios-of-the-week-5/2010/</loc>
		<lastmod>2010-02-18T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8380: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-value-investing-dead-2/2010/</loc>
		<lastmod>2010-02-18T11:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8372: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/edmund-optics-unique-stock-optics-catalog-published-for-access-online-or-offline-photonicsonline/2010/</loc>
		<lastmod>2010-02-18T06:19:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8373: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/osk-lifts-price-forecast-on-ccm-duopharma-business-times-malaysia/2010/</loc>
		<lastmod>2010-02-18T01:58:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8378: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-labs-deserves-more-respect/2010/</loc>
		<lastmod>2010-02-18T01:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8375: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/osk-lifts-price-forecast-on-ccm-duopharama-business-times-malaysia/2010/</loc>
		<lastmod>2010-02-18T01:34:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8371: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/despite-what-you-may-have-heard-statins-dont-cause-diabetes/2010/</loc>
		<lastmod>2010-02-18T00:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8367: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fomc-minutes-asset-sales-favored/2010/</loc>
		<lastmod>2010-02-17T22:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8351: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-slump-on-improved-housing-data/2010/</loc>
		<lastmod>2010-02-17T21:40:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8346: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-extend-gains/2010/</loc>
		<lastmod>2010-02-17T21:16:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8368: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/execute-well-or-youre-out/2010/</loc>
		<lastmod>2010-02-17T19:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8369: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/execute-well-or-youre-out-2/2010/</loc>
		<lastmod>2010-02-17T19:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8366: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-is-not-your-generic-cash-production/2010/</loc>
		<lastmod>2010-02-17T19:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8359: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-ordinary-investors-trounced-the-lost-decade/2010/</loc>
		<lastmod>2010-02-17T18:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8360: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-ordinary-investors-trounced-the-lost-decade/2010/</loc>
		<lastmod>2010-02-17T18:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8361: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genzyme-falls-on-weak-10-eps-view/2010/</loc>
		<lastmod>2010-02-17T18:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8362: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genzyme-falls-on-weak-10-eps-view-2/2010/</loc>
		<lastmod>2010-02-17T18:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8353: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/1-24-billion-deal-shares-fall-9-that-makes-sense/2010/</loc>
		<lastmod>2010-02-17T18:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8365: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/good-stocks-to-buy-now-4/2010/</loc>
		<lastmod>2010-02-17T18:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8356: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dont-regret-this/2010/</loc>
		<lastmod>2010-02-17T16:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8342: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/in-phase-iii-data-merck%e2%80%99s-gardasil%c2%ae-was-efficacious-against-anal-disease-caused-by-hpv-61116-and-18/2010/</loc>
		<lastmod>2010-02-17T15:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8374: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/hot-shots-feb-17-gilead-sciences-optionetics-com-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-17T15:00:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8341: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-recovers-losses/2010/</loc>
		<lastmod>2010-02-17T14:40:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8343: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/for-more-otc-buys-look-to-japan/2010/</loc>
		<lastmod>2010-02-17T13:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8339: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-discovery-laboratories-issued-by-stockpreacher-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-17T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8340: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-advances-on-optimism/2010/</loc>
		<lastmod>2010-02-17T11:45:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8338: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/world-stocks-rise-euro-keep-gains-after-rally/2010/</loc>
		<lastmod>2010-02-17T11:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8335: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/asian-european-shares-follow-dow-higher/2010/</loc>
		<lastmod>2010-02-17T11:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8337: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-extend-run/2010/</loc>
		<lastmod>2010-02-17T10:30:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8334: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tamiflu-contract-to-boost-ccmd-earnings-in-2010-malaysianews-net/2010/</loc>
		<lastmod>2010-02-17T07:33:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8329: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/osk-tamiflu-contract-to-boost-ccmd-earnings-in-2010-the-star/2010/</loc>
		<lastmod>2010-02-17T05:05:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8336: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-jump-on-commodity-rally/2010/</loc>
		<lastmod>2010-02-17T00:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8321: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/crude-gains-3-9-on-weaker-dollar/2010/</loc>
		<lastmod>2010-02-17T00:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8348: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-boston-scientific-corporation-johnson-johnson-medtronic-inc-abbott-laboratories-and-st-jude-medical-inc-3/2010/</loc>
		<lastmod>2010-02-17T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8270: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-surges-170-points/2010/</loc>
		<lastmod>2010-02-16T23:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8296: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/earnings-economic-optimism-boost-wall-street/2010/</loc>
		<lastmod>2010-02-16T23:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8281: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-closes-near-days-high/2010/</loc>
		<lastmod>2010-02-16T23:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8317: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/layoffs-continue-to-mount/2010/</loc>
		<lastmod>2010-02-16T23:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8314: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/starlims-announces-shareholder-approval-of-acquisition-by-abbott/2010/</loc>
		<lastmod>2010-02-16T23:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8352: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-posts-profit-trims-the-fat/2010/</loc>
		<lastmod>2010-02-16T22:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8287: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-end-choppy-day-higher/2010/</loc>
		<lastmod>2010-02-16T22:16:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8256: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-falls-as-sentiment-turns-bullish/2010/</loc>
		<lastmod>2010-02-16T21:47:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8274: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-in-triple-digit-rally/2010/</loc>
		<lastmod>2010-02-16T21:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8330: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/caleco-pharma-provides-corporate-update-ccnmatthews-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-16T21:16:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8331: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/caleco-pharma-provides-corporate-update-marketwire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-16T21:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8255: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-jumps-above-77/2010/</loc>
		<lastmod>2010-02-16T21:02:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8294: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/schering-buy-boosts-mercks-net/2010/</loc>
		<lastmod>2010-02-16T20:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8295: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sell-merck-against-the-grain/2010/</loc>
		<lastmod>2010-02-16T20:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8309: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dont-leave-these-big-bucks-on-the-table/2010/</loc>
		<lastmod>2010-02-16T20:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8303: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-earnings-boost-drug-makers-mrk-pfe-gsk-nvs-jnj/2010/</loc>
		<lastmod>2010-02-16T19:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8304: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-earnings-boost-drug-makers-mrk-pfe-gsk-nvs-jnj/2010/</loc>
		<lastmod>2010-02-16T19:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8354: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rigel-investors-balk-at-astrazeneca-deal/2010/</loc>
		<lastmod>2010-02-16T19:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8318: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-gets-a-pass-for-now/2010/</loc>
		<lastmod>2010-02-16T19:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8319: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-gets-a-pass-for-now/2010/</loc>
		<lastmod>2010-02-16T19:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8275: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-4-astra-pays-up-to-1-2-bln-for-rigel-arthritis-drug/2010/</loc>
		<lastmod>2010-02-16T18:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8292: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/for-blockbuster-cancer-drugs-approvals-are-the-easy-part/2010/</loc>
		<lastmod>2010-02-16T18:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8283: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/headline-stocks-some-u-s-stocks-on-the-move-on-feb-16/2010/</loc>
		<lastmod>2010-02-16T18:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8357: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tevas-ms-treatment-copaxone-chalks-up-25-sales-gain/2010/</loc>
		<lastmod>2010-02-16T17:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8355: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/expense-savings-and-cash-flow-will-drive-merck/2010/</loc>
		<lastmod>2010-02-16T17:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8290: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-europe-credit-crisis/2010/</loc>
		<lastmod>2010-02-16T17:46:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8328: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/imclone-scandal-a-timeline-thestreet-com/2010/</loc>
		<lastmod>2010-02-16T17:25:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8327: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-firm-launches-new-fuel-enzyme-afp-via-yahoo-news/2010/</loc>
		<lastmod>2010-02-16T17:19:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8268: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/earnings-krafts-light-sales-mercks-double-beat/2010/</loc>
		<lastmod>2010-02-16T17:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8272: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/street-gets-strong-start-to-short-week/2010/</loc>
		<lastmod>2010-02-16T16:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8277: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/imclone-founder-waksal-forming-new-biotech-venture/2010/</loc>
		<lastmod>2010-02-16T16:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8288: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-prescription-savings-programs-help-more-patients-in-2009/2010/</loc>
		<lastmod>2010-02-16T16:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8293: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-streets-buy-list/2010/</loc>
		<lastmod>2010-02-16T16:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8278: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-beats-sales-target-on-first-schering-plough-quarter/2010/</loc>
		<lastmod>2010-02-16T16:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8284: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-big-upgrade-for-vical/2010/</loc>
		<lastmod>2010-02-16T15:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8258: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-profit-meets-views-sees-deal-savings-ahead/2010/</loc>
		<lastmod>2010-02-16T15:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8279: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-stocks-could-save-your-portfolio/2010/</loc>
		<lastmod>2010-02-16T15:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8264: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-three-pronged-strategy-price-quality-cash-management/2010/</loc>
		<lastmod>2010-02-16T15:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8260: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rocket-stocks-for-the-week-6/2010/</loc>
		<lastmod>2010-02-16T15:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8326: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/imclone-founder-waksal-forming-new-biotech-venture-thestreet-com/2010/</loc>
		<lastmod>2010-02-16T14:55:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8266: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-and-centocor-ortho-biotech-products-finalize-esa-risk-evaluation-and-mitigation-strategy-rems-with-fda-pr-newswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-16T14:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8261: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-to-trim-staff-as-profit-meets-views/2010/</loc>
		<lastmod>2010-02-16T14:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8289: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-best-undercover-dividends-3/2010/</loc>
		<lastmod>2010-02-16T14:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8262: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-co-profit-jumps/2010/</loc>
		<lastmod>2010-02-16T14:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8263: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-announces-fourth-quarter-and-full-year-2009-financial-results/2010/</loc>
		<lastmod>2010-02-16T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8267: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bionime-corporation-and-ypsomed-ag-announce-new-us-retail-initiative-business-wire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-16T13:51:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8265: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drug-induced-speculation-in-india/2010/</loc>
		<lastmod>2010-02-16T13:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8347: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/five-etfs-to-watch-this-week/2010/</loc>
		<lastmod>2010-02-16T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8251: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rigel-may-get-1-245b-in-drug-license-pact/2010/</loc>
		<lastmod>2010-02-16T11:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8257: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/quintiles%e2%80%99-new-era-%e2%80%93-%e2%80%98having-skin-in-the-game%e2%80%99-for-drug-development-local-tech-wire/2010/</loc>
		<lastmod>2010-02-16T10:48:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8250: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-rise/2010/</loc>
		<lastmod>2010-02-16T10:13:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8252: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-rigel-sign-arthritis-license-deal/2010/</loc>
		<lastmod>2010-02-16T09:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8276: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-completes-acquisition-of-solvay-pharmaceuticals/2010/</loc>
		<lastmod>2010-02-16T08:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8248: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vwr-international-bvba-held-third-annual-european-sales-conference-business-wire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-16T08:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8253: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/europeans-spend-billions-on-fake-medicines-survey/2010/</loc>
		<lastmod>2010-02-16T02:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8247: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/roadshow-planned-for-nusajaya-biotech-park-malaysianews-net/2010/</loc>
		<lastmod>2010-02-16T01:32:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8245: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-appoints-bridgette-p-heller-as-executive-vice-president-and-president-consumer-health-care/2010/</loc>
		<lastmod>2010-02-15T23:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8246: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/disgraced-cyclist-turned-hip-pitchman-floyd-landis-lands-in-trouble-again/2010/</loc>
		<lastmod>2010-02-15T23:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8285: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/teva-and-novartis-reach-settlement-on-famvir-suit/2010/</loc>
		<lastmod>2010-02-15T21:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8229: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/european-shares-rise-ahead-of-finance-meeting/2010/</loc>
		<lastmod>2010-02-15T20:54:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8237: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-streets-toy-story/2010/</loc>
		<lastmod>2010-02-15T16:54:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8235: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/israel-stocks-israel-stocks-up-5th-day-teva-report-awaited-market-watch/2010/</loc>
		<lastmod>2010-02-15T14:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8233: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-up-on-lingering-debt-concerns/2010/</loc>
		<lastmod>2010-02-15T13:38:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8234: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-up-on-lingering-debt-concerns/2010/</loc>
		<lastmod>2010-02-15T13:38:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8228: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/carl-icahns-top-activist-plays-guru-focus/2010/</loc>
		<lastmod>2010-02-14T23:12:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8239: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/housing-and-inflation-economic-first-look/2010/</loc>
		<lastmod>2010-02-14T21:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8240: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/housing-and-inflation-economic-first-look/2010/</loc>
		<lastmod>2010-02-14T21:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8254: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/danones-water-business-could-quench-kirins-thirst/2010/</loc>
		<lastmod>2010-02-14T20:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8226: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-down-but-not-out/2010/</loc>
		<lastmod>2010-02-14T15:30:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8224: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/4m-boost-for-pig-cell-treatment-the-new-zealand-herald/2010/</loc>
		<lastmod>2010-02-14T15:13:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8225: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/don-dions-weekly-etf-blog-wrap-thestreet-com-2/2010/</loc>
		<lastmod>2010-02-14T14:16:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8222: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/follow-up-2/2010/</loc>
		<lastmod>2010-02-13T12:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8223: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/you-dont-really-care-about-investing-but-thats-cool/2010/</loc>
		<lastmod>2010-02-13T10:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8219: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/can-decode-a-biotech-star-gone-bust-come-back-newsweek-2/2010/</loc>
		<lastmod>2010-02-13T03:09:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8221: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/on-tap-next-week-more-dow-component-earnings-price-data/2010/</loc>
		<lastmod>2010-02-13T00:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8243: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-boston-scientific-corporation-johnson-johnson-medtronic-inc-abbott-laboratories-and-st-jude-medical-inc-2/2010/</loc>
		<lastmod>2010-02-13T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8213: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/europe-remains-a-concern-in-coming-week/2010/</loc>
		<lastmod>2010-02-12T23:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8214: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-close-mixed-in-light-trading/2010/</loc>
		<lastmod>2010-02-12T23:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8220: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/top-drug-lobbyist-resigns-clouds-us-health-reform/2010/</loc>
		<lastmod>2010-02-12T23:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8216: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/can-decode-a-biotech-star-gone-bust-come-back-newsweek/2010/</loc>
		<lastmod>2010-02-12T23:04:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8215: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/buffetts-berkshire-joins-the-sp-500/2010/</loc>
		<lastmod>2010-02-12T22:45:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8209: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/learning-from-the-best/2010/</loc>
		<lastmod>2010-02-12T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8187: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-slides-on-china-worries/2010/</loc>
		<lastmod>2010-02-12T20:48:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8181: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-slides-on-global-recovery-doubts/2010/</loc>
		<lastmod>2010-02-12T20:35:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8211: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/must-read-mutual-fund-news/2010/</loc>
		<lastmod>2010-02-12T19:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8205: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mrk-preview-sizable-cash-flow-from-schering-plough-merger/2010/</loc>
		<lastmod>2010-02-12T19:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8210: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dont-ignore-this-potential-blockbuster/2010/</loc>
		<lastmod>2010-02-12T19:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8238: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/indian-ceo-u-s-would-grant-a-patent-to-a-piece-of-toilet-paper/2010/</loc>
		<lastmod>2010-02-12T19:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8249: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/beware-the-return-of-the-buyback/2010/</loc>
		<lastmod>2010-02-12T18:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8212: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/too-bad-its-not-in-the-restructuring-business/2010/</loc>
		<lastmod>2010-02-12T18:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8202: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-boosted-by-retail-sales/2010/</loc>
		<lastmod>2010-02-12T18:24:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8203: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-boosted-by-retail-sales-2/2010/</loc>
		<lastmod>2010-02-12T18:24:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8206: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-value-investing-legends-are-buying/2010/</loc>
		<lastmod>2010-02-12T17:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8198: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/whats-wrong-with-this-picture-kodak-tops-sp/2010/</loc>
		<lastmod>2010-02-12T17:43:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8201: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tomorrows-monster-stock-4/2010/</loc>
		<lastmod>2010-02-12T17:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8200: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-jump-on-global-recovery-fears/2010/</loc>
		<lastmod>2010-02-12T17:24:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8189: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dream-stocks-for-biotech-investors-the-motley-fool-3/2010/</loc>
		<lastmod>2010-02-12T17:17:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8190: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dream-stocks-for-biotech-investors-the-motley-fool-3/2010/</loc>
		<lastmod>2010-02-12T17:17:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8197: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/india-sets-high-bar-for-patent-protection-but-is-it-too-high/2010/</loc>
		<lastmod>2010-02-12T16:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8204: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eu-mergers-and-takeovers-feb-12/2010/</loc>
		<lastmod>2010-02-12T16:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8193: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-dividend-investing-dead/2010/</loc>
		<lastmod>2010-02-12T16:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8194: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dream-stocks-for-biotech-investors-2/2010/</loc>
		<lastmod>2010-02-12T16:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8188: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-we-love/2010/</loc>
		<lastmod>2010-02-12T15:28:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8199: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-nexmed/2010/</loc>
		<lastmod>2010-02-12T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8179: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-drop-at-open-2/2010/</loc>
		<lastmod>2010-02-12T11:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8182: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nows-the-time-to-double-down-on-dividends-3/2010/</loc>
		<lastmod>2010-02-12T11:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8172: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/own-the-world-with-oakmark-and-harbor/2010/</loc>
		<lastmod>2010-02-11T23:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8186: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-abt-12/2010/</loc>
		<lastmod>2010-02-11T22:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8174: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-receives-u-s-fda-approval-for-heat-stable-norvirr-ritonavir-tablets/2010/</loc>
		<lastmod>2010-02-11T22:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8183: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jump-into-the-big-pharma-pullback/2010/</loc>
		<lastmod>2010-02-11T21:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8141: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-gains-100-points-as-greek-debt-fears-ebb/2010/</loc>
		<lastmod>2010-02-11T21:19:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8173: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drug-makers-decry-indian-system/2010/</loc>
		<lastmod>2010-02-11T21:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8164: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-buy-of-solvay-drug-unit-wins-eu-approval/2010/</loc>
		<lastmod>2010-02-11T20:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8132: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-climbs-above-75/2010/</loc>
		<lastmod>2010-02-11T20:28:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8167: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/earnings-preview-merck-to-report-4th-qtr-results-san-francisco-chronicle/2010/</loc>
		<lastmod>2010-02-11T19:45:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8159: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/getting-better-beats-from-weakened-hearts/2010/</loc>
		<lastmod>2010-02-11T19:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8160: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/getting-better-beats-from-weakened-hearts/2010/</loc>
		<lastmod>2010-02-11T19:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8162: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mwg-biotech-to-divest-microarray-laboratory-automation-product-units-genomeweb-news/2010/</loc>
		<lastmod>2010-02-11T19:05:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8163: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/earnings-preview-merck-to-report-4th-qtr-results-ap-via-yahoo-news/2010/</loc>
		<lastmod>2010-02-11T19:00:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8161: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-after-auction-3/2010/</loc>
		<lastmod>2010-02-11T18:35:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8151: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/buffetts-baby-berkshires-buy-or-bust/2010/</loc>
		<lastmod>2010-02-11T17:54:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8152: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/buffetts-baby-berkshires-buy-or-bust-2/2010/</loc>
		<lastmod>2010-02-11T17:54:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8154: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/breaking-news-caleco-pharma-corp-february-11-2010-malaysianews-net/2010/</loc>
		<lastmod>2010-02-11T17:20:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8153: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/markets-sink-as-upbeat-jobless-number-flops/2010/</loc>
		<lastmod>2010-02-11T17:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8150: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-wonder-drug-with-not-so-wonderful-side-effects/2010/</loc>
		<lastmod>2010-02-11T16:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8155: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/roundtable-will-free-etfs-change-your-life/2010/</loc>
		<lastmod>2010-02-11T16:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8144: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-turnaround-year%c2%a0but-not-in-a-good-way/2010/</loc>
		<lastmod>2010-02-11T16:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8145: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-closes-yet-another-chapter-in-the-vioxx-nightmare/2010/</loc>
		<lastmod>2010-02-11T16:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8156: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/blockbuster-in-hand-its-time-to-show-a-profit/2010/</loc>
		<lastmod>2010-02-11T15:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8143: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-in-retreat-alexza-rebounds-market-watch/2010/</loc>
		<lastmod>2010-02-11T15:56:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8148: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/simple-health-care-fix-fizzles-out/2010/</loc>
		<lastmod>2010-02-11T15:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8139: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ahead-of-the-bell-caleco-pharma-corp-february-11-2010-malaysianews-net/2010/</loc>
		<lastmod>2010-02-11T15:04:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8140: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ahead-of-the-bell-caleco-pharma-corp-february-11-2010-malaysianews-net/2010/</loc>
		<lastmod>2010-02-11T14:57:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8135: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-down-as-eu-meets/2010/</loc>
		<lastmod>2010-02-11T12:45:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8130: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-poised-for-higher-open/2010/</loc>
		<lastmod>2010-02-11T12:26:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8134: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-international-stem-cell-corp-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-11T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8128: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/low-oil-prices-a-tool-to-control-iran/2010/</loc>
		<lastmod>2010-02-11T09:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8149: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-market-uncertainty/2010/</loc>
		<lastmod>2010-02-11T02:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8142: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/boston-scientific-falls-on-weak-10-view-plans-10-layoffs/2010/</loc>
		<lastmod>2010-02-11T01:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8129: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-isis-says-mipomersen-trial-positive-but-investors-disagree-north-county-times/2010/</loc>
		<lastmod>2010-02-11T01:01:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8136: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-agrees-to-drug-safety-changes/2010/</loc>
		<lastmod>2010-02-11T00:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8133: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-becton-dickinson-and-company-baxter-international-inc-johnson-johnson-abbott-laboratories-and-nissan-motor-co/2010/</loc>
		<lastmod>2010-02-11T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8120: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/10-02-2010-press-release-agennix-ag-announces-u-s-class-action-lawsuit-against-predecessor-gpc-biotech-ag-fully-4investors/2010/</loc>
		<lastmod>2010-02-10T09:40:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8121: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-agreements-should-be-public/2010/</loc>
		<lastmod>2010-02-09T23:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8111: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-much-should-cancer-drugs-cost/2010/</loc>
		<lastmod>2010-02-09T23:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8127: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/blue-chips-to-buy-for-the-long-run/2010/</loc>
		<lastmod>2010-02-09T23:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8122: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/caterpillar-tops-the-dow/2010/</loc>
		<lastmod>2010-02-09T22:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8074: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rises-3-on-weaker-dollar/2010/</loc>
		<lastmod>2010-02-09T20:25:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8106: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-goes-to-the-well-one-last-time/2010/</loc>
		<lastmod>2010-02-09T19:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8098: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/some-gray-amid-the-black-and-white-thinking/2010/</loc>
		<lastmod>2010-02-09T19:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8078: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-rally-on-greek-bailout-hopes/2010/</loc>
		<lastmod>2010-02-09T19:08:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8118: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-stock-has-tremendous-upside-the-motley-fool-5/2010/</loc>
		<lastmod>2010-02-09T18:46:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8102: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-bipartisan-health-care-reform-means-for-investors/2010/</loc>
		<lastmod>2010-02-09T18:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8104: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-stock-has-tremendous-upside-2/2010/</loc>
		<lastmod>2010-02-09T17:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8099: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tysabri-boosts-biogen-earnings/2010/</loc>
		<lastmod>2010-02-09T17:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8097: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-burger-and-beverage-recession/2010/</loc>
		<lastmod>2010-02-09T17:37:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8080: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-stocks-chinas-been-buying-and-why/2010/</loc>
		<lastmod>2010-02-09T17:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8119: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-postpones-panel-meeting-to-review-cell-therapeutics-drug-seattle-times/2010/</loc>
		<lastmod>2010-02-09T17:34:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8105: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/make-thousands-from-millions/2010/</loc>
		<lastmod>2010-02-09T17:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8089: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-down-ahead-of-3-year-sale/2010/</loc>
		<lastmod>2010-02-09T17:23:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8100: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dont-invest-another-penny-2/2010/</loc>
		<lastmod>2010-02-09T16:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8081: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/caterpillar-analysts-upgrades-downgrades/2010/</loc>
		<lastmod>2010-02-09T16:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8083: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-merck-lowes-memc-electronic-materials-lennar-and-kinross-gold-released-by-seven-summits-research/2010/</loc>
		<lastmod>2010-02-09T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8088: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-slippery-slope/2010/</loc>
		<lastmod>2010-02-09T16:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8108: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bone-up-on-this-potential-blockbuster/2010/</loc>
		<lastmod>2010-02-09T16:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8084: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cholesterol-drug-approved-for-people-without-high-cholesterol/2010/</loc>
		<lastmod>2010-02-09T16:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8085: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cholesterol-drug-approved-for-people-without-high-cholesterol/2010/</loc>
		<lastmod>2010-02-09T16:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8117: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-cell-therapeutics-astrazeneca-lead-drug-stocks-market-watch/2010/</loc>
		<lastmod>2010-02-09T15:40:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8079: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-down-versus-euro/2010/</loc>
		<lastmod>2010-02-09T15:33:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8076: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-move-may-bolster-crestor/2010/</loc>
		<lastmod>2010-02-09T15:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8086: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-best-undercover-dividends-2/2010/</loc>
		<lastmod>2010-02-09T14:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8087: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-best-undercover-dividends-2/2010/</loc>
		<lastmod>2010-02-09T14:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8095: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-nvs-18/2010/</loc>
		<lastmod>2010-02-09T14:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8090: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dont-let-your-investments-blindside-you/2010/</loc>
		<lastmod>2010-02-09T14:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8077: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/great-off-the-radar-stocks/2010/</loc>
		<lastmod>2010-02-09T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8069: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-rebound-in-the-works/2010/</loc>
		<lastmod>2010-02-09T11:57:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8071: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-says-fda-approves-crestor-indication/2010/</loc>
		<lastmod>2010-02-09T09:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8072: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-azn-14/2010/</loc>
		<lastmod>2010-02-09T08:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8075: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-licenses-hepatitis-c-drug/2010/</loc>
		<lastmod>2010-02-09T08:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8068: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-fda-approves-new-indication-for-crestorr-rosuvastatin-calcium/2010/</loc>
		<lastmod>2010-02-09T02:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8058: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-win-for-crestor-astrazeneca/2010/</loc>
		<lastmod>2010-02-09T00:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8050: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mcginn-likes-ford-citi-merck-pfizer/2010/</loc>
		<lastmod>2010-02-08T22:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8059: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-etfs-immune-to-broad-selling-investors-business-daily-via-yahoo-news/2010/</loc>
		<lastmod>2010-02-08T22:34:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8067: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/kenya-researchers-map-areas-suitable-for-green-energy-crops-allafrica-com/2010/</loc>
		<lastmod>2010-02-08T22:06:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8036: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/debt-fears-drag-dow-below-10000/2010/</loc>
		<lastmod>2010-02-08T21:09:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8060: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cell-therapeutics-stock-plunges-on-negative-fda-review-of-cancer-drug-seattle-times/2010/</loc>
		<lastmod>2010-02-08T20:26:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8064: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/alkermes-retains-neutral-rec-zacks-com-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-08T20:07:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8052: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drugstore-strength-could-mean-upside-for-consumer-etf/2010/</loc>
		<lastmod>2010-02-08T20:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8029: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cic-offers-a-glimpse-of-holdings/2010/</loc>
		<lastmod>2010-02-08T19:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8125: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eu-expected-to-clear-abbott-solvay-deal-sources/2010/</loc>
		<lastmod>2010-02-08T18:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8040: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-pushes-discount-cards-in-emerging-markets/2010/</loc>
		<lastmod>2010-02-08T18:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8041: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gsk-rare-diseases-now-big-business/2010/</loc>
		<lastmod>2010-02-08T17:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8048: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-slips-against-the-euro/2010/</loc>
		<lastmod>2010-02-08T17:51:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8049: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-slips-against-the-euro-2/2010/</loc>
		<lastmod>2010-02-08T17:51:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8065: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cell-therapeutics-plunges-on-negative-fda-review-ap-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-08T17:42:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8043: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/after-the-gold-rush/2010/</loc>
		<lastmod>2010-02-08T16:53:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8045: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-government-induced-drought/2010/</loc>
		<lastmod>2010-02-08T16:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8039: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-abt-11/2010/</loc>
		<lastmod>2010-02-08T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8035: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-submits-new-automated-ovarian-cancer-test-for-u-s-approval/2010/</loc>
		<lastmod>2010-02-08T16:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8062: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/roth-capital-partners-to-hold-22nd-annual-oc-growth-stock-conference-march-15-17-2010-business-wire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-08T16:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8038: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-ahead-of-auctions-2/2010/</loc>
		<lastmod>2010-02-08T16:18:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8063: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-turn-higher-cell-therapeutics-tumbles-market-watch/2010/</loc>
		<lastmod>2010-02-08T16:15:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8053: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/youll-become-a-millionaire-heres-when/2010/</loc>
		<lastmod>2010-02-08T16:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8054: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/youll-become-a-millionaire-heres-when/2010/</loc>
		<lastmod>2010-02-08T16:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8057: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fitz-bits-watch-59-in-pepsi/2010/</loc>
		<lastmod>2010-02-08T15:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8037: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/good-news-about-the-worst-year/2010/</loc>
		<lastmod>2010-02-08T14:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8033: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-and-keas-partner-to-help-consumers-take-a-more-active-role-in-their-health-and-wellness/2010/</loc>
		<lastmod>2010-02-08T14:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8034: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-and-keas-partner-to-help-consumers-take-a-more-active-role-in-their-health-and-wellness/2010/</loc>
		<lastmod>2010-02-08T14:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8066: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/experienced-global-biotech-executive-joins-bioasis-as-executive-vice-president-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-08T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8061: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/edmund-optics%c2%ae-unique-stock-optics-catalog-published-for-access-online-or-offline-thomasnet/2010/</loc>
		<lastmod>2010-02-08T13:47:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8032: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rebounds-on-weaker-dollar/2010/</loc>
		<lastmod>2010-02-08T13:34:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8028: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-early-pullback/2010/</loc>
		<lastmod>2010-02-08T13:04:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8055: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-stocks-from-bottom-to-top/2010/</loc>
		<lastmod>2010-02-08T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8022: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novavax-rovi-end-flu-vaccine-development-plan-malaysianews-net/2010/</loc>
		<lastmod>2010-02-08T08:58:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8025: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novavax-rovi-end-flu-vaccine-development-plan-fox-news/2010/</loc>
		<lastmod>2010-02-08T08:19:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8023: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2010-02-08-0404-diary-taiwan-initial-public-offerings-feb-8-interactive-investor/2010/</loc>
		<lastmod>2010-02-08T04:26:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8024: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-markets-short-term-gain-long-term-pain-guru-focus/2010/</loc>
		<lastmod>2010-02-07T23:27:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8042: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sanofi-to-decide-on-merck-venture/2010/</loc>
		<lastmod>2010-02-07T21:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8026: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/israel-stocks-israel-stocks-off-potash-corp-lifts-icl-stake-market-watch/2010/</loc>
		<lastmod>2010-02-07T18:55:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8027: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-weeks-barrons-roundup-thestreet-com-2/2010/</loc>
		<lastmod>2010-02-07T14:40:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8020: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/markets-shaky-after-the-slump/2010/</loc>
		<lastmod>2010-02-07T12:44:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8021: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/3-great-american-stocks/2010/</loc>
		<lastmod>2010-02-06T20:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8014: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-wrap-the-real-story-february-5/2010/</loc>
		<lastmod>2010-02-05T23:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7999: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ge-shares-continue-losing-streak/2010/</loc>
		<lastmod>2010-02-05T23:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8015: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/swine-flu-still-out-there-officials-caution/2010/</loc>
		<lastmod>2010-02-05T21:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7994: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/do-disease-awareness-campaigns-really-work/2010/</loc>
		<lastmod>2010-02-05T21:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7979: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-claw-out-a-gain-after-late-rally/2010/</loc>
		<lastmod>2010-02-05T21:21:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8007: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/city-welcomes-rare-catch-in-competitive-biotech-field-las-vegas-business-press-2/2010/</loc>
		<lastmod>2010-02-05T20:29:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7995: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-profit-principle/2010/</loc>
		<lastmod>2010-02-05T20:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7996: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-decision-due-on-wider-use-for-crestor/2010/</loc>
		<lastmod>2010-02-05T19:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8010: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/financial-times-ft-com-financial-times-2/2010/</loc>
		<lastmod>2010-02-05T19:30:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7991: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-gain-on-global-economic-jitters/2010/</loc>
		<lastmod>2010-02-05T18:10:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7980: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-falls-toward-70-after-jobs-report/2010/</loc>
		<lastmod>2010-02-05T17:45:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7986: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-panic-returns-sort-of/2010/</loc>
		<lastmod>2010-02-05T17:30:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7982: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-strengthens-after-jobs-report/2010/</loc>
		<lastmod>2010-02-05T16:28:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8009: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-tale-of-two-biotechs-genomeweb-news/2010/</loc>
		<lastmod>2010-02-05T16:05:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8005: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-fall-alkermes-rallies-on-upgrade-market-watch/2010/</loc>
		<lastmod>2010-02-05T16:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7988: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-pharmas-patent-cliff-is-good-news-for-pharmacies/2010/</loc>
		<lastmod>2010-02-05T15:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7983: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-will-you-regret-not-buying-in-20-years/2010/</loc>
		<lastmod>2010-02-05T15:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7973: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-headed-for-a-weak-rally/2010/</loc>
		<lastmod>2010-02-05T14:03:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7975: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/international-markets-in-big-selloff/2010/</loc>
		<lastmod>2010-02-05T12:40:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8004: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-soligenix-thestreet-com/2010/</loc>
		<lastmod>2010-02-05T12:00:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7984: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-stocks-the-top-six-picks/2010/</loc>
		<lastmod>2010-02-05T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7981: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/time-to-sue-toyota/2010/</loc>
		<lastmod>2010-02-05T01:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7976: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-time-warner-inc-aol-time-warner-cable-news-corporation-and-pfizer-inc/2010/</loc>
		<lastmod>2010-02-05T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8012: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/alkermes-reports-3q-loss-smaller-than-expected-ap-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-04T23:21:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7968: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/qiagen-unit-and-pfizer-enter-into-an-agreement-to-develop-a-companion-diagnostic-for-brain-tumor-patients/2010/</loc>
		<lastmod>2010-02-04T23:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7939: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/debt-fears-rattle-market/2010/</loc>
		<lastmod>2010-02-04T22:59:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7963: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/two-pharmas/2010/</loc>
		<lastmod>2010-02-04T22:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7970: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/compelling-companies-with-competitive-advantages/2010/</loc>
		<lastmod>2010-02-04T21:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7992: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/surfing-the-wave-of-the-future-personalized-medicine/2010/</loc>
		<lastmod>2010-02-04T21:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8011: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/edmund-optics-unique-stock-optics-catalog-published-for-access-online-or-offline-print-and-electronic-dbusinessnews-com/2010/</loc>
		<lastmod>2010-02-04T20:24:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7938: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-sliding-closer-to-10000/2010/</loc>
		<lastmod>2010-02-04T20:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7961: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/commodity-prices-slip-on-recovery-doubts/2010/</loc>
		<lastmod>2010-02-04T18:30:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7960: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-jump-on-global-stock-selloff/2010/</loc>
		<lastmod>2010-02-04T18:29:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7952: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/brother-can-you-spare-a-dividend/2010/</loc>
		<lastmod>2010-02-04T17:51:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7948: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cuts-are-coming-for-glaxo-rd/2010/</loc>
		<lastmod>2010-02-04T17:51:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7941: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wheres-the-sunshine-for-unemployables/2010/</loc>
		<lastmod>2010-02-04T17:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7942: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/glaxo-ceo-u-s-health-care-reform-unlikely-in-2010/2010/</loc>
		<lastmod>2010-02-04T17:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7944: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-adults-forgo-routine-immunization-report/2010/</loc>
		<lastmod>2010-02-04T17:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8008: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-fall-allergan-zigzags-market-watch/2010/</loc>
		<lastmod>2010-02-04T16:45:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7943: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/visa-analysts-upgrades-downgrades/2010/</loc>
		<lastmod>2010-02-04T16:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7947: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-gains-on-global-jitters/2010/</loc>
		<lastmod>2010-02-04T16:27:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7945: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/three-safe-stocks-with-good-yield/2010/</loc>
		<lastmod>2010-02-04T15:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7940: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-slip-on-job-worries/2010/</loc>
		<lastmod>2010-02-04T14:54:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7934: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-drop-at-open/2010/</loc>
		<lastmod>2010-02-04T12:40:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7926: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/in-depth-10-questions-about-high-cholesterol/2010/</loc>
		<lastmod>2010-02-04T03:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7936: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ten-questions-about-high-cholesterol/2010/</loc>
		<lastmod>2010-02-04T03:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7927: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/auxiliums-new-hand-drug-jives-with-investors/2010/</loc>
		<lastmod>2010-02-04T00:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7920: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-stumble-tech-shines/2010/</loc>
		<lastmod>2010-02-04T00:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7922: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/auxilium-gets-the-go-ahead-on-new-drug/2010/</loc>
		<lastmod>2010-02-03T23:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7915: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-drags-down-pharma/2010/</loc>
		<lastmod>2010-02-03T23:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7880: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-down-on-recovery-doubts/2010/</loc>
		<lastmod>2010-02-03T23:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7869: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-chills-dow-after-strong-two-days/2010/</loc>
		<lastmod>2010-02-03T23:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7919: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-stocks-retreat-after-two-day-advance/2010/</loc>
		<lastmod>2010-02-03T23:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7929: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/roches-superior-prospects/2010/</loc>
		<lastmod>2010-02-03T21:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7868: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-falls-on-surprise-supply-build/2010/</loc>
		<lastmod>2010-02-03T21:00:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7885: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-slips-on-renewed-regulation-concerns/2010/</loc>
		<lastmod>2010-02-03T20:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7884: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-struggle-after-rally-2/2010/</loc>
		<lastmod>2010-02-03T20:06:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7964: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/street-slips-on-jobs-earnings/2010/</loc>
		<lastmod>2010-02-03T19:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7906: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-slide-as-refunding-announced/2010/</loc>
		<lastmod>2010-02-03T19:03:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7886: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-stocks-wall-st-falls-after-pfizer-transport-earnings/2010/</loc>
		<lastmod>2010-02-03T18:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7894: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/you-should-buy-stocks-just-like-this-one-2/2010/</loc>
		<lastmod>2010-02-03T18:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7874: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pace-of-private-sector-job-losses-slows/2010/</loc>
		<lastmod>2010-02-03T17:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7931: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-hedge-pays-off/2010/</loc>
		<lastmod>2010-02-03T17:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7932: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-hedge-pays-off/2010/</loc>
		<lastmod>2010-02-03T17:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7876: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wrapup-2-pace-of-us-private-sector-job-losses-slows/2010/</loc>
		<lastmod>2010-02-03T17:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7878: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-stocks-decline-pfizer-among-disappointments/2010/</loc>
		<lastmod>2010-02-03T17:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7904: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-firms-on-stronger-u-s-economic-data/2010/</loc>
		<lastmod>2010-02-03T17:32:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7905: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-firms-on-stronger-u-s-economic-data-2/2010/</loc>
		<lastmod>2010-02-03T17:32:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7881: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-decline-despite-decent-data-2/2010/</loc>
		<lastmod>2010-02-03T17:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7888: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-off-2-as-2010-targets-miss-posts-revised-2012-targets/2010/</loc>
		<lastmod>2010-02-03T17:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7958: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-stocks-snapshot-wall-st-open-weighed-down-by-earnings/2010/</loc>
		<lastmod>2010-02-03T16:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7889: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-problem-with-dow-etfs/2010/</loc>
		<lastmod>2010-02-03T16:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7892: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-chemical-analysts-upgrades-downgrades/2010/</loc>
		<lastmod>2010-02-03T16:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7861: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-pfizer-profit-misses-2010-outlook-below-street/2010/</loc>
		<lastmod>2010-02-03T15:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7950: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-story-stocks-pfe/2010/</loc>
		<lastmod>2010-02-03T15:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8006: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-breakout-tradingmarkets-com-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-03T15:29:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7860: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-2010-forecast-below-estimates/2010/</loc>
		<lastmod>2010-02-03T15:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7871: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/adp-report-wednesdays-headlines/2010/</loc>
		<lastmod>2010-02-03T15:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7890: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ftse-up-for-fourth-day-miners-banks-gain/2010/</loc>
		<lastmod>2010-02-03T14:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7891: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-answer-youve-been-waiting-for/2010/</loc>
		<lastmod>2010-02-03T14:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7872: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-net-doubles-on-08-charges/2010/</loc>
		<lastmod>2010-02-03T14:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7863: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-profit-more-than-doubles/2010/</loc>
		<lastmod>2010-02-03T14:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7073: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-futures-flat-ahead-of-jobs-services-data/2010/</loc>
		<lastmod>2010-02-03T14:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7923: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-reports-fourth-quarter-and-full-year-2009-results-provides-2010-financial-guidance-and-2012-financial-targets/2010/</loc>
		<lastmod>2010-02-03T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7924: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/atlantis%e2%84%a2-patient-specific-abutment-now-available-for-nobelactive%e2%84%a2-implants/2010/</loc>
		<lastmod>2010-02-03T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7856: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-lackluster-open/2010/</loc>
		<lastmod>2010-02-03T13:39:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7873: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-stocks-we-cant-live-without/2010/</loc>
		<lastmod>2010-02-03T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7866: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/miner-bank-gains-see-ftse-ahead-for-fourth-day/2010/</loc>
		<lastmod>2010-02-03T11:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7853: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/life-sciences-tops-new-england-stock-performance-mass-high-tech-the-journal-of-new-england-technology/2010/</loc>
		<lastmod>2010-02-03T05:06:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7858: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mad-money-lightning-round-stick-with-merck/2010/</loc>
		<lastmod>2010-02-03T02:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7928: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-financials-rally/2010/</loc>
		<lastmod>2010-02-03T02:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7849: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-recap-the-obama-bashing-trade-final/2010/</loc>
		<lastmod>2010-02-03T02:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7846: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ten-misleading-drug-ads/2010/</loc>
		<lastmod>2010-02-03T01:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7847: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/former-wyeth-ceo-pharma-chiefs-face-more-punishing-environment/2010/</loc>
		<lastmod>2010-02-03T00:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7843: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/adp-report-tomorrows-headliners/2010/</loc>
		<lastmod>2010-02-02T22:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7820: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-triple-digit-gain-for-2nd-day/2010/</loc>
		<lastmod>2010-02-02T21:56:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7831: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-steady-ahead-of-refunding-auction/2010/</loc>
		<lastmod>2010-02-02T21:05:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7838: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-lancets-incomprehensible-autism-retraction/2010/</loc>
		<lastmod>2010-02-02T21:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7848: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/defense-defense/2010/</loc>
		<lastmod>2010-02-02T20:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7839: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/shaking-up-the-biotech-industry/2010/</loc>
		<lastmod>2010-02-02T19:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7840: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-8000/2010/</loc>
		<lastmod>2010-02-02T19:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7844: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/an-options-play-on-pfizer/2010/</loc>
		<lastmod>2010-02-02T19:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7816: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-weakens-as-stocks-advance/2010/</loc>
		<lastmod>2010-02-02T19:21:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7832: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/foolish-forecast-first-look-at-pfizer-plus/2010/</loc>
		<lastmod>2010-02-02T18:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7830: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medivations-alzheimer-trial-data-in-early-march-biobuzz/2010/</loc>
		<lastmod>2010-02-02T17:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7821: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfe-preview-wyeth-integration-going-smoothly/2010/</loc>
		<lastmod>2010-02-02T17:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7827: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/good-news-sales-growth-is-back-the-buzz/2010/</loc>
		<lastmod>2010-02-02T17:12:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7828: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/good-news-sales-growth-is-back-the-buzz-2/2010/</loc>
		<lastmod>2010-02-02T17:12:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7822: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/start-the-week-with-good-data/2010/</loc>
		<lastmod>2010-02-02T16:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7855: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medivations-alzheimer-trial-data-in-early-march-biobuzz-thestreet-com/2010/</loc>
		<lastmod>2010-02-02T15:46:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7854: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-gain-warner-chilcott-climbs-market-watch/2010/</loc>
		<lastmod>2010-02-02T15:45:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7829: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-best-undercover-dividends/2010/</loc>
		<lastmod>2010-02-02T15:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7817: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-gains-on-inventory-forecasts/2010/</loc>
		<lastmod>2010-02-02T13:38:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7813: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-edge-higher/2010/</loc>
		<lastmod>2010-02-02T12:22:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7814: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-power-3-medical-products-inc-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-02T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7812: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bang-for-the-buck-finally/2010/</loc>
		<lastmod>2010-02-02T08:54:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7835: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/humanas-disheartening-outlook/2010/</loc>
		<lastmod>2010-02-02T01:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7852: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/your-brand-reputational-value-is-irreplaceable-protect-it/2010/</loc>
		<lastmod>2010-02-02T01:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7807: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/humanas-healthier-results-2/2010/</loc>
		<lastmod>2010-02-02T00:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7810: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/city-welcomes-rare-catch-in-competitive-biotech-field-las-vegas-business-press/2010/</loc>
		<lastmod>2010-02-01T23:44:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7800: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/boston-sci-to-pay-jj-1-73-billion-in-settlement/2010/</loc>
		<lastmod>2010-02-01T22:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7808: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/study-links-hormone-to-addiction-risk-taking/2010/</loc>
		<lastmod>2010-02-01T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7804: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/boston-scientific-jj-settle-patent-dispute-2/2010/</loc>
		<lastmod>2010-02-01T21:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7806: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ten-dividend-stocks-to-pad-your-portfolio/2010/</loc>
		<lastmod>2010-02-01T21:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7780: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-bounce-after-battering/2010/</loc>
		<lastmod>2010-02-01T21:11:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7811: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cephalon-to-acquire-mepha-ag-for-590-million-fox-news/2010/</loc>
		<lastmod>2010-02-01T20:48:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7798: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/humanas-healthier-results/2010/</loc>
		<lastmod>2010-02-01T20:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7793: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ipo-on-tap-ironwood-aims-for-big-pharma/2010/</loc>
		<lastmod>2010-02-01T20:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7799: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/1-7-billion-settlement-tops-jjs-2009-sales-of-coated-stents/2010/</loc>
		<lastmod>2010-02-01T20:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7805: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/now-thats-some-expensive-risk-mitigation/2010/</loc>
		<lastmod>2010-02-01T20:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7782: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-closes-above-74/2010/</loc>
		<lastmod>2010-02-01T20:20:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7796: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cephalon-like-big-pharma-looks-to-global-generics-for-growth/2010/</loc>
		<lastmod>2010-02-01T19:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7801: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/boston-scientific-jj-settle-patent-dispute/2010/</loc>
		<lastmod>2010-02-01T18:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7797: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cephalon-to-buy-swiss-drug-maker/2010/</loc>
		<lastmod>2010-02-01T18:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7789: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-and-pierre-fabre-sa-announce-collaboration-to-research-and-develop-novel-treatments-for-cancer/2010/</loc>
		<lastmod>2010-02-01T17:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7794: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rises-on-upbeat-reports/2010/</loc>
		<lastmod>2010-02-01T17:31:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7795: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-it-safe-to-buy-toyota-stock/2010/</loc>
		<lastmod>2010-02-01T17:23:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7784: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bullmarket-com-previews-earnings-for-cisco-akamai-electronic-arts-pfizer/2010/</loc>
		<lastmod>2010-02-01T17:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7790: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/boston-sci-pays-jj-1-7b-to-end-stent-patent-dispute/2010/</loc>
		<lastmod>2010-02-01T16:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7785: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-analysts-upgrades-downgrades/2010/</loc>
		<lastmod>2010-02-01T16:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7786: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/picture-picture-on-the-wall/2010/</loc>
		<lastmod>2010-02-01T16:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7787: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bears-hold-sway-over-sentiment/2010/</loc>
		<lastmod>2010-02-01T16:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7783: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-down-on-obama-budget/2010/</loc>
		<lastmod>2010-02-01T16:01:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7774: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/reports-glaxosmithkline-to-cut-more-than-3000-jobs/2010/</loc>
		<lastmod>2010-02-01T15:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7809: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-gain-warner-chilcott-shares-retreat-market-watch/2010/</loc>
		<lastmod>2010-02-01T15:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7781: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-bounce-back-3/2010/</loc>
		<lastmod>2010-02-01T14:59:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7777: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dose-up-on-health-care-stocks-cnn-money/2010/</loc>
		<lastmod>2010-02-01T14:11:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7779: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-bills-target-tanning-snack-machines/2010/</loc>
		<lastmod>2010-02-01T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7776: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-health-discovery-corp-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-02-01T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7770: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-ready-to-claw-back/2010/</loc>
		<lastmod>2010-02-01T10:33:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7769: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/strong-year-for-biotech-the-edge-daily/2010/</loc>
		<lastmod>2010-02-01T04:56:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7775: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/scientists-say-crack-hivaids-puzzle-for-drugs/2010/</loc>
		<lastmod>2010-01-31T20:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7764: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-new-month-same-worries/2010/</loc>
		<lastmod>2010-01-31T16:16:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7772: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jobs-again-center-stage-in-coming-week/2010/</loc>
		<lastmod>2010-01-30T16:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7762: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-the-brokers-stack-up/2010/</loc>
		<lastmod>2010-01-30T13:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7510: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/barrons-2010-roundtable-part-two-a-few-good-ideas/2010/</loc>
		<lastmod>2010-01-30T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7761: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-only-asset-worth-owning-today-2/2010/</loc>
		<lastmod>2010-01-30T12:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7756: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lab-maker-plans-factory-the-indianapolis-star/2010/</loc>
		<lastmod>2010-01-30T07:14:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7758: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-january-chill/2010/</loc>
		<lastmod>2010-01-30T03:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7757: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/in-pictures-15-laughable-warning-labels/2010/</loc>
		<lastmod>2010-01-30T01:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7778: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-ford-motor-co-motorola-inc-google-bristol-myers-squibb-company-and-astrazeneca-plc/2010/</loc>
		<lastmod>2010-01-30T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7747: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-little-blue-pill-or-the-other-white-meat/2010/</loc>
		<lastmod>2010-01-29T22:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7735: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dividend-stocks-for-the-week-6/2010/</loc>
		<lastmod>2010-01-29T22:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7734: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/judge-refuses-to-dismiss-fosamax-case-sets-trial/2010/</loc>
		<lastmod>2010-01-29T22:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7733: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pivotal-trial-results-for-motavizumab-published-in-current-issue-of-pediatrics/2010/</loc>
		<lastmod>2010-01-29T21:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7745: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-to-make-billions-of-dollars-without-really-trying/2010/</loc>
		<lastmod>2010-01-29T20:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7717: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nasdaq-battered-as-techs-slump/2010/</loc>
		<lastmod>2010-01-29T20:39:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7719: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-reverses-gains-ends-lower/2010/</loc>
		<lastmod>2010-01-29T20:33:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7728: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-eli-lilly-foreboding-for-sector-2/2010/</loc>
		<lastmod>2010-01-29T20:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7714: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rallies-after-gdp-report/2010/</loc>
		<lastmod>2010-01-29T19:47:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7737: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/let-big-mutual-funds-finish-their-damage/2010/</loc>
		<lastmod>2010-01-29T19:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7738: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/let-big-mutual-funds-finish-their-damage-2/2010/</loc>
		<lastmod>2010-01-29T19:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7739: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/all-grown-up-with-cash-to-burn/2010/</loc>
		<lastmod>2010-01-29T18:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7740: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/all-grown-up-with-cash-to-burn-2/2010/</loc>
		<lastmod>2010-01-29T18:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7721: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-stocks-for-a-double-dip/2010/</loc>
		<lastmod>2010-01-29T18:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7725: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/independence-day-for-the-fed/2010/</loc>
		<lastmod>2010-01-29T17:23:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7755: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/china-kangtai-cactus-biotech-receives-5-94-million-for-transfer-of-property-and-equipment-to-local-government-business-wire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-29T16:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7722: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-only-bond-bear-worth-listening-to/2010/</loc>
		<lastmod>2010-01-29T16:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7723: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/peering-out-from-the-bear-cave/2010/</loc>
		<lastmod>2010-01-29T13:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7715: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-gains-against-yen/2010/</loc>
		<lastmod>2010-01-29T12:21:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7753: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-keryx-biopharmaceuticals-thestreet-com/2010/</loc>
		<lastmod>2010-01-29T12:15:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7711: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/executive-of-the-year-pushing-the-biotech-envelope-gazette-net/2010/</loc>
		<lastmod>2010-01-29T09:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7712: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-early-gains-4/2010/</loc>
		<lastmod>2010-01-29T09:35:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7720: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-wrap-the-real-story-january-28/2010/</loc>
		<lastmod>2010-01-28T23:51:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7716: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-to-whittle-worldwide-workforce/2010/</loc>
		<lastmod>2010-01-28T23:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7696: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/quest-offers-growth-at-a-value-price/2010/</loc>
		<lastmod>2010-01-28T22:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7702: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-leads-europe-lower/2010/</loc>
		<lastmod>2010-01-28T21:51:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7671: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-get-hammered/2010/</loc>
		<lastmod>2010-01-28T21:26:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7691: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-pharmas-messy-pipeline-astra-lilly-fall-bristol-rises/2010/</loc>
		<lastmod>2010-01-28T20:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7692: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-pharmas-messy-pipeline-astra-lilly-fall-bristol-rises/2010/</loc>
		<lastmod>2010-01-28T20:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7709: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pharma-biotech-stock-review-zacks-com-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-28T20:24:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7697: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/crushing-the-market-is-easier-than-you-think/2010/</loc>
		<lastmod>2010-01-28T20:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7698: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-reform-is-dead-probably/2010/</loc>
		<lastmod>2010-01-28T20:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7660: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-gives-back-gains-as-stocks-tumble/2010/</loc>
		<lastmod>2010-01-28T20:12:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7684: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-feels-effects-of-age/2010/</loc>
		<lastmod>2010-01-28T19:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7685: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/economy-jitters-push-ftse-to-near-three-month-low/2010/</loc>
		<lastmod>2010-01-28T19:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7703: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-biggest-development-stage-drugmaker-ever/2010/</loc>
		<lastmod>2010-01-28T19:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7693: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/only-the-strong-survive-at-pfizer/2010/</loc>
		<lastmod>2010-01-28T19:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7683: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/obama-clears-way-for-pharma-plays/2010/</loc>
		<lastmod>2010-01-28T19:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7694: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-next-amgen-not-yet/2010/</loc>
		<lastmod>2010-01-28T18:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7674: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wrapup-2-pharma-fails-to-impress-as-patent-problems-loom/2010/</loc>
		<lastmod>2010-01-28T18:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7678: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/long-term-treasurys-slide/2010/</loc>
		<lastmod>2010-01-28T18:33:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7695: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-winners-for-small-investors-4/2010/</loc>
		<lastmod>2010-01-28T18:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7657: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-to-cut-more-jobs/2010/</loc>
		<lastmod>2010-01-28T18:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7682: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/time-for-tim-geithner-to-go/2010/</loc>
		<lastmod>2010-01-28T17:36:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7662: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drug-lobby-health-bill-up-in-air/2010/</loc>
		<lastmod>2010-01-28T17:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7663: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-myers-lilly-report-higher-sales/2010/</loc>
		<lastmod>2010-01-28T16:51:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7679: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-turn-mixed/2010/</loc>
		<lastmod>2010-01-28T16:49:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7672: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-boeing-pfizer-t-rowe-price-stryker-and-toll-brothers-released-by-seven-summits-research/2010/</loc>
		<lastmod>2010-01-28T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7673: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-boeing-pfizer-t-rowe-price-stryker-and-toll-brothers-released-by-seven-summits-research-2/2010/</loc>
		<lastmod>2010-01-28T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7648: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-3-astrazeneca-sees-tough-year-cuts-jobs/2010/</loc>
		<lastmod>2010-01-28T15:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7710: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wednesdays-biggest-stock-stars-the-motley-fool-7/2010/</loc>
		<lastmod>2010-01-28T15:26:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7666: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-to-make-a-billion-bucks-in-biotech/2010/</loc>
		<lastmod>2010-01-28T14:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7667: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medivation-poised-for-volatile-spring/2010/</loc>
		<lastmod>2010-01-28T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7647: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-poised-to-push-forward/2010/</loc>
		<lastmod>2010-01-28T13:46:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7658: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-profit-climbs-14-sees-2010-eps-drop/2010/</loc>
		<lastmod>2010-01-28T13:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7653: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-mixed-after-obama-speech/2010/</loc>
		<lastmod>2010-01-28T12:35:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7654: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-mixed-after-obama-speech/2010/</loc>
		<lastmod>2010-01-28T12:35:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7650: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sinovac-biotech-increases-size-of-stock-offering-ino-news/2010/</loc>
		<lastmod>2010-01-28T11:56:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7649: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sinovac-biotech-increases-size-of-stock-offering-ap-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-28T11:42:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7661: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-is-why-buffetts-buying-stocks-3/2010/</loc>
		<lastmod>2010-01-28T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7754: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pharma-biotech-stock-review-zacks-com-via-yahoo-finance-2/2010/</loc>
		<lastmod>2010-01-28T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7646: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/futures-advance-on-obamas-speech-malaysianews-net/2010/</loc>
		<lastmod>2010-01-28T05:21:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7645: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fed-techs-lift-wall-st-futures-cheer-obama-reuters-via-yahoo-news/2010/</loc>
		<lastmod>2010-01-28T04:29:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7656: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-apples-master-plan/2010/</loc>
		<lastmod>2010-01-28T03:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7668: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-com-featured-expert-kevin-matras-highlights-abbott-labs-aflac-inc-emerson-electric-co-olin-corp-and-snap-on-inc/2010/</loc>
		<lastmod>2010-01-28T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7599: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-advance-as-fed-soothes/2010/</loc>
		<lastmod>2010-01-28T00:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7655: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rotavirus-vaccine-can-sicken-immune-deficient-babies/2010/</loc>
		<lastmod>2010-01-28T00:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7643: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-whittles-post-wyeth-pipeline/2010/</loc>
		<lastmod>2010-01-27T23:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7608: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-after-fed-statement-2/2010/</loc>
		<lastmod>2010-01-27T22:40:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7598: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-4-abbott-sales-jump-but-humira-sales-weigh-on-stock/2010/</loc>
		<lastmod>2010-01-27T22:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7604: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-manage-gains-after-fed/2010/</loc>
		<lastmod>2010-01-27T21:28:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7616: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-details-its-research-efforts/2010/</loc>
		<lastmod>2010-01-27T21:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7618: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/selling-a-health-business-in-the-developing-world-call-abbott/2010/</loc>
		<lastmod>2010-01-27T20:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7640: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/humira-or-not-abbotts-on-a-roll/2010/</loc>
		<lastmod>2010-01-27T20:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7613: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/apple-ipad-sends-stock-down-then-up/2010/</loc>
		<lastmod>2010-01-27T20:26:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7619: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-pfizer-trims-drug-pipeline-after-wyeth-merger/2010/</loc>
		<lastmod>2010-01-27T20:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7620: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-pfizer-trims-drug-pipeline-after-wyeth-merger/2010/</loc>
		<lastmod>2010-01-27T20:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7594: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-strengthens-after-fed-statement/2010/</loc>
		<lastmod>2010-01-27T19:33:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7621: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/will-berkshire-hathaway-become-a-dow-component-brk-a-brk-b-gs-ge-bni-v-aa-pfe/2010/</loc>
		<lastmod>2010-01-27T19:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7622: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/will-berkshire-hathaway-become-a-dow-component-brk-a-brk-b-gs-ge-bni-v-aa-pfe/2010/</loc>
		<lastmod>2010-01-27T19:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7636: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nice-novartis-very-nice/2010/</loc>
		<lastmod>2010-01-27T19:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7699: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-pfe-6/2010/</loc>
		<lastmod>2010-01-27T19:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7623: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-this-guy-the-next-buffett/2010/</loc>
		<lastmod>2010-01-27T18:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7624: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-this-guy-the-next-buffett-2/2010/</loc>
		<lastmod>2010-01-27T18:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7596: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-slides-below-74/2010/</loc>
		<lastmod>2010-01-27T18:37:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7610: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-sells-off-on-quirky-guidance/2010/</loc>
		<lastmod>2010-01-27T18:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7605: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-the-markets-hate-washington/2010/</loc>
		<lastmod>2010-01-27T16:52:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7602: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-labs-posts-fourth-quarter-profit/2010/</loc>
		<lastmod>2010-01-27T15:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7644: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-gilead-gains-abbott-slides-on-quarterly-reports-market-watch/2010/</loc>
		<lastmod>2010-01-27T15:31:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7617: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/are-you-too-old-for-a-roth-ira/2010/</loc>
		<lastmod>2010-01-27T15:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7600: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-reports-double-digit-sales-and-earnings-growth-in-fourth-quarter-issues-strong-earnings-outlook-for-2010/2010/</loc>
		<lastmod>2010-01-27T14:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7590: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-advance-at-open/2010/</loc>
		<lastmod>2010-01-27T12:14:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7591: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-alkermes-inc-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-27T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7592: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-market-review-for-dynavax-technologies-corp-issued-by-stockpreacher-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-27T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7597: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gilead-rises-as-q4-sales-profit-beat/2010/</loc>
		<lastmod>2010-01-27T00:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7588: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/teva-moves-ahead-in-brain-drug-battle/2010/</loc>
		<lastmod>2010-01-26T23:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7589: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-3-teva-wins-patent-battle-over-mercks-temodar/2010/</loc>
		<lastmod>2010-01-26T22:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7560: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mostly-higher-on-stronger-dollar/2010/</loc>
		<lastmod>2010-01-26T21:41:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7559: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/banks-drag-on-stocks/2010/</loc>
		<lastmod>2010-01-26T21:27:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7574: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/with-apple-tablet-imminent-fakes-abound-online/2010/</loc>
		<lastmod>2010-01-26T20:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7575: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-pharmas-best-chief-steps-down/2010/</loc>
		<lastmod>2010-01-26T20:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7581: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/timing-is-everything-for-amgen/2010/</loc>
		<lastmod>2010-01-26T20:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7583: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-to-cash-in-on-the-next-global-boom/2010/</loc>
		<lastmod>2010-01-26T20:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7584: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-to-cash-in-on-the-next-global-boom-2/2010/</loc>
		<lastmod>2010-01-26T20:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7578: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-district-court-rules-against-merck-in-temodar%c2%ae-temozolomide-patent-lawsuit/2010/</loc>
		<lastmod>2010-01-26T19:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7580: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-victozas-victory-in-vain/2010/</loc>
		<lastmod>2010-01-26T19:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7576: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/apple-is-still-cheating-you/2010/</loc>
		<lastmod>2010-01-26T18:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7566: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/new-novartis-chief-needs-surgery-skills/2010/</loc>
		<lastmod>2010-01-26T18:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7567: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-says-u-s-unit-to-pay-fine-over-marketing-of-epilepsy-drug/2010/</loc>
		<lastmod>2010-01-26T18:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7585: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abt-preview-defensive-stocks-back-in-vogue/2010/</loc>
		<lastmod>2010-01-26T18:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7573: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-continues-its-slide/2010/</loc>
		<lastmod>2010-01-26T18:20:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7568: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/spiking-sales-bring-jnj-to-profit/2010/</loc>
		<lastmod>2010-01-26T18:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7569: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-welcomes-novartis-reshuffle/2010/</loc>
		<lastmod>2010-01-26T18:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7570: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/best-places-to-work-no-stock-no-problem/2010/</loc>
		<lastmod>2010-01-26T17:48:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7577: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jjs-annual-sales-fall-first-time-since-depression/2010/</loc>
		<lastmod>2010-01-26T17:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7612: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vasellas-impeccable-timing/2010/</loc>
		<lastmod>2010-01-26T16:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7562: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-pepsico-chesapeake-energy-seagate-technology-abbott-laboratories-and-harris-corp-released-by-seven-summits-research/2010/</loc>
		<lastmod>2010-01-26T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7554: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jj-falls-as-year-outlook-misses/2010/</loc>
		<lastmod>2010-01-26T16:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7607: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/new-novartis-ceo-cafepharma-reader-former-heinz-exec/2010/</loc>
		<lastmod>2010-01-26T15:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7556: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/verizon-apple-tuesdays-headlines/2010/</loc>
		<lastmod>2010-01-26T15:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7563: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-big-upgrade-for-cepheid/2010/</loc>
		<lastmod>2010-01-26T14:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7555: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/doubts-build-on-glaxos-antiaging-drugs/2010/</loc>
		<lastmod>2010-01-26T13:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7553: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-up-vs-euro-and-pound/2010/</loc>
		<lastmod>2010-01-26T13:12:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7557: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/britain-sneaks-out-of-recession/2010/</loc>
		<lastmod>2010-01-26T12:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7546: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/top-dividend-funds-trounce-sp-500/2010/</loc>
		<lastmod>2010-01-26T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7544: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-poised-to-pull-back/2010/</loc>
		<lastmod>2010-01-26T10:12:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7549: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-q4-profit-rises-new-ceo-appointed/2010/</loc>
		<lastmod>2010-01-26T09:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7550: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-q4-profit-rises-new-ceo-appointed/2010/</loc>
		<lastmod>2010-01-26T09:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7534: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/clueless-about-oil-prices/2010/</loc>
		<lastmod>2010-01-26T09:04:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7551: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-net-rises-54-names-new-ceo/2010/</loc>
		<lastmod>2010-01-26T08:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7552: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-net-rises-54-names-new-ceo-2/2010/</loc>
		<lastmod>2010-01-26T08:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7561: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/blue-chips-for-the-long-run/2010/</loc>
		<lastmod>2010-01-26T07:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7564: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bringing-atkins-back-from-the-dead/2010/</loc>
		<lastmod>2010-01-26T06:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7540: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-reports-2-dip-in-sales-revenue-ventura-county-star/2010/</loc>
		<lastmod>2010-01-26T05:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7520: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/corporate-trumping-country-debt/2010/</loc>
		<lastmod>2010-01-26T00:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7547: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-drug-giants-outmuscle-sp-500/2010/</loc>
		<lastmod>2010-01-26T00:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7529: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/betting-on-fresh-highs-for-vistaprint/2010/</loc>
		<lastmod>2010-01-25T23:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7532: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbotts-many-trials/2010/</loc>
		<lastmod>2010-01-25T23:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7535: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/guilty-plea-on-biotech-counts-herald-sun/2010/</loc>
		<lastmod>2010-01-25T23:20:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7506: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-muster-gains-2/2010/</loc>
		<lastmod>2010-01-25T23:14:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7523: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bill-miller-likes-big-stocks/2010/</loc>
		<lastmod>2010-01-25T22:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7526: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-2/2010/</loc>
		<lastmod>2010-01-25T22:35:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7518: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-easiest-way-to-gamble-your-money-away/2010/</loc>
		<lastmod>2010-01-25T20:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7509: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rebounds-after-choppy-trading/2010/</loc>
		<lastmod>2010-01-25T20:35:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7533: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/an-acorda-win-ups-the-takeover-ante/2010/</loc>
		<lastmod>2010-01-25T20:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7524: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/obamacare-fail-the-one-stock-to-buy/2010/</loc>
		<lastmod>2010-01-25T19:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7516: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pay-for-delay-is-under-the-spotlight/2010/</loc>
		<lastmod>2010-01-25T19:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7498: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-weakens-as-stocks-rebound/2010/</loc>
		<lastmod>2010-01-25T19:08:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7511: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/no-way-to-hide-this-drug-approval/2010/</loc>
		<lastmod>2010-01-25T18:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7512: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tysabri-updates-all-you-have-to-do-is-ask/2010/</loc>
		<lastmod>2010-01-25T18:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7514: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/harvard-doc-steps-down-to-keep-drug-industry-speaking-gig/2010/</loc>
		<lastmod>2010-01-25T17:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7525: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-sues-teva-over-simcor-patents/2010/</loc>
		<lastmod>2010-01-25T17:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7500: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-submits-new-hiv-test-to-fda-for-expedited-review/2010/</loc>
		<lastmod>2010-01-25T16:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7541: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-sluggish-poniard-sinks-market-watch/2010/</loc>
		<lastmod>2010-01-25T16:16:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7503: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/succeed-by-being-unconventional-2/2010/</loc>
		<lastmod>2010-01-25T13:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7536: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-hemispherx-biopharma-inc-issued-by-investorsoup-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-25T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7537: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-geopharma-inc-issued-by-stockpreacher-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-25T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7538: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-aastrom-biosciences-inc-issued-by-investorsoup-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-25T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7539: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-hana-biosciences-incorporated-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-25T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7496: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-set-for-a-bounce/2010/</loc>
		<lastmod>2010-01-25T09:51:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7497: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-set-for-a-bounce/2010/</loc>
		<lastmod>2010-01-25T09:51:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7494: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-bulls-cheer-the-jets-loss/2010/</loc>
		<lastmod>2010-01-25T00:35:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7499: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/two-winning-stocks-2/2010/</loc>
		<lastmod>2010-01-24T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7486: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-trying-to-reverse-the-slide/2010/</loc>
		<lastmod>2010-01-24T13:05:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7487: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-trying-to-reverse-the-slide/2010/</loc>
		<lastmod>2010-01-24T13:05:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7492: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nows-a-great-time-to-invest-so-dont-blow-it-like-this-3/2010/</loc>
		<lastmod>2010-01-24T12:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7491: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-long-should-you-ride-this-rally/2010/</loc>
		<lastmod>2010-01-24T10:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7501: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fake-alli-dangerous-for-some-consumers/2010/</loc>
		<lastmod>2010-01-24T00:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7485: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/acorda-spikes-on-fda-approval-for-ms-drug-thestreet-com/2010/</loc>
		<lastmod>2010-01-23T19:40:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7475: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/forest-labs-prescription-for-success/2010/</loc>
		<lastmod>2010-01-23T13:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7477: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/handset-wars-heating-up/2010/</loc>
		<lastmod>2010-01-23T13:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7478: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/corrections-amplifications/2010/</loc>
		<lastmod>2010-01-23T13:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7488: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eyes-on-the-exits-as-stocks-give-back-2010-gains/2010/</loc>
		<lastmod>2010-01-23T13:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7469: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/kane-biotech-grants-175000-stock-options-at-0-15-per-common-share-news-medical-net/2010/</loc>
		<lastmod>2010-01-23T06:58:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7479: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-recap-next-weeks-game-plan-listen-dont-buy-final/2010/</loc>
		<lastmod>2010-01-23T02:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7448: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/worst-day-in-3-months/2010/</loc>
		<lastmod>2010-01-22T21:07:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7449: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-tumbles-below-75/2010/</loc>
		<lastmod>2010-01-22T20:27:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7471: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/kane-biotech-announces-grant-of-options-marketwire/2010/</loc>
		<lastmod>2010-01-22T20:18:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7483: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-stocks-will-burn-you-3/2010/</loc>
		<lastmod>2010-01-22T19:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7465: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-great-data-wont-do-much/2010/</loc>
		<lastmod>2010-01-22T19:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7462: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dont-fear-the-dollars-demise-profit-from-it/2010/</loc>
		<lastmod>2010-01-22T19:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7461: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-take-away-statins-are-still-in-the-cabinet/2010/</loc>
		<lastmod>2010-01-22T19:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7476: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-2-moves-could-save-your-portfolio/2010/</loc>
		<lastmod>2010-01-22T17:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7451: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-pfizer-seeks-sutent-ok-for-pancreatic-cancer/2010/</loc>
		<lastmod>2010-01-22T17:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7456: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/revenge-of-the-regional-banks/2010/</loc>
		<lastmod>2010-01-22T17:28:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7472: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-mixed-curis-and-achillion-tumble-market-watch/2010/</loc>
		<lastmod>2010-01-22T16:31:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7454: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bond-prices-mixed/2010/</loc>
		<lastmod>2010-01-22T16:14:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7455: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bond-prices-mixed-2/2010/</loc>
		<lastmod>2010-01-22T16:14:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7460: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eu-mergers-and-takeovers-jan-22/2010/</loc>
		<lastmod>2010-01-22T15:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7447: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/data-show-progression-free-survival-advantage-with-sutent%c2%ae-in-patients-with-pancreatic-neuroendocrine-tumors/2010/</loc>
		<lastmod>2010-01-22T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7459: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-genvec/2010/</loc>
		<lastmod>2010-01-22T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7445: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-st-bulls-should-hate-the-j-e-t-s/2010/</loc>
		<lastmod>2010-01-22T13:39:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7444: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-mixed-as-investors-pause/2010/</loc>
		<lastmod>2010-01-22T13:15:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7437: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-headed-lower-again/2010/</loc>
		<lastmod>2010-01-22T12:47:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7446: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eu-extends-review-deadline-for-solvayabbott-deal/2010/</loc>
		<lastmod>2010-01-22T12:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7470: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-genvec-thestreet-com/2010/</loc>
		<lastmod>2010-01-22T12:15:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7474: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2010-01-22-1124-update-1-glaxo-genmab-win-eu-backing-for-leukaemia-drug-interactive-investor/2010/</loc>
		<lastmod>2010-01-22T11:43:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7442: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/i-am-so-tired-of-warren-buffett/2010/</loc>
		<lastmod>2010-01-22T11:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7434: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/getting-in-on-chinas-stock-boom/2010/</loc>
		<lastmod>2010-01-22T08:56:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7466: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-where-to-hide/2010/</loc>
		<lastmod>2010-01-22T03:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7473: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/symetra-stock-closes-higher-in-trading-debut-seattle-times/2010/</loc>
		<lastmod>2010-01-22T00:49:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7419: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/diet-drug-faces-european-ban/2010/</loc>
		<lastmod>2010-01-22T00:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7403: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-turns-negative-for-10/2010/</loc>
		<lastmod>2010-01-22T00:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7424: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/meridia-another-diet-drug-warning/2010/</loc>
		<lastmod>2010-01-21T23:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7390: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/auxilium-to-get-15-million-payment-from-pfizer/2010/</loc>
		<lastmod>2010-01-21T23:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7402: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-3-eu-agency-urges-ban-on-abbott-diet-drug/2010/</loc>
		<lastmod>2010-01-21T22:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7391: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-streets-worst-day-in-months/2010/</loc>
		<lastmod>2010-01-21T21:13:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7410: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dogs-of-the-dow-table/2010/</loc>
		<lastmod>2010-01-21T20:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7439: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/teva-gets-tentative-fda-ok-for-generic-femara/2010/</loc>
		<lastmod>2010-01-21T20:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7440: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/teva-gets-tentative-fda-ok-for-generic-femara/2010/</loc>
		<lastmod>2010-01-21T20:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7408: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/islamic-fund-star/2010/</loc>
		<lastmod>2010-01-21T20:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7411: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-pharma-is-pushing-its-drug-pushers-out/2010/</loc>
		<lastmod>2010-01-21T20:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7416: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-slips-2/2010/</loc>
		<lastmod>2010-01-21T20:00:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7420: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dont-sell-that-stock-2/2010/</loc>
		<lastmod>2010-01-21T19:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7401: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gsk-ceo-on-big-deals-paying-a-premium-to-fire-people/2010/</loc>
		<lastmod>2010-01-21T19:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7433: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wednesdays-biggest-stock-stars-the-motley-fool-6/2010/</loc>
		<lastmod>2010-01-21T19:30:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7414: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/heres-that-critical-merck-info-you-missed/2010/</loc>
		<lastmod>2010-01-21T18:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7409: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-gain-on-triple-digit-dow-selloff/2010/</loc>
		<lastmod>2010-01-21T18:06:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7392: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/experimental-drug-update-multiple-sclerosis-hiv-c-difficile/2010/</loc>
		<lastmod>2010-01-21T17:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7405: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-gains-on-global-economic-worries/2010/</loc>
		<lastmod>2010-01-21T17:09:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7393: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/populist-rage-and-the-fragility-of-recovery/2010/</loc>
		<lastmod>2010-01-21T17:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7396: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/doing-this-will-just-drive-you-crazy/2010/</loc>
		<lastmod>2010-01-21T15:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7394: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/new-survey-finds-infertility-delivers-a-serious-blow-to-self-esteem/2010/</loc>
		<lastmod>2010-01-21T14:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7432: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-readers-portfolio-thestreet-com/2010/</loc>
		<lastmod>2010-01-21T14:30:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7385: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-and-auxilium-announce-commencement-of-european-regulatory-review-of-xiaflextm-for-the-treatment-of-dupuytren%e2%80%99s-contracture/2010/</loc>
		<lastmod>2010-01-21T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7377: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lackluster-open-seen-for-stocks/2010/</loc>
		<lastmod>2010-01-21T13:45:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7406: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-upped-to-overweight-at-morgan-stanley/2010/</loc>
		<lastmod>2010-01-21T13:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7381: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-genvec-inc-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-21T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7382: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-helicos-biosciences-corp-issued-by-stockpreacher-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-21T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7384: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-worth-buying-again-2/2010/</loc>
		<lastmod>2010-01-21T11:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7383: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/investors-betting-heavily-on-vivus-obesity-drug-market-watch/2010/</loc>
		<lastmod>2010-01-21T11:15:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7386: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/theres-nothing-generic-about-tevas-stock/2010/</loc>
		<lastmod>2010-01-21T01:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7431: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-nvs-17/2010/</loc>
		<lastmod>2010-01-21T00:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7379: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-forest-laboratories-inc-cypress-biosciences-astrazeneca-boeing-company-and-honeywell-international-inc/2010/</loc>
		<lastmod>2010-01-21T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7380: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ms-pills-hold-promise/2010/</loc>
		<lastmod>2010-01-21T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7366: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-to-pick-stocks-by-ignoring-the-herd/2010/</loc>
		<lastmod>2010-01-20T23:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7367: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-stocks-love-scott-brown/2010/</loc>
		<lastmod>2010-01-20T23:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7368: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-stocks-love-scott-brown/2010/</loc>
		<lastmod>2010-01-20T23:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7378: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-hiv-drug-from-schering-merger-fails-trials/2010/</loc>
		<lastmod>2010-01-20T23:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7340: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-drop-amid-rate-anxiety/2010/</loc>
		<lastmod>2010-01-20T23:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7397: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tax-breaks-for-haiti-relief-widening/2010/</loc>
		<lastmod>2010-01-20T23:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7398: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tax-breaks-for-haiti-relief-widening/2010/</loc>
		<lastmod>2010-01-20T23:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7362: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-wont-seek-fda-approval-for-hiv-drug/2010/</loc>
		<lastmod>2010-01-20T23:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7363: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/glaxosmithklines-malaria-plan-limit-profits-open-labs/2010/</loc>
		<lastmod>2010-01-20T22:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7352: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/unhealthy-market/2010/</loc>
		<lastmod>2010-01-20T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7373: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-next-million-dollar-penny-stock-the-motley-fool/2010/</loc>
		<lastmod>2010-01-20T21:28:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7353: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chantix-continues-to-be-a-cancer-on-pfizer/2010/</loc>
		<lastmod>2010-01-20T21:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7355: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/winners-and-losers-if-the-health-care-bill-fails/2010/</loc>
		<lastmod>2010-01-20T21:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7329: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-get-knocked-back/2010/</loc>
		<lastmod>2010-01-20T21:06:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7349: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/china-kills-stocks/2010/</loc>
		<lastmod>2010-01-20T21:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7358: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/those-are-fighting-words/2010/</loc>
		<lastmod>2010-01-20T20:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7359: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-you-shouldnt-listen-to-jim-cramer-2/2010/</loc>
		<lastmod>2010-01-20T20:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7336: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-tumbles-2-on-china-worries/2010/</loc>
		<lastmod>2010-01-20T20:47:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7418: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-reform-its-not-over-yet/2010/</loc>
		<lastmod>2010-01-20T19:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7356: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-says-3-drugs-approved-in-japan/2010/</loc>
		<lastmod>2010-01-20T19:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7347: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-turn-higher-on-recovery-doubts/2010/</loc>
		<lastmod>2010-01-20T18:50:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7346: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-brown-out-for-health-care-stocks/2010/</loc>
		<lastmod>2010-01-20T18:49:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7338: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/whats-next-for-health-care-companies/2010/</loc>
		<lastmod>2010-01-20T18:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7341: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/with-health-reform-in-icu-the-play-is/2010/</loc>
		<lastmod>2010-01-20T18:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7339: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/group-urges-recall-of-drug-for-fibromyalgia/2010/</loc>
		<lastmod>2010-01-20T17:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7328: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pharma-should-see-upside-on-browns-win/2010/</loc>
		<lastmod>2010-01-20T17:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7332: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/managed-care-shares-open-higher/2010/</loc>
		<lastmod>2010-01-20T16:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7337: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-falls-on-china-stronger-dollar-2/2010/</loc>
		<lastmod>2010-01-20T16:39:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7333: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/citigroup-analyst-upgrades-downgrades/2010/</loc>
		<lastmod>2010-01-20T16:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7371: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-medics-inc-files-lawsuit-against-wells-fargo-bank-1st-global-stock-transfer-llc-and-others-marketwire/2010/</loc>
		<lastmod>2010-01-20T16:31:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7365: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-aig-procter-gamble-gilead-sciences-thermo-fisher-scientific-and-astrazeneca-released-by-seven-summits-research/2010/</loc>
		<lastmod>2010-01-20T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7372: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-diverge-shire-lexicon-in-spotlight-market-watch/2010/</loc>
		<lastmod>2010-01-20T15:40:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7330: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-at-4-month-high-vs-euro/2010/</loc>
		<lastmod>2010-01-20T15:33:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7404: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/your-first-step-toward-financial-security/2010/</loc>
		<lastmod>2010-01-20T15:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7325: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/kolltan-closes-10m-series-b-round-mass-high-tech-the-journal-of-new-england-technology/2010/</loc>
		<lastmod>2010-01-20T14:15:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7327: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/alcon-group-says-novartis-bid-inadequate/2010/</loc>
		<lastmod>2010-01-20T13:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7324: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/orasure-technologies-and-roche-diagnostics-sign-worldwide-commercialization-agreement-for-fully-automated-oral-fluid-pharmaceuticalonline/2010/</loc>
		<lastmod>2010-01-20T12:08:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7323: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-neostem-inc-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-20T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7314: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-fall-back/2010/</loc>
		<lastmod>2010-01-20T10:05:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7315: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/planned-biotech-plant-could-employ-up-to-70-the-indianapolis-star/2010/</loc>
		<lastmod>2010-01-20T07:14:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7374: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genvec-novartis-ink-deal-for-hearing-loss-remedy-washington-post/2010/</loc>
		<lastmod>2010-01-20T05:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7375: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dows-dogs-poised-for-a-comeback/2010/</loc>
		<lastmod>2010-01-20T03:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7376: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dows-dogs-poised-for-a-comeback/2010/</loc>
		<lastmod>2010-01-20T03:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7319: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genvec-stands-to-gain-213m-in-novartis-hearing-loss-pact-bioworld/2010/</loc>
		<lastmod>2010-01-20T01:48:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7317: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/louisville-biotech-globeimmune-raises-17-5m-boulder-daily-camera/2010/</loc>
		<lastmod>2010-01-19T23:47:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7281: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-ends-at-15-month-high/2010/</loc>
		<lastmod>2010-01-19T23:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7310: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/companies-send-aid-to-haiti/2010/</loc>
		<lastmod>2010-01-19T22:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7320: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dupont-proceeds-with-modified-soybean-amid-court-loss-update2-bloomberg/2010/</loc>
		<lastmod>2010-01-19T22:22:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7305: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-boosts-haiti-donations-to-2-5-million/2010/</loc>
		<lastmod>2010-01-19T21:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7318: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/monsantos-legal-wins-are-just-the-beginning-the-motley-fool/2010/</loc>
		<lastmod>2010-01-19T21:15:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7277: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-recharges-the-rally/2010/</loc>
		<lastmod>2010-01-19T21:13:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7311: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/terrible-advice-you-should-ignore/2010/</loc>
		<lastmod>2010-01-19T20:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7322: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/options-are-you-nuts-3/2010/</loc>
		<lastmod>2010-01-19T20:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7300: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sector-snap-drug-managed-care-stocks-climb/2010/</loc>
		<lastmod>2010-01-19T20:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7301: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-eyes-bigger-push-into-emerging-markets/2010/</loc>
		<lastmod>2010-01-19T20:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7286: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-tops-79/2010/</loc>
		<lastmod>2010-01-19T20:23:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7309: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/limited-swine-flu-vaccine-demand-dents-drug-cos/2010/</loc>
		<lastmod>2010-01-19T19:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7307: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-gets-serious-about-generics/2010/</loc>
		<lastmod>2010-01-19T19:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7294: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-stocks-watch-mass-senate-race-today/2010/</loc>
		<lastmod>2010-01-19T19:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7297: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-ease-in-quiet-trading/2010/</loc>
		<lastmod>2010-01-19T19:17:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7298: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-ease-in-quiet-trading/2010/</loc>
		<lastmod>2010-01-19T19:17:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7289: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/scott-brown-boosts-health-stocks/2010/</loc>
		<lastmod>2010-01-19T18:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7292: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/old-gm-is-a-hot-stock-again-but-why/2010/</loc>
		<lastmod>2010-01-19T18:09:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7354: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wyeth-wont-market-sleeplessness-treatment/2010/</loc>
		<lastmod>2010-01-19T18:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7282: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-19/2010/</loc>
		<lastmod>2010-01-19T17:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7287: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-hovers-near-77/2010/</loc>
		<lastmod>2010-01-19T17:21:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7283: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-surprising-prescription/2010/</loc>
		<lastmod>2010-01-19T16:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7316: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/investment-philosophy-top-stock-picks-and-insights-into-market-trends-by-highly-ranked-portfolio-manager-wall-street-transcript-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-19T16:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7288: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/you-can-soon-own-a-little-piece-of-buffett/2010/</loc>
		<lastmod>2010-01-19T16:33:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7296: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genvec-signs-development-deal-with-novartis/2010/</loc>
		<lastmod>2010-01-19T16:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7295: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/get-ready-for-the-fall-4/2010/</loc>
		<lastmod>2010-01-19T16:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7273: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/patricia-russo-is-saving-america-one-board-at-a-time/2010/</loc>
		<lastmod>2010-01-19T15:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7278: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-in-early-rally/2010/</loc>
		<lastmod>2010-01-19T14:58:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7269: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genvec-allied-defense-early-volume-plays/2010/</loc>
		<lastmod>2010-01-19T14:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7321: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-to-wall-street-coverage-upgrades-and-downgrades-minyanville-via-yahoo-finance-2/2010/</loc>
		<lastmod>2010-01-19T14:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7272: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rises-against-the-euro/2010/</loc>
		<lastmod>2010-01-19T12:44:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7259: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-headed-for-weak-open/2010/</loc>
		<lastmod>2010-01-19T12:12:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7260: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-bionovo-inc-issued-by-stockpreacher-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-19T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7271: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/you-can-make-money-in-any-market/2010/</loc>
		<lastmod>2010-01-19T11:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7263: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pioneer-ruling-won%e2%80%99t-alter-plans-for-seeds-the-des-moines-register/2010/</loc>
		<lastmod>2010-01-19T10:10:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7279: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/updated-abbott-statement-to-help-respond-to-growing-health-crisis-abbott-increases-aid-to-2-5-million-for-haiti-relief-and-recovery-efforts/2010/</loc>
		<lastmod>2010-01-19T02:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7274: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ma-outperformed-market-in-2009/2010/</loc>
		<lastmod>2010-01-18T19:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7243: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/european-markets-gain-on-merger-talk/2010/</loc>
		<lastmod>2010-01-18T18:40:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7252: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-mixed-in-quiet-trading/2010/</loc>
		<lastmod>2010-01-18T17:57:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7251: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/greece-is-the-word/2010/</loc>
		<lastmod>2010-01-18T17:53:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7331: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-and-dako-sign-agreement-to-develop-companion-diagnostics-for-cancer-treatments/2010/</loc>
		<lastmod>2010-01-18T17:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7241: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/profits-and-losses-and-banks-oh-my/2010/</loc>
		<lastmod>2010-01-18T16:56:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7257: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/philippines-seeks-voluntary-drug-price-cuts/2010/</loc>
		<lastmod>2010-01-18T13:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7262: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/financial-times-ft-com-financial-times/2010/</loc>
		<lastmod>2010-01-18T12:46:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7261: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cytopia-set-to-quit-asx-herald-sun/2010/</loc>
		<lastmod>2010-01-18T12:27:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7264: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2010-01-18-0905-diary-taiwan-initial-public-offerings-jan-18-interactive-investor/2010/</loc>
		<lastmod>2010-01-18T09:27:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7250: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-under-10-2-hot-biotech-names-2/2010/</loc>
		<lastmod>2010-01-17T19:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7246: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-streets-worst-kept-secret/2010/</loc>
		<lastmod>2010-01-17T12:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7240: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-mistake-could-cost-you-a-fortune/2010/</loc>
		<lastmod>2010-01-17T10:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7210: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-accuses-jj-of-kickback-scheme-with-omnicare/2010/</loc>
		<lastmod>2010-01-17T08:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7236: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/baidu-bulls-hit-the-options-hard/2010/</loc>
		<lastmod>2010-01-16T18:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7232: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/groomed-for-a-comeback/2010/</loc>
		<lastmod>2010-01-16T14:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7231: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/charting-the-market-3/2010/</loc>
		<lastmod>2010-01-16T14:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7244: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/back-on-target/2010/</loc>
		<lastmod>2010-01-16T14:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7228: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/news-you-need/2010/</loc>
		<lastmod>2010-01-16T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7229: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-will-be-the-markets-next-big-movers-2/2010/</loc>
		<lastmod>2010-01-16T12:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7230: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-wealth-building-strategy-for-the-next-10-years/2010/</loc>
		<lastmod>2010-01-16T12:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7222: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-company-settles-lawsuit-san-diego-union-tribune/2010/</loc>
		<lastmod>2010-01-16T08:11:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7237: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-does-your-401k-measure-up/2010/</loc>
		<lastmod>2010-01-16T02:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7225: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-companies-giving-15-5m-for-haiti-relief/2010/</loc>
		<lastmod>2010-01-16T01:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7245: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/doj-suit-not-the-first-for-jj-drug/2010/</loc>
		<lastmod>2010-01-15T23:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7219: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/traders-extend-bets-on-pfizer-energy-cos/2010/</loc>
		<lastmod>2010-01-15T23:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7223: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genzyme-shifts-gears-in-bid-for-rebound-investors-business-daily-via-yahoo-news/2010/</loc>
		<lastmod>2010-01-15T22:42:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7208: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jnjs-really-tough-day-of-kickbacks-and-recalls/2010/</loc>
		<lastmod>2010-01-15T22:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7209: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/breadwinner-moms-stay-at-home-dads-at-all-time-high/2010/</loc>
		<lastmod>2010-01-15T21:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7190: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/triple-digit-selloff-for-the-dow/2010/</loc>
		<lastmod>2010-01-15T21:18:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7193: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-slides-as-weather-warms-stocks-slide/2010/</loc>
		<lastmod>2010-01-15T21:03:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7215: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/get-out-now/2010/</loc>
		<lastmod>2010-01-15T20:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7216: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bank-shares-slide-in-europe/2010/</loc>
		<lastmod>2010-01-15T20:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7200: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/microsoft-abbott-laboratories-money-flow-leaders-msft-abt/2010/</loc>
		<lastmod>2010-01-15T19:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7221: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/michigan%e2%80%99s-aastrom-biosciences-prices-stock-offering-shares-tumble-to-52-week-low-medcity-news/2010/</loc>
		<lastmod>2010-01-15T19:30:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7197: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/feds-accuse-doc-of-faking-research-on-pfizer-merck-drugs/2010/</loc>
		<lastmod>2010-01-15T19:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7204: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oops-sorry-about-that-pfizer/2010/</loc>
		<lastmod>2010-01-15T18:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7198: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fed-up-with-the-fed/2010/</loc>
		<lastmod>2010-01-15T17:45:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7199: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-advance-on-recovery-doubts/2010/</loc>
		<lastmod>2010-01-15T17:33:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7192: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/baby-love/2010/</loc>
		<lastmod>2010-01-15T16:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7224: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-novo-nordisk-bayer-and-jj-lead-downward-trend-market-watch/2010/</loc>
		<lastmod>2010-01-15T16:25:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7194: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/monsanto-rounds-up-documents-for-the-doj/2010/</loc>
		<lastmod>2010-01-15T15:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7187: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-gains-on-euro/2010/</loc>
		<lastmod>2010-01-15T12:55:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7188: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-gains-on-euro-2/2010/</loc>
		<lastmod>2010-01-15T12:55:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7182: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-rxi-pharmaceutical-corp-issued-by-stockpreacher-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-15T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7183: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-cerus-corp-issued-by-stockpreacher-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-15T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7184: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-antigenics-inc-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-15T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7189: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/be-a-penny-stock-millionaire-2/2010/</loc>
		<lastmod>2010-01-15T11:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7180: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-weak-start/2010/</loc>
		<lastmod>2010-01-15T09:53:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7186: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mass-doctor-accused-of-fraud-by-faking-research/2010/</loc>
		<lastmod>2010-01-15T02:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7168: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-stocks-end-at-15-month-high/2010/</loc>
		<lastmod>2010-01-14T23:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7173: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/turns-out-pfizer-was-also-questioned-in-eu-on-generic-deals/2010/</loc>
		<lastmod>2010-01-14T23:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7160: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-finds-no-heart-risk-with-spiriva-inhaler/2010/</loc>
		<lastmod>2010-01-14T23:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7126: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-ease-after-auction/2010/</loc>
		<lastmod>2010-01-14T22:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7161: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-no-heart-risk-seen-with-pfizer-copd-drug-fda/2010/</loc>
		<lastmod>2010-01-14T22:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7128: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-flat-after-retail-sales-report/2010/</loc>
		<lastmod>2010-01-14T22:26:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7162: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/spiriva-safety-confirmed/2010/</loc>
		<lastmod>2010-01-14T22:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7195: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-18/2010/</loc>
		<lastmod>2010-01-14T21:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7196: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-18/2010/</loc>
		<lastmod>2010-01-14T21:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7220: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-fda-sees-no-link-to-risks-with-pfizers-spiriva/2010/</loc>
		<lastmod>2010-01-14T21:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7141: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-manage-gains-in-choppy-session/2010/</loc>
		<lastmod>2010-01-14T21:19:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7157: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/that-novartis-alcon-deal-may-have-a-tax-problem/2010/</loc>
		<lastmod>2010-01-14T20:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7211: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-your-401k-one-of-the-best/2010/</loc>
		<lastmod>2010-01-14T20:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7156: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jpmorgan-challenge-do-you-heart-this-company/2010/</loc>
		<lastmod>2010-01-14T19:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7212: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/roundtable-which-health-care-stocks-to-buy-now/2010/</loc>
		<lastmod>2010-01-14T19:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7148: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-firms-aid-victims-of-haiti-earthquake/2010/</loc>
		<lastmod>2010-01-14T18:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7152: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tax-big-banks-to-death-hold-on-a-sec/2010/</loc>
		<lastmod>2010-01-14T18:15:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7227: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/from-30000-to-retired-in-15-years/2010/</loc>
		<lastmod>2010-01-14T18:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7140: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-merck-rating-that-got-everybody-so-excited/2010/</loc>
		<lastmod>2010-01-14T18:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7136: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-gets-european-approval-for-cancer-test/2010/</loc>
		<lastmod>2010-01-14T17:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7132: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/flying-with-airlines-apple-and-google/2010/</loc>
		<lastmod>2010-01-14T17:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7146: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-doing-right-by-shareholders-3/2010/</loc>
		<lastmod>2010-01-14T16:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7130: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-says-cooperating-with-eu-on-patent-probe/2010/</loc>
		<lastmod>2010-01-14T16:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7144: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-falls-on-warmer-weather/2010/</loc>
		<lastmod>2010-01-14T16:38:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7133: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-merck-halliburton-electronic-arts-netapp-and-cbs-released-by-seven-summits-research/2010/</loc>
		<lastmod>2010-01-14T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7137: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-receives-european-regulatory-approval-for-new-ovarian-cancer-diagnostic-test/2010/</loc>
		<lastmod>2010-01-14T16:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7201: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-abt-9/2010/</loc>
		<lastmod>2010-01-14T16:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7147: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-value-investing-dead/2010/</loc>
		<lastmod>2010-01-14T15:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7131: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-to-invest-for-the-next-10-years/2010/</loc>
		<lastmod>2010-01-14T14:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7129: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rises-ahead-of-economic-reports/2010/</loc>
		<lastmod>2010-01-14T13:12:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7127: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-edge-higher/2010/</loc>
		<lastmod>2010-01-14T13:05:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7185: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-cancer-push-on-bone-drug-may-key-stock-turnaround-in-2010-businessweek/2010/</loc>
		<lastmod>2010-01-14T12:41:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7124: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-la-jolla-pharmaceutical-co-issued-by-stockpreacher-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-14T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7125: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-mdrna-inc-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-14T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7120: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/flat-start-seen-for-stocks-2/2010/</loc>
		<lastmod>2010-01-14T09:48:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7121: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/flat-start-seen-for-stocks-2/2010/</loc>
		<lastmod>2010-01-14T09:48:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7118: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/banks-face-big-losses-and-bonus-backlash/2010/</loc>
		<lastmod>2010-01-14T09:07:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7113: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-cancer-push-on-bone-drug-may-key-stock-turnaround-in-2010-bloomberg/2010/</loc>
		<lastmod>2010-01-14T05:42:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7138: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/foundations-corporations-pledge-haiti-relief/2010/</loc>
		<lastmod>2010-01-14T04:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7107: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-to-provide-1-million-in-funding-products-to-help-address-health-needs-in-haiti/2010/</loc>
		<lastmod>2010-01-14T03:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7102: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sectors-set-to-pop-in-the-next-stage-of-the-rally/2010/</loc>
		<lastmod>2010-01-14T03:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7123: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/weak-grilling-lifts-stocks/2010/</loc>
		<lastmod>2010-01-14T02:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7103: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-recap-how-to-profit-from-googles-speed-bump-in-china-final/2010/</loc>
		<lastmod>2010-01-14T02:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7104: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-recap-how-to-profit-from-googles-speed-bump-in-china-final/2010/</loc>
		<lastmod>2010-01-14T02:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7097: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-get-sector-boost/2010/</loc>
		<lastmod>2010-01-14T00:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5393: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/hershey-green-mountain-google-are-movers/2010/</loc>
		<lastmod>2010-01-14T00:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7145: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-supervalu-inc-target-novartis-vanda-pharmaceuticals-and-eli-lilly/2010/</loc>
		<lastmod>2010-01-14T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7066: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-leads-bounce-in-dow/2010/</loc>
		<lastmod>2010-01-13T23:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7058: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-rally-in-late-trade/2010/</loc>
		<lastmod>2010-01-13T23:22:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7096: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/diabetes-is-killing-our-citizens-and-our-economy/2010/</loc>
		<lastmod>2010-01-13T23:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7172: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-stocks-snapshot-sp-rises-1-pct-as-market-extends-gains/2010/</loc>
		<lastmod>2010-01-13T22:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7060: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-after-auction-2/2010/</loc>
		<lastmod>2010-01-13T22:25:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7081: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/better-marks-for-merck/2010/</loc>
		<lastmod>2010-01-13T21:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7166: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ftc-wants-ban-on-drug-settlements-in-health-bill/2010/</loc>
		<lastmod>2010-01-13T21:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7167: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ftc-wants-ban-on-drug-settlements-in-health-bill/2010/</loc>
		<lastmod>2010-01-13T21:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7083: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-upgraded-on-drug-pipeline-shares-rise/2010/</loc>
		<lastmod>2010-01-13T21:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7158: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/street-rallies-after-slow-start/2010/</loc>
		<lastmod>2010-01-13T20:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7174: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/top-takes-from-realmoney-4/2010/</loc>
		<lastmod>2010-01-13T20:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7049: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-closes-below-80-on-supply-concerns/2010/</loc>
		<lastmod>2010-01-13T20:26:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7092: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/making-the-most-of-your-dividends/2010/</loc>
		<lastmod>2010-01-13T20:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7078: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/enzon-shares-jump-on-pfizer-rumor/2010/</loc>
		<lastmod>2010-01-13T20:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7159: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-stocks-markets-rise-on-merck-upgrade-kraft-outlook/2010/</loc>
		<lastmod>2010-01-13T20:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7072: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/currencies-stocks-rebound-after-china-scare/2010/</loc>
		<lastmod>2010-01-13T19:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7089: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-best-stocks-to-buy-in-this-market-2/2010/</loc>
		<lastmod>2010-01-13T19:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7093: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jpmorgan-challenge-on-the-cusp-of-greatness/2010/</loc>
		<lastmod>2010-01-13T19:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7084: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-azn-13/2010/</loc>
		<lastmod>2010-01-13T19:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7163: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-best-stocks-for-your-ira/2010/</loc>
		<lastmod>2010-01-13T19:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7074: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/protalix-drug-recommended-for-special-status/2010/</loc>
		<lastmod>2010-01-13T18:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7077: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/google-rolls-the-dice-in-china/2010/</loc>
		<lastmod>2010-01-13T18:06:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7065: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/watching-and-waiting/2010/</loc>
		<lastmod>2010-01-13T17:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7075: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-offers-online-enrollment-and-additional-improvements-to-patient-assistance-program/2010/</loc>
		<lastmod>2010-01-13T17:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7153: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-17/2010/</loc>
		<lastmod>2010-01-13T17:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7149: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-pfe-5/2010/</loc>
		<lastmod>2010-01-13T16:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7150: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-pfe-5/2010/</loc>
		<lastmod>2010-01-13T16:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7080: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/serbia-to-stop-import-of-swine-flu-vaccines/2010/</loc>
		<lastmod>2010-01-13T16:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7067: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ahead-of-the-bell-merck-upgraded-on-drug-pipeline/2010/</loc>
		<lastmod>2010-01-13T16:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7055: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-analysts-upgrades-downgrades/2010/</loc>
		<lastmod>2010-01-13T16:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7114: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-merck-pharmacyclics-lead-drug-stocks-north-market-watch/2010/</loc>
		<lastmod>2010-01-13T15:56:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7063: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/credit-suisse-upgrades-astrazeneca/2010/</loc>
		<lastmod>2010-01-13T15:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7061: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-mixed-against-rivals-4/2010/</loc>
		<lastmod>2010-01-13T15:32:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7056: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-gets-upgraded-by-credit-suisse/2010/</loc>
		<lastmod>2010-01-13T15:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7057: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-pharma-generic-competition-and-cash/2010/</loc>
		<lastmod>2010-01-13T15:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7134: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/live-chat-how-to-profit-in-any-market/2010/</loc>
		<lastmod>2010-01-13T14:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7070: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/european-medicines-agencys-comp-adopts-positive-opinion-for-the-orphan-drug-designation-for-protalixs-taliglucerase-alfa/2010/</loc>
		<lastmod>2010-01-13T14:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7109: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/allon-ceo-to-present-at-biotech-showcase-2010-marketwire/2010/</loc>
		<lastmod>2010-01-13T14:15:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7111: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/allon-ceo-to-present-at-biotech-showcase-2010-marketwire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-13T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7135: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/four-things-to-watch-for-in-4q-earnings/2010/</loc>
		<lastmod>2010-01-13T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7054: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/europe-cancels-vaccine-orders/2010/</loc>
		<lastmod>2010-01-13T12:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7047: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/europe-cancels-h1n1-shots/2010/</loc>
		<lastmod>2010-01-13T12:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7108: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-spectrum-pharmaceuticals-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-13T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7110: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-peregrine-pharmaceuticals-inc-issued-by-stockpreacher-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-13T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7050: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/profit-on-a-flat-stock-3/2010/</loc>
		<lastmod>2010-01-13T11:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7059: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-are-the-markets-strongest-buys/2010/</loc>
		<lastmod>2010-01-13T11:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7046: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-tepid-start/2010/</loc>
		<lastmod>2010-01-13T09:51:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7112: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/omnia-biologics-and-biotech-experts-announce-deal-for-manufacturing-and-process-development-services-news-medical-net/2010/</loc>
		<lastmod>2010-01-13T04:35:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7048: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-flu-shot-goes-to-india/2010/</loc>
		<lastmod>2010-01-12T23:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7043: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/illuminas-cheap-new-gene-machine/2010/</loc>
		<lastmod>2010-01-12T22:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7042: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medco-2010-profit-outlook-is-near-street-estimates/2010/</loc>
		<lastmod>2010-01-12T21:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7015: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-sink-on-earnings-woes/2010/</loc>
		<lastmod>2010-01-12T21:17:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7115: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wound-management-technologies-inc-taps-veteran-deborah-jenkins-hutchinson-as-president-to-spearhead-biotech-and-pr-newswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-12T21:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7032: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/putting-the-spotlight-on-high-drug-prices/2010/</loc>
		<lastmod>2010-01-12T21:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7035: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tysabri-its-a-blockbuster-yawn-so-what/2010/</loc>
		<lastmod>2010-01-12T19:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7024: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-sees-big-prevnar-13-sales-among-adults/2010/</loc>
		<lastmod>2010-01-12T19:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7033: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-under-10-2-hot-biotech-names/2010/</loc>
		<lastmod>2010-01-12T19:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7028: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/swine-flu-the-side-dish-that-couldnt-last/2010/</loc>
		<lastmod>2010-01-12T19:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7029: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-stock-screaming-buy-me-5/2010/</loc>
		<lastmod>2010-01-12T18:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7022: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/hip-hip-hooray-oh-wait/2010/</loc>
		<lastmod>2010-01-12T18:22:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7034: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-5-eu-to-scrutinise-drug-patent-settlements/2010/</loc>
		<lastmod>2010-01-12T18:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7030: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sciclone-drug-strengthens-swine-flu-shot-in-tests/2010/</loc>
		<lastmod>2010-01-12T16:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7017: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-firms-on-china-earnings-jitters/2010/</loc>
		<lastmod>2010-01-12T15:46:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7018: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-firms-on-china-earnings-jitters/2010/</loc>
		<lastmod>2010-01-12T15:46:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7019: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fearful-stocks-for-greedy-investors-3/2010/</loc>
		<lastmod>2010-01-12T14:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7021: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sciclone-says-zadaxin-is-effective/2010/</loc>
		<lastmod>2010-01-12T14:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7016: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-slides-as-u-s-weather-warms/2010/</loc>
		<lastmod>2010-01-12T14:13:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7020: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-health-care-gurus-stock-picks-for-2010/2010/</loc>
		<lastmod>2010-01-12T13:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7014: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ventirx-pharmaceuticals-raises-25-million-in-series-a-extension-financing/2010/</loc>
		<lastmod>2010-01-12T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7012: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-advance-on-earnings-concern/2010/</loc>
		<lastmod>2010-01-12T12:34:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7039: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/johnson-johnson-profitability-from-stability/2010/</loc>
		<lastmod>2010-01-12T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7116: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-stemcells-inc-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-12T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7117: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-alert-for-vivus-inc-issued-by-beacon-equity-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-12T11:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7008: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-tumble/2010/</loc>
		<lastmod>2010-01-12T10:04:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7009: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/iraqi-oil-may-rival-saudi-arabia/2010/</loc>
		<lastmod>2010-01-12T08:58:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7006: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/european-stocks-seen-flat-to-lower-ino-news/2010/</loc>
		<lastmod>2010-01-12T07:26:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7013: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/correction-shareholders-file-lawsuit-against-novartis-alcon-over-merger-ksf-announces-lawsuit/2010/</loc>
		<lastmod>2010-01-12T06:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6967: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-churn-as-results-start-to-pour-in/2010/</loc>
		<lastmod>2010-01-11T23:15:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6993: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/in-depth-seven-ways-germs-can-be-good-for-you/2010/</loc>
		<lastmod>2010-01-11T23:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6994: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/in-depth-seven-ways-germs-can-be-good-for-you/2010/</loc>
		<lastmod>2010-01-11T23:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6987: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/germs-that-are-good-for-you/2010/</loc>
		<lastmod>2010-01-11T23:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6988: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drug-news-impotence-arthritis-and-schizophrenia/2010/</loc>
		<lastmod>2010-01-11T22:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6990: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/shareholders-file-lawsuit-against-novartis-alcon-over-merger-ksf-announces-lawsuit/2010/</loc>
		<lastmod>2010-01-11T21:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6989: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-merck-cutting-jobs-following-mergers/2010/</loc>
		<lastmod>2010-01-11T21:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7005: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/spherix-to-present-at-annual-onemedplace-finance-forum-and-at-ebd-biotech-showcase-in-san-francisco-pr-newswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-11T20:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7011: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/targacept-gets-200m-payment-from-astrazeneca/2010/</loc>
		<lastmod>2010-01-11T20:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6963: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-slides-on-outlook-for-warmer-weather/2010/</loc>
		<lastmod>2010-01-11T20:00:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6982: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-stocks-are-growth-traps-2/2010/</loc>
		<lastmod>2010-01-11T19:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7000: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/capstone-therapeutics-to-present-at-biotech-showcase-2010-globenewswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-11T19:40:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6979: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facebook-gm-lead-2010-ipo-candidates/2010/</loc>
		<lastmod>2010-01-11T19:27:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6984: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/celgene-revs-up-for-a-new-year/2010/</loc>
		<lastmod>2010-01-11T19:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6976: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/analyst-reaffirms-mannkind-rating/2010/</loc>
		<lastmod>2010-01-11T19:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6991: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/our-supercomputer-loves-these-stocks-2/2010/</loc>
		<lastmod>2010-01-11T18:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6992: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-to-do-with-that-holiday-cash/2010/</loc>
		<lastmod>2010-01-11T18:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6975: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/flu-vaccine-u-s-cuts-order-u-k-tries-to-recoup-costs/2010/</loc>
		<lastmod>2010-01-11T18:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6980: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-recover-on-fed-outlook/2010/</loc>
		<lastmod>2010-01-11T17:41:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6977: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/questionable-spin-marketers-push-the-envelope-in-tough-times/2010/</loc>
		<lastmod>2010-01-11T17:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7004: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-smackdown-cramer-vs-caps-the-motley-fool-3/2010/</loc>
		<lastmod>2010-01-11T17:14:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6972: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stanfords-continuing-medical-ed-brought-to-you-by-pfizer/2010/</loc>
		<lastmod>2010-01-11T16:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7001: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/resverlogix-presenting-at-biotech-showcase-cnw-group-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-11T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7002: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/resverlogix-presenting-at-biotech-showcase-pr-newswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-11T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6971: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bracing-for-earnings-season-kickoff/2010/</loc>
		<lastmod>2010-01-11T15:39:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7003: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/osteologix-to-present-at-biotech-showcase-2010-business-wire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-11T15:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6968: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-falls-to-3-week-low/2010/</loc>
		<lastmod>2010-01-11T14:59:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 7007: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cyclacel-takes-the-money-and-runs-biobuzz-thestreet-com/2010/</loc>
		<lastmod>2010-01-11T14:41:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6973: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-dogs-are-best-2010-bets-poll/2010/</loc>
		<lastmod>2010-01-11T14:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6964: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bulls-charge-into-earnings-season/2010/</loc>
		<lastmod>2010-01-11T14:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6965: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/low-vix-doesnt-necessarily-mean-a-market-top/2010/</loc>
		<lastmod>2010-01-11T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6962: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-kick-off-the-week-higher/2010/</loc>
		<lastmod>2010-01-11T09:35:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 128: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bull-market-grows-up/2010/</loc>
		<lastmod>2010-01-10T21:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6961: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-mistake-to-blame-for-mannkind-delay/2010/</loc>
		<lastmod>2010-01-10T18:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6955: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-rally-into-earnings-season/2010/</loc>
		<lastmod>2010-01-10T12:41:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6960: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/which-stocks-will-be-2020s-10-baggers/2010/</loc>
		<lastmod>2010-01-10T12:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6957: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-wrong-way-to-invest-in-china-2/2010/</loc>
		<lastmod>2010-01-10T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6958: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-pharma-feed-biotech-startups-record-funds-san-francisco-chronicle/2010/</loc>
		<lastmod>2010-01-10T08:44:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6959: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-pharma-feed-biotech-startups-record-funds-san-francisco-chronicle/2010/</loc>
		<lastmod>2010-01-10T08:44:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6956: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/good-riddance-2009/2010/</loc>
		<lastmod>2010-01-09T14:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6969: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/review-2/2010/</loc>
		<lastmod>2010-01-09T14:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6935: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-tech-shines/2010/</loc>
		<lastmod>2010-01-09T02:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6929: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mannkind-faces-fda-delay-on-inhaled-insulin/2010/</loc>
		<lastmod>2010-01-09T00:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6930: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/phrma-adds-7-biotech-companies-to-its-membership/2010/</loc>
		<lastmod>2010-01-08T22:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6931: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbotts-stent-struggling-to-maintain-market-share/2010/</loc>
		<lastmod>2010-01-08T21:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6932: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbotts-stent-struggling-to-maintain-market-share/2010/</loc>
		<lastmod>2010-01-08T21:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6896: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-stage-late-advance/2010/</loc>
		<lastmod>2010-01-08T21:15:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6921: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/teva-and-the-narrowing-gap-between-generics-and-big-pharma/2010/</loc>
		<lastmod>2010-01-08T21:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6897: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rebounds-after-jobs-report/2010/</loc>
		<lastmod>2010-01-08T20:33:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6917: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/heartburn-relieved-for-now/2010/</loc>
		<lastmod>2010-01-08T19:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6918: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/heartburn-relieved-for-now/2010/</loc>
		<lastmod>2010-01-08T19:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6945: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-stock-has-tremendous-upside-the-motley-fool-4/2010/</loc>
		<lastmod>2010-01-08T19:14:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6948: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/an-unusual-options-play-bets-on-a-big-move-for-this-biotech-firm-schaeffers-research/2010/</loc>
		<lastmod>2010-01-08T18:37:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6922: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-having-a-garage-sale/2010/</loc>
		<lastmod>2010-01-08T18:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6912: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-boston-scientific-stent-approved-in-japan/2010/</loc>
		<lastmod>2010-01-08T18:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6905: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sell-bank-of-america-against-the-grain/2010/</loc>
		<lastmod>2010-01-08T18:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6906: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sell-bank-of-america-against-the-grain/2010/</loc>
		<lastmod>2010-01-08T18:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6915: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-great-job-fake-out/2010/</loc>
		<lastmod>2010-01-08T17:27:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6916: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-great-job-fake-out-2/2010/</loc>
		<lastmod>2010-01-08T17:27:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6895: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-get-boost-as-job-market-weakens/2010/</loc>
		<lastmod>2010-01-08T16:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6941: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-a-victim-of-frustration-otago-daily-times/2010/</loc>
		<lastmod>2010-01-08T16:16:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6951: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/japan-regulators-approve-abbott-xience-v-stent/2010/</loc>
		<lastmod>2010-01-08T15:51:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6940: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-cytori-genzyme-teva-lead-drug-stock-north-market-watch/2010/</loc>
		<lastmod>2010-01-08T15:40:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6952: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-abt-8/2010/</loc>
		<lastmod>2010-01-08T15:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6900: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbotts-xience-vr-approved-in-japan-second-largest-drug-eluting-stent-market-worldwide/2010/</loc>
		<lastmod>2010-01-08T15:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6898: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-slips-on-jobs-drop/2010/</loc>
		<lastmod>2010-01-08T15:19:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6899: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-slips-on-jobs-drop/2010/</loc>
		<lastmod>2010-01-08T15:19:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6923: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/indias-rising-tech-stars/2010/</loc>
		<lastmod>2010-01-08T13:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6901: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/hancock-fund-soars-during-recession/2010/</loc>
		<lastmod>2010-01-08T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6903: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/make-millions-from-thousands/2010/</loc>
		<lastmod>2010-01-08T11:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6939: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nows-the-time-to-invest-in-these-stocks/2010/</loc>
		<lastmod>2010-01-08T11:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6894: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-brace-for-jobs-report/2010/</loc>
		<lastmod>2010-01-08T09:30:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6943: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-stock-falls-as-fda-says-it-will-study-anemia-drugs-ventura-county-star/2010/</loc>
		<lastmod>2010-01-08T08:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6942: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-plant-being-set-up-the-star/2010/</loc>
		<lastmod>2010-01-08T02:29:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6892: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/teva-sees-revenue-more-than-doubling-by-2015/2010/</loc>
		<lastmod>2010-01-08T00:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6893: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/qorvis-new-hires-support-advertising-interactive-public-affairs-clients/2010/</loc>
		<lastmod>2010-01-07T23:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6891: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-labs-pays-22-5m-to-settle-state-lawsuits/2010/</loc>
		<lastmod>2010-01-07T22:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6872: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-abbott-to-pay-states-22-5-mln-in-tricor-deal/2010/</loc>
		<lastmod>2010-01-07T22:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6919: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/alcon-shareholders-without-rights/2010/</loc>
		<lastmod>2010-01-07T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6920: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/alcon-shareholders-without-rights/2010/</loc>
		<lastmod>2010-01-07T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6867: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/blue-chips-gain-ahead-of-jobs-report/2010/</loc>
		<lastmod>2010-01-07T21:22:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6884: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/uh-oh-the-return-of-3-gas/2010/</loc>
		<lastmod>2010-01-07T20:23:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6873: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cash-crunch-may-force-ny-to-delay-checks-again-gov/2010/</loc>
		<lastmod>2010-01-07T19:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6877: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-strides-farther-into-generics/2010/</loc>
		<lastmod>2010-01-07T19:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6880: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-latest-deal-in-the-big-pharma-generics-wars/2010/</loc>
		<lastmod>2010-01-07T19:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6887: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/warning-potential-anemic-growth-ahead/2010/</loc>
		<lastmod>2010-01-07T19:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6874: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-staff-against-new-use-of-forest-labs-drug/2010/</loc>
		<lastmod>2010-01-07T19:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6885: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-fall-on-employment-outlook/2010/</loc>
		<lastmod>2010-01-07T18:34:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6882: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-enters-melanoma-partnership-with-debiopharm/2010/</loc>
		<lastmod>2010-01-07T17:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6888: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/time-for-u-k-biotech-to-scale-up-or-die/2010/</loc>
		<lastmod>2010-01-07T17:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6871: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-hits-4-month-high-against-yen/2010/</loc>
		<lastmod>2010-01-07T16:21:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6878: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-to-hold-fourth-quarter-2009-sales-and-earnings-conference-call-on-feb-16/2010/</loc>
		<lastmod>2010-01-07T15:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6869: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-and-debiopharm-collaborate-to-co-develop-investigational-compound-tremelimumab-cp-675206-in-advanced-melanoma/2010/</loc>
		<lastmod>2010-01-07T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6875: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-makes-deal-with-generic-challenger/2010/</loc>
		<lastmod>2010-01-07T13:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6864: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-slips-below-83/2010/</loc>
		<lastmod>2010-01-07T12:50:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6946: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/methylgene-to-present-at-biotech-showcase-2010-ccnmatthews-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-07T12:32:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6944: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/methylgene-to-present-at-biotech-showcase-2010-marketwire/2010/</loc>
		<lastmod>2010-01-07T12:32:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6947: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/methylgene-to-present-at-biotech-showcase-2010-marketwire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-07T12:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6863: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/good-stocks-to-buy-now-3/2010/</loc>
		<lastmod>2010-01-07T11:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6858: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-a-lower-start/2010/</loc>
		<lastmod>2010-01-07T09:36:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6862: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/portfolio-the-clarion-ledger/2010/</loc>
		<lastmod>2010-01-07T07:07:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6861: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/corporate-report-the-sarasota-herald-tribune/2010/</loc>
		<lastmod>2010-01-07T06:02:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6865: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-i-wrote-last-year/2010/</loc>
		<lastmod>2010-01-07T01:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6849: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/blood-thinner-battle-heats-up-2/2010/</loc>
		<lastmod>2010-01-07T01:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6851: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/little-warning-big-message-2/2010/</loc>
		<lastmod>2010-01-07T01:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6852: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-biogeneric-no-brainer-2/2010/</loc>
		<lastmod>2010-01-07T01:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6866: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-kraft-foods-alcon-inc-novartis-ag-cadbury-plc-and-ford-motor-co/2010/</loc>
		<lastmod>2010-01-07T00:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6847: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mannkind-shares-gain-ground-ahead-of-fda-decision/2010/</loc>
		<lastmod>2010-01-06T23:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6838: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-hates-political-uncertainty/2010/</loc>
		<lastmod>2010-01-06T21:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6839: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/can-a-japanese-cloth-company-make-drugs-fda-says-yes/2010/</loc>
		<lastmod>2010-01-06T21:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6818: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-end-with-little-change/2010/</loc>
		<lastmod>2010-01-06T21:22:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6814: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rallies-to-14-month-high/2010/</loc>
		<lastmod>2010-01-06T20:58:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6835: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dodd-dorgan-and-health-care-stocks/2010/</loc>
		<lastmod>2010-01-06T20:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6854: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gilead-goes-it-alone-for-now/2010/</loc>
		<lastmod>2010-01-06T20:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6836: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-2010-winners/2010/</loc>
		<lastmod>2010-01-06T19:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6826: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/three-etfs-for-the-new-bull-market/2010/</loc>
		<lastmod>2010-01-06T19:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6821: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/google-vs-apple-which-stock-rules/2010/</loc>
		<lastmod>2010-01-06T19:08:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6827: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-like-much-of-big-pharma-pushes-further-into-generics/2010/</loc>
		<lastmod>2010-01-06T18:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6860: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/small-cap-biotech-stocks-why-this-sector-is-set-for-a-huge-year-guru-focus/2010/</loc>
		<lastmod>2010-01-06T18:34:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6828: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-and-strides-arcolab-in-generic-drug-pact/2010/</loc>
		<lastmod>2010-01-06T18:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6829: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ensemble-signs-development-deal-with-pfizer/2010/</loc>
		<lastmod>2010-01-06T18:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6833: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-doing-right-by-shareholders-2/2010/</loc>
		<lastmod>2010-01-06T17:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6837: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/your-false-sense-of-financial-security/2010/</loc>
		<lastmod>2010-01-06T17:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6859: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/google-vs-apple-which-is-the-better-stock-cnn-money/2010/</loc>
		<lastmod>2010-01-06T17:27:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6823: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-slip-on-upbeat-jobs-data/2010/</loc>
		<lastmod>2010-01-06T17:16:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6815: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-expands-generics-business-with-strides-deal/2010/</loc>
		<lastmod>2010-01-06T17:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6816: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-and-strides-arcolab-to-collaborate-on-generic-products/2010/</loc>
		<lastmod>2010-01-06T17:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6824: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-this-the-year-of-the-dollar/2010/</loc>
		<lastmod>2010-01-06T16:57:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6825: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/economics-and-employee-wellness/2010/</loc>
		<lastmod>2010-01-06T16:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6817: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/skadden-takes-top-seat-as-legal-dealmaker-of-2009/2010/</loc>
		<lastmod>2010-01-06T16:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6820: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-dips-against-euro-2/2010/</loc>
		<lastmod>2010-01-06T15:51:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6812: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biopharmaceutical-industry-is-banking-on-boston-new-york-times/2010/</loc>
		<lastmod>2010-01-06T09:47:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6811: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-ease-downward/2010/</loc>
		<lastmod>2010-01-06T09:32:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6834: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ma-looks-good-for-2010/2010/</loc>
		<lastmod>2010-01-06T01:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6796: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/study-undermines-case-for-antidepressants/2010/</loc>
		<lastmod>2010-01-06T00:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6793: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/green-innovation/2010/</loc>
		<lastmod>2010-01-05T23:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6797: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/spending-worries-damp-stocks/2010/</loc>
		<lastmod>2010-01-05T23:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6794: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/deal-profile-novartis-moves-to-take-control-of-nestles-alcon/2010/</loc>
		<lastmod>2010-01-05T23:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6805: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eight-firms-in-gwdn-index-return-triple-digit-stock-price-increases-in-09-genomeweb-news/2010/</loc>
		<lastmod>2010-01-05T23:00:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6789: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/berkshire-warns-kraft-on-cadbury-bid/2010/</loc>
		<lastmod>2010-01-05T22:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6775: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-little-changed-after-mixed-economic-data/2010/</loc>
		<lastmod>2010-01-05T22:07:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6773: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-steadies-at-14-month-high/2010/</loc>
		<lastmod>2010-01-05T21:30:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6798: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/defensives-still-offer-value-here/2010/</loc>
		<lastmod>2010-01-05T21:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6763: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-struggle-after-rally/2010/</loc>
		<lastmod>2010-01-05T21:15:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6779: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/warren-buffetts-ma-101-lesson-for-kraft/2010/</loc>
		<lastmod>2010-01-05T20:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6784: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-deal-manufactured-by-necessity/2010/</loc>
		<lastmod>2010-01-05T19:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6785: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/find-your-biggest-cash-flow-leaks/2010/</loc>
		<lastmod>2010-01-05T19:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6786: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vertex-shares-dip-on-wedbush-securities-downgrade/2010/</loc>
		<lastmod>2010-01-05T19:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6782: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-up-on-home-sales-drop/2010/</loc>
		<lastmod>2010-01-05T19:09:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6783: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lillys-effient-cheap-enough-for-now/2010/</loc>
		<lastmod>2010-01-05T18:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6781: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/two-fake-insights-that-will-sink-your-portfolio/2010/</loc>
		<lastmod>2010-01-05T18:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6804: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-stocks-recent-slide-has-attracted-the-attention-of-put-players-schaeffers-research/2010/</loc>
		<lastmod>2010-01-05T17:52:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6757: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-invites-public-to-view-and-listen-to-webcast-of-pfizer-presentation-at-healthcare-conference/2010/</loc>
		<lastmod>2010-01-05T17:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6758: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-pfizer-hewlett-packard-applied-materials-ppg-industries-and-anglogold-ashanti-released-by-seven-summits-research/2010/</loc>
		<lastmod>2010-01-05T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6776: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/morning-movers-berkshire-votes-no-on-kraft-cadbury-bid-brokers-outlook-cut/2010/</loc>
		<lastmod>2010-01-05T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6777: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-smartest-money-move-youll-ever-make/2010/</loc>
		<lastmod>2010-01-05T16:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6760: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fitz-bits-two-ways-to-trade-pfizer/2010/</loc>
		<lastmod>2010-01-05T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6806: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-dip-biogen-slips-on-ceo-update-market-watch/2010/</loc>
		<lastmod>2010-01-05T15:55:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6759: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nestl-sharpens-food-portfolio/2010/</loc>
		<lastmod>2010-01-05T15:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6762: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mondays-biggest-stock-stars/2010/</loc>
		<lastmod>2010-01-05T14:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6803: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/your-money-with-chuck-jaffe-four-tech-two-biotech-stocks-lead-managers-picks-market-watch/2010/</loc>
		<lastmod>2010-01-05T14:10:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6751: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/j-p-morgan-healthcare-confab-preview/2010/</loc>
		<lastmod>2010-01-05T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6741: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-a-flat-open/2010/</loc>
		<lastmod>2010-01-05T12:36:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6742: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/kraft-sells-pizza-ups-cash-bid-for-cadbury/2010/</loc>
		<lastmod>2010-01-05T12:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6749: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mindup-cancer-project-integrated-into-hiru-news-medical-net/2010/</loc>
		<lastmod>2010-01-05T10:12:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6750: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mutual-fund-glossary-usa-today/2010/</loc>
		<lastmod>2010-01-05T02:08:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6748: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biogen-idec-ceo-to-retire-in-june-malaysianews-net/2010/</loc>
		<lastmod>2010-01-05T00:24:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6735: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gains-to-ring-in-2010-on-wall-street/2010/</loc>
		<lastmod>2010-01-05T00:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6729: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-johnson-johnson-viropharma-theravance-cubist-pharmaceutical-and-pfizer/2010/</loc>
		<lastmod>2010-01-05T00:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6730: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-gets-european-ok-for-intravenous-revatio/2010/</loc>
		<lastmod>2010-01-04T23:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6737: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/one-in-the-eye-for-alcon-investors/2010/</loc>
		<lastmod>2010-01-04T22:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6732: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-i-wrote-this-year/2010/</loc>
		<lastmod>2010-01-04T22:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6733: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-i-wrote-this-year/2010/</loc>
		<lastmod>2010-01-04T22:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6724: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-stocks-charge-into-2010/2010/</loc>
		<lastmod>2010-01-04T21:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6693: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-industrials-jump-1-5/2010/</loc>
		<lastmod>2010-01-04T21:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6746: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/you-ask-stockpickr-answers-thestreet-com/2010/</loc>
		<lastmod>2010-01-04T21:31:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6726: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-deal-could-move-swiss-etf-further/2010/</loc>
		<lastmod>2010-01-04T21:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6687: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-ends-at-highest-level-in-14-months/2010/</loc>
		<lastmod>2010-01-04T20:47:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6706: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-start-off-2010-with-a-rally/2010/</loc>
		<lastmod>2010-01-04T19:42:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6738: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/you-dont-need-your-contacts-in-to-see-this-deal/2010/</loc>
		<lastmod>2010-01-04T19:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6683: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bulls-break-out-in-new-year/2010/</loc>
		<lastmod>2010-01-04T19:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6707: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-invites-public-to-listen-to-webcast-of-pfizer-discussion-at-healthcare-conference-3/2010/</loc>
		<lastmod>2010-01-04T19:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6708: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/european-commission-approves-new-intravenous-formulation-of-pfizer%e2%80%99s-revatio%c2%ae-sildenafil-for-the-treatment-of-pulmonary-arterial-hypertension/2010/</loc>
		<lastmod>2010-01-04T19:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6720: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/kraft-is-sweet-like-candy/2010/</loc>
		<lastmod>2010-01-04T18:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6682: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-seeks-control-of-alcon/2010/</loc>
		<lastmod>2010-01-04T18:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6723: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-amid-investor-optimism/2010/</loc>
		<lastmod>2010-01-04T18:30:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6716: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-starts-new-year-in-decline/2010/</loc>
		<lastmod>2010-01-04T18:10:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6717: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/surprise-the-fed-says-dont-blame-the-fed/2010/</loc>
		<lastmod>2010-01-04T17:59:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6699: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/alcon-deal-gives-nestle-the-cash-for-cadbury-bid/2010/</loc>
		<lastmod>2010-01-04T17:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6710: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/which-health-stock-will-be-healthiest-in-2010/2010/</loc>
		<lastmod>2010-01-04T17:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6711: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/which-health-stock-will-be-healthiest-in-2010/2010/</loc>
		<lastmod>2010-01-04T17:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6743: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-closes-the-year-on-an-upswing-pr-newswire-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-04T17:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6701: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/morning-movers-morgan-stanley-gets-two-thumbs-up-chesapeakes-big-deal/2010/</loc>
		<lastmod>2010-01-04T16:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6702: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-alcon-not-really-a-consumer-health-deal/2010/</loc>
		<lastmod>2010-01-04T16:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6703: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nestle-clearing-way-for-cadbury-bid/2010/</loc>
		<lastmod>2010-01-04T16:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6780: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/deals-of-the-day-is-the-bidding-for-cadbury-about-to-heat-up/2010/</loc>
		<lastmod>2010-01-04T16:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6696: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-to-present-at-j-p-morgan-healthcare-conference/2010/</loc>
		<lastmod>2010-01-04T16:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6745: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/andrew-corn-of-bacon-trust-company-looks-towards-established-biotech-and-generic-drug-companies-as-part-of-his-wall-street-transcript-via-yahoo-finance/2010/</loc>
		<lastmod>2010-01-04T16:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6712: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dogs-of-the-caps/2010/</loc>
		<lastmod>2010-01-04T15:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6713: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dogs-of-the-caps/2010/</loc>
		<lastmod>2010-01-04T15:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6714: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-new-years-best-investing-ideas-fortune-vs-caps/2010/</loc>
		<lastmod>2010-01-04T15:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6715: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-new-years-best-investing-ideas-fortune-vs-caps/2010/</loc>
		<lastmod>2010-01-04T15:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6774: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-story-stocks-nvs-2/2010/</loc>
		<lastmod>2010-01-04T15:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6691: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ma-monday-mondays-headlines/2010/</loc>
		<lastmod>2010-01-04T15:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6698: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/harvard-affiliated-hospitals-limit-top-docs-industry-ties/2010/</loc>
		<lastmod>2010-01-04T15:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6747: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/harvard-hospitals-limit-industry-pay-to-doctors-npr/2010/</loc>
		<lastmod>2010-01-04T15:27:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6694: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-futures-point-to-strong-debut/2010/</loc>
		<lastmod>2010-01-04T15:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6744: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotechs-movers-and-shakers-2009-biobuzz-thestreet-com/2010/</loc>
		<lastmod>2010-01-04T15:00:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6684: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bulls-get-back-to-work/2010/</loc>
		<lastmod>2010-01-04T13:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6685: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/euro-stocks-strong-start-to-2010/2010/</loc>
		<lastmod>2010-01-04T13:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6695: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/three-best-dow-stocks-for-2010/2010/</loc>
		<lastmod>2010-01-04T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6680: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-looks-to-buy-the-rest-of-alcon/2010/</loc>
		<lastmod>2010-01-04T11:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6679: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-initial-10-gain/2010/</loc>
		<lastmod>2010-01-04T09:32:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6678: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-announces-option-exercise-and-merger-proposal/2010/</loc>
		<lastmod>2010-01-04T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6686: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-calendar-key-dates-for-january/2010/</loc>
		<lastmod>2010-01-04T07:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6673: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-calendar-key-dates-for-january-thestreet-com/2010/</loc>
		<lastmod>2010-01-04T07:05:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6676: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ipos-a-modest-turn-around-the-corner-businessweek/2010/</loc>
		<lastmod>2010-01-04T05:10:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6677: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ge-healthcare-millipore-serologicals-harvard-stanford-dharmacon-bio-rad-biomerieux-art-takara-bio-genomeweb-news/2010/</loc>
		<lastmod>2010-01-04T03:05:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6672: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/recession-takes-bite-out-of-global-ma/2010/</loc>
		<lastmod>2010-01-03T21:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6675: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sa-resource-stocks-tipped-to-win-adelaide-now/2010/</loc>
		<lastmod>2010-01-03T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6674: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-market-outlook-2010-omaha-world-herald/2010/</loc>
		<lastmod>2010-01-03T12:18:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6666: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cities-counties-take-back-corporate-tax-breaks/2010/</loc>
		<lastmod>2010-01-03T08:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6663: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/local-stocks-bounce-back-san-diego-union-tribune/2010/</loc>
		<lastmod>2010-01-03T08:08:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6664: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/roche-to-acquire-nimblegen-for-272-5m-eyes-additional-genomic-vendors-genomeweb-news/2010/</loc>
		<lastmod>2010-01-03T03:15:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6653: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-state-of-natural-beauty-the-courier-mail/2010/</loc>
		<lastmod>2010-01-02T13:24:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6654: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-good-year-bad-decade/2010/</loc>
		<lastmod>2010-01-02T13:08:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6652: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-could-go-wrong-in-2010-2/2010/</loc>
		<lastmod>2010-01-02T12:58:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6656: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-rally-is-ridiculous/2010/</loc>
		<lastmod>2010-01-02T10:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6689: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/top-2010-health-care-stocks/2010/</loc>
		<lastmod>2010-01-02T04:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6645: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-didnt-catch-markets-wave-in-2009-contra-costa-times/2010/</loc>
		<lastmod>2010-01-01T22:42:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6638: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-shares-exception-to-health-care-stock-rally-south-bend-tribune/2010/</loc>
		<lastmod>2010-01-01T12:15:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6639: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-shares-exception-to-health-care-stock-rally-south-bend-tribune/2010/</loc>
		<lastmod>2010-01-01T12:15:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6637: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-buck-markets-rally-slide-in-2009-malaysianews-net/2010/</loc>
		<lastmod>2010-01-01T08:36:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6606: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/indian-hill-students-play-the-market-community-press-recorder/2009/</loc>
		<lastmod>2010-01-01T06:37:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6630: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-ticker-boston-herald/2009/</loc>
		<lastmod>2010-01-01T05:10:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6629: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/targacept-is-exception-in-biotechs-fall-winston-salem-journal/2009/</loc>
		<lastmod>2010-01-01T05:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6631: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/phylogica-gets-big-raps-from-new-york-analyst-thewest-com-au/2009/</loc>
		<lastmod>2010-01-01T02:11:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6626: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nasdaq-2009-winners-losers/2009/</loc>
		<lastmod>2010-01-01T00:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6633: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/government-will-dominate-2010-agenda-investors-business-daily-via-yahoo-news/2009/</loc>
		<lastmod>2010-01-01T00:03:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6635: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/government-will-dominate-2010-agenda-investors-business-daily-via-yahoo-finance/2009/</loc>
		<lastmod>2010-01-01T00:03:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6627: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-planet-versus-monsanto/2009/</loc>
		<lastmod>2009-12-31T23:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6634: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinese-growth-companies-led-the-way-in-2009-new-issue-market-investors-business-daily-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-31T23:16:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6636: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinese-growth-companies-led-the-way-in-2009-new-issue-market-investors-business-daily-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-31T23:16:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6624: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinese-parents-discover-social-networking/2009/</loc>
		<lastmod>2009-12-31T22:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6655: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-stocks-drop-exxon-adds-to-its-decline-for-year/2009/</loc>
		<lastmod>2009-12-31T22:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6600: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-falter-at-the-end-of-an-up-year/2009/</loc>
		<lastmod>2009-12-31T21:08:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6621: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/make-money-even-when-drugs-fail/2009/</loc>
		<lastmod>2009-12-31T19:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6607: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/buy-pfizer-against-the-grain/2009/</loc>
		<lastmod>2009-12-31T18:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6608: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-shares-fall-after-prevnar-fda-delay/2009/</loc>
		<lastmod>2009-12-31T17:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6611: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-fall-on-jobless-claims-drop/2009/</loc>
		<lastmod>2009-12-31T17:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6612: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-fall-on-jobless-claims-drop/2009/</loc>
		<lastmod>2009-12-31T17:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6613: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-healthy-way-to-juice-your-stocks-yield/2009/</loc>
		<lastmod>2009-12-31T16:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6615: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-a-weak-dollar-the-best-healthcare-bet/2009/</loc>
		<lastmod>2009-12-31T15:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6601: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-to-play-healthcare-in-2010/2009/</loc>
		<lastmod>2009-12-31T15:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6602: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-weakens-in-year-end-trade/2009/</loc>
		<lastmod>2009-12-31T14:49:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6599: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-nears-80/2009/</loc>
		<lastmod>2009-12-31T12:02:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6596: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-early-gain/2009/</loc>
		<lastmod>2009-12-31T10:32:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6595: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-year-of-hits-among-investing-misses-malaysianews-net/2009/</loc>
		<lastmod>2009-12-31T08:20:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6593: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-year-of-hits-among-investing-misses-fox-news/2009/</loc>
		<lastmod>2009-12-31T06:32:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6594: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chuck-jaffe-a-year-of-hits-among-investing-misses-market-watch/2009/</loc>
		<lastmod>2009-12-31T05:31:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6597: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-u-s-review-of-pfizer-vaccine-not-completed/2009/</loc>
		<lastmod>2009-12-31T00:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6598: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-u-s-review-of-pfizer-vaccine-not-completed/2009/</loc>
		<lastmod>2009-12-31T00:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6587: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-says-fda-is-still-reviewing-prevnar-13/2009/</loc>
		<lastmod>2009-12-31T00:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6588: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-provides-u-s-regulatory-update-on-prevnar-13%e2%84%a2-vaccine/2009/</loc>
		<lastmod>2009-12-31T00:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6570: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-nearly-flat-as-oil-prices-rise/2009/</loc>
		<lastmod>2009-12-30T23:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6569: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-nasdaq-at-2009-highs/2009/</loc>
		<lastmod>2009-12-30T23:09:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6581: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/scammers-prey-on-health-conscious/2009/</loc>
		<lastmod>2009-12-30T21:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6592: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nuance-buys-british-voice-to-text-company-spinvox-physorg/2009/</loc>
		<lastmod>2009-12-30T20:11:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6585: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-back-door-biofuel-investment/2009/</loc>
		<lastmod>2009-12-30T19:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6580: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-after-auction/2009/</loc>
		<lastmod>2009-12-30T18:53:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6579: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-real-reason-banks-arent-lending/2009/</loc>
		<lastmod>2009-12-30T17:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6568: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-tops-79-on-inventory-drop/2009/</loc>
		<lastmod>2009-12-30T17:34:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6574: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-the-big-phone-companies-are-dogs/2009/</loc>
		<lastmod>2009-12-30T17:26:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6576: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-firms-on-manufacturing-strength/2009/</loc>
		<lastmod>2009-12-30T17:01:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6573: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-best-stocks-for-2010/2009/</loc>
		<lastmod>2009-12-30T16:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6610: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-right-place-to-put-your-money/2009/</loc>
		<lastmod>2009-12-30T15:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6591: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-slip-compugen-rallies-market-watch/2009/</loc>
		<lastmod>2009-12-30T15:45:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6572: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-fed-wont-hike-rates-anytime-soon/2009/</loc>
		<lastmod>2009-12-30T15:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6565: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-basilea-vows-strategy-review-amid-antibiotic-setback-nasdaq/2009/</loc>
		<lastmod>2009-12-30T12:18:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6564: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-headed-for-lower-start/2009/</loc>
		<lastmod>2009-12-30T10:32:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6566: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/basilea-shares-dive-after-antibiotic-setback-reviews-options-nasdaq/2009/</loc>
		<lastmod>2009-12-30T09:18:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6560: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-ends-trial-of-lung-cancer-drug-candidate/2009/</loc>
		<lastmod>2009-12-30T00:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6562: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-astrazeneca-pfizer-mylan-laboratories-novartis-and-boston-scientific-corp/2009/</loc>
		<lastmod>2009-12-30T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6563: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-astrazeneca-pfizer-mylan-laboratories-novartis-and-boston-scientific-corp-2/2009/</loc>
		<lastmod>2009-12-30T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6556: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-discontinues-a-phase-3-trial-of-figitumumab-in-non-small-cell-lung-cancer-nsclc-for-futility/2009/</loc>
		<lastmod>2009-12-30T00:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6536: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-break-six-day-win-streak/2009/</loc>
		<lastmod>2009-12-29T21:21:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6557: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/some-brand-name-patents-going-going-gone-in-2010/2009/</loc>
		<lastmod>2009-12-29T20:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6534: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-recovers-losses/2009/</loc>
		<lastmod>2009-12-29T20:13:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6554: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/enzyme-developer-codexis-files-for-100m-ipo/2009/</loc>
		<lastmod>2009-12-29T19:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6549: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/codexis-takes-another-stab-at-ipo/2009/</loc>
		<lastmod>2009-12-29T19:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6550: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/china-bak-vical-midday-volume-plays/2009/</loc>
		<lastmod>2009-12-29T19:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6559: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-may-take-a-year-to-conquer-h1n1-flu-pandemic-who/2009/</loc>
		<lastmod>2009-12-29T18:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6548: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-mixed-on-downbeat-housing-report/2009/</loc>
		<lastmod>2009-12-29T18:00:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6547: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/beware-the-big-winners-of-2009/2009/</loc>
		<lastmod>2009-12-29T17:47:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6543: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-gains-on-consumer-confidence/2009/</loc>
		<lastmod>2009-12-29T16:11:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6544: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-slip-trimeris-falls-on-failed-merger-market-watch/2009/</loc>
		<lastmod>2009-12-29T16:10:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6541: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dwindling-options-at-take-two/2009/</loc>
		<lastmod>2009-12-29T15:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6546: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/consumer-confidence-hits-3-month-high-forbes/2009/</loc>
		<lastmod>2009-12-29T15:38:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6539: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-next-market-leader/2009/</loc>
		<lastmod>2009-12-29T15:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6537: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-struggle-after-six-up-days/2009/</loc>
		<lastmod>2009-12-29T15:03:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6523: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-looking-for-lucky-7th-gain/2009/</loc>
		<lastmod>2009-12-29T10:40:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6526: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-industry-set-to-ride-on-global-economic-recovery-bernama/2009/</loc>
		<lastmod>2009-12-29T10:04:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6524: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/roth-capital-prolor-among-top-3-biotech-firms-globes-online/2009/</loc>
		<lastmod>2009-12-29T09:59:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6520: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-industry-set-to-ride-on-global-economic-recovery-bernama-com-bernama/2009/</loc>
		<lastmod>2009-12-29T09:55:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6521: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/malaysia-biotech-industry-to-ride-on-recovery-business-times-malaysia/2009/</loc>
		<lastmod>2009-12-29T09:42:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6522: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/hamilton-venture-capitalists-make-business-case-for-going-green-toronto-star/2009/</loc>
		<lastmod>2009-12-29T09:34:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6525: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-business-summary-reuters-via-yahoo-philippines-news-2/2009/</loc>
		<lastmod>2009-12-29T09:25:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6533: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-industry-set-to-ride-on-global-economic-recovery-bernama-via-yahoo-malaysia-news/2009/</loc>
		<lastmod>2009-12-29T09:13:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6538: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-to-do-when-the-dow-hits-7500-again-2/2009/</loc>
		<lastmod>2009-12-29T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6518: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-business-summary-reuters-via-yahoo-singapore-news-2/2009/</loc>
		<lastmod>2009-12-29T04:48:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6527: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ipos-to-test-financial-biotech-appetite/2009/</loc>
		<lastmod>2009-12-29T04:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6528: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wrapup-1-ipos-to-test-financial-biotech-appetite/2009/</loc>
		<lastmod>2009-12-29T03:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6529: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-u-s-biotech-codexis-files-for-100-mln-ipo/2009/</loc>
		<lastmod>2009-12-29T02:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6530: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-u-s-biotech-codexis-files-for-100-mln-ipo/2009/</loc>
		<lastmod>2009-12-29T02:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6531: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-codexis-files-for-100-mln-ipo/2009/</loc>
		<lastmod>2009-12-29T01:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6532: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-codexis-files-for-100-mln-ipo/2009/</loc>
		<lastmod>2009-12-29T01:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6511: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-stocks-stuck-in-waiting-room/2009/</loc>
		<lastmod>2009-12-28T22:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6515: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/emami-counts-gains-from-new-ventures-the-telegraph/2009/</loc>
		<lastmod>2009-12-28T22:21:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6513: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fannie-mae-cal-maine-foods-are-big-movers-the-daily-reflector/2009/</loc>
		<lastmod>2009-12-28T22:15:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6512: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fannie-mae-cal-maine-foods-are-big-movers-ap-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-28T22:07:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6516: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/top-2010-healthcare-stocks-2/2009/</loc>
		<lastmod>2009-12-28T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6483: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-hit-new-highs/2009/</loc>
		<lastmod>2009-12-28T21:22:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6477: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-hits-5-week-high-nears-80/2009/</loc>
		<lastmod>2009-12-28T20:12:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6506: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mead-johnson-highly-attractive-target/2009/</loc>
		<lastmod>2009-12-28T19:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6510: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotechs-race-to-battle-the-bulge/2009/</loc>
		<lastmod>2009-12-28T19:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6503: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-is-why-buffetts-buying-stocks-2/2009/</loc>
		<lastmod>2009-12-28T18:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6484: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-fall-as-auctions-begin/2009/</loc>
		<lastmod>2009-12-28T18:53:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6496: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/compugen-soars-32-on-cancer-target-find/2009/</loc>
		<lastmod>2009-12-28T18:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6495: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-could-go-wrong-in-2010/2009/</loc>
		<lastmod>2009-12-28T18:03:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6491: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-12-28-1705-update-2-compugen-discovers-cancer-drug-target-shares-rally-interactive-investor/2009/</loc>
		<lastmod>2009-12-28T17:26:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6493: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/compugen-discovers-cancer-drug-target-shares-rally-reuters-via-yahoo-singapore-news/2009/</loc>
		<lastmod>2009-12-28T16:50:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6488: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-drifts-in-quiet-trading/2009/</loc>
		<lastmod>2009-12-28T15:47:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6486: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/airline-stocks-lower-after-failed-terror-attack/2009/</loc>
		<lastmod>2009-12-28T15:40:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6485: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sinovac-makes-hand-foot-and-mouth-vaccine-filing-ap-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-28T15:20:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6487: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/early-market-movers-compugen-amicas-fox-news/2009/</loc>
		<lastmod>2009-12-28T15:11:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6480: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/get-ready-for-the-fall-3/2009/</loc>
		<lastmod>2009-12-28T14:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6489: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-business-summary-reuters-via-yahoo-singapore-news/2009/</loc>
		<lastmod>2009-12-28T14:41:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6479: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-venture-capital-firms-glimpse-some-exit-signs-nasdaq/2009/</loc>
		<lastmod>2009-12-28T14:03:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6478: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/compugen-sinovac-early-volume-plays-thestreet-com/2009/</loc>
		<lastmod>2009-12-28T14:00:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6482: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/in-pictures-etfs-for-2010/2009/</loc>
		<lastmod>2009-12-28T13:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6475: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-start-the-week-higher/2009/</loc>
		<lastmod>2009-12-28T10:42:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6490: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-business-summary-reuters-via-yahoo-asia-news/2009/</loc>
		<lastmod>2009-12-28T00:36:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6481: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-benefits-of-sanofis-chattem-deal/2009/</loc>
		<lastmod>2009-12-27T21:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6468: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/israel-stocks-israel-stocks-fall-isramco-delek-up-on-iec-deal-market-watch/2009/</loc>
		<lastmod>2009-12-27T17:45:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6469: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/israel-stocks-israel-stocks-fall-isramco-delek-up-on-iec-deal-market-watch/2009/</loc>
		<lastmod>2009-12-27T17:40:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6463: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/even-as-economy-mends-a-jobless-decade-may-loom-chattanooga-times-free-press/2009/</loc>
		<lastmod>2009-12-27T14:19:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6464: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/even-as-economy-mends-a-jobless-decade-may-loom-chattanooga-times-free-press/2009/</loc>
		<lastmod>2009-12-27T14:19:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6465: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinese-premier-strikes-defiant-yuan-tone/2009/</loc>
		<lastmod>2009-12-27T13:41:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6466: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinese-premier-strikes-defiant-yuan-tone-2/2009/</loc>
		<lastmod>2009-12-27T13:41:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6462: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/economic-woes-dominated-year-honolulu-advertiser/2009/</loc>
		<lastmod>2009-12-27T12:25:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6459: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dendreons-big-hq-lease-may-go-to-selig-seattle-times/2009/</loc>
		<lastmod>2009-12-27T08:13:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6458: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/school-lunches-follow-usdaaregs-williston-herald-2/2009/</loc>
		<lastmod>2009-12-27T01:57:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6470: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/preview-5/2009/</loc>
		<lastmod>2009-12-26T15:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6457: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jim-cramers-portfolios-of-the-week-5/2009/</loc>
		<lastmod>2009-12-25T19:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6455: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-counts-down-to-a-new-year/2009/</loc>
		<lastmod>2009-12-25T18:35:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6452: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/school-lunches-follow-usdaaregs-williston-herald/2009/</loc>
		<lastmod>2009-12-25T06:13:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6446: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/matthew-herper-and-robert-langreth-on-the-pharmaceutical-industry/2009/</loc>
		<lastmod>2009-12-25T01:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6447: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/large-cap-biotechs-face-familiar-problem-investors-business-daily-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-24T22:59:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6448: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/alcoa-travelers-advance-wellpoint-falls/2009/</loc>
		<lastmod>2009-12-24T21:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6443: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/reits-lead-charge-as-small-caps-hit-09-peak/2009/</loc>
		<lastmod>2009-12-24T21:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6449: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-hit-new-09-highs/2009/</loc>
		<lastmod>2009-12-24T20:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6440: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sec-men-made-illicit-profits-in-sanofi-chattem-deal/2009/</loc>
		<lastmod>2009-12-24T20:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6442: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medicines-co-s-lackluster-pfizer-deal/2009/</loc>
		<lastmod>2009-12-24T20:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6454: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dividend-stocks-for-the-week-5/2009/</loc>
		<lastmod>2009-12-24T20:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6418: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-climbs-above-78-on-inventory-decline/2009/</loc>
		<lastmod>2009-12-24T19:06:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6422: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-end-at-new-2009-highs/2009/</loc>
		<lastmod>2009-12-24T18:11:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6429: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-ease-ahead-of-auctions/2009/</loc>
		<lastmod>2009-12-24T15:51:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6430: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-ease-ahead-of-auctions/2009/</loc>
		<lastmod>2009-12-24T15:51:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6437: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-reform-from-here/2009/</loc>
		<lastmod>2009-12-24T14:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6426: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/another-reason-to-worry-about-pfizer/2009/</loc>
		<lastmod>2009-12-24T14:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6423: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-lyrica-for-gad-rejected-by-fda/2009/</loc>
		<lastmod>2009-12-24T13:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6419: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/china-kangtai-cactus-biotech-adopts-eitf-07-05-expects-to-file-amended-10-q-10-k-business-wire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-24T13:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6416: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-slips-from-3-month-high/2009/</loc>
		<lastmod>2009-12-24T13:28:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6420: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dumb-and-dumber-the-worst-fund-launches-of-the-2000s-morningstar-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-24T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6417: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-home-run-stock-buffett-cant-buy/2009/</loc>
		<lastmod>2009-12-24T11:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6413: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-looks-for-cheery-open/2009/</loc>
		<lastmod>2009-12-24T10:59:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6410: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/trascept-pharmaceuticals-tspt-cell-therapeutics-ctic-osip-and-acorda-acor-events-added-to-fda-and-biotech-prweb-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-24T07:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6408: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/almost-gone-neurogen-stockholders-ok-deal-with-calif-company-new-haven-register/2009/</loc>
		<lastmod>2009-12-24T06:49:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6415: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-tells-pfizer-its-lyrica-gad-data-insufficient/2009/</loc>
		<lastmod>2009-12-24T06:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6407: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer%e2%80%99s-lyrica-receives-complete-response-letter-from-fda-for-generalized-anxiety-disorder-monotherapy-treatment/2009/</loc>
		<lastmod>2009-12-24T02:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6406: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-spent-5-4m-lobbying-government-in-3q/2009/</loc>
		<lastmod>2009-12-24T01:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6378: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-edge-up-oil-jumps/2009/</loc>
		<lastmod>2009-12-24T00:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6396: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/arena-pharma-says-merck-ends-collaboration/2009/</loc>
		<lastmod>2009-12-24T00:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6558: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-moody%e2%80%99s-investor-service-alcoa-incyte-eli-lilly-and-novartis/2009/</loc>
		<lastmod>2009-12-24T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6399: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-in-the-spotlight-wednesday/2009/</loc>
		<lastmod>2009-12-23T23:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6389: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pharmaceutical-group-spent-6-8m-lobbying-in-3q/2009/</loc>
		<lastmod>2009-12-23T23:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6391: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/synta-pharma-starts-midstage-study-of-cancer-drug/2009/</loc>
		<lastmod>2009-12-23T23:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6360: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-end-higher-for-4th-day/2009/</loc>
		<lastmod>2009-12-23T21:18:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6421: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-buying-novexel-makes-deal-with-forest/2009/</loc>
		<lastmod>2009-12-23T21:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6385: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-spent-1-5m-in-3q-lobbying-on-health-reform/2009/</loc>
		<lastmod>2009-12-23T20:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6393: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dividend-darlings/2009/</loc>
		<lastmod>2009-12-23T20:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6394: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dividend-darlings/2009/</loc>
		<lastmod>2009-12-23T20:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6397: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-these-companies-beat-the-market/2009/</loc>
		<lastmod>2009-12-23T20:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6384: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cancer-isnt-mercks-biggest-problem/2009/</loc>
		<lastmod>2009-12-23T19:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6387: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-worlds-best-dividend-stocks-3/2009/</loc>
		<lastmod>2009-12-23T19:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6386: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/deals-from-pfizer-novartis-and-astrazeneca-also-snake-oil/2009/</loc>
		<lastmod>2009-12-23T19:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6374: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-myers-parts-ways-with-mead-johnson/2009/</loc>
		<lastmod>2009-12-23T18:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6375: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-astra-forest-to-develop-combo-antibiotics/2009/</loc>
		<lastmod>2009-12-23T18:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6369: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-to-buy-frances-novexel/2009/</loc>
		<lastmod>2009-12-23T18:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6379: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/trade-like-a-hedge-fund-master/2009/</loc>
		<lastmod>2009-12-23T17:51:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6380: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/its-hard-not-to-end-up-rich-the-motley-fool/2009/</loc>
		<lastmod>2009-12-23T17:02:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6381: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/its-hard-not-to-end-up-rich-the-motley-fool/2009/</loc>
		<lastmod>2009-12-23T17:02:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6371: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-invites-public-to-view-and-listen-to-webcast-of-february-3-conference-call-with-analysts/2009/</loc>
		<lastmod>2009-12-23T17:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6356: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-myers-off-on-sale-of-mead-johnson/2009/</loc>
		<lastmod>2009-12-23T16:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6367: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-trade-higher-sanofi-achillion-gain-market-watch/2009/</loc>
		<lastmod>2009-12-23T16:00:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6368: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-trade-higher-sanofi-achillion-gain-market-watch/2009/</loc>
		<lastmod>2009-12-23T16:00:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6361: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-shaken-by-weak-housing-report/2009/</loc>
		<lastmod>2009-12-23T15:25:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6358: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/compugen-signs-development-deal-with-pfizer/2009/</loc>
		<lastmod>2009-12-23T15:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6364: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rises-to-2-month-high-against-yen/2009/</loc>
		<lastmod>2009-12-23T14:45:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6365: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/signs-of-recovery-look-to-the-yield-curve-2/2009/</loc>
		<lastmod>2009-12-23T14:42:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6362: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rises-on-surprise-inventory-drop/2009/</loc>
		<lastmod>2009-12-23T14:39:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6363: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rises-on-surprise-inventory-drop-2/2009/</loc>
		<lastmod>2009-12-23T14:39:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6355: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/not-the-time-to-load-up/2009/</loc>
		<lastmod>2009-12-23T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6299: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-sharpens-ethics-focus/2009/</loc>
		<lastmod>2009-12-23T12:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6354: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/china-makes-nice-with-neighbors/2009/</loc>
		<lastmod>2009-12-23T12:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6346: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-12-23-1031-update-1-sanofi-may-take-zealand-pharma-stake-les-echos-interactive-investor/2009/</loc>
		<lastmod>2009-12-23T10:58:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6344: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-12-23-1025-sanofi-may-take-zealand-pharma-stake-les-echos-interactive-investor/2009/</loc>
		<lastmod>2009-12-23T10:41:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6345: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/more-pre-holiday-cheer-on-wall-street/2009/</loc>
		<lastmod>2009-12-23T10:17:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6348: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-buying-u-s-maker-of-heart-drug/2009/</loc>
		<lastmod>2009-12-23T09:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6372: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nows-a-great-time-to-invest-so-dont-blow-it-like-this-2/2009/</loc>
		<lastmod>2009-12-23T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6373: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nows-a-great-time-to-invest-so-dont-blow-it-like-this-2/2009/</loc>
		<lastmod>2009-12-23T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2385: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nasal-swine-flu-vaccine-recalled-over-potency/2009/</loc>
		<lastmod>2009-12-23T02:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6349: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medicines-co-buys-pfizer-heart-drug-candidate/2009/</loc>
		<lastmod>2009-12-23T01:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6334: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/correction-the-medicines-company-acquires-apoa-i-milano-from-pfizer/2009/</loc>
		<lastmod>2009-12-23T01:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6338: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/c-reactive-protein-no-cause-of-heart-trouble-study/2009/</loc>
		<lastmod>2009-12-22T22:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6330: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-shadowy-science-of-sex-addiction/2009/</loc>
		<lastmod>2009-12-22T22:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6326: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/keep-irs-auditors-away-earn-less-than-200000/2009/</loc>
		<lastmod>2009-12-22T22:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6341: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/look-for-novartis-alcon-deal-in-early-2010/2009/</loc>
		<lastmod>2009-12-22T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6308: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-gains-versus-rivals/2009/</loc>
		<lastmod>2009-12-22T21:50:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6298: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-push-higher-in-light-trading/2009/</loc>
		<lastmod>2009-12-22T21:15:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6302: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-climbs-above-74/2009/</loc>
		<lastmod>2009-12-22T20:46:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6316: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/signs-of-recovery-look-to-the-yield-curve/2009/</loc>
		<lastmod>2009-12-22T20:03:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6321: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-slides-more-than-20-in-two-days/2009/</loc>
		<lastmod>2009-12-22T19:39:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6322: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-acquisition-is-icy-hot/2009/</loc>
		<lastmod>2009-12-22T19:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6310: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-says-unlikely-that-vytorin-zetia-increase-cancer-risk/2009/</loc>
		<lastmod>2009-12-22T18:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6313: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tomorrows-monster-stock-3/2009/</loc>
		<lastmod>2009-12-22T18:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6311: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-to-make-1-million/2009/</loc>
		<lastmod>2009-12-22T18:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6314: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-swings-for-the-fences/2009/</loc>
		<lastmod>2009-12-22T17:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6315: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/some-incyte-into-why-these-drugs-rock/2009/</loc>
		<lastmod>2009-12-22T17:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6296: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-gain-athersys-soars-for-second-day-market-watch/2009/</loc>
		<lastmod>2009-12-22T16:10:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6297: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zulily-gets-funded-ontela-merges-with-photobucket-oncogenex-secures-60m-from-teva-more-seattle-area-deals-news-seattlepi-com/2009/</loc>
		<lastmod>2009-12-22T15:57:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6303: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/who-owns-most-of-the-market/2009/</loc>
		<lastmod>2009-12-22T15:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6292: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mondays-biggest-stock-stars-the-motley-fool-4/2009/</loc>
		<lastmod>2009-12-22T14:47:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6293: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mondays-biggest-stock-stars-the-motley-fool-4/2009/</loc>
		<lastmod>2009-12-22T14:47:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6300: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mylan-sued-over-plans-for-generic-vytorin/2009/</loc>
		<lastmod>2009-12-22T14:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6283: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-poised-for-early-pop/2009/</loc>
		<lastmod>2009-12-22T13:49:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6291: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/europe-gains-a-second-day/2009/</loc>
		<lastmod>2009-12-22T13:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6285: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/religion-based-etfs-find-going-slow/2009/</loc>
		<lastmod>2009-12-22T13:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6290: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-dips-against-euro/2009/</loc>
		<lastmod>2009-12-22T12:19:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6284: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-continues-to-hover-in-73-range/2009/</loc>
		<lastmod>2009-12-22T11:39:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6289: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-recap-smart-money-is-in-dividend-stocks-final/2009/</loc>
		<lastmod>2009-12-22T02:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6273: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sanofis-allegra-gambit/2009/</loc>
		<lastmod>2009-12-22T00:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6280: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/phillydeals-card-reader-company-faces-a-rough-road-the-philadelphia-inquirer/2009/</loc>
		<lastmod>2009-12-22T00:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6276: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-etfs-rally-on-chattem-buyout-investors-business-daily-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-21T23:49:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6277: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-etfs-rally-on-chattem-buyout-investors-business-daily-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-21T23:49:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6278: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-etfs-rally-on-chattem-buyout-investors-business-daily-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-21T23:49:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6279: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-etfs-rally-on-chattem-buyout-investors-business-daily-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-21T23:49:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6274: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rigel-pharma-gives-up-gains/2009/</loc>
		<lastmod>2009-12-21T23:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6256: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/djia-back-in-black-for-december/2009/</loc>
		<lastmod>2009-12-21T23:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6275: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/five-software-stocks-to-watch-in-2010/2009/</loc>
		<lastmod>2009-12-21T22:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6271: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/snow-slows-shoppers-not-stocks-indie-research-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-21T22:27:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6226: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-pares-gains-settles-lower/2009/</loc>
		<lastmod>2009-12-21T22:26:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6268: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-under-pressure-2/2009/</loc>
		<lastmod>2009-12-21T21:38:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6245: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-in-positive-territory-for-december/2009/</loc>
		<lastmod>2009-12-21T21:30:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6336: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-hires-ex-cdc-chief-new-pbm-boss-at-cvs/2009/</loc>
		<lastmod>2009-12-21T21:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6269: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cvs-goes-to-generation-health-for-caremark-head/2009/</loc>
		<lastmod>2009-12-21T20:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6239: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sanofi-aventis-to-buy-gold-bond-maker-chattem/2009/</loc>
		<lastmod>2009-12-21T20:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6264: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/healthy-drug-deals/2009/</loc>
		<lastmod>2009-12-21T20:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6040: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ex-cdc-director-will-lead-merck-vaccines-business/2009/</loc>
		<lastmod>2009-12-21T19:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6261: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-former-cdc-head-lands-vaccine-job-at-merck/2009/</loc>
		<lastmod>2009-12-21T19:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6263: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/preparing-for-bearish-action-in-mannkind-forbes/2009/</loc>
		<lastmod>2009-12-21T19:25:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6259: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocking-stuffers-cel-sci-novelos-cyrtx-medclean-and-biomedical-technology-solutions-marketwire/2009/</loc>
		<lastmod>2009-12-21T18:50:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6262: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocking-stuffers-cel-sci-novelos-cyrtx-medclean-and-biomedical-technology-solutions-marketwire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-21T18:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6252: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/former-cdc-head-lands-vaccine-job-at-merck/2009/</loc>
		<lastmod>2009-12-21T18:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6255: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dr-julie-gerberding-named-president-of-merck-vaccines/2009/</loc>
		<lastmod>2009-12-21T18:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6251: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oncogenex-slammed-on-teva-parnership-biobuzz/2009/</loc>
		<lastmod>2009-12-21T17:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6247: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-drug-companies-want-to-sell-foot-powder/2009/</loc>
		<lastmod>2009-12-21T17:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6241: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sanofi-to-buy-u-s-group-chattem-for-1-9-billion/2009/</loc>
		<lastmod>2009-12-21T17:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6243: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/incyte-jumps-5-on-pact-with-lilly/2009/</loc>
		<lastmod>2009-12-21T16:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6304: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-point-higher-as-dollar-slips/2009/</loc>
		<lastmod>2009-12-21T15:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6238: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cvs-taps-lofberg-for-pbm-arm/2009/</loc>
		<lastmod>2009-12-21T15:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6246: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-fall-amid-recovery-hopes/2009/</loc>
		<lastmod>2009-12-21T15:21:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6305: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/incyte-licenses-drug-to-eli-lilly/2009/</loc>
		<lastmod>2009-12-21T15:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6229: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/standing-firm-on-health-stocks-despite-d-c-deals/2009/</loc>
		<lastmod>2009-12-21T15:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6230: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-futures-rise-with-commods-dollar-weakens/2009/</loc>
		<lastmod>2009-12-21T15:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6231: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/athersys-signs-development-deal-with-pfizer/2009/</loc>
		<lastmod>2009-12-21T14:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6237: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-to-wall-street-coverage-upgrades-and-downgrades-minyanville-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-21T14:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6235: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/call-trading-soars-on-visa-inc-v-as-stock-faces-round-number-resistance-schaeffers-research/2009/</loc>
		<lastmod>2009-12-21T14:14:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6236: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pessimism-blankets-sprint-nextel-corporation-s-as-stock-struggles-schaeffers-research/2009/</loc>
		<lastmod>2009-12-21T14:14:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6232: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-licenses-athersys-stem-cell-drug-biobuzz/2009/</loc>
		<lastmod>2009-12-21T13:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6234: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-steadies-against-euro-2/2009/</loc>
		<lastmod>2009-12-21T13:11:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6233: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-agrees-deal-to-develop-athersys-therapy/2009/</loc>
		<lastmod>2009-12-21T13:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6287: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-focuses-on-rare-diseases/2009/</loc>
		<lastmod>2009-12-21T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6288: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-focuses-on-rare-diseases/2009/</loc>
		<lastmod>2009-12-21T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6225: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-rise-at-open/2009/</loc>
		<lastmod>2009-12-21T11:52:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6244: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/better-buy-pfizer-or-glaxosmithkline/2009/</loc>
		<lastmod>2009-12-21T11:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6224: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/europe-snaps-losing-streak-forbes/2009/</loc>
		<lastmod>2009-12-21T10:51:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6151: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-bracing-for-a-volatile-week/2009/</loc>
		<lastmod>2009-12-21T10:48:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6218: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/asx-closed-lower-on-consumer-staples-bigpond-news/2009/</loc>
		<lastmod>2009-12-21T09:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6219: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/europe-shares-snap-2-day-losing-run-banks-recover-reuters-via-yahoo-singapore-news/2009/</loc>
		<lastmod>2009-12-21T09:03:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6212: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-company-has-survival-skills-san-diego-union-tribune/2009/</loc>
		<lastmod>2009-12-21T08:12:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6213: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-company-has-survival-skills-san-diego-union-tribune/2009/</loc>
		<lastmod>2009-12-21T08:12:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6222: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-to-buy-stem-cell-therapy-from-athersys-ny-times/2009/</loc>
		<lastmod>2009-12-21T08:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6214: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-close-lower-herald-sun/2009/</loc>
		<lastmod>2009-12-21T07:47:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6204: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/aust-stocks-close-lower-led-by-banks-bigpond-news/2009/</loc>
		<lastmod>2009-12-21T06:49:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6205: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-down-on-telstra-herald-sun/2009/</loc>
		<lastmod>2009-12-21T06:19:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6206: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-closes-lower-the-courier-mail/2009/</loc>
		<lastmod>2009-12-21T05:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6223: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-weeks-barrons-roundup-3/2009/</loc>
		<lastmod>2009-12-20T17:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6180: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/israel-stocks-africa-israel-leads-market-higher-market-watch/2009/</loc>
		<lastmod>2009-12-20T16:55:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6176: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/general-mills-is-cooking/2009/</loc>
		<lastmod>2009-12-19T12:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6141: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mad-money-lightning-round-three-bank-buys/2009/</loc>
		<lastmod>2009-12-19T02:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6129: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-recap-playing-defense-final/2009/</loc>
		<lastmod>2009-12-19T02:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6149: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-16/2009/</loc>
		<lastmod>2009-12-19T00:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6125: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-industry-outlook-highlights-unitedhealth-group-inc-cigna-corp-pfizer-inc-glaxosmithkline-plc-and-merck-co-inc/2009/</loc>
		<lastmod>2009-12-19T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6124: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-flat-versus-euro/2009/</loc>
		<lastmod>2009-12-18T23:26:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6098: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-gain-in-volatile-session-end-week-lower/2009/</loc>
		<lastmod>2009-12-18T22:22:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6127: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-one-percent-of-u-s-children-have-autism-study/2009/</loc>
		<lastmod>2009-12-18T21:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6194: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/safe-haven-treasurys-get-tricky/2009/</loc>
		<lastmod>2009-12-18T20:17:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6189: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/swine-flu-just-isnt-bringing-home-the-bacon/2009/</loc>
		<lastmod>2009-12-18T20:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6111: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/despite-stresses-of-today-survey-finds-women-and-men-set-health-and-wellness-goals-%e2%80%93-but-sex-often-influences-success/2009/</loc>
		<lastmod>2009-12-18T20:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6114: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/buy-a-company-get-the-plant-for-free/2009/</loc>
		<lastmod>2009-12-18T20:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6113: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/combinatorx-neuromed-shareholders-approve-merger-ap-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-18T19:51:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6118: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-that-keep-paying-you-back/2009/</loc>
		<lastmod>2009-12-18T19:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6115: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-only-asset-worth-owning-today/2009/</loc>
		<lastmod>2009-12-18T18:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6119: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/indias-rich-pickings-for-pharma-ma/2009/</loc>
		<lastmod>2009-12-18T18:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6107: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rises-on-weaker-dollar/2009/</loc>
		<lastmod>2009-12-18T17:36:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6106: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-nvs-16/2009/</loc>
		<lastmod>2009-12-18T16:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6104: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/buy-gilead-ignore-study/2009/</loc>
		<lastmod>2009-12-18T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6101: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-celgene-sanofi-lead-drug-stocks-higher-market-watch/2009/</loc>
		<lastmod>2009-12-18T15:41:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6102: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/top-3-dividend-stocks-for-2010/2009/</loc>
		<lastmod>2009-12-18T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6099: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-fall-on-rebounding-stocks/2009/</loc>
		<lastmod>2009-12-18T14:50:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6100: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-weakens-against-euro/2009/</loc>
		<lastmod>2009-12-18T14:45:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5037: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-boehringers-spiriva-gets-new-fda-approval/2009/</loc>
		<lastmod>2009-12-18T14:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6096: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mylan-sells-stake-in-concord-biotech-the-economic-times-3/2009/</loc>
		<lastmod>2009-12-18T14:19:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6108: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genzyme-founder-says-ceo-must-go-exclusive/2009/</loc>
		<lastmod>2009-12-18T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6088: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drugmakers-win-with-democrats-help/2009/</loc>
		<lastmod>2009-12-18T12:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6090: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-eyes-early-gains/2009/</loc>
		<lastmod>2009-12-18T12:17:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6089: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/energy-shares-lift-europe/2009/</loc>
		<lastmod>2009-12-18T12:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6086: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-accused-of-doctoring-data-san-diego-union-tribune/2009/</loc>
		<lastmod>2009-12-18T08:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6087: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-accused-of-doctoring-data-san-diego-union-tribune/2009/</loc>
		<lastmod>2009-12-18T08:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6091: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merger-activity-to-show-tepid-recovery-in-2010/2009/</loc>
		<lastmod>2009-12-18T07:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6083: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-approves-spiriva%c2%ae-handihaler%c2%ae-for-the-reduction-of-copd-exacerbations/2009/</loc>
		<lastmod>2009-12-18T01:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6085: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-to-acquire-biotech-firm/2009/</loc>
		<lastmod>2009-12-17T23:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6081: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-dips-on-stronger-dollar/2009/</loc>
		<lastmod>2009-12-17T21:23:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6084: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/neb-inmate-loses-appeal-in-lawsuit-blaming-zoloft/2009/</loc>
		<lastmod>2009-12-17T20:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6082: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-buys-british-maker-of-biotech-medicines/2009/</loc>
		<lastmod>2009-12-17T20:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6072: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-plummets-as-the-dollar-firms/2009/</loc>
		<lastmod>2009-12-17T20:22:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6078: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/healthcare-stock-review-dec-2009-zacks-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-17T20:12:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6074: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-and-jj-land-deals-biogen-idec-not-so-much/2009/</loc>
		<lastmod>2009-12-17T19:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6075: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-and-jj-land-deals-biogen-idec-not-so-much-2/2009/</loc>
		<lastmod>2009-12-17T19:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6077: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-five-greatest-lies-about-investing/2009/</loc>
		<lastmod>2009-12-17T18:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6076: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-just-in-upgrades-and-downgrades-2/2009/</loc>
		<lastmod>2009-12-17T18:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6069: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rises-off-3-month-lows/2009/</loc>
		<lastmod>2009-12-17T17:38:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6067: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-bill-paying-to-help-the-poor-to-quit-smoking/2009/</loc>
		<lastmod>2009-12-17T17:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6060: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-slump-on-global-jitters/2009/</loc>
		<lastmod>2009-12-17T15:52:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6065: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotech-shareholders-reject-biogen-idec-offer-nasdaq/2009/</loc>
		<lastmod>2009-12-17T15:34:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6064: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-pare-gains-on-strong-manufacturing-data/2009/</loc>
		<lastmod>2009-12-17T15:32:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6066: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-dips-near-72-on-stronger-dollar/2009/</loc>
		<lastmod>2009-12-17T15:20:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6105: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-15/2009/</loc>
		<lastmod>2009-12-17T14:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6061: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-slump-at-open/2009/</loc>
		<lastmod>2009-12-17T14:35:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6062: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-jumps-to-a-3-month-high/2009/</loc>
		<lastmod>2009-12-17T14:33:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6058: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/matthew-herper-on-the-new-genetic-revolution/2009/</loc>
		<lastmod>2009-12-17T13:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6052: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-co-inc-to-acquire-avecia-biologics/2009/</loc>
		<lastmod>2009-12-17T12:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6055: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-early-slump/2009/</loc>
		<lastmod>2009-12-17T12:29:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6059: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/meds-without-passports/2009/</loc>
		<lastmod>2009-12-17T11:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6054: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-dividend-stock-holiday-shopping-list/2009/</loc>
		<lastmod>2009-12-17T01:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6049: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/toviaz-8-mg-was-more-effective-than-detrol-la-in-treating-urge-urinary-incontinence-in-patients-with-overactive-bladder/2009/</loc>
		<lastmod>2009-12-17T00:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6042: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bug-juice-on-the-gold-bugs/2009/</loc>
		<lastmod>2009-12-16T22:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6039: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-shares-slide-on-stock-update-malaysianews-net/2009/</loc>
		<lastmod>2009-12-16T20:08:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6018: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-slip-after-fed-holds-rates-steady/2009/</loc>
		<lastmod>2009-12-16T19:51:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6041: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/no-holiday-goodwill-twixt-biogen-and-facet/2009/</loc>
		<lastmod>2009-12-16T19:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6028: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-climbs-nearly-3-on-inventory-drop/2009/</loc>
		<lastmod>2009-12-16T19:38:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6029: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-firms-against-euro-after-fed-statement/2009/</loc>
		<lastmod>2009-12-16T19:36:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6024: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-lands-med-school-dean-an-acting-cfo-at-bristol-myers/2009/</loc>
		<lastmod>2009-12-16T19:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6003: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-skid-after-fed-holds-rates/2009/</loc>
		<lastmod>2009-12-16T19:25:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6035: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gileads-phase-3-train-wreck/2009/</loc>
		<lastmod>2009-12-16T19:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6033: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lets-hand-out-crestor-like-candy/2009/</loc>
		<lastmod>2009-12-16T18:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6025: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sterling-biotech-rs-98-7-buy-the-hindu/2009/</loc>
		<lastmod>2009-12-16T18:38:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6027: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-shares-slide-on-stock-update-fox-news/2009/</loc>
		<lastmod>2009-12-16T18:05:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6037: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-most-painfully-annoying-business-jargon/2009/</loc>
		<lastmod>2009-12-16T17:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6026: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotech-enters-agreement-with-the-baupost-group-to-allow-purchase-of-additional-shares-marketwire/2009/</loc>
		<lastmod>2009-12-16T17:40:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6019: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotech-enters-agreement-with-the-baupost-group-to-allow-purchase-of-additional-shares-marketwire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-16T17:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6014: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/five-biotech-events-to-watch-in-2010/2009/</loc>
		<lastmod>2009-12-16T17:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6015: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/upgrades-downgrades-party-time-for-carnival/2009/</loc>
		<lastmod>2009-12-16T16:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6021: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/hyatt-analysts-upgrades-dowgrades/2009/</loc>
		<lastmod>2009-12-16T16:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6034: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-cholesterol-drug-for-people-without-high-cholesterol/2009/</loc>
		<lastmod>2009-12-16T16:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6006: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-appoints-dr-michael-rosenblatt-as-executive-vice-president-chief-medical-officer/2009/</loc>
		<lastmod>2009-12-16T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5998: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-edges-lower-ahead-of-fed-statement/2009/</loc>
		<lastmod>2009-12-16T15:37:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6001: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-fed-s-gotta-listen-up/2009/</loc>
		<lastmod>2009-12-16T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6004: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-open-higher-ahead-of-fed/2009/</loc>
		<lastmod>2009-12-16T14:48:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6000: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-eyes-china-growth/2009/</loc>
		<lastmod>2009-12-16T14:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6020: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/option-watch-dec-16-ho-ho-hopeful-or-just-fast-money-in-vvus-optionetics-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-16T13:43:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5997: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-extends-gains-on-inventory-drop/2009/</loc>
		<lastmod>2009-12-16T11:36:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5994: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/five-biotech-events-to-watch-in-2010-thestreet-com/2009/</loc>
		<lastmod>2009-12-16T11:10:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5996: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-built-for-life-under-the-radar-thestreet-com/2009/</loc>
		<lastmod>2009-12-16T10:25:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6005: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-gets-favorable-fda-vote-on-crestor/2009/</loc>
		<lastmod>2009-12-16T09:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5995: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/weaker-dollar-stronger-returns/2009/</loc>
		<lastmod>2009-12-16T09:44:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5993: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-gain-as-fed-awaited/2009/</loc>
		<lastmod>2009-12-16T09:24:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5992: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mylan-sells-stake-in-concord-biotech-the-economic-times-2/2009/</loc>
		<lastmod>2009-12-16T06:49:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5989: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cobalt-international-energy-ipo-prices-below-range-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-16T02:12:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5999: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-azn-12/2009/</loc>
		<lastmod>2009-12-16T00:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5986: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/favorable-vote-from-fda-advisory-committee-on-benefitrisk-of-crestorr-rosuvastatin-calcium-in-jupiter-study/2009/</loc>
		<lastmod>2009-12-16T00:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5983: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-panel-backs-new-use-for-astrazenecas-crestor/2009/</loc>
		<lastmod>2009-12-16T00:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5948: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/banks-card-woes-hurt-stocks/2009/</loc>
		<lastmod>2009-12-16T00:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5981: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-panel-backs-wider-use-of-crestor/2009/</loc>
		<lastmod>2009-12-15T23:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5987: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-do-bill-gates-warren-buffett-and-you-have-in-common/2009/</loc>
		<lastmod>2009-12-15T23:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5988: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-do-bill-gates-warren-buffett-and-you-have-in-common/2009/</loc>
		<lastmod>2009-12-15T23:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5985: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-in-china-aids-drugs-in-africa-vaccine-recall-in-u-s/2009/</loc>
		<lastmod>2009-12-15T22:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5951: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-breaks-win-streak/2009/</loc>
		<lastmod>2009-12-15T21:31:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5980: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotechs-board-of-directors-reiterates-recommendation-that-stockholders-not-tender-at-17-50-per-share-marketwire/2009/</loc>
		<lastmod>2009-12-15T21:23:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5979: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotechs-board-of-directors-reiterates-recommendation-that-stockholders-not-tender-at-17-50-per-share-marketwire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-15T21:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5967: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/progress-on-aids-plan/2009/</loc>
		<lastmod>2009-12-15T20:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5975: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/beat-the-street-with-25-cents-the-motley-fool/2009/</loc>
		<lastmod>2009-12-15T20:39:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5976: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/beat-the-street-with-25-cents-the-motley-fool/2009/</loc>
		<lastmod>2009-12-15T20:39:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5972: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/orasure-gets-key-eu-approval-for-hepatitis-c-test/2009/</loc>
		<lastmod>2009-12-15T20:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5973: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biogen-threatens-proxy-over-rejected-bid-for-facet-update1-bloomberg/2009/</loc>
		<lastmod>2009-12-15T20:30:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5974: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biogen-threatens-proxy-over-rejected-bid-for-facet-update1-bloomberg/2009/</loc>
		<lastmod>2009-12-15T20:30:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6043: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-does-everyone-hate-monsanto/2009/</loc>
		<lastmod>2009-12-15T20:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5966: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/which-doctors-are-getting-paid-by-glaxo-lilly-and-merck/2009/</loc>
		<lastmod>2009-12-15T19:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5977: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cobalt-international-energy-seeks-1-1b-in-ipo-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-15T19:38:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5968: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-us-warns-abbott-unit-on-problems-at-swedish-plant/2009/</loc>
		<lastmod>2009-12-15T19:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6036: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/top-10-ceo-departures-of-2009/2009/</loc>
		<lastmod>2009-12-15T18:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5961: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-takeda-sign-china-marketing-deal/2009/</loc>
		<lastmod>2009-12-15T18:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5990: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/prospecting-for-stocks-abbott-laboratories/2009/</loc>
		<lastmod>2009-12-15T17:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5955: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rallies-after-a-9-day-retreat/2009/</loc>
		<lastmod>2009-12-15T17:36:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5982: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/its-nice-to-have-friends-with-cash/2009/</loc>
		<lastmod>2009-12-15T17:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5956: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/out-of-the-money-option-traders-target-biogen-idec-inc-biib-schaeffers-research/2009/</loc>
		<lastmod>2009-12-15T16:44:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5964: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-azn-11/2009/</loc>
		<lastmod>2009-12-15T16:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5957: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-and-the-university-of-virginia-sign-strategic-research-collaboration-to-develop-novel-treatments-for-cardiovascular-disease/2009/</loc>
		<lastmod>2009-12-15T16:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5949: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-merck-alcoa-sears-holdings-cimarex-energy-and-asiainfo-released-by-seven-summits-research/2009/</loc>
		<lastmod>2009-12-15T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5962: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/takeda-and-pfizer-to-co-promote-takeda%e2%80%99s-actos%c2%ae-pioglitazone-hcl-for-the-treatment-of-type-2-diabetes-in-china/2009/</loc>
		<lastmod>2009-12-15T16:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5954: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-fall-on-renewed-inflation-fears/2009/</loc>
		<lastmod>2009-12-15T15:57:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6016: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/congress-cares-about-your-ears/2009/</loc>
		<lastmod>2009-12-15T15:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5959: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/elan-leads-drug-stocks-lower-fox-news/2009/</loc>
		<lastmod>2009-12-15T15:06:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5958: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/huge-leaps-for-small-cap-pharma-plays-indie-research-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-15T15:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5952: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-hits-highest-level-since-october/2009/</loc>
		<lastmod>2009-12-15T14:47:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5953: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-biotech-company-is-shelving-its-experimental-blood-pressure-drug-schaeffers-research/2009/</loc>
		<lastmod>2009-12-15T14:42:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5944: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-array-biopharma-enter-development-agreement-ap-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-15T13:51:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5945: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/by-ben-hirschler-london-euronews/2009/</loc>
		<lastmod>2009-12-15T13:31:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6002: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/safety-dogs-elan-alzheimers-drug-seattle-genetics-finds-new-partner-biobuzz/2009/</loc>
		<lastmod>2009-12-15T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5970: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-calendar-upcoming-fda-dates/2009/</loc>
		<lastmod>2009-12-15T12:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5941: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-lower-start/2009/</loc>
		<lastmod>2009-12-15T12:04:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5942: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramer-monday-was-a-good-day-for-bulls/2009/</loc>
		<lastmod>2009-12-15T08:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5940: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biz-week-everett-herald-2/2009/</loc>
		<lastmod>2009-12-15T07:43:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5950: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfenex-inks-vaccine-development-deal-with-merck/2009/</loc>
		<lastmod>2009-12-15T00:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5947: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-to-buy-laboratory-software-maker-starlims/2009/</loc>
		<lastmod>2009-12-15T00:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5938: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lionbridge-technologies-says-revenue-will-hit-high-end-of-forecast-fox-news/2009/</loc>
		<lastmod>2009-12-15T00:31:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5991: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-pfizer-lifts-dividend-yield-closer-to-rivals/2009/</loc>
		<lastmod>2009-12-15T00:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5943: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-abbott-to-buy-starlims-technologies-for-123-mln/2009/</loc>
		<lastmod>2009-12-15T00:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5937: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-labs-to-buy-starlims-tech-for-123-mln/2009/</loc>
		<lastmod>2009-12-15T00:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5932: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-12-14-2315-update-1-ambrilia-closes-manufacturing-facility-cuts-jobs-interactive-investor/2009/</loc>
		<lastmod>2009-12-14T23:43:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5936: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mimicking-red-blood-cells-to-improve-drug-delivery-scientific-american/2009/</loc>
		<lastmod>2009-12-14T23:38:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5935: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-raises-dividend-to-18-cents-per-share/2009/</loc>
		<lastmod>2009-12-14T23:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5925: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-good-day-to-be-a-bull/2009/</loc>
		<lastmod>2009-12-14T22:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5926: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-raises-dividend-to-18-cents/2009/</loc>
		<lastmod>2009-12-14T22:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5927: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-declares-an-18-cent-first-quarter-2010-dividend/2009/</loc>
		<lastmod>2009-12-14T22:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5960: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/extended-release-antipsychotics-for-extended-patent-protection/2009/</loc>
		<lastmod>2009-12-14T21:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5906: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-jumps-to-14-month-highs/2009/</loc>
		<lastmod>2009-12-14T21:11:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5924: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-streets-worst-kept-secret-the-motley-fool/2009/</loc>
		<lastmod>2009-12-14T20:43:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5931: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mozarts-humbling-advice/2009/</loc>
		<lastmod>2009-12-14T20:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5928: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ppdi-shares-climb-on-analyst-upgrade/2009/</loc>
		<lastmod>2009-12-14T20:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5919: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/human-genomes-ceo-biotechs-best-09/2009/</loc>
		<lastmod>2009-12-14T18:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5920: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/finally-released-from-an-extended-review/2009/</loc>
		<lastmod>2009-12-14T18:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5921: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/its-still-smart-to-own-these-stocks/2009/</loc>
		<lastmod>2009-12-14T17:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5913: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/human-genomes-ceo-biotechs-best-09-thestreet-com/2009/</loc>
		<lastmod>2009-12-14T16:56:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 6195: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-10-best-stocks-for-2010/2009/</loc>
		<lastmod>2009-12-14T16:44:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5916: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/get-ready-for-the-fall-2/2009/</loc>
		<lastmod>2009-12-14T16:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5911: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-rise-modestly/2009/</loc>
		<lastmod>2009-12-14T16:04:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5912: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-14/2009/</loc>
		<lastmod>2009-12-14T15:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5907: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-pfe-4/2009/</loc>
		<lastmod>2009-12-14T14:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5910: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/top-2010-healthcare-stocks/2009/</loc>
		<lastmod>2009-12-14T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5905: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-retreats-for-9th-day/2009/</loc>
		<lastmod>2009-12-14T12:16:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5914: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vivakor-launches-new-website-to-promote-its-remarkable-vivathermic-vial-news-medical-net/2009/</loc>
		<lastmod>2009-12-14T12:14:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5902: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-dips-on-dubais-bailout/2009/</loc>
		<lastmod>2009-12-14T12:11:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5899: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-climb-on-citi-dubai-news/2009/</loc>
		<lastmod>2009-12-14T12:07:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5898: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biz-week-everett-herald/2009/</loc>
		<lastmod>2009-12-14T09:04:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5897: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/insbio-clinches-deals-with-two-companies-the-edge-daily/2009/</loc>
		<lastmod>2009-12-14T07:10:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5896: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/aastrom-moves-to-version-4-0-new-ceo-change-in-focus-crains-detroit-business/2009/</loc>
		<lastmod>2009-12-14T01:16:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5904: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/disturbing-fine-print-on-nakheel-bonds/2009/</loc>
		<lastmod>2009-12-13T21:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5895: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/naughty-funds-get-lumps-of-coal-malaysianews-net/2009/</loc>
		<lastmod>2009-12-13T18:50:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5892: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/naughty-funds-get-lumps-of-coal-fox-news/2009/</loc>
		<lastmod>2009-12-13T17:34:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5891: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/all-eyes-on-the-fed/2009/</loc>
		<lastmod>2009-12-13T16:39:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5890: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/options-are-you-nuts-2/2009/</loc>
		<lastmod>2009-12-13T10:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5889: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-inc-affirms-confidence-in-its-hormone-therapy-medicines-as-important-treatment-options/2009/</loc>
		<lastmod>2009-12-13T04:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5885: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-announces-neratinib-data-in-her2-positive-breast-cancer/2009/</loc>
		<lastmod>2009-12-13T01:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5874: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/be-a-penny-stock-millionaire/2009/</loc>
		<lastmod>2009-12-12T12:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5871: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/hawaii-biotech-strapped-for-cash-honolulu-advertiser/2009/</loc>
		<lastmod>2009-12-12T12:06:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5876: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-motley-fools-weekly-editors-picks/2009/</loc>
		<lastmod>2009-12-12T10:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5900: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-labs-sets-dividend-of-40-cents/2009/</loc>
		<lastmod>2009-12-12T00:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5917: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/crestors-benefits-seen-outweighing-risks/2009/</loc>
		<lastmod>2009-12-11T23:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5863: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/etfs-stay-focused-with-big-stakes/2009/</loc>
		<lastmod>2009-12-11T23:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5864: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/etfs-stay-focused-with-big-stakes-2/2009/</loc>
		<lastmod>2009-12-11T23:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5820: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-at-new-09-high/2009/</loc>
		<lastmod>2009-12-11T21:12:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5851: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/profit-whichever-way-a-stock-goes-the-motley-fool-2/2009/</loc>
		<lastmod>2009-12-11T21:12:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5834: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-3-us-panel-to-weigh-safety-of-astrazenecas-crestor/2009/</loc>
		<lastmod>2009-12-11T21:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5817: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-falls-below-70-2/2009/</loc>
		<lastmod>2009-12-11T20:44:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5852: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-reform-for-dummies/2009/</loc>
		<lastmod>2009-12-11T20:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5859: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/options-explained-sort-of/2009/</loc>
		<lastmod>2009-12-11T20:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5860: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/options-explained-sort-of/2009/</loc>
		<lastmod>2009-12-11T20:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5861: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/glaxo-pursues-needle-free-vaccines/2009/</loc>
		<lastmod>2009-12-11T19:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5862: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/glaxo-pursues-needle-free-vaccines/2009/</loc>
		<lastmod>2009-12-11T19:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5841: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/roche-and-biogens-blockbuster-making-good-progress/2009/</loc>
		<lastmod>2009-12-11T18:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5842: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/roche-and-biogens-blockbuster-making-good-progress/2009/</loc>
		<lastmod>2009-12-11T18:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5847: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/advisory-committee-briefing-materials-for-crestorr-snda-available-on-us-fda-web-site/2009/</loc>
		<lastmod>2009-12-11T18:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5835: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lly-caris-cuts-to-hold/2009/</loc>
		<lastmod>2009-12-11T18:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5848: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gilead-gets-the-experts-on-its-side/2009/</loc>
		<lastmod>2009-12-11T18:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5840: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-sink-on-upbeat-economic-news/2009/</loc>
		<lastmod>2009-12-11T17:59:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5839: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rises-to-2-month-high-on-euro/2009/</loc>
		<lastmod>2009-12-11T17:42:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5827: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-declares-344th-consecutive-quarterly-dividend/2009/</loc>
		<lastmod>2009-12-11T17:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5849: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/prospecting-for-stocks-mylan-laboratories/2009/</loc>
		<lastmod>2009-12-11T17:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5828: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eli-lilly-isnt-planning-to-buy-its-way-around-the-patent-cliff/2009/</loc>
		<lastmod>2009-12-11T17:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5883: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dont-ignore-these-winners-in-2010/2009/</loc>
		<lastmod>2009-12-11T15:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5821: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-rise-on-retail-sales-2/2009/</loc>
		<lastmod>2009-12-11T14:57:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5829: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/expect-more-of-this-in-2010/2009/</loc>
		<lastmod>2009-12-11T14:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5830: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-childrens-vaccine-receives-european-ok/2009/</loc>
		<lastmod>2009-12-11T14:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5812: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-pfizer-wins-europe-approval-for-new-vaccine/2009/</loc>
		<lastmod>2009-12-11T14:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5826: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-cell-therapeutics/2009/</loc>
		<lastmod>2009-12-11T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5811: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-rally-on-retail-sales/2009/</loc>
		<lastmod>2009-12-11T13:54:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5813: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/showdown-over-aids-drugs/2009/</loc>
		<lastmod>2009-12-11T13:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5808: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-gets-european-authorization-for-prevenar-13/2009/</loc>
		<lastmod>2009-12-11T13:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5809: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-receives-european-authorization-for-prevenar-13-for-the-prevention-of-pneumococcal-disease-in-infants-and-young-children/2009/</loc>
		<lastmod>2009-12-11T12:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5814: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-cell-therapeutics-thestreet-com-2/2009/</loc>
		<lastmod>2009-12-11T12:01:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5869: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-tech-comeback/2009/</loc>
		<lastmod>2009-12-11T02:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5822: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-reports-positive-faslodex-data/2009/</loc>
		<lastmod>2009-12-11T00:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5823: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-reports-positive-faslodex-data/2009/</loc>
		<lastmod>2009-12-11T00:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5800: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sens-move-to-block-drugmakers-from-mining-rx-data/2009/</loc>
		<lastmod>2009-12-11T00:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5795: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bone-drugs-may-cut-cancer-risk/2009/</loc>
		<lastmod>2009-12-11T00:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5796: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/studies-bone-drugs-may-help-prevent-breast-cancer/2009/</loc>
		<lastmod>2009-12-11T00:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5801: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/phase-iii-confirm-study-shows-faslodexr-fulvestrant-injection-500-mg-may-delay-time-of-disease-progression-over-250-mg-dose-in-postmenopausal-women-with-hormone-receptor-positive-advanced-breast/2009/</loc>
		<lastmod>2009-12-11T00:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5802: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-azn-10/2009/</loc>
		<lastmod>2009-12-11T00:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5798: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-next-aids-crisis/2009/</loc>
		<lastmod>2009-12-10T22:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5765: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-tumble-after-lackluster-30-year-sale/2009/</loc>
		<lastmod>2009-12-10T21:38:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5788: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotech%e2%80%99s-board-rejects-biogen%e2%80%99s-revised-offer-update2-bloomberg/2009/</loc>
		<lastmod>2009-12-10T21:26:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5784: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/movers-roundup-western-union-oncothyreon/2009/</loc>
		<lastmod>2009-12-10T21:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5792: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-extends-medication-giveaway-for-jobless/2009/</loc>
		<lastmod>2009-12-10T21:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5785: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/osteoporosis-meds-may-cut-breast-cancer-risk-study/2009/</loc>
		<lastmod>2009-12-10T20:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5749: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-retreats-for-7th-day/2009/</loc>
		<lastmod>2009-12-10T20:28:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5790: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-tale-of-two-lillys/2009/</loc>
		<lastmod>2009-12-10T20:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5854: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/an-easy-strategy-to-ease-into-options/2009/</loc>
		<lastmod>2009-12-10T20:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5786: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oncothyreon-shares-rise-on-new-late-stage-study/2009/</loc>
		<lastmod>2009-12-10T19:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5780: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eli-lilly-predicts-earnings-growth-touts-pipeline/2009/</loc>
		<lastmod>2009-12-10T19:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5793: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dreadful-stocks-to-avoid/2009/</loc>
		<lastmod>2009-12-10T18:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5850: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-doing-right-by-shareholders/2009/</loc>
		<lastmod>2009-12-10T18:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5781: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-announces-updated-trial-results-for-aromasin%c2%ae-exemestane-tablets-in-switch-and-upfront-settings/2009/</loc>
		<lastmod>2009-12-10T18:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5779: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-abt-7/2009/</loc>
		<lastmod>2009-12-10T18:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5772: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-seeks-fda-approval-of-new-dosage-strengths-of-simcorr-niacin-extended-releasesimvastatin/2009/</loc>
		<lastmod>2009-12-10T18:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5782: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pimco-funds-outperform-bond-portfolios/2009/</loc>
		<lastmod>2009-12-10T17:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5783: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-public-option-is-dead-again-maybe/2009/</loc>
		<lastmod>2009-12-10T17:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5787: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dendreon-grasps-for-400m-zymogenetics-cuts-52-jobs-calistoga-advances-at-ash-more-seattle-area-life-sciences-news-seattlepi-com/2009/</loc>
		<lastmod>2009-12-10T17:42:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5764: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-in-broad-based-rally/2009/</loc>
		<lastmod>2009-12-10T17:04:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5773: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/upgrades-downgrades-dont-dial-up-aol/2009/</loc>
		<lastmod>2009-12-10T16:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5771: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-climb-lilly-falls-on-forecast-market-watch/2009/</loc>
		<lastmod>2009-12-10T16:15:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5837: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oncothyreon-netlist-early-volume-plays/2009/</loc>
		<lastmod>2009-12-10T16:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5762: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-merck-abbott-and-lilly-deals-in-sec-insider-trading-probe/2009/</loc>
		<lastmod>2009-12-10T16:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5770: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotech%e2%80%99s-board-rejects-biogen%e2%80%99s-revised-offer-update1-bloomberg/2009/</loc>
		<lastmod>2009-12-10T15:41:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5752: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sec-eyes-9-deals-in-insider-trading-probe-report/2009/</loc>
		<lastmod>2009-12-10T14:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5753: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-sec-eyes-9-deals-in-insider-trading-probe-wsj/2009/</loc>
		<lastmod>2009-12-10T14:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5755: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lilly-sees-more-growth-in-2010/2009/</loc>
		<lastmod>2009-12-10T14:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5761: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotechs-board-of-directors-unanimously-rejects-biogen-idecs-revised-unsolicited-tender-offer-as-inadequate-marketwire/2009/</loc>
		<lastmod>2009-12-10T13:44:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5748: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotechs-board-of-directors-unanimously-rejects-biogen-idecs-revised-unsolicited-tender-offer-as-inadequate-marketwire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-10T13:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5747: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-steadies-against-euro/2009/</loc>
		<lastmod>2009-12-10T13:08:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5746: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-markets-to-focus-on-jobs/2009/</loc>
		<lastmod>2009-12-10T09:33:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5744: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dendreon-proposes-public-stock-offer-daily-record/2009/</loc>
		<lastmod>2009-12-10T09:14:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5745: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/generex-biotech-corp-stock-world-2/2009/</loc>
		<lastmod>2009-12-10T09:10:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5760: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/profit-on-a-flat-stock-2/2009/</loc>
		<lastmod>2009-12-10T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5736: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genzyme-names-independent-director/2009/</loc>
		<lastmod>2009-12-10T00:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5737: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genzyme-elects-bertolini-to-board/2009/</loc>
		<lastmod>2009-12-09T22:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5705: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-fall-on-poor-10-year-debt-sale/2009/</loc>
		<lastmod>2009-12-09T22:01:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5731: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/elan-to-present-at-deutsche-bank-securities-biotech-boston-confab-conference-business-wire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-09T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5688: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-falls-below-71/2009/</loc>
		<lastmod>2009-12-09T21:17:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5730: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-crown-to-study-cancers-common-in-asia/2009/</loc>
		<lastmod>2009-12-09T21:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5695: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-gain-as-dollar-falls/2009/</loc>
		<lastmod>2009-12-09T21:13:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5758: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tomorrows-monster-stock-2/2009/</loc>
		<lastmod>2009-12-09T20:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5724: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/investing-in-a-high-unemployment-era/2009/</loc>
		<lastmod>2009-12-09T20:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5726: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-strategy-for-all-situations/2009/</loc>
		<lastmod>2009-12-09T20:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5727: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-strategy-for-all-situations/2009/</loc>
		<lastmod>2009-12-09T20:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5728: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rising-from-the-ashes/2009/</loc>
		<lastmod>2009-12-09T20:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5729: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rising-from-the-ashes/2009/</loc>
		<lastmod>2009-12-09T20:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5725: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/welcome-to-club-biogeneric-pfizer/2009/</loc>
		<lastmod>2009-12-09T19:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5722: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-biogeneric-no-brainer/2009/</loc>
		<lastmod>2009-12-09T19:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5714: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-rises-as-analyst-expects-dividend-increase/2009/</loc>
		<lastmod>2009-12-09T19:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5715: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/hints-of-a-brighter-jobs-picture/2009/</loc>
		<lastmod>2009-12-09T18:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5721: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/benefiting-from-a-down-dollar/2009/</loc>
		<lastmod>2009-12-09T18:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5799: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-eu-raids-pharma-firms-over-suspected-abuse/2009/</loc>
		<lastmod>2009-12-09T17:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5720: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/another-medical-school-reports-doctors-industry-ties/2009/</loc>
		<lastmod>2009-12-09T17:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5716: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novavax-closes-offering-for-6-8-million-shares-san-francisco-chronicle/2009/</loc>
		<lastmod>2009-12-09T17:15:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5699: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-at-a-critical-level/2009/</loc>
		<lastmod>2009-12-09T16:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5700: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-tidbits-dividend-murmurs-generic-biotech-china-rd/2009/</loc>
		<lastmod>2009-12-09T16:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5704: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novavax-closes-offering-for-6-8-million-shares-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-09T16:01:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5706: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novavax-closes-offering-for-6-8-million-shares-ap-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-09T16:01:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5698: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-picking-freedom-helps-lord-abbett/2009/</loc>
		<lastmod>2009-12-09T15:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5701: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/physicians-more-likely-to-report-drug-safety-information-through-electronic-health-records-system/2009/</loc>
		<lastmod>2009-12-09T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5686: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/healthy-start-seen-for-stocks/2009/</loc>
		<lastmod>2009-12-09T13:03:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5689: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-falls-against-euro-2/2009/</loc>
		<lastmod>2009-12-09T11:59:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5693: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-stock-screaming-buy-me-4/2009/</loc>
		<lastmod>2009-12-09T11:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5694: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/no-im-not-playing-with-fire/2009/</loc>
		<lastmod>2009-12-09T11:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5690: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-seeks-boost-from-biotech-drugs-within-5-years-update1-bloomberg/2009/</loc>
		<lastmod>2009-12-09T10:45:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5687: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-slight-gains-2/2009/</loc>
		<lastmod>2009-12-09T09:30:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5702: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-seeks-to-broaden-use-of-some-cancer-drugs/2009/</loc>
		<lastmod>2009-12-09T08:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5691: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/correcting-and-replacing-pfizer-and-crown-bioscience-announce-a-collaboration-to-research-and-develop-new-treatments-for-asian-cancers/2009/</loc>
		<lastmod>2009-12-09T03:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5679: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/analyst-pharma-profit-will-fall-on-patent-losses/2009/</loc>
		<lastmod>2009-12-09T00:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5682: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-drug-beats-gleevec-in-trial/2009/</loc>
		<lastmod>2009-12-08T22:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5651: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-rise-on-interest-rate-outlook/2009/</loc>
		<lastmod>2009-12-08T21:55:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5675: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cell-therapeutics-on-dilution-watch-biobuzz/2009/</loc>
		<lastmod>2009-12-08T21:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5680: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/early-and-often-a-drug-investors-dream/2009/</loc>
		<lastmod>2009-12-08T20:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5681: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-stocks-are-growth-traps/2009/</loc>
		<lastmod>2009-12-08T20:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5677: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-take-on-headline-stocks-dec-8/2009/</loc>
		<lastmod>2009-12-08T18:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5670: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/golds-luster-continues-to-fade/2009/</loc>
		<lastmod>2009-12-08T18:01:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5667: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drugmakers-back-in-spotlight-as-u-s-reform-amps-up/2009/</loc>
		<lastmod>2009-12-08T17:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5665: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-nvs-15/2009/</loc>
		<lastmod>2009-12-08T16:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5649: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-retreats/2009/</loc>
		<lastmod>2009-12-08T16:15:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5668: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-endo-celgene-lead-drug-stocks-lower-market-watch/2009/</loc>
		<lastmod>2009-12-08T16:00:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5683: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-to-cover-copays-for-some-patients/2009/</loc>
		<lastmod>2009-12-08T15:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5652: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-rise-on-bernankes-comments/2009/</loc>
		<lastmod>2009-12-08T15:41:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5655: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/better-drug-stock-pfizer-or-merck/2009/</loc>
		<lastmod>2009-12-08T15:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5656: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/better-drug-stock-pfizer-or-merck/2009/</loc>
		<lastmod>2009-12-08T15:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5650: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-slump-in-morning-trading-2/2009/</loc>
		<lastmod>2009-12-08T14:59:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5647: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-mixed-against-rivals-3/2009/</loc>
		<lastmod>2009-12-08T14:31:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5638: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-brace-for-selloff/2009/</loc>
		<lastmod>2009-12-08T13:45:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5644: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-continues-retreat/2009/</loc>
		<lastmod>2009-12-08T12:14:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5666: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/are-you-playing-with-fire/2009/</loc>
		<lastmod>2009-12-08T11:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5639: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-a-mixed-open/2009/</loc>
		<lastmod>2009-12-08T09:52:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5635: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/in-brief-amgen-approves-another-5-billion-stock-buyback-ventura-county-star/2009/</loc>
		<lastmod>2009-12-08T06:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5669: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-not-to-wear-to-the-office-party/2009/</loc>
		<lastmod>2009-12-08T03:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5631: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/indexes-churn-to-flat-finish/2009/</loc>
		<lastmod>2009-12-07T23:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5642: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotechs-to-watch-in-the-blood-business/2009/</loc>
		<lastmod>2009-12-07T22:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5608: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/choppy-day-on-wall-street/2009/</loc>
		<lastmod>2009-12-07T21:10:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5597: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-tarnished-by-dollar-run/2009/</loc>
		<lastmod>2009-12-07T20:59:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5596: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-slumps-below-74/2009/</loc>
		<lastmod>2009-12-07T20:55:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5623: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mylan-sells-stake-in-concord-biotech-the-economic-times/2009/</loc>
		<lastmod>2009-12-07T19:17:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5622: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-approves-5-billion-stock-buyback-malaysianews-net/2009/</loc>
		<lastmod>2009-12-07T18:42:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5619: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dick-boves-bold-bank-call/2009/</loc>
		<lastmod>2009-12-07T17:30:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5595: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rises-to-5-week-high/2009/</loc>
		<lastmod>2009-12-07T17:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5634: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jeff-saut-will-the-upside-continue-into-year-end/2009/</loc>
		<lastmod>2009-12-07T17:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5615: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-rise-amgen-zigzags-on-buyback-market-watch/2009/</loc>
		<lastmod>2009-12-07T16:01:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5613: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-says-board-approved-5b-stock-buyback-plan-current-repurchase-has-1-2b-remaining-malaysianews-net/2009/</loc>
		<lastmod>2009-12-07T15:28:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5614: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drug-stocks-flat-amgen-gains-on-stock-buyback-fox-news/2009/</loc>
		<lastmod>2009-12-07T15:15:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5611: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-approves-5-billion-stock-buyback-boston-herald/2009/</loc>
		<lastmod>2009-12-07T15:10:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5610: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-recover-ahead-of-auctions/2009/</loc>
		<lastmod>2009-12-07T15:00:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5609: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-approves-5-billion-stock-buyback-san-francisco-chronicle/2009/</loc>
		<lastmod>2009-12-07T14:45:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5599: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-approves-5-billion-stock-buyback-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-07T14:33:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5600: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-approves-5-billion-stock-buyback-ap-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-07T14:33:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5605: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/santarus-ja-solar-early-volume-plays-thestreet-com/2009/</loc>
		<lastmod>2009-12-07T14:31:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5602: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-approves-5-billion-stock-buyback-the-daily-reflector/2009/</loc>
		<lastmod>2009-12-07T14:30:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5604: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-approves-5-billion-stock-buyback-bay-news-9-tampa-bay/2009/</loc>
		<lastmod>2009-12-07T14:27:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5626: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-approves-5-billion-stock-buyback-ino-news/2009/</loc>
		<lastmod>2009-12-07T14:27:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5601: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-approves-5-billion-stock-buyback-san-diego-union-tribune/2009/</loc>
		<lastmod>2009-12-07T14:26:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5603: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-approves-5-billion-stock-buyback-rocky-mount-telegram/2009/</loc>
		<lastmod>2009-12-07T14:22:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5612: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-approves-5-billion-stock-buyback-ap-via-yahoo-asia-news/2009/</loc>
		<lastmod>2009-12-07T14:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5632: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgen-approves-5-billion-stock-buyback-ap-via-yahoo-singapore-news/2009/</loc>
		<lastmod>2009-12-07T14:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5606: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ventana-enters-final-stage-of-negotiations-marketwire/2009/</loc>
		<lastmod>2009-12-07T13:35:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5598: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merieux-alliance-becomes-institut-merieux-redorbit/2009/</loc>
		<lastmod>2009-12-07T13:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5617: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/transcript-james-kieffer/2009/</loc>
		<lastmod>2009-12-07T13:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5591: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/get-briefed-james-kieffer/2009/</loc>
		<lastmod>2009-12-07T13:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5590: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-may-get-tarnished-at-open/2009/</loc>
		<lastmod>2009-12-07T11:55:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5589: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merieux-alliance-becomes-institut-merieux-itnews/2009/</loc>
		<lastmod>2009-12-07T07:43:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5581: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merieux-alliance-becomes-institut-merieux-pr-newswire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-07T07:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5579: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/senator-schumer-slams-double-whammy-of-atm-fees-amnewyork/2009/</loc>
		<lastmod>2009-12-07T02:52:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5616: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/putting-a-price-on-social-networking/2009/</loc>
		<lastmod>2009-12-06T22:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5582: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/blood-thinner-battle-heats-up/2009/</loc>
		<lastmod>2009-12-06T21:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5576: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/canadian-bankers-brace-for-slower-bonus-payouts-malaysianews-net-2/2009/</loc>
		<lastmod>2009-12-06T19:35:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5592: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-under-10-2-potential-buys-2/2009/</loc>
		<lastmod>2009-12-06T19:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5583: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-weeks-barrons-roundup-2/2009/</loc>
		<lastmod>2009-12-06T17:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5575: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/best-performing-stocks-of-decade-vs-prior-predictions-guru-focus/2009/</loc>
		<lastmod>2009-12-06T16:47:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5584: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/don-dions-weekly-etf-blog-wrap/2009/</loc>
		<lastmod>2009-12-06T16:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5574: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/better-biotech-buy-celgene-or-genzyme-the-motley-fool/2009/</loc>
		<lastmod>2009-12-06T05:22:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5585: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/even-better-than-bonds/2009/</loc>
		<lastmod>2009-12-05T14:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5572: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-rally-rest-or-recharge/2009/</loc>
		<lastmod>2009-12-05T14:00:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5586: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/adding-multimedia-bristol-myers-squibb-and-pfizer-announce-plans-to-submit-regulatory-filing-for-apixaban-in-europe/2009/</loc>
		<lastmod>2009-12-05T02:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5587: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/adding-multimedia-bristol-myers-squibb-and-pfizer-announce-plans-to-submit-regulatory-filing-for-apixaban-in-europe/2009/</loc>
		<lastmod>2009-12-05T02:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5571: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/raised-biogen-offer-unlikely-to-tempt-facet-shareholders-bioworld/2009/</loc>
		<lastmod>2009-12-05T02:18:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5569: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/antipsychotics-diabetes-kids/2009/</loc>
		<lastmod>2009-12-05T00:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5565: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-citibank-keycorp-ford-abbott-laboratories-inc-and-teva-pharmaceutical-industries-ltd/2009/</loc>
		<lastmod>2009-12-05T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5567: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-spdr-sp-500-trust-money-flow-leaders-mrk-spy/2009/</loc>
		<lastmod>2009-12-04T23:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5534: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-rally-on-jobs-report/2009/</loc>
		<lastmod>2009-12-04T22:33:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5570: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-pharmas-sick-ad-budgets/2009/</loc>
		<lastmod>2009-12-04T22:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5529: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-falls-on-stronger-dollar/2009/</loc>
		<lastmod>2009-12-04T20:13:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5547: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-prices-fall-4/2009/</loc>
		<lastmod>2009-12-04T20:03:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5568: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/little-warning-big-message/2009/</loc>
		<lastmod>2009-12-04T20:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5556: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/panel-urges-antipsychotic-drug-review/2009/</loc>
		<lastmod>2009-12-04T19:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5557: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/panel-urges-antipsychotic-drug-review/2009/</loc>
		<lastmod>2009-12-04T19:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5555: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/prospecting-for-stocks-oculus-innovative-sciences/2009/</loc>
		<lastmod>2009-12-04T19:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5554: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/after-rising-500-what-did-you-expect/2009/</loc>
		<lastmod>2009-12-04T18:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5553: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ny-court-deals-setback-to-columbia-expansion-plan/2009/</loc>
		<lastmod>2009-12-04T18:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5548: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/seroquel-cleared-for-limited-use/2009/</loc>
		<lastmod>2009-12-04T17:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5549: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-fda-staff-suggests-liver-warning-on-mercks-cancidas/2009/</loc>
		<lastmod>2009-12-04T15:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5536: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-tumble-on-bullish-jobs-report/2009/</loc>
		<lastmod>2009-12-04T15:40:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5531: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rises-after-bullish-jobs-data/2009/</loc>
		<lastmod>2009-12-04T15:24:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5535: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-spike-on-jobs-report/2009/</loc>
		<lastmod>2009-12-04T15:04:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5541: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-to-present-clinical-data-from-expanded-breast-cancer-portfolio-at-the-san-antonio-breast-cancer-symposium/2009/</loc>
		<lastmod>2009-12-04T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5538: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-safest-bets-in-bank-stocks/2009/</loc>
		<lastmod>2009-12-04T14:56:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5546: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sun-microsystems-take-two-western-gas-u-s-equity-preview-bloomberg/2009/</loc>
		<lastmod>2009-12-04T14:46:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2781: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-drug-wins-partial-us-approval/2009/</loc>
		<lastmod>2009-12-04T14:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5573: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-azn-9/2009/</loc>
		<lastmod>2009-12-04T14:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5522: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-fda-approves-seroquel-xrr-for-add-on-treatment-of-major-depressive-disorder/2009/</loc>
		<lastmod>2009-12-04T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5517: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-readies-for-a-strong-rally/2009/</loc>
		<lastmod>2009-12-04T13:47:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5519: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-hemispherx-biopharma-thestreet-com/2009/</loc>
		<lastmod>2009-12-04T12:15:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5520: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biogen-idec-increases-its-offer-to-17-50-for-purchase-of-facet-biotech-shares-news-medical-net/2009/</loc>
		<lastmod>2009-12-04T12:03:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5530: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/best-buys-now/2009/</loc>
		<lastmod>2009-12-04T11:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5523: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-gets-fda-ok-for-seroquel-xr-add-on/2009/</loc>
		<lastmod>2009-12-04T09:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5524: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-gets-fda-ok-for-seroquel-xr-add-on/2009/</loc>
		<lastmod>2009-12-04T09:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5525: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/switzerlands-300-richest-lose-10-billion-in-2009/2009/</loc>
		<lastmod>2009-12-04T06:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5512: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biogen-idec-boosts-offer-to-buy-facet-biotech-by-21-update3-bloomberg/2009/</loc>
		<lastmod>2009-12-04T00:07:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5513: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biogen-idec-boosts-offer-to-buy-facet-biotech-by-21-update2-bloomberg/2009/</loc>
		<lastmod>2009-12-03T23:56:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5514: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotech-advises-stockholders-to-take-no-action-in-response-to-revised-biogen-idec-tender-offer-marketwire/2009/</loc>
		<lastmod>2009-12-03T23:31:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5515: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-12-03-2255-update-2-biogen-ups-offer-for-facet-biotech-to-17-50share-interactive-investor/2009/</loc>
		<lastmod>2009-12-03T23:13:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5494: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astra-to-buy-targacept-drug-for-1-24bln%c2%a0-reuters-via-yahoo-uk-ireland-news/2009/</loc>
		<lastmod>2009-12-03T22:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5509: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biogen-raises-facet-offer-to-17-50-per-share-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-03T22:25:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5483: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-us-consumer-group-asks-fda-to-ban-abbott-diet-drug/2009/</loc>
		<lastmod>2009-12-03T22:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5498: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/two-ways-to-play-a-rise-in-pharma/2009/</loc>
		<lastmod>2009-12-03T21:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5502: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-the-drug-industry-spends-20-billion-a-year-on-marketing/2009/</loc>
		<lastmod>2009-12-03T21:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5505: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biogen-idec-increases-offer-to-acquire-facet-biotech-to-17-50-per-share-in-cash-sends-letter-to-facet-biotech-business-wire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-03T21:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5474: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-steadies-near-76/2009/</loc>
		<lastmod>2009-12-03T20:52:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5475: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-5-astra-to-pay-up-to-1-24-bln-for-targacept-drug/2009/</loc>
		<lastmod>2009-12-03T20:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5508: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/i-love-this-industry/2009/</loc>
		<lastmod>2009-12-03T20:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5473: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-falter-ahead-of-jobs-report/2009/</loc>
		<lastmod>2009-12-03T20:43:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5484: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-canadas-absolute-software-buys-lanrev-for-14-6-mln/2009/</loc>
		<lastmod>2009-12-03T20:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5492: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/targacept-selling-is-just-silly-biobuzz/2009/</loc>
		<lastmod>2009-12-03T19:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5499: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-reform-is-very-taxing/2009/</loc>
		<lastmod>2009-12-03T19:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5493: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-buys-targacept-rights/2009/</loc>
		<lastmod>2009-12-03T19:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5491: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/consumer-advocate-asks-fda-to-ban-weight-loss-pill/2009/</loc>
		<lastmod>2009-12-03T18:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5470: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-slips-after-european-bank-meeting/2009/</loc>
		<lastmod>2009-12-03T17:15:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5489: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biolinerx-meets-underwriters-on-nasdaq-listing-globes-online/2009/</loc>
		<lastmod>2009-12-03T17:07:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5542: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-group-asks-fda-to-ban-abbott-diet-drug/2009/</loc>
		<lastmod>2009-12-03T17:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5500: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fitz-bits-dont-give-up-on-nike/2009/</loc>
		<lastmod>2009-12-03T17:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5486: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-slip-on-upbeat-jobs-data/2009/</loc>
		<lastmod>2009-12-03T16:46:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5480: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/generex-biotech-corp-stock-world/2009/</loc>
		<lastmod>2009-12-03T16:30:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5481: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/generex-biotech-corp-stock-world/2009/</loc>
		<lastmod>2009-12-03T16:30:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5479: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/behind-the-business-3-questions-for-vical/2009/</loc>
		<lastmod>2009-12-03T14:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5476: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/targacept-astra-in-blockbuster-deal/2009/</loc>
		<lastmod>2009-12-03T13:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5488: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/movers-shakers-thursdays-biggest-gaining-and-declining-stocks-market-watch-2/2009/</loc>
		<lastmod>2009-12-03T12:55:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5471: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/markets-absorbed-by-probiotic-swedish-tampons-the-local/2009/</loc>
		<lastmod>2009-12-03T12:39:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5469: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-watch-investorsoup-com-issues-market-alert-for-keryx-pharmaceuticals-inc-globenewswire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-03T12:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5472: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-targacept-to-develop-depression-drug/2009/</loc>
		<lastmod>2009-12-03T09:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5467: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-ready-for-a-boost/2009/</loc>
		<lastmod>2009-12-03T09:28:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5628: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-cleared-by-ec-for-a-copd-treatment/2009/</loc>
		<lastmod>2009-12-03T09:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5460: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vertex-raising-money-again-biobuzz/2009/</loc>
		<lastmod>2009-12-02T23:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5465: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tough-sell-sanofi-hands-out-750-pink-slips-to-sales-force/2009/</loc>
		<lastmod>2009-12-02T23:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5446: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-you-may-need-cholesterol-drugs/2009/</loc>
		<lastmod>2009-12-02T23:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5447: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/most-popular-cholesterol-drugs/2009/</loc>
		<lastmod>2009-12-02T23:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5462: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-cos-rise-as-govt-oks-new-stem-cell-lines-newsday/2009/</loc>
		<lastmod>2009-12-02T22:56:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5421: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-struggle-after-record/2009/</loc>
		<lastmod>2009-12-02T22:52:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5451: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-and-the-abbott-fund-honored-with-corporate-citizenship-award-for-international-community-service/2009/</loc>
		<lastmod>2009-12-02T22:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5453: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/war-at-la-jolla-farms-san-diego-reader/2009/</loc>
		<lastmod>2009-12-02T22:32:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5466: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/defense-stock-buys/2009/</loc>
		<lastmod>2009-12-02T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5416: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-gains-against-yen-and-euro/2009/</loc>
		<lastmod>2009-12-02T21:34:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5417: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-falls-2-on-inventory-build/2009/</loc>
		<lastmod>2009-12-02T21:27:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5456: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/long-term-treasurys-rise-on-struggling-stocks/2009/</loc>
		<lastmod>2009-12-02T21:22:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5457: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/long-term-treasurys-rise-on-struggling-stocks/2009/</loc>
		<lastmod>2009-12-02T21:22:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5443: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-cos-rise-as-govt-oks-new-stem-cell-lines-boston-herald/2009/</loc>
		<lastmod>2009-12-02T20:50:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5440: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-cos-rise-as-govt-oks-new-stem-cell-lines-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-02T20:39:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5442: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-cos-rise-as-govt-oks-new-stem-cell-lines-san-francisco-chronicle/2009/</loc>
		<lastmod>2009-12-02T20:24:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5437: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-ends-at-record-high-above-1200/2009/</loc>
		<lastmod>2009-12-02T20:01:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5452: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbotts-ibis-technology-named-one-of-the-top-innovations-for-2009-by-the-scientist/2009/</loc>
		<lastmod>2009-12-02T20:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5503: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/you-missed-the-bottom-now-what/2009/</loc>
		<lastmod>2009-12-02T19:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5444: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-cos-rise-as-govt-oks-new-stem-cell-lines-rocky-mount-telegram/2009/</loc>
		<lastmod>2009-12-02T19:57:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5461: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tired-of-waiting-teva-advances/2009/</loc>
		<lastmod>2009-12-02T19:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5432: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-co-ishares-russell-2000-money-flow-leaders-mrk-iwm/2009/</loc>
		<lastmod>2009-12-02T19:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5434: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/roche-makes-strides-in-race-against-merck/2009/</loc>
		<lastmod>2009-12-02T19:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5433: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sunny-re-rating-of-pharma-companies-business-standard-india/2009/</loc>
		<lastmod>2009-12-02T18:33:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5504: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-ceo-cites-publics-legitimate-anger-at-corporations/2009/</loc>
		<lastmod>2009-12-02T18:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5425: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/department-of-justice-demand-for-open-playing-field-for-medical-waste-likely-to-help-medclean-technologies-otcbb-mcln-marketwire/2009/</loc>
		<lastmod>2009-12-02T16:17:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5424: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/watson-completes-acquisition-of-arrow-group-redorbit/2009/</loc>
		<lastmod>2009-12-02T16:16:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5435: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ahead-of-the-bell-santarus-soars-on-otc-zegerid/2009/</loc>
		<lastmod>2009-12-02T16:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5423: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dyax-rf-micro-early-volume-plays/2009/</loc>
		<lastmod>2009-12-02T15:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5419: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-approves-two-new-drugs-biobuzz/2009/</loc>
		<lastmod>2009-12-02T14:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5422: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/watson-completes-acquisition-of-arrow-group-pr-newswire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-02T14:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5430: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/movers-shakers-wednesdays-biggest-gaining-and-declining-stocks-market-watch-3/2009/</loc>
		<lastmod>2009-12-02T13:55:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5415: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/flat-start-seen-for-stocks/2009/</loc>
		<lastmod>2009-12-02T12:02:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5418: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-falls-on-demand-doubts/2009/</loc>
		<lastmod>2009-12-02T11:59:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5441: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ubs-ups-europe-pharma-rating-to-overweight/2009/</loc>
		<lastmod>2009-12-02T10:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5411: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/burrill-biotech-select-index-manages-to-claw-back-almost-half-the-value-it-lost-in-october-news-medical-net/2009/</loc>
		<lastmod>2009-12-02T10:00:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5414: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/taxing-stock-trades-to-pay-for-jobs/2009/</loc>
		<lastmod>2009-12-02T09:54:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5409: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mixed-start-seen-for-stocks/2009/</loc>
		<lastmod>2009-12-02T09:28:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5420: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-approves-otc-version-of-heartburn-drug-zegerid/2009/</loc>
		<lastmod>2009-12-02T02:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5404: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/protalix-115m-gauchers-deal-with-pfizer-is-just-the-beginning-bioworld/2009/</loc>
		<lastmod>2009-12-02T02:03:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5403: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/santarus-shares-rise-on-fda-drug-approval/2009/</loc>
		<lastmod>2009-12-02T00:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5400: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/movers-roundup-bed-bath-beyond/2009/</loc>
		<lastmod>2009-12-02T00:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5401: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-inks-deal-for-new-drugmaking-technology/2009/</loc>
		<lastmod>2009-12-01T23:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5394: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-rise-as-dubai-fears-ebb/2009/</loc>
		<lastmod>2009-12-01T23:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5395: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-ceo-declines-to-comment-on-dividend/2009/</loc>
		<lastmod>2009-12-01T22:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5397: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-staples-omnivision-guess-are-big-movers-kjct-8-grand-junction/2009/</loc>
		<lastmod>2009-12-01T21:50:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5398: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-staples-omnivision-guess-are-big-movers-the-daily-reflector/2009/</loc>
		<lastmod>2009-12-01T21:37:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5388: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-staples-omnivision-guess-are-big-movers-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-01T21:27:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5353: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-at-14-month-high/2009/</loc>
		<lastmod>2009-12-01T21:18:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5396: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/protalix-shares-fall-following-pfizer-deal/2009/</loc>
		<lastmod>2009-12-01T21:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5383: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/of-pfizer-a-new-treatment-for-a-rare-disease-and-carrot-cells/2009/</loc>
		<lastmod>2009-12-01T21:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5377: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-top-15-aids-drugs/2009/</loc>
		<lastmod>2009-12-01T21:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5399: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drug-firms-get-a-boost-on-world-aids-day/2009/</loc>
		<lastmod>2009-12-01T21:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5449: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-under-10-2-potential-buys/2009/</loc>
		<lastmod>2009-12-01T20:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5450: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-under-10-2-potential-buys/2009/</loc>
		<lastmod>2009-12-01T20:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5378: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/aids-still-a-problem-still-big-business-for-pharma/2009/</loc>
		<lastmod>2009-12-01T20:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5454: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fool-blog-investment-classics-for-short-attention-spans/2009/</loc>
		<lastmod>2009-12-01T20:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5355: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rises-on-chinese-data-and-weak-dollar/2009/</loc>
		<lastmod>2009-12-01T20:22:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5448: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-hewlett-packard-crazy/2009/</loc>
		<lastmod>2009-12-01T19:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5380: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/china-orders-1m-doses-of-sinovac-swine-flu-shot-rocky-mount-telegram/2009/</loc>
		<lastmod>2009-12-01T19:00:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5369: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/china-orders-1m-doses-of-sinovac-swine-flu-shot-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-01T18:44:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5370: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/china-orders-1m-doses-of-sinovac-swine-flu-shot-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-12-01T18:44:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5384: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-makes-a-mark-on-good-cholesterol/2009/</loc>
		<lastmod>2009-12-01T18:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5410: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-makes-all-the-right-moves/2009/</loc>
		<lastmod>2009-12-01T18:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5386: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/former-jj-executive-charged-with-bribery/2009/</loc>
		<lastmod>2009-12-01T18:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5387: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/former-jj-executive-charged-with-bribery/2009/</loc>
		<lastmod>2009-12-01T18:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5373: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vivalis-enters-nyse-euronext-indexes-sbf-250-and-cac-small-90-marketwire/2009/</loc>
		<lastmod>2009-12-01T17:31:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5374: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vivalis-enters-nyse-euronext-indexes-sbf-250-and-cac-small-90-marketwire/2009/</loc>
		<lastmod>2009-12-01T17:31:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5375: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vivalis-enters-nyse-euronext-indexes-sbf-250-and-cac-small-90-marketwire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-01T17:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5376: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vivalis-enters-nyse-euronext-indexes-sbf-250-and-cac-small-90-marketwire-via-yahoo-finance-2/2009/</loc>
		<lastmod>2009-12-01T17:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5357: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-higher-on-protalix-deal/2009/</loc>
		<lastmod>2009-12-01T17:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5358: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/analyst-note-goldman-cautious-on-abbott-lilly/2009/</loc>
		<lastmod>2009-12-01T17:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5368: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-slip-as-dubai-debt-woes-wane/2009/</loc>
		<lastmod>2009-12-01T16:40:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5356: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-to-supremes-investors-should-have-sued-us-sooner/2009/</loc>
		<lastmod>2009-12-01T16:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5360: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-gets-back-on-track-in-november-pr-newswire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-01T16:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5343: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-hits-1200-an-ounce/2009/</loc>
		<lastmod>2009-12-01T16:34:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5431: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genzyme-resumes-shipping-from-allston-plant/2009/</loc>
		<lastmod>2009-12-01T16:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5364: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-12-01-1534-russia-stem-cell-firm-sees-ipo-at-low-end-of-range-interactive-investor/2009/</loc>
		<lastmod>2009-12-01T15:57:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5354: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/breaking-news-primegen-energy-december-1-2009-malaysianews-net/2009/</loc>
		<lastmod>2009-12-01T15:23:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5341: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-pfizer-acquires-rights-to-protalixs-gaucher-drug/2009/</loc>
		<lastmod>2009-12-01T14:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5342: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-signs-development-deal-with-protalix/2009/</loc>
		<lastmod>2009-12-01T13:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5349: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medclean-technologies-otcbb-mcln-one-mans-medical-waste-is-another-mans-treasure-marketwire/2009/</loc>
		<lastmod>2009-12-01T13:51:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5346: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-news-alert-breaking-news-primegen-energy-december-1-2009-marketwire/2009/</loc>
		<lastmod>2009-12-01T13:50:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5347: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/are-open-source-developers-suffering-zdnet/2009/</loc>
		<lastmod>2009-12-01T13:45:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5339: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/swiss-fine-drug-firms-5-7m-for-price-fixing/2009/</loc>
		<lastmod>2009-12-01T13:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5340: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-and-protalix-enter-into-agreement-to-develop-and-commercialize-gaucher%e2%80%99s-disease-treatment/2009/</loc>
		<lastmod>2009-12-01T13:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5350: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/clearly-defined-range-in-the-sp-500-tradingmarkets-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-12-01T13:21:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5362: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/movers-shakers-tuesdays-biggest-gaining-and-declining-stocks-market-watch/2009/</loc>
		<lastmod>2009-12-01T13:00:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5344: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-falls-as-dubai-debt-fears-ease/2009/</loc>
		<lastmod>2009-12-01T12:40:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5345: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gyros-di-biotech-sign-distribution-pact-for-korean-market-pharmabiz/2009/</loc>
		<lastmod>2009-12-01T11:43:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5337: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-pop-higher/2009/</loc>
		<lastmod>2009-12-01T11:27:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5334: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/could-biotech-save-the-state-the-daily-news-tribune/2009/</loc>
		<lastmod>2009-12-01T07:44:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5335: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/could-biotech-save-the-state-the-daily-news-tribune/2009/</loc>
		<lastmod>2009-12-01T07:44:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5348: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-sorting-out-dubai/2009/</loc>
		<lastmod>2009-12-01T03:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5332: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/aig-shares-tumble-15/2009/</loc>
		<lastmod>2009-11-30T23:38:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5326: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/some-justices-voice-skepticism-of-merck-in-vioxx-case/2009/</loc>
		<lastmod>2009-11-30T23:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5327: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/court-hears-vioxx-lawsuit-arguments/2009/</loc>
		<lastmod>2009-11-30T22:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5328: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/court-hears-vioxx-lawsuit-arguments/2009/</loc>
		<lastmod>2009-11-30T22:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5329: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/accord-set-with-teva-on-rights-to-generic-tricor/2009/</loc>
		<lastmod>2009-11-30T22:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5363: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/study-tests-blood-pressure-drugs-for-diabetics/2009/</loc>
		<lastmod>2009-11-30T22:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5324: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/illumina-roche-holding-geneservice-university-of-oxford-broad-institute-gene-it-sanair-technologies-abi-ge-genomeweb-news/2009/</loc>
		<lastmod>2009-11-30T22:05:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5297: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bank-shares-boost-market/2009/</loc>
		<lastmod>2009-11-30T21:20:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5315: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-abbott-settles-tricor-patent-row-with-teva/2009/</loc>
		<lastmod>2009-11-30T20:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5316: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-gives-teva-tricor-rights-as-early-as-2011/2009/</loc>
		<lastmod>2009-11-30T20:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5313: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/patheon-jll-settle-legal-battle-reuters-via-yahoo-canada-news/2009/</loc>
		<lastmod>2009-11-30T20:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5330: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/one-stock-thats-better-than-gold/2009/</loc>
		<lastmod>2009-11-30T20:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5314: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/making-money-more-efficiently/2009/</loc>
		<lastmod>2009-11-30T19:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5318: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/anxious-no-longer/2009/</loc>
		<lastmod>2009-11-30T18:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5312: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/call-volume-ramped-up-last-week-but-pessimism-still-dominates-the-sentiment-backdrop-schaeffers-research/2009/</loc>
		<lastmod>2009-11-30T18:37:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5320: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-fda-moves-the-goalposts/2009/</loc>
		<lastmod>2009-11-30T18:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5311: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/research-firm-lays-out-surprise-bio-events-for-2010-biobuzz/2009/</loc>
		<lastmod>2009-11-30T18:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5308: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ca-business-summary-the-globe-and-mail-4/2009/</loc>
		<lastmod>2009-11-30T18:01:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5321: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/johnson-johnson-good-bad-news/2009/</loc>
		<lastmod>2009-11-30T17:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5317: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/your-ticket-to-true-investing-wealth/2009/</loc>
		<lastmod>2009-11-30T17:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5306: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lipitor-the-era-of-mega-blockbusters-also-fungi/2009/</loc>
		<lastmod>2009-11-30T17:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5310: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-real-problem-with-the-public-health-care-plan/2009/</loc>
		<lastmod>2009-11-30T16:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5307: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-calendar-key-dates-for-december/2009/</loc>
		<lastmod>2009-11-30T16:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5302: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/out-of-the-money-put-volume-escalates-on-genworth-financial-inc-gnw-schaeffers-research/2009/</loc>
		<lastmod>2009-11-30T16:44:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5304: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/long-term-bears-buy-puts-on-td-ameritrade-holding-corp-amtd-schaeffers-research/2009/</loc>
		<lastmod>2009-11-30T15:29:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5305: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/long-term-bears-buy-puts-on-td-ameritrade-holding-corp-amtd-schaeffers-research/2009/</loc>
		<lastmod>2009-11-30T15:29:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5303: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-key-ingredient-for-your-financial-success/2009/</loc>
		<lastmod>2009-11-30T15:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5301: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-slip-as-dubai-jitters-ease/2009/</loc>
		<lastmod>2009-11-30T15:17:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5296: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/traders-jump-on-delta-air-lines-dal-puts-schaeffers-research/2009/</loc>
		<lastmod>2009-11-30T14:14:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5294: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/canadian-bankers-brace-for-slower-bonus-payouts-malaysianews-net/2009/</loc>
		<lastmod>2009-11-30T14:05:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5295: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/canadian-bankers-brace-for-slower-bonus-payouts-malaysianews-net/2009/</loc>
		<lastmod>2009-11-30T14:05:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5292: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/put-trading-spikes-on-united-rentals-uri-schaeffers-research/2009/</loc>
		<lastmod>2009-11-30T13:59:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5293: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/put-trading-spikes-on-united-rentals-uri-schaeffers-research/2009/</loc>
		<lastmod>2009-11-30T13:59:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5298: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/combine-growth-and-value/2009/</loc>
		<lastmod>2009-11-30T13:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5290: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dubai-shares-plummet-7/2009/</loc>
		<lastmod>2009-11-30T13:00:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5291: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/canadian-bankers-brace-for-slower-bonus-payouts-national-post/2009/</loc>
		<lastmod>2009-11-30T12:45:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5284: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-ready-for-post-holiday-drop/2009/</loc>
		<lastmod>2009-11-30T12:23:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5287: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-retreats-as-dubai-concerns-wane/2009/</loc>
		<lastmod>2009-11-30T11:35:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5288: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-edges-higher-2/2009/</loc>
		<lastmod>2009-11-30T11:24:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5286: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/enthusiasm-for-lupus-drug-fuels-hgs-shares-market-watch/2009/</loc>
		<lastmod>2009-11-30T11:15:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5285: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-ready-for-early-post-holiday-gain/2009/</loc>
		<lastmod>2009-11-30T09:35:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5283: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/john-dorfman-some-pricey-stocks-offer-growth-asbury-park-press-2/2009/</loc>
		<lastmod>2009-11-30T08:03:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5281: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sluggish-growth-in-sales-and-profit-by-75-pharma-cos-in-first-half-of-2009-10-pharmabiz/2009/</loc>
		<lastmod>2009-11-30T02:44:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5280: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/roches-merger-formula-for-genentech-businessweek/2009/</loc>
		<lastmod>2009-11-30T01:39:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5279: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-11-29-1545-bay-street-canadian-bankers-brace-for-slower-bonus-payouts-interactive-investor/2009/</loc>
		<lastmod>2009-11-29T15:56:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5278: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/canadian-bankers-brace-for-slower-bonus-payouts-reuters-via-yahoo-canada-news/2009/</loc>
		<lastmod>2009-11-29T15:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5277: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/could-biotech-save-the-state-the-country-gazette/2009/</loc>
		<lastmod>2009-11-29T14:23:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5276: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eye-on-the-consumer/2009/</loc>
		<lastmod>2009-11-29T12:49:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5275: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/john-dorfman-some-pricey-stocks-offer-growth-asbury-park-press/2009/</loc>
		<lastmod>2009-11-29T09:15:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5273: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/could-biotech-save-the-state-the-metrowest-daily-news/2009/</loc>
		<lastmod>2009-11-29T05:14:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5272: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/12-years-of-patent-protection-for-biologics-based-research-and-development-creates-buying-opportunity-in-biotech-stocks-wall-street-transcript-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-28T15:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5271: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-says-fda-approves-agriflu-seasonal-shot/2009/</loc>
		<lastmod>2009-11-27T23:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5269: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-portfolios-of-the-week-3/2009/</loc>
		<lastmod>2009-11-27T19:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5252: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-sinks-on-dubai-debt-concerns/2009/</loc>
		<lastmod>2009-11-27T19:24:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5249: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/european-shares-buck-global-selloff/2009/</loc>
		<lastmod>2009-11-27T18:46:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5251: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-slip-on-dubai-debt-woes/2009/</loc>
		<lastmod>2009-11-27T18:13:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5268: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dubai-jitters-rattle-drug-stocks-qlt-gains-malaysianews-net/2009/</loc>
		<lastmod>2009-11-27T17:52:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5267: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dubai-jitters-rattle-drug-stocks-qlt-gains-nasdaq/2009/</loc>
		<lastmod>2009-11-27T17:33:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5263: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-weeks-5-dumbest-stock-moves/2009/</loc>
		<lastmod>2009-11-27T17:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5262: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-dubai-jitters-rattle-drug-stocks-qlt-gains-market-watch/2009/</loc>
		<lastmod>2009-11-27T16:55:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5253: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-bargains-for-your-portfolio-the-motley-fool/2009/</loc>
		<lastmod>2009-11-27T16:13:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5254: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-gains-on-dubai-debt-concerns/2009/</loc>
		<lastmod>2009-11-27T16:00:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5255: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-rally-as-credit-fears-sap-confidence/2009/</loc>
		<lastmod>2009-11-27T15:35:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5258: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-mostly-meaningless-fda-approval/2009/</loc>
		<lastmod>2009-11-27T15:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5259: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/discover-this-secret-weapon-for-your-portfolio/2009/</loc>
		<lastmod>2009-11-27T14:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5246: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-set-to-open-lower/2009/</loc>
		<lastmod>2009-11-27T13:52:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5243: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zetias-miraculous-popularity/2009/</loc>
		<lastmod>2009-11-26T22:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5241: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/integrity-underpins-reputation-the-innovators/2009/</loc>
		<lastmod>2009-11-26T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5231: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/inside-washington-stream-of-wh-health-care-visits/2009/</loc>
		<lastmod>2009-11-26T10:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5238: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/whos-visiting-the-white-house/2009/</loc>
		<lastmod>2009-11-26T03:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5256: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/charting-the-market-wednesday/2009/</loc>
		<lastmod>2009-11-25T23:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5229: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sitting-atop-an-earnings-powder-keg/2009/</loc>
		<lastmod>2009-11-25T23:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5225: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/corrected-us-sees-rise-in-secondary-infections-after-flu/2009/</loc>
		<lastmod>2009-11-25T23:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5195: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-hits-new-09-high-ahead-of-holiday/2009/</loc>
		<lastmod>2009-11-25T21:21:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5217: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-group-behind-the-mammogram-guidelines/2009/</loc>
		<lastmod>2009-11-25T21:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5218: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/black-friday-short-squeeze-opportunities/2009/</loc>
		<lastmod>2009-11-25T20:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5223: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dream-stocks-for-biotech-investors-the-motley-fool-2/2009/</loc>
		<lastmod>2009-11-25T20:42:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5224: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dream-stocks-for-biotech-investors-the-motley-fool-2/2009/</loc>
		<lastmod>2009-11-25T20:42:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5210: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tiny-incyte-gets-boost-from-novartis-deal/2009/</loc>
		<lastmod>2009-11-25T20:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5221: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dream-stocks-for-biotech-investors/2009/</loc>
		<lastmod>2009-11-25T19:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5222: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dream-stocks-for-biotech-investors/2009/</loc>
		<lastmod>2009-11-25T19:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5227: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-big-upgrade-for-amylin-pharmaceuticals/2009/</loc>
		<lastmod>2009-11-25T19:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5211: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/idera-novartis-deal-ends-merck-pact-extended/2009/</loc>
		<lastmod>2009-11-25T19:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5228: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/prospecting-for-stocks-novartis/2009/</loc>
		<lastmod>2009-11-25T19:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5239: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-didnt-know-jak-until-now/2009/</loc>
		<lastmod>2009-11-25T18:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5219: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/human-genome-sciences-seeks-approval-for-zalbin/2009/</loc>
		<lastmod>2009-11-25T18:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5208: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facebook-downplays-ipo-talk-amid-stock-shuffle-internetnews-com/2009/</loc>
		<lastmod>2009-11-25T18:44:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5212: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/three-reasons-mercks-time-has-come/2009/</loc>
		<lastmod>2009-11-25T18:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5220: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/incyte-could-get-1-3b-from-novartis-in-team-up/2009/</loc>
		<lastmod>2009-11-25T17:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5209: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/are-options-traders-too-optimistic-toward-this-biotech-firm-schaeffers-research/2009/</loc>
		<lastmod>2009-11-25T17:27:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5194: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rises-after-supply-report/2009/</loc>
		<lastmod>2009-11-25T17:23:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5207: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-ease-after-jobs-data/2009/</loc>
		<lastmod>2009-11-25T17:11:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5204: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-slides-to-a-15-month-low/2009/</loc>
		<lastmod>2009-11-25T17:01:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5202: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/incyte-sequenom-early-volume-plays/2009/</loc>
		<lastmod>2009-11-25T16:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5196: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/making-flu-vaccine-eggs-arent-the-only-problem/2009/</loc>
		<lastmod>2009-11-25T15:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5197: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-terminates-pact-with-idera/2009/</loc>
		<lastmod>2009-11-25T15:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5200: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/beacon-equity-issues-technical-trading-overview-for-nexmed-inc-2/2009/</loc>
		<lastmod>2009-11-25T13:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5201: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/beacon-equity-issues-technical-trading-overview-for-nexmed-inc-2/2009/</loc>
		<lastmod>2009-11-25T13:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5193: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-hits-record-on-talk-of-indian-buying/2009/</loc>
		<lastmod>2009-11-25T12:47:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5190: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-poised-to-rise/2009/</loc>
		<lastmod>2009-11-25T10:07:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5192: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/incyte-to-license-2-hematology-drugs-to-novartis/2009/</loc>
		<lastmod>2009-11-25T09:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5199: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-worlds-best-dividend-stocks-2/2009/</loc>
		<lastmod>2009-11-25T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5191: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-gold-conundrum/2009/</loc>
		<lastmod>2009-11-25T03:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5188: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-follow-up-nov-24/2009/</loc>
		<lastmod>2009-11-25T00:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5186: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/can-drug-device-makers-innovate-themselves-to-extinction/2009/</loc>
		<lastmod>2009-11-24T23:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5187: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-declares-dividend-and-3b-stock-buyback/2009/</loc>
		<lastmod>2009-11-24T22:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5185: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/arnprior-biotech-firm-rescinds-merger-ottawa-business-journal/2009/</loc>
		<lastmod>2009-11-24T22:40:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5171: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-merck-board-approves-3-bln-share-repurchase/2009/</loc>
		<lastmod>2009-11-24T22:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5183: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-11-24-2157-update-2-aeterna-stock-jumps-ebbs-after-cancer-trial-data-interactive-investor/2009/</loc>
		<lastmod>2009-11-24T22:27:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5172: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-to-buy-back-3-bln-in-common-shares/2009/</loc>
		<lastmod>2009-11-24T22:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5173: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-announces-quarterly-dividends-and-new-3-billion-share-repurchase-program/2009/</loc>
		<lastmod>2009-11-24T22:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5184: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-teams-up-with-the-us-for-vaccines/2009/</loc>
		<lastmod>2009-11-24T22:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5182: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/aeterna-stock-jumps-ebbs-after-cancer-trial-data-the-globe-and-mail/2009/</loc>
		<lastmod>2009-11-24T22:01:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5158: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-end-choppy-day-lower/2009/</loc>
		<lastmod>2009-11-24T21:22:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5163: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-gain-after-strong-42-billion-auction/2009/</loc>
		<lastmod>2009-11-24T21:13:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5164: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-hits-6-week-low-against-yen/2009/</loc>
		<lastmod>2009-11-24T21:08:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5230: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/companies-you-should-buy-right-now/2009/</loc>
		<lastmod>2009-11-24T20:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5181: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facebook-changes-stock-structure-is-an-ipo-next-paidcontent-org-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-24T20:29:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5170: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-winners-for-small-investors-3/2009/</loc>
		<lastmod>2009-11-24T18:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5168: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-falls-2-on-gdp/2009/</loc>
		<lastmod>2009-11-24T17:50:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5165: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/global-general-technologies-glgt-announces-32-reduction-of-shares-outstanding-rescission-of-merger-with-iti-biotech-pr-newswire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-24T16:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5213: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/h-p-analysts-upgrades-downgrades/2009/</loc>
		<lastmod>2009-11-24T16:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5162: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-rorschach-on-health-care-pfizer-hit-with-28m-in-punitives/2009/</loc>
		<lastmod>2009-11-24T16:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5167: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/focus-fuels-a-comeback/2009/</loc>
		<lastmod>2009-11-24T15:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5166: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/are-emerging-markets-the-next-bubble/2009/</loc>
		<lastmod>2009-11-24T15:53:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5160: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-says-key-fosamax-lawsuit-dismissed/2009/</loc>
		<lastmod>2009-11-24T14:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5156: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ahead-of-the-bell-china-armco-metals-november-24-2009-marketwire/2009/</loc>
		<lastmod>2009-11-24T13:46:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5152: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/flat-open-seen-for-stocks/2009/</loc>
		<lastmod>2009-11-24T12:22:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5151: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rm5b-financing-for-ict-biotech-firms-business-times-malaysia/2009/</loc>
		<lastmod>2009-11-24T07:10:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5179: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mad-money-lightning-round-cienas-a-bargain/2009/</loc>
		<lastmod>2009-11-24T02:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5180: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mad-money-lightning-round-cienas-a-bargain-2/2009/</loc>
		<lastmod>2009-11-24T02:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5189: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-13/2009/</loc>
		<lastmod>2009-11-24T02:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5157: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-wins-summary-judgment-in-second-federal-bellwether-case-involving-fosamax%c2%ae-alendronate-sodium/2009/</loc>
		<lastmod>2009-11-24T02:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5159: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zeroing-in-on-whats-important/2009/</loc>
		<lastmod>2009-11-24T01:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5216: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-pozen-sanofi-aventis-bristol-myers-astrazeneca-and-adc-telecommunications-inc/2009/</loc>
		<lastmod>2009-11-24T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5145: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/hmo-implant-nightmare-batteries-not-included/2009/</loc>
		<lastmod>2009-11-24T00:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5147: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-spdr-gold-money-flow-leaders-mrk-gld/2009/</loc>
		<lastmod>2009-11-23T23:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5148: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-spdr-gold-money-flow-leaders-mrk-gld/2009/</loc>
		<lastmod>2009-11-23T23:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5153: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-told-to-pay-28-mln-damages-in-prempro-case/2009/</loc>
		<lastmod>2009-11-23T23:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5114: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-breaks-losing-streak/2009/</loc>
		<lastmod>2009-11-23T23:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5142: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vioxx-and-heart-attack-linked-in-2001/2009/</loc>
		<lastmod>2009-11-23T23:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5144: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/polybatics-edges-closer-to-commercializing-magic-bullet-that-targets-cells-sharechat/2009/</loc>
		<lastmod>2009-11-23T22:21:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5143: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/polybatics-closer-to-commercialising-%e2%80%98magic-bullet%e2%80%99-stuff/2009/</loc>
		<lastmod>2009-11-23T22:10:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5146: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dividend-stocks-get-a-boost/2009/</loc>
		<lastmod>2009-11-23T21:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5126: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sage-advice-on-vytorin/2009/</loc>
		<lastmod>2009-11-23T21:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5088: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rises-modestly-on-softer-dollar/2009/</loc>
		<lastmod>2009-11-23T20:52:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5133: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oncolytics-completes-12-8m-stock-and-warrant-sale-rocky-mount-telegram/2009/</loc>
		<lastmod>2009-11-23T20:52:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5128: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/glaxosmithkline-pulls-application-for-new-drug-use/2009/</loc>
		<lastmod>2009-11-23T20:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5134: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oncolytics-completes-12-8m-stock-and-warrant-sale-bay-news-9-tampa-bay/2009/</loc>
		<lastmod>2009-11-23T20:42:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5132: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oncolytics-completes-12-8m-stock-and-warrant-sale-ino-news/2009/</loc>
		<lastmod>2009-11-23T20:41:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5135: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/calix-plans-100-million-ipo-the-petaluma-argus-courier/2009/</loc>
		<lastmod>2009-11-23T20:39:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5131: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oncolytics-completes-12-8m-stock-and-warrant-sale-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-11-23T20:37:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5138: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-side-effect-of-developing-obesity-drugs/2009/</loc>
		<lastmod>2009-11-23T20:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5113: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/remember-remember-the-strength-of-november/2009/</loc>
		<lastmod>2009-11-23T20:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5136: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-laboratories-mead-johnson-nutrition-money-flow-leaders-abt-mjn/2009/</loc>
		<lastmod>2009-11-23T20:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5117: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/poniard-finds-cash-to-keep-lights-on-biobuzz/2009/</loc>
		<lastmod>2009-11-23T19:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5118: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/healthcare-stocks-safe-and-speculative/2009/</loc>
		<lastmod>2009-11-23T19:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5100: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-spikes-to-13-month-high/2009/</loc>
		<lastmod>2009-11-23T19:44:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5137: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-im-grabbing-20-dividend-yields/2009/</loc>
		<lastmod>2009-11-23T19:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5110: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/does-pfizer-ceo-regret-sale-of-consumer-products-to-jj/2009/</loc>
		<lastmod>2009-11-23T19:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5111: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-immunovaccine-in-animal-vaccine-deal/2009/</loc>
		<lastmod>2009-11-23T18:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5105: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jeff-saut-was-the-long-position-a-bad-trade/2009/</loc>
		<lastmod>2009-11-23T17:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5109: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-surges-to-a-fresh-record/2009/</loc>
		<lastmod>2009-11-23T17:18:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5101: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cel-sci-chairman-sells-stock-despite-sweetheart-loan-deal-biobuzz/2009/</loc>
		<lastmod>2009-11-23T17:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5106: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/emerging-stock-report-initiates-independent-research-coverage-on-origin-agritech-limited-globenewswire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-23T16:10:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5108: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-claims-win-in-texas-lawsuit-over-vioxx/2009/</loc>
		<lastmod>2009-11-23T15:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5107: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pending-key-developments-ahead-for-cytrx-corporation-nasdaq-cytr-marketwire/2009/</loc>
		<lastmod>2009-11-23T15:47:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5091: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-wins-summary-judgment-in-texas-lawsuit/2009/</loc>
		<lastmod>2009-11-23T15:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5102: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-issues-new-obesity-drug-heart-warning-biobuzz/2009/</loc>
		<lastmod>2009-11-23T15:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5093: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sanofi-has-lots-of-upside-catalysts/2009/</loc>
		<lastmod>2009-11-23T15:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5096: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-12/2009/</loc>
		<lastmod>2009-11-23T15:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5097: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-wins-summary-judgment-in-texas-attorney-generals-lawsuit-involving-vioxx%c2%ae/2009/</loc>
		<lastmod>2009-11-23T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5103: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-ease-ahead-of-auction/2009/</loc>
		<lastmod>2009-11-23T14:55:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5104: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/are-these-dividends-too-good-to-be-true/2009/</loc>
		<lastmod>2009-11-23T14:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5082: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/get-briefed-the-bulls-and-the-bears/2009/</loc>
		<lastmod>2009-11-23T13:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5099: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/transcript-the-bulls-and-the-bears/2009/</loc>
		<lastmod>2009-11-23T13:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5086: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-falls-broadly-on-fed-comments/2009/</loc>
		<lastmod>2009-11-23T12:08:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5087: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-hits-another-new-record/2009/</loc>
		<lastmod>2009-11-23T11:54:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5081: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-buckles-in-for-a-bumpy-ride/2009/</loc>
		<lastmod>2009-11-23T09:52:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5080: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-may-follow-the-world-higher/2009/</loc>
		<lastmod>2009-11-23T09:47:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5079: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/agennix-ag-reports-financial-results-for-third-quarter-and-first-nine-months-of-2009-marketwire/2009/</loc>
		<lastmod>2009-11-23T08:01:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5077: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/three-stocks-show-growth-at-a-reasonable-price-john-dorfman-bloomberg/2009/</loc>
		<lastmod>2009-11-23T02:28:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5078: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/three-stocks-show-growth-at-a-reasonable-price-john-dorfman-bloomberg/2009/</loc>
		<lastmod>2009-11-23T02:24:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5075: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/7-stocks-that-are-swimming-in-cash-2/2009/</loc>
		<lastmod>2009-11-22T10:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5129: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/10-for-the-money/2009/</loc>
		<lastmod>2009-11-21T18:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5083: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sp-500-weekly-wrap-up/2009/</loc>
		<lastmod>2009-11-21T17:51:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5085: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jim-cramers-best-blogs-3/2009/</loc>
		<lastmod>2009-11-21T17:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5120: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-court-of-appeals-upholds-astrazeneca-awp-settlement/2009/</loc>
		<lastmod>2009-11-21T02:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5121: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-court-of-appeals-upholds-astrazeneca-awp-settlement/2009/</loc>
		<lastmod>2009-11-21T02:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5063: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-oks-abilify-for-autism-linked-irritability/2009/</loc>
		<lastmod>2009-11-21T02:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5066: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-pare-losses-finish-down/2009/</loc>
		<lastmod>2009-11-21T01:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5064: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biocryst-49m-public-offering-cashes-in-on-stock-momentum-bioworld/2009/</loc>
		<lastmod>2009-11-21T00:50:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4682: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/worse-than-you-think/2009/</loc>
		<lastmod>2009-11-21T00:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5058: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-dip-as-investors-fret-about-recovery/2009/</loc>
		<lastmod>2009-11-20T23:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5059: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tech-unfazed-by-dismal-dell/2009/</loc>
		<lastmod>2009-11-20T23:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5024: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-mixed-week-ends-on-a-low-note/2009/</loc>
		<lastmod>2009-11-20T22:07:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5071: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-11/2009/</loc>
		<lastmod>2009-11-20T21:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5053: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-healthcor-urges-biogen-board-consider-number-of-changes-nasdaq/2009/</loc>
		<lastmod>2009-11-20T21:32:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5062: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-geodon-gets-expanded-fda-approval/2009/</loc>
		<lastmod>2009-11-20T21:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5054: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-baby-is-a-nice-addition/2009/</loc>
		<lastmod>2009-11-20T20:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5055: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/taking-fido-on-your-trip-theres-a-drug-for-that/2009/</loc>
		<lastmod>2009-11-20T20:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5039: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-climbs-to-record-high/2009/</loc>
		<lastmod>2009-11-20T20:18:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5043: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-receives-fda-approval-for-geodon%c2%ae-ziprasidone-hci-capsules-for-the-adjunctive-maintenance-treatment-of-bipolar-disorder-in-adults/2009/</loc>
		<lastmod>2009-11-20T20:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5072: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-pfe-3/2009/</loc>
		<lastmod>2009-11-20T20:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5049: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nyssa-presents-13th-annual-biotech-and-specialty-pharmaceuticals-conference-finanzen-net/2009/</loc>
		<lastmod>2009-11-20T20:10:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5048: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biogen-shareholders-ceo-pay-inconsistent-with-poor-stock-performance-mass-high-tech-the-journal-of-new-england-technology/2009/</loc>
		<lastmod>2009-11-20T20:05:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5046: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nyssa-presents-13th-annual-biotech-and-specialty-pharmaceuticals-conference-business-wire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-20T20:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5044: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-healthcare-cos-set-for-record-lobbying-in-2009/2009/</loc>
		<lastmod>2009-11-20T18:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5045: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-healthcare-cos-set-for-record-lobbying-in-2009/2009/</loc>
		<lastmod>2009-11-20T18:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5036: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-generics-business-takes-shape/2009/</loc>
		<lastmod>2009-11-20T18:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5060: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-fertility-drug-gets-european-recommendation/2009/</loc>
		<lastmod>2009-11-20T17:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5033: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/healthcor-urges-biogen-board-consider-number-of-changes-nasdaq/2009/</loc>
		<lastmod>2009-11-20T17:32:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5057: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-and-the-philadelphia-department-of-public-health-provide-free-medicines-to-pennsylvanias-uninsured/2009/</loc>
		<lastmod>2009-11-20T17:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5065: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/now-is-the-time-to-buy-risk/2009/</loc>
		<lastmod>2009-11-20T16:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5034: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/welichem-announces-2009-agm-board-members-election-and-management-changes-t-net-british-columbia/2009/</loc>
		<lastmod>2009-11-20T16:46:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5035: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/short-term-treasurys-rally/2009/</loc>
		<lastmod>2009-11-20T16:41:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5028: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-inovio-merck-gain-novavax-falls-market-watch/2009/</loc>
		<lastmod>2009-11-20T16:10:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5027: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novavax-plans-offering-of-6-8m-shares-stock-falls-ap-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-20T15:36:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5038: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-approves-intravenous-formulation-of-pfizer%e2%80%99s-revatio%c2%ae-sildenafil-for-the-treatment-of-pulmonary-arterial-hypertension/2009/</loc>
		<lastmod>2009-11-20T15:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5031: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jim-cramers-portfolios-of-the-week-4/2009/</loc>
		<lastmod>2009-11-20T15:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5032: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/investorideas-asks-investors-publish-your-stock-picks-and-stock-profiles-pr-com/2009/</loc>
		<lastmod>2009-11-20T14:36:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5020: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/trading-review-for-vivus-inc-issued-by-beacon-equity/2009/</loc>
		<lastmod>2009-11-20T13:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5018: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-continues-slide-as-dollar-strengthens/2009/</loc>
		<lastmod>2009-11-20T12:51:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5019: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-gains-ground/2009/</loc>
		<lastmod>2009-11-20T12:31:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5013: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-another-slump/2009/</loc>
		<lastmod>2009-11-20T12:23:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5022: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/king-donaldson-lead-high-flying-stocks/2009/</loc>
		<lastmod>2009-11-20T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5015: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-easiest-money-youll-ever-make/2009/</loc>
		<lastmod>2009-11-20T11:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5014: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-fda-playbook-thestreet-com/2009/</loc>
		<lastmod>2009-11-20T11:16:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5011: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/credit-cards-party-bears-smell-blood-at-etrade-forbes/2009/</loc>
		<lastmod>2009-11-20T06:54:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5016: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-playing-defense/2009/</loc>
		<lastmod>2009-11-20T02:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4991: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/blue-chips-in-two-day-skid/2009/</loc>
		<lastmod>2009-11-20T00:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5009: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-advisory-committee-finds-data-support-the-claim-that-spiriva%c2%ae-handihaler%c2%ae-reduces-copd-exacerbations/2009/</loc>
		<lastmod>2009-11-19T23:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5030: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/for-lillys-rd-chief-a-2-million-exit-handshake/2009/</loc>
		<lastmod>2009-11-19T23:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4998: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-panel-backs-safety-benefits-of-spiriva/2009/</loc>
		<lastmod>2009-11-19T22:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5000: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-us-panel-backs-new-claim-for-pfizer-lung-drug/2009/</loc>
		<lastmod>2009-11-19T22:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4977: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-drop-for-second-straight-day/2009/</loc>
		<lastmod>2009-11-19T22:05:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5001: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-enters-the-race-for-the-next-plavix/2009/</loc>
		<lastmod>2009-11-19T22:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5005: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-stock-is-a-train-wreck-the-motley-fool/2009/</loc>
		<lastmod>2009-11-19T21:00:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4993: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-deal-names-abbott-top-dealmaker-for-second-consecutive-year/2009/</loc>
		<lastmod>2009-11-19T21:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4994: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/moodys-gives-negative-view-on-pharma-credit/2009/</loc>
		<lastmod>2009-11-19T20:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4995: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/moodys-gives-negative-view-on-pharma-credit/2009/</loc>
		<lastmod>2009-11-19T20:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5004: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-dodges-a-bullet/2009/</loc>
		<lastmod>2009-11-19T20:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4975: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-hits-fresh-record-high-2/2009/</loc>
		<lastmod>2009-11-19T20:24:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4987: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-to-value-a-middling-market/2009/</loc>
		<lastmod>2009-11-19T19:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5006: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-generic-growth-with-a-side-of-sashimi/2009/</loc>
		<lastmod>2009-11-19T19:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4984: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-masters-of-the-universe-are-back/2009/</loc>
		<lastmod>2009-11-19T18:02:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4985: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-gain-on-sliding-stocks/2009/</loc>
		<lastmod>2009-11-19T17:50:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4988: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-pfizer-wants-you-to-take-your-dog-home-for-thanksgiving/2009/</loc>
		<lastmod>2009-11-19T17:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5050: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-10/2009/</loc>
		<lastmod>2009-11-19T17:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4979: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-merck-monsanto-urban-outfitters-petrohawk-energy-and-vistaprint-released-by-seven-summits-research/2009/</loc>
		<lastmod>2009-11-19T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4970: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-sinks-on-dollar-demand/2009/</loc>
		<lastmod>2009-11-19T16:08:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4978: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-encourages-families-to-bring-their-dogs-to-this-year%e2%80%99s-holiday-celebration/2009/</loc>
		<lastmod>2009-11-19T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4981: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cash-for-clunkers-100-gainers-to-sell-now/2009/</loc>
		<lastmod>2009-11-19T15:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4976: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/act-seeks-fda-ok-for-stem-cell-study-to-treat-blindness-mass-high-tech-the-journal-of-new-england-technology/2009/</loc>
		<lastmod>2009-11-19T15:15:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4973: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/overbought-with-negative-divergences/2009/</loc>
		<lastmod>2009-11-19T14:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 5007: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/beacon-equity-issues-technical-trading-overview-for-questcor-pharmaceuticals-inc/2009/</loc>
		<lastmod>2009-11-19T13:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4961: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-early-slide/2009/</loc>
		<lastmod>2009-11-19T12:21:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4971: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rises-as-investors-seek-safety/2009/</loc>
		<lastmod>2009-11-19T11:59:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4963: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-brief-introduction-to-bond-investing/2009/</loc>
		<lastmod>2009-11-19T09:48:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4962: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jpmorgan-takes-control-of-cazenove/2009/</loc>
		<lastmod>2009-11-19T09:29:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4972: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-submits-brilinta-nda-to-fda/2009/</loc>
		<lastmod>2009-11-19T09:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4964: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-submits-us-new-drug-application-for-ticagrelor-brilintatm-an-investigational-antiplatelet-agent/2009/</loc>
		<lastmod>2009-11-19T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4965: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-submits-us-new-drug-application-for-ticagrelor-brilintatm-an-investigational-antiplatelet-agent-2/2009/</loc>
		<lastmod>2009-11-19T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4982: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-you-cant-afford-to-miss-these-stocks-2/2009/</loc>
		<lastmod>2009-11-19T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4974: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-to-begin-selling-generics-in-japan/2009/</loc>
		<lastmod>2009-11-19T07:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4959: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-panel-backs-pfizers-enhanced-vaccine-for-kids/2009/</loc>
		<lastmod>2009-11-19T02:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4960: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-advisory-committee-finds-data-support-the-safety-and-effectiveness-of-prevnar-13%e2%84%a2-vaccine-for-the-prevention-of-invasive-pneumococcal-disease-in-infants-and-young-children/2009/</loc>
		<lastmod>2009-11-19T02:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4955: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/business-highlights/2009/</loc>
		<lastmod>2009-11-19T00:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4954: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sector-snap-ubs-upbeat-on-medical-tech-stocks/2009/</loc>
		<lastmod>2009-11-18T23:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4966: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-u-s-democrats-demand-analysis-of-drug-price-rises/2009/</loc>
		<lastmod>2009-11-18T23:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4956: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-us-panel-backs-pfizers-newer-prevnar-vaccine/2009/</loc>
		<lastmod>2009-11-18T22:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4950: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/obesity-and-ed-two-big-markets-one-tiny-company/2009/</loc>
		<lastmod>2009-11-18T22:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4941: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/corrected-update-1-us-democrats-seek-study-of-drug-prices-hikes/2009/</loc>
		<lastmod>2009-11-18T21:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4928: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-hit-a-roadblock/2009/</loc>
		<lastmod>2009-11-18T21:53:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4951: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vivus-shares-rise-on-erectile-dysfunction-drug-success-fox-news/2009/</loc>
		<lastmod>2009-11-18T21:44:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4946: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/housing-savant-paulson-now-looks-to-gold/2009/</loc>
		<lastmod>2009-11-18T19:46:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4947: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drug-lowers-cholesterol-stock-follows/2009/</loc>
		<lastmod>2009-11-18T19:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4948: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drug-lowers-cholesterol-stock-follows/2009/</loc>
		<lastmod>2009-11-18T19:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4949: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/your-heart-or-your-stomach/2009/</loc>
		<lastmod>2009-11-18T19:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4968: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-government-wont-be-there-for-you/2009/</loc>
		<lastmod>2009-11-18T19:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4942: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vivus-gets-a-spark/2009/</loc>
		<lastmod>2009-11-18T18:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4944: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-stocks-will-burn-you-2/2009/</loc>
		<lastmod>2009-11-18T18:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4943: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vivus-shares-rise-on-positive-avanafil-study-data/2009/</loc>
		<lastmod>2009-11-18T18:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4940: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasury-prices-dip-on-inflation-data/2009/</loc>
		<lastmod>2009-11-18T17:38:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4958: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-astra-drug-shows-faster-onsetoffset-than-plavix/2009/</loc>
		<lastmod>2009-11-18T17:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4938: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astra-drug-shows-faster-onsetoffset-than-plavix/2009/</loc>
		<lastmod>2009-11-18T16:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4925: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rim-analysts-upgrades-downgrades/2009/</loc>
		<lastmod>2009-11-18T16:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4930: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/results-from-two-phase-ii-trials-add-to-understanding-of-ticagrelor-brilintatm-and-how-it-works-in-the-body/2009/</loc>
		<lastmod>2009-11-18T16:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4931: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/harte-hanks-and-medimmune-win-medical-marketing-media-gold-award/2009/</loc>
		<lastmod>2009-11-18T15:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4934: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-drug-stocks-follow-broader-market-south-market-watch-2/2009/</loc>
		<lastmod>2009-11-18T15:41:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4926: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-and-dndi-advancing-international-research-efforts-in-the-fight-against-neglected-tropical-diseases/2009/</loc>
		<lastmod>2009-11-18T15:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4936: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-the-small-cap-rally-done-for-good/2009/</loc>
		<lastmod>2009-11-18T15:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4927: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oncolytics-biotechr-inc-announces-terms-of-unit-offering-cnw-group-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-18T14:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4929: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-hits-another-record-2/2009/</loc>
		<lastmod>2009-11-18T14:06:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4924: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/answering-the-vytorin-question/2009/</loc>
		<lastmod>2009-11-18T13:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4923: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-11-18-1219-brief-sinovac-biotech-files-stock-shelf-interactive-investor/2009/</loc>
		<lastmod>2009-11-18T12:44:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4911: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-modest-gains-3/2009/</loc>
		<lastmod>2009-11-18T12:28:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4909: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/forget-100-oil-80-oil-is-a-problem/2009/</loc>
		<lastmod>2009-11-18T12:16:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4912: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rises-on-lower-supply/2009/</loc>
		<lastmod>2009-11-18T12:01:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4919: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drugmakers-differences-analysts-toolkit/2009/</loc>
		<lastmod>2009-11-18T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4913: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-falls-after-british-central-bank-comments/2009/</loc>
		<lastmod>2009-11-18T11:43:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4910: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-submits-new-pediatric-data-for-lipitor%c2%ae-atorvastatin-to-the-european-medicines-agency-emea/2009/</loc>
		<lastmod>2009-11-18T11:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4937: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dividends-for-100-years-2/2009/</loc>
		<lastmod>2009-11-18T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4916: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/streetwalker-five-international-bets/2009/</loc>
		<lastmod>2009-11-18T01:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4906: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-hot-right-now-ho-hum-in-the-long-run-wallstreet-journal-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-18T00:20:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4905: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-tick-up-to-higher-close/2009/</loc>
		<lastmod>2009-11-18T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4908: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-plavix-warning/2009/</loc>
		<lastmod>2009-11-17T23:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4904: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oncolytics-biotechr-inc-announces-unit-offering-redorbit/2009/</loc>
		<lastmod>2009-11-17T23:16:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4899: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/even-the-pharaohs-needed-lipitor/2009/</loc>
		<lastmod>2009-11-17T23:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4891: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/crestor-shows-equal-or-better-benefit-to-women/2009/</loc>
		<lastmod>2009-11-17T23:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4892: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/many-in-u-s-still-lack-cholesterol-tests-drugs/2009/</loc>
		<lastmod>2009-11-17T23:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4893: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/video-crestorr-reduced-risk-of-cardiovascular-events-in-women-by-nearly-half-in-new-analysis-of-jupiter-study/2009/</loc>
		<lastmod>2009-11-17T23:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4900: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fairholme-sticks-to-quality-names/2009/</loc>
		<lastmod>2009-11-17T22:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4894: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vaccines-on-horizon-for-aids-alzheimers-herpes/2009/</loc>
		<lastmod>2009-11-17T22:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4873: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-at-13-month-highs-after-modest-gains/2009/</loc>
		<lastmod>2009-11-17T22:08:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4901: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oncolytics-biotechr-inc-announces-unit-offering-cnw-group-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-17T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4861: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-hits-record-high-2/2009/</loc>
		<lastmod>2009-11-17T20:51:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4882: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/benefit-of-merck-heart-drug-remains-after-stopping/2009/</loc>
		<lastmod>2009-11-17T20:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4889: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dividend-stocks-for-the-week-4/2009/</loc>
		<lastmod>2009-11-17T20:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4860: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-edges-higher-on-upbeat-demand-outlook/2009/</loc>
		<lastmod>2009-11-17T20:19:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4907: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/trading-higher-in-a-down-market/2009/</loc>
		<lastmod>2009-11-17T20:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4902: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/up-80-its-time-to-sell/2009/</loc>
		<lastmod>2009-11-17T20:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4890: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-with-room-to-run-2/2009/</loc>
		<lastmod>2009-11-17T19:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4884: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-warns-against-taking-plavix-with-prilosec/2009/</loc>
		<lastmod>2009-11-17T18:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4885: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-fda-warns-abbott-over-diagnostics-manufacturing/2009/</loc>
		<lastmod>2009-11-17T18:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4880: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genzymes-termeer-worst-biotech-ceo-of-09-thestreet-com/2009/</loc>
		<lastmod>2009-11-17T17:45:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4886: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-partnership-is-smoking/2009/</loc>
		<lastmod>2009-11-17T17:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4881: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasury-prices-rise-as-stocks-slump/2009/</loc>
		<lastmod>2009-11-17T17:37:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4878: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-us-fda-staff-question-pfizer-lung-drug-data/2009/</loc>
		<lastmod>2009-11-17T16:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4883: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mercks-investigational-anacetrapib-phase-iib-study-results-presented-at-american-heart-association-annual-scientific-sessions/2009/</loc>
		<lastmod>2009-11-17T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4869: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/green-card-seekers-wont-have-to-get-hpv-vaccine/2009/</loc>
		<lastmod>2009-11-17T15:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4876: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-to-develop-new-heart-failure-test-on-architectr-immunochemistry-diagnostics-platform/2009/</loc>
		<lastmod>2009-11-17T15:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4870: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/higher-dose-of-merck%e2%80%99s-cozaar%c2%ae-losartan-potassium-tablets-significantly-reduced-deaths-and-hospitalizations-due-to-heart-failure-in-investigational-study/2009/</loc>
		<lastmod>2009-11-17T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4872: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/glaxo-and-nabi-team-up-for-nicotine-vaccine/2009/</loc>
		<lastmod>2009-11-17T14:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4887: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-big-upgrade-for-sanofi-aventis/2009/</loc>
		<lastmod>2009-11-17T14:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4874: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-nvs-14/2009/</loc>
		<lastmod>2009-11-17T14:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4868: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/universal-healthcare-plays/2009/</loc>
		<lastmod>2009-11-17T13:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4862: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-edges-lower/2009/</loc>
		<lastmod>2009-11-17T12:18:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4859: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-slip-at-open/2009/</loc>
		<lastmod>2009-11-17T11:50:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4865: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rebounds-on-bernanke/2009/</loc>
		<lastmod>2009-11-17T11:42:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4866: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rebounds-on-bernanke/2009/</loc>
		<lastmod>2009-11-17T11:42:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4867: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-smaller-flu-vaccine-doses-suffice/2009/</loc>
		<lastmod>2009-11-17T09:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4871: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-recap-the-bernanke-bounce-update-2/2009/</loc>
		<lastmod>2009-11-17T01:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4877: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medimmune-announces-winners-of-the-4th-respiratory-immunology-and-autoimmunity-research-abstract-competition/2009/</loc>
		<lastmod>2009-11-17T00:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4848: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-stop-trading-bristol-myers/2009/</loc>
		<lastmod>2009-11-16T22:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4811: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sp-500-shoots-above-1100/2009/</loc>
		<lastmod>2009-11-16T22:40:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4850: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/doctors-gird-for-patient-anxiety-over-zetia-data/2009/</loc>
		<lastmod>2009-11-16T22:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4844: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-announces-positive-three-year-data-on-its-fully-bioabsorbable-stent-technology-initiates-large-scale-international-trial/2009/</loc>
		<lastmod>2009-11-16T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4817: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-merck-up-as-zetia-trial-less-damaging-than-feared/2009/</loc>
		<lastmod>2009-11-16T21:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4856: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-you-shouldnt-listen-to-jim-cramer/2009/</loc>
		<lastmod>2009-11-16T20:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4846: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vical-will-be-added-to-biotech-index-shares-rise-abc-news/2009/</loc>
		<lastmod>2009-11-16T20:16:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4831: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-shares-rise-following-niaspin-zetia-study/2009/</loc>
		<lastmod>2009-11-16T20:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4808: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-rises-on-weak-dollar/2009/</loc>
		<lastmod>2009-11-16T20:14:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4835: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vical-will-be-added-to-biotech-index-shares-rise-san-francisco-chronicle/2009/</loc>
		<lastmod>2009-11-16T20:09:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4838: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-smackdown-cramer-vs-caps-the-motley-fool-2/2009/</loc>
		<lastmod>2009-11-16T20:07:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4824: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mercks-dick-clark-has-opportunities-but-all-are-risky/2009/</loc>
		<lastmod>2009-11-16T20:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4825: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/indexes-retreat-from-highs/2009/</loc>
		<lastmod>2009-11-16T20:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4852: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-us-fda-wants-panel-to-probe-pfizer-vaccine-efficacy/2009/</loc>
		<lastmod>2009-11-16T19:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4826: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/etf-money-is-lifting-listless-stocks/2009/</loc>
		<lastmod>2009-11-16T19:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4757: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-move-a-new-blow-to-conn-city-in-land-fight/2009/</loc>
		<lastmod>2009-11-16T19:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4855: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/music-to-health-care-investors-ears/2009/</loc>
		<lastmod>2009-11-16T19:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4839: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vical-will-be-added-to-biotech-index-shares-rise-rocky-mount-telegram/2009/</loc>
		<lastmod>2009-11-16T19:35:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4836: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vical-will-be-added-to-biotech-index-shares-rise-bay-news-9-tampa-bay/2009/</loc>
		<lastmod>2009-11-16T19:32:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4837: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vical-will-be-added-to-biotech-index-shares-rise-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-11-16T19:27:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4827: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/financial-etfs-for-playing-ma-wave/2009/</loc>
		<lastmod>2009-11-16T19:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4842: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-hottest-sector-for-2010/2009/</loc>
		<lastmod>2009-11-16T19:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4843: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-puts-a-nail-in-mercks-coffin/2009/</loc>
		<lastmod>2009-11-16T18:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4832: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/golds-record-run-no-end-in-sight/2009/</loc>
		<lastmod>2009-11-16T18:45:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4822: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-5th-time-the-charm-for-the-sp-500/2009/</loc>
		<lastmod>2009-11-16T18:08:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4821: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/international-healthcare-stock-picks-from-natcan-investment-management-wall-street-transcript-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-16T18:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4830: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/exciting-young-funds-buck-the-trend/2009/</loc>
		<lastmod>2009-11-16T17:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4823: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/global-healthcare-company-stock-picks-by-serge-depatie-of-natcan-investment-management-inc-wall-street-transcript-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-16T17:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4813: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fitz-bits-dont-stall-on-research-in-motion/2009/</loc>
		<lastmod>2009-11-16T17:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4810: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/deals-of-the-day-happy-days-gm-loses-only-1-15-billion/2009/</loc>
		<lastmod>2009-11-16T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4819: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tiens-biotech-group-usa-inc-warming-up-or-cooling-off-the-motley-fool/2009/</loc>
		<lastmod>2009-11-16T16:06:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4820: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tiens-biotech-group-usa-inc-warming-up-or-cooling-off-the-motley-fool/2009/</loc>
		<lastmod>2009-11-16T16:06:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4816: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/collagen-disease-breakthrough/2009/</loc>
		<lastmod>2009-11-16T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4814: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rpt-update-3-niaspan-tops-zetia-in-new-setback-for-merck-drug/2009/</loc>
		<lastmod>2009-11-16T15:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4812: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-up-on-weak-retail-manufacturing/2009/</loc>
		<lastmod>2009-11-16T14:49:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4809: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/trading-outlook-for-vermillion-inc-issued-by-stockpreacher-com/2009/</loc>
		<lastmod>2009-11-16T13:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4802: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-ready-to-rally/2009/</loc>
		<lastmod>2009-11-16T13:02:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4805: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/clal-biotech-mgt-co-arte-sells-partial-stake-globes-online/2009/</loc>
		<lastmod>2009-11-16T12:34:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4807: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-slips-as-risk-demand-rises/2009/</loc>
		<lastmod>2009-11-16T12:33:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4803: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-hits-fresh-record-high/2009/</loc>
		<lastmod>2009-11-16T11:22:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4800: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-myers-splits-off-mead-johnson-shareholders-can-swap-bristol-shares-for-mead-stock-canadian-business/2009/</loc>
		<lastmod>2009-11-16T09:48:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4801: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-myers-splits-off-mead-johnson-shareholders-can-swap-bristol-shares-for-mead-stock-the-canadian-press-via-yahoo-canada-news/2009/</loc>
		<lastmod>2009-11-16T09:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4799: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-statement-on-arbiter-6-halts-results-and-abbotts-niaspan-niacin-extended-release/2009/</loc>
		<lastmod>2009-11-16T01:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4786: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/another-vytorin-mess-for-merck/2009/</loc>
		<lastmod>2009-11-16T01:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4794: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-myers-splits-off-mead-johnson-nutrition-abc-news/2009/</loc>
		<lastmod>2009-11-16T01:16:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4787: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/study-raises-new-questions-about-merck-pill-zetia/2009/</loc>
		<lastmod>2009-11-16T01:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4796: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-myers-splits-off-mead-johnson-nutrition-san-francisco-chronicle/2009/</loc>
		<lastmod>2009-11-16T01:15:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4795: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sinovac-reports-unaudited-third-quarter-2009-financial-results-redorbit/2009/</loc>
		<lastmod>2009-11-16T01:13:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4788: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-expresses-confidence-in-the-efficacy-and-safety-profiles-of-zetia%c2%ae-ezetimibe-and-vytorin%c2%ae-ezetimibesimvastatin-as-effective-medicines-for-managing-elevated-cholesterol/2009/</loc>
		<lastmod>2009-11-16T01:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4797: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-myers-splits-off-mead-johnson-nutrition-newsday/2009/</loc>
		<lastmod>2009-11-16T01:07:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4804: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/niaspan-tops-zetia-in-new-setback-for-merck-drug/2009/</loc>
		<lastmod>2009-11-16T01:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4792: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-myers-splits-off-mead-johnson-shareholders-can-swap-bristol-shares-for-mead-stock-minneapolis-st-paul-star-tribune/2009/</loc>
		<lastmod>2009-11-16T00:48:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4793: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-myers-splits-off-mead-johnson-nutrition-rocky-mount-telegram/2009/</loc>
		<lastmod>2009-11-16T00:47:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4785: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sinovac-reports-unaudited-third-quarter-2009-financial-results-pr-newswire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-15T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4783: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sac-capital-business-standard-india/2009/</loc>
		<lastmod>2009-11-15T20:30:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4784: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/recession-hangover-business-standard-india/2009/</loc>
		<lastmod>2009-11-15T19:16:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4791: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-astrazeneca-drug-tops-plavix-in-sickest-patients/2009/</loc>
		<lastmod>2009-11-15T17:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4780: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-drug-tops-plavix-in-sickest-patients/2009/</loc>
		<lastmod>2009-11-15T15:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4781: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/video-ticagrelor-brilintatm-demonstrated-greater-efficacy-over-clopidogrel-in-the-most-urgent-clinical-setting-patients-with-st-segment-elevation-myocardial-infarction-and-planned-percutaneous/2009/</loc>
		<lastmod>2009-11-15T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4779: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-all-eyes-on-the-consumer/2009/</loc>
		<lastmod>2009-11-15T13:13:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4789: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bargain-natural-gas-stocks/2009/</loc>
		<lastmod>2009-11-14T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4776: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-fda-find-bits-of-trash-in-genzyme-drugs-redorbit/2009/</loc>
		<lastmod>2009-11-14T15:44:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4777: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-strengthens-its-commitment-to-advancing-cardiovascular-health-care/2009/</loc>
		<lastmod>2009-11-14T13:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4769: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/preview-4/2009/</loc>
		<lastmod>2009-11-14T13:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4771: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sam-zell-too-soon-for-dancing/2009/</loc>
		<lastmod>2009-11-14T13:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4790: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/in-search-of-dividends-and-more/2009/</loc>
		<lastmod>2009-11-14T13:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4772: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/money-talks/2009/</loc>
		<lastmod>2009-11-14T12:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4773: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-that-are-better-than-gold-2/2009/</loc>
		<lastmod>2009-11-14T12:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4766: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/talecris-lured-with-20-million-the-news-observer/2009/</loc>
		<lastmod>2009-11-14T09:31:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4767: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/talecris-lured-with-20-million-the-news-observer-2/2009/</loc>
		<lastmod>2009-11-14T09:31:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4760: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/maxygen-buying-back-stock-analysts-say-no-trend-here-bioworld/2009/</loc>
		<lastmod>2009-11-14T01:50:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4759: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tiens-biotech-group-usa-reports-third-quarter-and-nine-month-results-redorbit/2009/</loc>
		<lastmod>2009-11-14T00:39:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4725: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-rally-two-weeks-and-counting/2009/</loc>
		<lastmod>2009-11-13T22:17:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4782: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lilly-names-new-research-head/2009/</loc>
		<lastmod>2009-11-13T22:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4720: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-amid-sentiment-shift/2009/</loc>
		<lastmod>2009-11-13T21:21:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4749: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tiens-biotech-group-usa-reports-third-quarter-and-nine-month-results-pr-newswire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-13T21:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4745: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-industry-spends-1-billion-a-year-on-continuing-medical-ed/2009/</loc>
		<lastmod>2009-11-13T20:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4737: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-closes-at-record-high/2009/</loc>
		<lastmod>2009-11-13T20:38:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4743: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cashing-in-on-obamacare-the-motley-fool/2009/</loc>
		<lastmod>2009-11-13T20:33:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4729: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-dips-near-76/2009/</loc>
		<lastmod>2009-11-13T20:33:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4758: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-best-yields-for-the-next-10-years/2009/</loc>
		<lastmod>2009-11-13T20:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4741: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-foreign-particles-found-in-some-genzyme-medicines-nasdaq/2009/</loc>
		<lastmod>2009-11-13T20:04:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4747: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-brave-or-stupid/2009/</loc>
		<lastmod>2009-11-13T19:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4746: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/questioning-pfizers-integrity/2009/</loc>
		<lastmod>2009-11-13T19:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4742: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ma-goes-hostile-businessweek-3/2009/</loc>
		<lastmod>2009-11-13T19:25:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4770: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/aspenbio-to-present-at-the-lazard-capital-market-6th-annual-healthcare-conference/2009/</loc>
		<lastmod>2009-11-13T18:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4739: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eli-lilly-head-of-research-development-to-retire/2009/</loc>
		<lastmod>2009-11-13T18:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4731: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/googles-pitch-to-fda-for-online-drug-ads/2009/</loc>
		<lastmod>2009-11-13T17:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4735: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/no-sex-for-this-citi/2009/</loc>
		<lastmod>2009-11-13T17:40:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4736: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/no-sex-for-this-citi/2009/</loc>
		<lastmod>2009-11-13T17:40:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4732: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/buy-this-consistent-grower-1-minute-trade/2009/</loc>
		<lastmod>2009-11-13T16:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4738: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/serbia-buys-3-million-swiss-swine-flu-vaccines/2009/</loc>
		<lastmod>2009-11-13T16:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4721: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-next-vytorin-study-why-is-everybody-so-worked-up/2009/</loc>
		<lastmod>2009-11-13T16:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4724: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-cardium-therapeutics-2/2009/</loc>
		<lastmod>2009-11-13T14:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4719: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/unique-strategy-generates-big-returns-for-baupost-indie-research-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-13T13:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4713: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/layoffs-sting-big-pharma/2009/</loc>
		<lastmod>2009-11-13T13:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4714: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/layoffs-sting-big-pharma-2/2009/</loc>
		<lastmod>2009-11-13T13:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4715: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-cardium-therapeutics-thestreet-com/2009/</loc>
		<lastmod>2009-11-13T12:45:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4716: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-cardium-therapeutics-thestreet-com-2/2009/</loc>
		<lastmod>2009-11-13T12:40:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4710: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stock-mailbag-cardium-therapeutics/2009/</loc>
		<lastmod>2009-11-13T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4712: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/russian-biomedical-plant-diod-plans-local-ipo-reuters-via-yahoo-singapore-news/2009/</loc>
		<lastmod>2009-11-13T10:43:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4709: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-higher-open-2/2009/</loc>
		<lastmod>2009-11-13T10:17:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4711: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/new-survey-shows-gap-in-diagnosis-and-treatment-of-osteoporosis-among-post-menopausal-women-studied-who-were-hospitalized-with-fractures/2009/</loc>
		<lastmod>2009-11-13T10:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4707: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-broader-appeal-fuels-chinas-nasdaq-presence-reuters-via-yahoo-philippines-news/2009/</loc>
		<lastmod>2009-11-13T06:22:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4730: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cdc-estimates-h1n1-has-killed-3900/2009/</loc>
		<lastmod>2009-11-12T23:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4691: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/other-peoples-money/2009/</loc>
		<lastmod>2009-11-12T23:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4692: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/other-peoples-money/2009/</loc>
		<lastmod>2009-11-12T23:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4683: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/trading-outlook-for-bioelectronics-corporation-issued-by-stockpreacher-com/2009/</loc>
		<lastmod>2009-11-12T23:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4690: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ma-goes-hostile-businessweek-2/2009/</loc>
		<lastmod>2009-11-12T22:20:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4688: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/inside-wall-street-businessweek-2/2009/</loc>
		<lastmod>2009-11-12T22:18:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4644: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-snap-winning-streak/2009/</loc>
		<lastmod>2009-11-12T21:45:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4684: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dreadful-stocks-to-avoid-the-motley-fool-2/2009/</loc>
		<lastmod>2009-11-12T21:18:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4687: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/six-reasons-to-say-no-to-your-doctor/2009/</loc>
		<lastmod>2009-11-12T21:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4685: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-do-you-say-drug-development-in-mandarin/2009/</loc>
		<lastmod>2009-11-12T20:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4674: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/do-you-have-the-guts-to-buy-the-motley-fool/2009/</loc>
		<lastmod>2009-11-12T20:21:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4679: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-after-30-year-bond-sale/2009/</loc>
		<lastmod>2009-11-12T20:03:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4686: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-life-and-death-situation-that-isnt/2009/</loc>
		<lastmod>2009-11-12T19:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4694: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-labs-is-making-the-right-moves/2009/</loc>
		<lastmod>2009-11-12T19:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4695: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-labs-is-making-the-right-moves-2/2009/</loc>
		<lastmod>2009-11-12T19:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4635: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-retreats-from-record-high/2009/</loc>
		<lastmod>2009-11-12T19:44:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4678: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/investment-ideas-from-tweedy-browne/2009/</loc>
		<lastmod>2009-11-12T19:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4673: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/do-you-have-the-guts-to-buy/2009/</loc>
		<lastmod>2009-11-12T19:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4671: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-slides-3-on-inventory-jump/2009/</loc>
		<lastmod>2009-11-12T18:35:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4696: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/does-hewlett-packard-have-cisco-worried/2009/</loc>
		<lastmod>2009-11-12T17:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4649: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-pharma-scrambles-for-a-piece-of-the-vaccine-pie/2009/</loc>
		<lastmod>2009-11-12T17:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4667: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/for-retailers-xmas-is-only-kind-of-blue/2009/</loc>
		<lastmod>2009-11-12T17:30:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4666: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-pushes-higher/2009/</loc>
		<lastmod>2009-11-12T17:09:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4654: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-buys-pain-drug-candidate-for-up-to-190m/2009/</loc>
		<lastmod>2009-11-12T17:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4661: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wider-loss-for-alnylam-zacks-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-12T16:55:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4651: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/hp-chases-china-with-3com-deal/2009/</loc>
		<lastmod>2009-11-12T16:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4648: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/brocade-analysts-upgrades-downgrades/2009/</loc>
		<lastmod>2009-11-12T16:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4656: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-to-acquire-novel-investigational-biologic-to-treat-chronic-pain/2009/</loc>
		<lastmod>2009-11-12T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4657: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-to-acquire-novel-investigational-biologic-to-treat-chronic-pain/2009/</loc>
		<lastmod>2009-11-12T16:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4639: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/what-pfizer-kkr-and-goldman-reportedly-want-generics/2009/</loc>
		<lastmod>2009-11-12T15:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4641: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-sustainability-exec-duponts-linda-fisher-cnn-money/2009/</loc>
		<lastmod>2009-11-12T14:26:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4630: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-seen-pulling-back/2009/</loc>
		<lastmod>2009-11-12T10:16:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4631: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/talecris-picks-clayton-the-news-observer-2/2009/</loc>
		<lastmod>2009-11-12T10:07:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4643: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/talecris-picks-clayton-the-news-observer-3/2009/</loc>
		<lastmod>2009-11-12T10:07:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4622: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/talecris-picks-clayton-the-news-observer/2009/</loc>
		<lastmod>2009-11-12T07:02:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4613: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ma-goes-hostile-businessweek/2009/</loc>
		<lastmod>2009-11-12T05:25:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4612: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/investing-in-obama-with-etfs-indexuniverse-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-12T05:21:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4640: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pharmas-future-in-social-media/2009/</loc>
		<lastmod>2009-11-12T03:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4591: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-enzon-merck-osi-pharmaceuticals-pfizer-and-bank-of-america-corporation/2009/</loc>
		<lastmod>2009-11-12T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4595: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-boston-scientific-corporation-johnson-johnson-medtronic-inc-abbott-laboratories-and-st-jude-medical-inc/2009/</loc>
		<lastmod>2009-11-12T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4592: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/squeezing-the-shorts-large-cap-stocks/2009/</loc>
		<lastmod>2009-11-11T23:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4584: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/when-rival-drug-makers-compare-notes-on-safety-problems/2009/</loc>
		<lastmod>2009-11-11T22:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4646: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ftc-says-its-concerned-by-drug-makers-practices/2009/</loc>
		<lastmod>2009-11-11T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4566: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-hits-another-13-month-high/2009/</loc>
		<lastmod>2009-11-11T21:55:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4596: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/arnold-itkin-announces-lawsuits-over-defective-pain-pumps/2009/</loc>
		<lastmod>2009-11-11T21:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4588: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-company-is-a-value-stock-isnt-it-the-motley-fool/2009/</loc>
		<lastmod>2009-11-11T21:34:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4601: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/there-will-be-blood-plasma/2009/</loc>
		<lastmod>2009-11-11T20:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4585: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/keeping-up-with-the-kahn-brothers/2009/</loc>
		<lastmod>2009-11-11T20:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4593: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rolling-bull-markets/2009/</loc>
		<lastmod>2009-11-11T19:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4575: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drug-industry-presses-fda-to-allow-more-online-ads/2009/</loc>
		<lastmod>2009-11-11T19:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4582: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/now-thats-what-i-call-a-drug-deal/2009/</loc>
		<lastmod>2009-11-11T19:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4569: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-firms-near-15-month-low/2009/</loc>
		<lastmod>2009-11-11T19:09:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4586: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/actress-debi-mazar-talks-about-her-familys-experience-with-bipolar-depression/2009/</loc>
		<lastmod>2009-11-11T19:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4578: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-gains-slightly-on-weak-dollar/2009/</loc>
		<lastmod>2009-11-11T18:35:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4576: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sanofis-research-shift-billion-dollar-deal-venture-capital-fund/2009/</loc>
		<lastmod>2009-11-11T17:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4573: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/its-raining-pink-slips/2009/</loc>
		<lastmod>2009-11-11T15:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4568: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sprussell-recent-low-could-see-retest/2009/</loc>
		<lastmod>2009-11-11T15:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4565: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/healthcare-guru-adds-selected-biotech-pharma-stakes-indie-research-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-11T15:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4567: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-surges-to-a-record-high/2009/</loc>
		<lastmod>2009-11-11T14:40:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4583: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-awful-investment-should-just-die/2009/</loc>
		<lastmod>2009-11-11T14:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4562: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-early-gains-3/2009/</loc>
		<lastmod>2009-11-11T10:06:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4559: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-big-shift-businessweek/2009/</loc>
		<lastmod>2009-11-11T00:55:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4557: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/to-bet-against-pelosicare-buy-big-pharma/2009/</loc>
		<lastmod>2009-11-11T00:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4570: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-industry-outlook-highlights-alcon-novartis-gilead-sciences-biogen-idec-and-acorda-therapeutics/2009/</loc>
		<lastmod>2009-11-11T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4558: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-soars-to-record-high/2009/</loc>
		<lastmod>2009-11-10T23:24:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4554: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/investor-group-to-u-s-chamber-dont-kill-health-reform/2009/</loc>
		<lastmod>2009-11-10T22:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4552: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-industry-outlook-highlights-alcon-novartis-gilead-sciences-biogen-idec-and-acorda-therapeutics-business-wire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-10T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4551: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/xoma-zeroing-in-on-profits-lamorinda-sun/2009/</loc>
		<lastmod>2009-11-10T20:49:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4553: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/small-acquisitions-and-the-road-to-success/2009/</loc>
		<lastmod>2009-11-10T20:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4544: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/blood-cancer-meeting-abstracts-released-biobuzz/2009/</loc>
		<lastmod>2009-11-10T19:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4531: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-falls-near-78-as-ida-weakens/2009/</loc>
		<lastmod>2009-11-10T18:53:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4529: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-after-10-year-note-sale/2009/</loc>
		<lastmod>2009-11-10T18:44:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4542: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-dollar-is-weak-because/2009/</loc>
		<lastmod>2009-11-10T17:20:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4532: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-recovers-from-15-month-low/2009/</loc>
		<lastmod>2009-11-10T17:19:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4550: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-dows-new-high-signals-change/2009/</loc>
		<lastmod>2009-11-10T16:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4541: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-smackdown-cramer-vs-caps-the-motley-fool/2009/</loc>
		<lastmod>2009-11-10T16:34:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4536: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-licenses-arthritis-drug-biobuzz/2009/</loc>
		<lastmod>2009-11-10T16:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4535: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-lose-steam/2009/</loc>
		<lastmod>2009-11-10T16:12:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4537: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/refile-pfizer-will-close-rd-sites-and-cut-jobs/2009/</loc>
		<lastmod>2009-11-10T15:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4538: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/refile-pfizer-will-close-rd-sites-and-cut-jobs/2009/</loc>
		<lastmod>2009-11-10T15:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4533: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/correction-refile-pfizer-will-close-rd-sites-and-cut-jobs/2009/</loc>
		<lastmod>2009-11-10T15:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4555: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-washington-chainsaw-massacre/2009/</loc>
		<lastmod>2009-11-10T15:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4534: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/canadian-national-stock-exchange-cusip-correction-global-biotech-corp-gbq-cnw-group-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-10T14:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4527: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-poised-for-a-dip/2009/</loc>
		<lastmod>2009-11-10T10:16:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4560: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-to-cut-rd-sites-jobs/2009/</loc>
		<lastmod>2009-11-10T08:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4528: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-pharma-biotech-zacks-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-10T06:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4526: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/status-of-pfizer-and-wyeth-research-facilities/2009/</loc>
		<lastmod>2009-11-10T01:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4525: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinese-team-plans-visit-to-sort-out-je-vaccine-spoilage-issue-ie-via-yahoo-india-news/2009/</loc>
		<lastmod>2009-11-10T00:39:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4523: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-surges-to-new-2009-high/2009/</loc>
		<lastmod>2009-11-10T00:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4520: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/directv-group-merck-money-flow-leaders-dtv-mrk/2009/</loc>
		<lastmod>2009-11-09T23:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4480: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/upgrades-downgrades-abercrombies-in-fashion/2009/</loc>
		<lastmod>2009-11-09T22:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4521: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-pharma-and-biotech-zacks-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-09T21:52:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4504: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-to-close-6-research-sites/2009/</loc>
		<lastmod>2009-11-09T21:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4512: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sell-pfizer-against-the-grain-2/2009/</loc>
		<lastmod>2009-11-09T21:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4482: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-surges-to-13-month-high/2009/</loc>
		<lastmod>2009-11-09T21:15:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4517: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-stock-has-tremendous-upside-the-motley-fool-3/2009/</loc>
		<lastmod>2009-11-09T21:05:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4530: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/doc-offers-top-hep-c-drug-picks-biobuzz/2009/</loc>
		<lastmod>2009-11-09T20:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4473: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-continues-record-run-above-1100/2009/</loc>
		<lastmod>2009-11-09T20:16:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4509: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/techamerica-illinois-executives-open-nasdaq-stock-market-redorbit/2009/</loc>
		<lastmod>2009-11-09T20:13:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4522: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/guidant-the-gift-that-keeps-on-giving/2009/</loc>
		<lastmod>2009-11-09T20:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4494: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-jumps-nearly-3-on-storm-and-weak-dollar/2009/</loc>
		<lastmod>2009-11-09T20:11:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4513: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/health-care-reform-a-tale-of-two-chambers/2009/</loc>
		<lastmod>2009-11-09T19:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4505: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/which-rd-sites-is-pfizer-closing/2009/</loc>
		<lastmod>2009-11-09T19:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4497: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-to-shutter-six-out-of-20-rd-sites/2009/</loc>
		<lastmod>2009-11-09T19:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4498: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-trimming-research-plants-after-buying-wyeth/2009/</loc>
		<lastmod>2009-11-09T19:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4499: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/monsanto-to-purchase-chesterfield-village-research-center-from-pfizer/2009/</loc>
		<lastmod>2009-11-09T19:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4516: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-big-upgrade-for-gilead-sciences/2009/</loc>
		<lastmod>2009-11-09T18:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4501: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/siris-too-much-info-can-bring-trouble-new-york-daily-news/2009/</loc>
		<lastmod>2009-11-09T18:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4487: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-perfect-moment-for-the-bulls/2009/</loc>
		<lastmod>2009-11-09T17:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4506: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-major-mistake-could-ruin-your-retirement/2009/</loc>
		<lastmod>2009-11-09T17:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4490: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/techamerica-illinois-executives-open-nasdaq-stock-market-pr-newswire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-09T17:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4493: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-silence-of-the-bears/2009/</loc>
		<lastmod>2009-11-09T16:55:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4514: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/emerging-stock-report-initiates-independent-research-coverage-on-human-genome-sciences/2009/</loc>
		<lastmod>2009-11-09T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4489: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/house-passage-wont-kill-the-health-care-sector/2009/</loc>
		<lastmod>2009-11-09T15:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4484: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-ahead-of-auctions/2009/</loc>
		<lastmod>2009-11-09T15:15:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4485: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-ahead-of-auctions/2009/</loc>
		<lastmod>2009-11-09T15:15:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4483: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-off-to-a-solid-start/2009/</loc>
		<lastmod>2009-11-09T14:51:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4488: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rpt-reuters-summit-healthcare-seeks-new-prescription-for-growth/2009/</loc>
		<lastmod>2009-11-09T14:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4474: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/plastic-tubing-manufacturer-takes-steps-to-go-green-thomasnet/2009/</loc>
		<lastmod>2009-11-09T13:47:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4475: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-weakens-broadly/2009/</loc>
		<lastmod>2009-11-09T13:37:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4466: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/deals-could-buoy-wall-street/2009/</loc>
		<lastmod>2009-11-09T12:21:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4479: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/practicing-balance-with-pg-china-watch/2009/</loc>
		<lastmod>2009-11-09T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4481: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-lifted-to-buy-roche-cut-to-hold-rbs/2009/</loc>
		<lastmod>2009-11-09T10:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4467: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-poised-to-climb/2009/</loc>
		<lastmod>2009-11-09T10:35:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4468: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-downgraded-to-underweight-at-jp-morgan/2009/</loc>
		<lastmod>2009-11-09T10:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4465: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/carlsbad-ceo-excels-in-biotech-tool-field-san-diego-union-tribune/2009/</loc>
		<lastmod>2009-11-09T08:19:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4464: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-stock-screaming-buy-me-3/2009/</loc>
		<lastmod>2009-11-08T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4463: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-buyers-swooping-back-in/2009/</loc>
		<lastmod>2009-11-08T11:55:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4478: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jim-cramers-best-blogs-2/2009/</loc>
		<lastmod>2009-11-07T15:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4476: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/charting-the-market-2/2009/</loc>
		<lastmod>2009-11-07T13:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4459: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-dividend-stocks-wont-let-you-down/2009/</loc>
		<lastmod>2009-11-07T12:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4457: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/living-without-blockbusters-2/2009/</loc>
		<lastmod>2009-11-07T01:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4454: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jim-cramers-portfolios-of-the-week-3/2009/</loc>
		<lastmod>2009-11-06T23:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4456: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-abbott-faces-new-us-sales-probe-depakote-in-focus/2009/</loc>
		<lastmod>2009-11-06T22:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4436: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-rise-on-day-week/2009/</loc>
		<lastmod>2009-11-06T21:16:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4428: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-sinks-nearly-3-after-jobs-report/2009/</loc>
		<lastmod>2009-11-06T20:03:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4445: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nuvasive-appoints-new-cfo-and-other-executives/2009/</loc>
		<lastmod>2009-11-06T17:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4450: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/par-3q-profit-surges-on-product-sales/2009/</loc>
		<lastmod>2009-11-06T16:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4452: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/south-korean-fda-probes-roche-for-aiding-tamiflu-stockpiling/2009/</loc>
		<lastmod>2009-11-06T16:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4441: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-pop-after-jobs-report/2009/</loc>
		<lastmod>2009-11-06T16:11:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4440: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-breaks-1100/2009/</loc>
		<lastmod>2009-11-06T15:44:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4438: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ariads-3q-loss-widens-slightly-on-costs/2009/</loc>
		<lastmod>2009-11-06T15:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4443: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-another-lost-decade-coming-for-stocks/2009/</loc>
		<lastmod>2009-11-06T14:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4430: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-climbs-after-weak-jobs-report/2009/</loc>
		<lastmod>2009-11-06T14:17:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4431: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/global-biotech-corp-announces-listing-on-cnsx-marketwire/2009/</loc>
		<lastmod>2009-11-06T13:44:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4427: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/job-market-report-disappoints-wall-street/2009/</loc>
		<lastmod>2009-11-06T13:44:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4432: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/global-biotech-corp-announces-listing-on-cnsx-ccnmatthews-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-06T13:30:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4444: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-this-stock-is-a-winner/2009/</loc>
		<lastmod>2009-11-06T11:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4426: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/agennix-ag-shares-begin-trading-on-frankfurt-stock-exchange-marketwire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-06T08:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4451: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-investors-should-ignore-the-dow/2009/</loc>
		<lastmod>2009-11-06T03:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4423: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/alkermes-takes-2q-loss-cuts-full-year-estimates-san-francisco-chronicle/2009/</loc>
		<lastmod>2009-11-06T00:10:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4422: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/alkermes-takes-2q-loss-cuts-full-year-estimates-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-11-05T23:48:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4424: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/protecting-against-slippage-at-halliburton/2009/</loc>
		<lastmod>2009-11-05T23:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4418: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-3-dutch-pull-pfizer-vaccine-batch-after-infants-die/2009/</loc>
		<lastmod>2009-11-05T22:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4393: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-reclaims-10000/2009/</loc>
		<lastmod>2009-11-05T21:19:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4389: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-steadies-just-below-1100/2009/</loc>
		<lastmod>2009-11-05T21:04:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4411: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/moodys-upgrades-ratings-for-wyeth/2009/</loc>
		<lastmod>2009-11-05T20:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4379: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-slips-below-80/2009/</loc>
		<lastmod>2009-11-05T19:58:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4412: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/slow-down-there-merck/2009/</loc>
		<lastmod>2009-11-05T18:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4409: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-the-droid-wont-save-motorola/2009/</loc>
		<lastmod>2009-11-05T18:22:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4407: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-amgen-retreat-a-case-of-investor-overreaction-market-watch/2009/</loc>
		<lastmod>2009-11-05T18:00:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4410: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dont-buy-the-jobs-hype/2009/</loc>
		<lastmod>2009-11-05T17:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4402: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/deals-of-the-day-what-if-oracle-walks-out-on-sun/2009/</loc>
		<lastmod>2009-11-05T16:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4400: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-mixed-after-jobless-data/2009/</loc>
		<lastmod>2009-11-05T16:32:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4399: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/canadian-national-stock-exchange-new-listing-global-biotech-corp-gbq-marketwire/2009/</loc>
		<lastmod>2009-11-05T16:30:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4401: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/canadian-national-stock-exchange-new-listing-global-biotech-corp-gbq-ccnmatthews-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-05T16:16:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4397: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/canadian-national-stock-exchange-new-listing-global-biotech-corp-gbq-cnw-group-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-05T16:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4404: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/let-this-winning-combination-make-you-wealthy/2009/</loc>
		<lastmod>2009-11-05T15:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4433: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/flu-vaccine-update-beyond-chicken-eggs-seasonal-shortage/2009/</loc>
		<lastmod>2009-11-05T15:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4380: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/all-im-asking-for-is-rigor/2009/</loc>
		<lastmod>2009-11-05T13:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4381: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/trading-outlook-for-advanced-life-sciences-holdings-inc-issued-by-investorsoup-com/2009/</loc>
		<lastmod>2009-11-05T13:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4388: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merger-of-gpc-biotech-ag-into-agennix-ag-closes-marketwire/2009/</loc>
		<lastmod>2009-11-05T13:24:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4392: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wednesdays-biggest-stock-stars/2009/</loc>
		<lastmod>2009-11-05T13:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4387: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merger-of-gpc-biotech-ag-into-agennix-ag-closes-marketwire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-05T13:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4376: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/weak-open-seen-for-wall-street/2009/</loc>
		<lastmod>2009-11-05T12:31:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4385: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oncolytics-biotechr-inc-announces-2009-third-quarter-results-pr-newswire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-05T12:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4386: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-gains-on-cautious-tone/2009/</loc>
		<lastmod>2009-11-05T12:24:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4378: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ad-hoc-agennix-ag-merger-of-gpc-biotech-ag-into-stock-world/2009/</loc>
		<lastmod>2009-11-05T12:24:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4391: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/value-growth-both/2009/</loc>
		<lastmod>2009-11-05T09:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4375: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sinovac-biotech-to-transfer-quote-to-nasdaq-from-amex-china-daily/2009/</loc>
		<lastmod>2009-11-05T05:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4390: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fast-money-recap-ciscos-bullish-report/2009/</loc>
		<lastmod>2009-11-05T02:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4373: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sinovac-biotech-to-transfer-quote-to-nasdaq-from-amex-peoples-daily/2009/</loc>
		<lastmod>2009-11-05T02:34:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4425: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-pfe-2/2009/</loc>
		<lastmod>2009-11-04T23:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4366: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/significantly-more-smokers-with-mild-to-moderate-copd-quit-smoking-using-chantixchampix%c2%ae-varenicline-compared-with-placebo/2009/</loc>
		<lastmod>2009-11-04T23:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4349: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-finish-mixed-after-late-selloff/2009/</loc>
		<lastmod>2009-11-04T23:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4367: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nothing-more-than-a-rolling-rally/2009/</loc>
		<lastmod>2009-11-04T23:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4356: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/squeezing-the-shorts-late-earnings-plays/2009/</loc>
		<lastmod>2009-11-04T22:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4374: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/still-waiting-for-details-on-mercks-16000-job-cuts/2009/</loc>
		<lastmod>2009-11-04T22:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4364: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/buffett-railroad-business-is-in-tune-with-the-future-usa-today/2009/</loc>
		<lastmod>2009-11-04T21:48:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4360: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-casting-its-anti-obama-votes/2009/</loc>
		<lastmod>2009-11-04T21:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4340: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-give-up-gains-after-fed/2009/</loc>
		<lastmod>2009-11-04T21:13:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4372: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/officials-frustrated-by-vaccine-shortage/2009/</loc>
		<lastmod>2009-11-04T20:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4416: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merging-merck/2009/</loc>
		<lastmod>2009-11-04T20:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4348: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-after-fed-statement/2009/</loc>
		<lastmod>2009-11-04T20:29:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4337: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-holds-above-80-after-fed-statement/2009/</loc>
		<lastmod>2009-11-04T20:18:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4417: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/an-ode-to-schering-plough/2009/</loc>
		<lastmod>2009-11-04T20:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4355: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/buy-wellpoint/2009/</loc>
		<lastmod>2009-11-04T20:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4331: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-falls-after-fed-statement/2009/</loc>
		<lastmod>2009-11-04T19:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4352: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-cuomo-slapped-intel-forbes/2009/</loc>
		<lastmod>2009-11-04T19:24:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4347: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-now-no-2-drugmaker-set-for-future-buys-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-11-04T18:02:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4370: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bay-biz-buzz-cisco-profit-better-than-expected-contra-costa-times/2009/</loc>
		<lastmod>2009-11-04T17:42:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4338: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-now-no-2-drugmaker-set-for-future-buys/2009/</loc>
		<lastmod>2009-11-04T17:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4354: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/you-dont-need-much-to-start/2009/</loc>
		<lastmod>2009-11-04T16:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4343: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vaxgen-inc-q3-10q-out-greenbackd-exits-dammit-guru-focus/2009/</loc>
		<lastmod>2009-11-04T15:17:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4341: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ceo-of-vivakor-inc-otcbb-vivk-to-conduct-exclusive-webcast-interview-with-the-green-baron-report-new-stock-pick-business-wire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-04T15:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4403: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-9/2009/</loc>
		<lastmod>2009-11-04T15:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4339: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/new-merck-begins-operations/2009/</loc>
		<lastmod>2009-11-04T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4334: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/trading-outlook-for-novavax-inc-issued-by-investorsoup-com/2009/</loc>
		<lastmod>2009-11-04T13:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4319: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-strong-open/2009/</loc>
		<lastmod>2009-11-04T13:13:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4330: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-tops-80-as-dollar-weakens/2009/</loc>
		<lastmod>2009-11-04T12:25:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4328: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-hits-a-record-near-1100/2009/</loc>
		<lastmod>2009-11-04T12:12:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4329: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-hits-a-record-near-1100/2009/</loc>
		<lastmod>2009-11-04T12:12:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4324: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-11-04-1208-thrombogenics-drug-pipeline-on-track-interactive-investor/2009/</loc>
		<lastmod>2009-11-04T12:11:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4325: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-to-buy-85-of-chinese-vaccines-producer/2009/</loc>
		<lastmod>2009-11-04T10:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4310: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/riding-the-rails-at-a-high-price-new-york-times/2009/</loc>
		<lastmod>2009-11-04T04:35:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4346: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-capitalism-moral/2009/</loc>
		<lastmod>2009-11-04T01:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4293: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cramers-mad-money-follow-up-nov-3/2009/</loc>
		<lastmod>2009-11-04T00:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4321: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pharmas-hiring-in-china/2009/</loc>
		<lastmod>2009-11-03T23:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4299: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/china-led-world-again-in-october-gdp-lives-large-investors-business-daily-via-yahoo-news/2009/</loc>
		<lastmod>2009-11-03T23:28:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4300: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-pharma-again-taking-shot-at-vaccines-investors-business-daily-via-yahoo-news/2009/</loc>
		<lastmod>2009-11-03T23:26:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4297: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pensions-for-executives-soar/2009/</loc>
		<lastmod>2009-11-03T23:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4271: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-merck-schering-plough-set-to-complete-merger/2009/</loc>
		<lastmod>2009-11-03T21:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4287: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-picks-for-the-defensive-investor/2009/</loc>
		<lastmod>2009-11-03T21:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4242: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-churn-in-choppy-session/2009/</loc>
		<lastmod>2009-11-03T21:18:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4282: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/facet-biotech-reports-third-quarter-2009-financial-results-marketwire/2009/</loc>
		<lastmod>2009-11-03T21:10:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4238: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jj-to-slash-7000-to-8000-jobs/2009/</loc>
		<lastmod>2009-11-03T21:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4284: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mandel-a-gloomy-view-of-our-economic-future-businessweek/2009/</loc>
		<lastmod>2009-11-03T20:52:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4303: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-you-wont-be-able-to-retire/2009/</loc>
		<lastmod>2009-11-03T20:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4232: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-recovers-to-post-gains/2009/</loc>
		<lastmod>2009-11-03T20:11:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4278: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-mixed-ahead-of-fed-statement/2009/</loc>
		<lastmod>2009-11-03T20:00:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4289: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nice-quarter-teva-what-will-you-buy-next/2009/</loc>
		<lastmod>2009-11-03T19:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4286: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-little-distracted-are-you-merck/2009/</loc>
		<lastmod>2009-11-03T19:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4099: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-to-complete-41b-purchase-of-schering-plough/2009/</loc>
		<lastmod>2009-11-03T19:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4258: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-schering-plough-to-complete-merger-tuesday/2009/</loc>
		<lastmod>2009-11-03T19:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4265: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/recapping-40000-job-cuts-in-big-pharma/2009/</loc>
		<lastmod>2009-11-03T18:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4259: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-and-schering-plough-to-complete-merger-today/2009/</loc>
		<lastmod>2009-11-03T18:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4280: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amylin-scores-a-hat-trick/2009/</loc>
		<lastmod>2009-11-03T18:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4273: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jj-to-cut-7-of-workforce/2009/</loc>
		<lastmod>2009-11-03T18:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4267: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-stable-stock-could-still-surprise/2009/</loc>
		<lastmod>2009-11-03T18:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4255: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/steep-grades-and-sharp-curves/2009/</loc>
		<lastmod>2009-11-03T17:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4261: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gold-surges-to-an-all-time-high/2009/</loc>
		<lastmod>2009-11-03T17:33:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4263: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-warren-buffett-calling-a-bottom/2009/</loc>
		<lastmod>2009-11-03T17:24:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4245: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/president-of-tanzania-and-the-abbott-fund-dedicate-modern-emergency-medical-department/2009/</loc>
		<lastmod>2009-11-03T17:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4350: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/liveblog-jj-execs-discuss-job-cuts/2009/</loc>
		<lastmod>2009-11-03T16:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4248: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-just-in-upgrades-and-downgrades-the-motley-fool/2009/</loc>
		<lastmod>2009-11-03T15:43:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4235: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-tutorial-in-defensive-investing/2009/</loc>
		<lastmod>2009-11-03T15:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4236: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/rigel-3q-loss-narrows-on-lower-costs/2009/</loc>
		<lastmod>2009-11-03T14:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4241: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sinovac-to-transfer-stock-exchange-listing-to-nasdaq-global-market-pr-newswire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-03T14:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4234: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-climbs-to-one-month-high/2009/</loc>
		<lastmod>2009-11-03T12:54:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4227: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-set-to-slide/2009/</loc>
		<lastmod>2009-11-03T12:26:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4246: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/one-sign-of-a-strong-stock-3/2009/</loc>
		<lastmod>2009-11-03T11:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4228: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-clorox-company-arena-pharmaceuticals-vivus-inc-orexigen-therapeutics-and-amylin-zacks-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-03T11:23:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4229: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-clorox-company-arena-pharmaceuticals-vivus-inc-orexigen-therapeutics-and-amylin-zacks-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-03T11:23:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4252: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-to-spend-1-billion-on-china-rd/2009/</loc>
		<lastmod>2009-11-03T08:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4237: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-executive-pensions-rose-in-08-even-as-stocks-fell-report/2009/</loc>
		<lastmod>2009-11-03T06:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4240: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/new-damages-trial-for-wyeth-in-ark-hormones-case/2009/</loc>
		<lastmod>2009-11-03T02:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4226: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-2-absolute-software-posts-narrower-q1-loss/2009/</loc>
		<lastmod>2009-11-03T00:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4216: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/understanding-corporate-innovation/2009/</loc>
		<lastmod>2009-11-02T23:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4217: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zetia-plus-lipitor-for-now-fda-wont-consider-it/2009/</loc>
		<lastmod>2009-11-02T22:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4177: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-stage-late-day-rally/2009/</loc>
		<lastmod>2009-11-02T21:17:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4169: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-creeping-back-toward-80/2009/</loc>
		<lastmod>2009-11-02T20:23:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4251: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-fda-advisory-meetings-through-dec-18/2009/</loc>
		<lastmod>2009-11-02T20:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4213: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/investing-lessons-from-benjamin-graham/2009/</loc>
		<lastmod>2009-11-02T20:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4193: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-wont-accept-mercks-application-for-new-drug/2009/</loc>
		<lastmod>2009-11-02T20:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4198: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/busting-out-with-biotech-and-emerging-markets-forbes/2009/</loc>
		<lastmod>2009-11-02T19:32:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4197: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-surprisingly-decent-third-quarter/2009/</loc>
		<lastmod>2009-11-02T19:17:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4200: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/buffett-bank-favorite-gets-bigger/2009/</loc>
		<lastmod>2009-11-02T19:15:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4212: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/finally-convinced-benlysta-works/2009/</loc>
		<lastmod>2009-11-02T19:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4199: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-takes-it-on-the-chin-in-october-redorbit/2009/</loc>
		<lastmod>2009-11-02T19:09:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4194: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amylin-strikes-first-with-obesity-drug-deal-biobuzz/2009/</loc>
		<lastmod>2009-11-02T19:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4202: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gtx-shares-crater-on-fda-rejection-malaysianews-net/2009/</loc>
		<lastmod>2009-11-02T18:44:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4201: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinas-chinext-stock-market-is-the-great-red-hope-for-small-companies-daily-telegraph/2009/</loc>
		<lastmod>2009-11-02T18:18:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4192: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-saving-1-billion-gallons-of-water-annually/2009/</loc>
		<lastmod>2009-11-02T18:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4191: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gtx-shares-crater-on-fda-rejection-fox-news/2009/</loc>
		<lastmod>2009-11-02T17:54:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4189: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-takes-it-on-the-chin-in-october-pr-newswire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-02T17:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4187: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-research-in-motion-pfizer-potashcorp-memc-and-discover-released-by-seven-summits-research/2009/</loc>
		<lastmod>2009-11-02T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4185: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-slump-on-upbeat-economic-reports/2009/</loc>
		<lastmod>2009-11-02T16:30:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4211: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/get-ready-for-the-fall/2009/</loc>
		<lastmod>2009-11-02T16:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4186: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/future-of-gtx-bone-drug-program-in-doubt-after-fda-rejection-memphis-commercial-appeal/2009/</loc>
		<lastmod>2009-11-02T16:02:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4180: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dendreon-resubmits-provenge-to-fda-biobuzz/2009/</loc>
		<lastmod>2009-11-02T15:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4170: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-8/2009/</loc>
		<lastmod>2009-11-02T15:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4175: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drug-stocks-advance-human-genome-soars-fox-news/2009/</loc>
		<lastmod>2009-11-02T15:04:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4184: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-completes-acquisition-of-evalve-inc/2009/</loc>
		<lastmod>2009-11-02T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4188: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/europe-sees-some-sharp-declines/2009/</loc>
		<lastmod>2009-11-02T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4174: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/company-gives-investors-a-safety-net-the-star-ledger/2009/</loc>
		<lastmod>2009-11-02T14:37:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4205: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-business-summary-washington-post-2/2009/</loc>
		<lastmod>2009-11-02T14:26:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4172: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vertex-hep-c-drug-emerges-from-weekend-looking-stronger-biobuzz/2009/</loc>
		<lastmod>2009-11-02T14:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4173: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/vertex-hep-c-drug-emerges-from-weekend-looking-stronger-biobuzz-2/2009/</loc>
		<lastmod>2009-11-02T14:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4181: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/winners-and-losers-of-the-house-health-care-reform-bill/2009/</loc>
		<lastmod>2009-11-02T14:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4178: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-falls-against-euro/2009/</loc>
		<lastmod>2009-11-02T14:20:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4165: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-calendar-key-dates-for-november/2009/</loc>
		<lastmod>2009-11-02T14:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4166: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/schering-plough-reports-data-on-hepatitis-c-drug/2009/</loc>
		<lastmod>2009-11-02T13:51:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4190: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/movers-shakers-mondays-biggest-gaining-and-declining-stocks-market-watch-4/2009/</loc>
		<lastmod>2009-11-02T12:45:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4162: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-ready-for-november-bounce/2009/</loc>
		<lastmod>2009-11-02T12:37:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4176: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/morning-watch-nov-2-optionetics-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-11-02T11:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4163: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/world-shares-extend-losses/2009/</loc>
		<lastmod>2009-11-02T09:25:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4161: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/deal-for-schizophrenia-drug-fanapt-13-years-in-making-for-vanda-pharmaceuticals-washington-post/2009/</loc>
		<lastmod>2009-11-02T05:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4157: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinas-small-company-stock-market-starts-trading-newsday/2009/</loc>
		<lastmod>2009-11-02T02:13:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4168: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/employers-brace-for-swine-flu/2009/</loc>
		<lastmod>2009-11-01T22:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4155: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/living-without-blockbusters-forbes/2009/</loc>
		<lastmod>2009-11-01T19:25:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4150: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/utility-trade-could-be-powerful-stock-choice-the-oklahoman/2009/</loc>
		<lastmod>2009-11-01T05:00:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4147: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-streets-broken-rally/2009/</loc>
		<lastmod>2009-11-01T04:03:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4195: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/u-s-sees-10-mln-more-h1n1-vaccine-doses-next-week/2009/</loc>
		<lastmod>2009-10-31T17:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4156: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treading-carefully/2009/</loc>
		<lastmod>2009-10-31T15:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4144: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/obamacare-pass-the-one-stock-to-buy-the-motley-fool/2009/</loc>
		<lastmod>2009-10-31T11:46:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4164: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/amgens-anemic-results/2009/</loc>
		<lastmod>2009-10-31T03:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4142: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lobbying-spending-hits-record-849-million/2009/</loc>
		<lastmod>2009-10-31T01:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4139: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/djia-sinks-250-is-flat-on-month/2009/</loc>
		<lastmod>2009-10-31T00:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4140: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/abbott-suing-impax-labs-over-generic-tricor/2009/</loc>
		<lastmod>2009-10-30T23:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4134: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sanofi-expects-h1n1-vaccine-to-boost-sales/2009/</loc>
		<lastmod>2009-10-30T21:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4106: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-firms-as-stocks-tumble/2009/</loc>
		<lastmod>2009-10-30T21:28:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4135: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-pfires-up-say-on-pay/2009/</loc>
		<lastmod>2009-10-30T20:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4113: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-take-a-big-slide/2009/</loc>
		<lastmod>2009-10-30T20:18:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4145: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/shrugging-off-the-side-effects/2009/</loc>
		<lastmod>2009-10-30T20:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4132: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/earnings-yawn-trial-data-moving/2009/</loc>
		<lastmod>2009-10-30T19:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4133: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/its-not-as-frightening-as-it-first-appears/2009/</loc>
		<lastmod>2009-10-30T19:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4130: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medimmune-to-present-four-abstracts-on-rsv-and-influenza-at-47th-annual-idsa-meeting/2009/</loc>
		<lastmod>2009-10-30T18:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4105: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-slides-on-weak-consumer-data/2009/</loc>
		<lastmod>2009-10-30T18:29:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4131: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/of-one-time-gains-and-pipelines/2009/</loc>
		<lastmod>2009-10-30T18:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4121: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/yet-another-qui-tam-grand-slam/2009/</loc>
		<lastmod>2009-10-30T17:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4146: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-mrk-7/2009/</loc>
		<lastmod>2009-10-30T17:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4125: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/should-you-dump-these-dividend-stocks/2009/</loc>
		<lastmod>2009-10-30T17:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4126: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-only-way-to-profit-in-2010/2009/</loc>
		<lastmod>2009-10-30T17:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4124: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bond-market-still-going-strong/2009/</loc>
		<lastmod>2009-10-30T16:58:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4123: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/new-stock-exchange-in-china-for-small-tech-companies-starts-trading-san-jose-mercury-news/2009/</loc>
		<lastmod>2009-10-30T16:49:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4119: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/thursdays-biggest-stock-stars/2009/</loc>
		<lastmod>2009-10-30T16:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4118: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/international-bio-recovery-corporation-announces-options-grant-cnw-group-via-yahoo-finance/2009/</loc>
		<lastmod>2009-10-30T16:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4117: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ge-verizon-and-wal-mart-scary-stocks/2009/</loc>
		<lastmod>2009-10-30T16:13:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4111: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/deals-of-the-day-cisco-may-drop-bid-for-tandberg/2009/</loc>
		<lastmod>2009-10-30T16:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4114: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-then-and-now-shareholder-say-on-executive-pay/2009/</loc>
		<lastmod>2009-10-30T15:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4120: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/worlds-scariest-stocks-pfizer/2009/</loc>
		<lastmod>2009-10-30T15:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4107: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-completes-consent-solicitation/2009/</loc>
		<lastmod>2009-10-30T15:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4109: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-mailbag-the-reasons-for-this-selloff-thestreet-com/2009/</loc>
		<lastmod>2009-10-30T12:33:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4108: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sanofi-aventis-lifts-outlook-on-vaccine-sales/2009/</loc>
		<lastmod>2009-10-30T12:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4112: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/come-on-they-represent-your-mom/2009/</loc>
		<lastmod>2009-10-30T12:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4098: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/living-without-blockbusters/2009/</loc>
		<lastmod>2009-10-30T10:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4102: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-step-back/2009/</loc>
		<lastmod>2009-10-30T09:22:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4103: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/china-opens-new-stock-exchange-new-york-times/2009/</loc>
		<lastmod>2009-10-30T08:50:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4100: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinas-small-company-stock-market-starts-trading-abc-news/2009/</loc>
		<lastmod>2009-10-30T07:01:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4101: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinas-small-company-stock-market-starts-trading-san-francisco-chronicle/2009/</loc>
		<lastmod>2009-10-30T06:45:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4096: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinas-small-company-stock-market-starts-trading-rocky-mount-telegram/2009/</loc>
		<lastmod>2009-10-30T06:18:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4095: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinas-small-company-stock-market-starts-trading-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-10-30T06:04:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4094: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinas-small-company-stock-market-starts-trading-ap-via-yahoo-finance/2009/</loc>
		<lastmod>2009-10-30T05:36:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4085: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-shareholders-to-get-vote-on-executive-pay/2009/</loc>
		<lastmod>2009-10-30T02:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4104: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/priceline-com-to-join-sp-500-as-drug-firms-merge/2009/</loc>
		<lastmod>2009-10-30T01:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4086: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-to-allow-shareholder-vote-on-executive-pay/2009/</loc>
		<lastmod>2009-10-30T00:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4088: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer%e2%80%99s-board-of-directors-approves-shareholder-advisory-vote-on-executive-compensation/2009/</loc>
		<lastmod>2009-10-30T00:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4092: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/three-things-to-consider-before-investing/2009/</loc>
		<lastmod>2009-10-29T23:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4091: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-ishares-msci-emerging-markets-money-flow-leaders-mrk-eem/2009/</loc>
		<lastmod>2009-10-29T23:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4093: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gdp-spurs-a-return-to-stocks/2009/</loc>
		<lastmod>2009-10-29T23:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4110: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/as-many-as-5-million-in-us-infected-with-h1n1-study/2009/</loc>
		<lastmod>2009-10-29T23:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4072: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/time-warner-elects-schering-plough-ceo-to-board/2009/</loc>
		<lastmod>2009-10-29T22:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4097: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/swine-flu-and-the-health-etfs/2009/</loc>
		<lastmod>2009-10-29T22:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4048: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dows-best-day-in-3-months/2009/</loc>
		<lastmod>2009-10-29T22:06:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4073: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/todays-bargains-are-right-under-your-nose/2009/</loc>
		<lastmod>2009-10-29T21:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4077: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/statin-drugs-may-lower-deaths-from-flu-study/2009/</loc>
		<lastmod>2009-10-29T20:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4079: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/now-is-the-time-to-invest-and-get-rich-2/2009/</loc>
		<lastmod>2009-10-29T19:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4084: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/simple-lessons-from-an-investing-genius/2009/</loc>
		<lastmod>2009-10-29T19:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4074: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/small-and-volatile-but-not-for-long/2009/</loc>
		<lastmod>2009-10-29T19:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4080: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pharma-researchers-need-a-cure/2009/</loc>
		<lastmod>2009-10-29T19:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4075: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eye-on-insiders-amgen/2009/</loc>
		<lastmod>2009-10-29T18:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4038: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-climbs-3-on-gdp-growth/2009/</loc>
		<lastmod>2009-10-29T18:56:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4068: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-earns-up-but-investors-cautious/2009/</loc>
		<lastmod>2009-10-29T18:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4061: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/your-move-ben-bernanke/2009/</loc>
		<lastmod>2009-10-29T17:01:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4056: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-stocks-biomarin-human-genome-lead-drug-stocks-higher-market-watch/2009/</loc>
		<lastmod>2009-10-29T17:00:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4051: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/risk-aversion-is-a-market-theme/2009/</loc>
		<lastmod>2009-10-29T16:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4065: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/winning-with-buy-and-hold-mutual-funds/2009/</loc>
		<lastmod>2009-10-29T16:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4066: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/jensen-fund-bets-on-abbott-adobe/2009/</loc>
		<lastmod>2009-10-29T15:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4063: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-retreats-as-u-s-economy-grows/2009/</loc>
		<lastmod>2009-10-29T14:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4054: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-common-move-will-get-you-nowhere/2009/</loc>
		<lastmod>2009-10-29T14:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4076: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-winning-opportunity-no-one-talks-about/2009/</loc>
		<lastmod>2009-10-29T14:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4039: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-astrazeneca-ups-outlook-as-flu-and-crestor-shine/2009/</loc>
		<lastmod>2009-10-29T14:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4040: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-quarterly-profit-jumps-sales-up/2009/</loc>
		<lastmod>2009-10-29T14:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4045: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eli-lilly-stock-hurt-by-patent-loss-cnn-money/2009/</loc>
		<lastmod>2009-10-29T14:04:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4043: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-slide-after-strong-gdp-report/2009/</loc>
		<lastmod>2009-10-29T14:01:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4046: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rally-stocks/2009/</loc>
		<lastmod>2009-10-29T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4052: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/trading-review-for-jazz-pharmaceuticals-inc-issued-by-beacon-equity/2009/</loc>
		<lastmod>2009-10-29T13:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4053: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/trading-review-for-jazz-pharmaceuticals-inc-issued-by-beacon-equity/2009/</loc>
		<lastmod>2009-10-29T13:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4047: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/morning-report-for-biotech-better-but-not-best-voice-of-san-diego/2009/</loc>
		<lastmod>2009-10-29T13:40:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4044: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-lower-before-key-economic-report/2009/</loc>
		<lastmod>2009-10-29T11:50:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4036: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/early-gains-seen-for-stocks/2009/</loc>
		<lastmod>2009-10-29T09:15:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4037: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/aldagen-dusts-off-its-ipo-plan-the-news-observer-2/2009/</loc>
		<lastmod>2009-10-29T09:04:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4041: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pg-could-sell-some-brands-buy-others/2009/</loc>
		<lastmod>2009-10-29T07:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4028: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/aldagen-dusts-off-its-ipo-plan-the-news-observer/2009/</loc>
		<lastmod>2009-10-29T06:04:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4022: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ecuador-to-make-cheap-versions-of-patented-drugs/2009/</loc>
		<lastmod>2009-10-28T23:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4019: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-giving-2-execs-bonuses-after-wyeth-deal/2009/</loc>
		<lastmod>2009-10-28T23:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4025: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stryker-unit-indicted-in-marketing-scheme-doj-reuters-via-yahoo-news/2009/</loc>
		<lastmod>2009-10-28T23:32:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4020: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-pfizer-awards-bonuses-to-execs-for-wyeth-deal/2009/</loc>
		<lastmod>2009-10-28T22:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4021: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-10-28-2219-update-3-stryker-unit-charged-in-marketing-scheme-doj-interactive-investor/2009/</loc>
		<lastmod>2009-10-28T22:26:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3991: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dated-treasurys-gain-after-41-billion-auction/2009/</loc>
		<lastmod>2009-10-28T20:53:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4017: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-10-28-2005-update-1-pfizer-awards-bonuses-to-execs-for-wyeth-deal-interactive-investor/2009/</loc>
		<lastmod>2009-10-28T20:28:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3990: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-slammed/2009/</loc>
		<lastmod>2009-10-28T20:18:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4012: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/saved-by-emerging-markets-sort-of/2009/</loc>
		<lastmod>2009-10-28T19:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4013: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-superstar-stock-picker-moves-to-bonds/2009/</loc>
		<lastmod>2009-10-28T19:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4015: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-sleuth-exposes-market-winners-and-traps-fox-news/2009/</loc>
		<lastmod>2009-10-28T19:36:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4006: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/half-price-sale-on-3-great-stocks/2009/</loc>
		<lastmod>2009-10-28T18:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4004: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chuck-jaffe-stock-sleuth-exposes-market-winners-and-traps-market-watch/2009/</loc>
		<lastmod>2009-10-28T18:40:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4002: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-champions-renewable-energy-with-new-vacaville-solar-array/2009/</loc>
		<lastmod>2009-10-28T18:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4003: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-champions-renewable-energy-with-new-vacaville-solar-array/2009/</loc>
		<lastmod>2009-10-28T18:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4014: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/uncover-the-markets-best-bargains/2009/</loc>
		<lastmod>2009-10-28T17:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3998: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-prices-fall-below-78/2009/</loc>
		<lastmod>2009-10-28T17:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3999: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/markets-dont-kill-investors-bad-decisions-do/2009/</loc>
		<lastmod>2009-10-28T17:12:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4023: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bay-biz-buzz-end-is-near-for-east-bay-biotech-company-contra-costa-times/2009/</loc>
		<lastmod>2009-10-28T16:52:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3995: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stemcells-drops-on-heavy-volume-thestreet-com/2009/</loc>
		<lastmod>2009-10-28T16:46:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3994: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/caught-between-opposing-factors/2009/</loc>
		<lastmod>2009-10-28T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3993: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-nvs-13/2009/</loc>
		<lastmod>2009-10-28T14:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3988: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-firms-as-investors-seek-safety/2009/</loc>
		<lastmod>2009-10-28T11:06:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 4026: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/us-business-summary-washington-post/2009/</loc>
		<lastmod>2009-10-28T10:55:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3985: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-heads-for-weak-open/2009/</loc>
		<lastmod>2009-10-28T10:40:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3987: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-ilaris-approved-in-eu-to-treat-caps/2009/</loc>
		<lastmod>2009-10-28T10:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3989: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-pulls-zactima-combination-submission/2009/</loc>
		<lastmod>2009-10-28T10:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3984: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/struggling-biotech-metabasis-will-be-taken-over-by-ligand-san-diego-union-tribune/2009/</loc>
		<lastmod>2009-10-28T09:07:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3983: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/gene-marcials-stock-picks-covance-businessweek/2009/</loc>
		<lastmod>2009-10-28T05:09:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3981: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/marcial-why-pros-covet-covance-businessweek/2009/</loc>
		<lastmod>2009-10-28T04:05:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3986: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/charts-and-fundamentals-are-a-powerful-pair/2009/</loc>
		<lastmod>2009-10-28T02:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3968: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-theravance-viropharma-pfizer-johnson-johnson-and-forest-laboratories/2009/</loc>
		<lastmod>2009-10-28T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3980: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-mitchells-climbs-higher-as-confidence-rises-independent/2009/</loc>
		<lastmod>2009-10-28T00:02:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3979: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-firm-cephalon-3q-profit-falls-2-7-percent-newsday/2009/</loc>
		<lastmod>2009-10-28T00:01:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3982: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/hefty-side-effect-for-kids-on-antipsychotics/2009/</loc>
		<lastmod>2009-10-27T23:51:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3970: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/targeting-tysabri/2009/</loc>
		<lastmod>2009-10-27T23:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3971: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/targeting-tysabri/2009/</loc>
		<lastmod>2009-10-27T23:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3978: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/techs-would-be-takeover-con-artist-forbes/2009/</loc>
		<lastmod>2009-10-27T22:54:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3975: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-firm-cephalon-3q-profit-falls-2-7-percent-the-daily-reflector/2009/</loc>
		<lastmod>2009-10-27T22:52:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3976: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-firm-cephalon-3q-profit-falls-2-7-pct-absent-a-tax-benefit-provigil-drug-sales-dip-minneapolis-st-paul-star-tribune/2009/</loc>
		<lastmod>2009-10-27T22:45:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3977: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-firm-cephalon-3q-profit-falls-2-7-percent-rocky-mount-telegram/2009/</loc>
		<lastmod>2009-10-27T22:42:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3973: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-firm-cephalon-3q-profit-falls-2-7-percent-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-10-27T22:39:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3974: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-firm-cephalon-3q-profit-falls-2-7-percent-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-10-27T22:39:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3963: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizers-and-mercks-loss-is-these-companies-gain/2009/</loc>
		<lastmod>2009-10-27T20:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3944: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nasdaq-slumps-dow-snaps-slide/2009/</loc>
		<lastmod>2009-10-27T20:15:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3972: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/king-licenses-us-sales-rights-to-cyanide-antidote/2009/</loc>
		<lastmod>2009-10-27T19:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3969: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/small-market-small-acquisition-still-a-good-move/2009/</loc>
		<lastmod>2009-10-27T19:41:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3962: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-azn-8/2009/</loc>
		<lastmod>2009-10-27T19:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3941: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-recovers-to-hold-above-79/2009/</loc>
		<lastmod>2009-10-27T19:30:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3959: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ligand-to-buy-metabasis-san-diego-business-journal/2009/</loc>
		<lastmod>2009-10-27T19:01:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3957: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/voros-bankrupt-zombie-stocks-should-scare-you-contra-costa-times/2009/</loc>
		<lastmod>2009-10-27T18:12:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3956: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-10-27-1702-glance-ftse-gains-0-2-pct-driven-by-oils-on-bp-numbers-interactive-investor/2009/</loc>
		<lastmod>2009-10-27T17:30:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3937: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-hold-gains-after-44-billion-auction/2009/</loc>
		<lastmod>2009-10-27T17:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3943: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-hits-2-week-high/2009/</loc>
		<lastmod>2009-10-27T17:07:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3954: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/london-close-footsie-clings-on-sharecast/2009/</loc>
		<lastmod>2009-10-27T17:04:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3951: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ftse-gains-driven-by-oil-stocks%c2%a0-reuters-via-yahoo-uk-ireland-news/2009/</loc>
		<lastmod>2009-10-27T16:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3952: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-plays-new-game-of-risk/2009/</loc>
		<lastmod>2009-10-27T16:50:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3958: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ftse-gains-0-2-pct-driven-by-oils-on-bp-numbers-reuters-via-yahoo-philippines-news/2009/</loc>
		<lastmod>2009-10-27T16:47:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3946: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-bull-and-bear-story-on-gtxs-pending-drug-approval-biobuzz-thestreet-com/2009/</loc>
		<lastmod>2009-10-27T15:10:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3967: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/heres-when-the-crash-will-happen/2009/</loc>
		<lastmod>2009-10-27T15:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3945: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/medivation-lands-partner-for-prostate-cancer-drug/2009/</loc>
		<lastmod>2009-10-27T14:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3948: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/trading-review-for-discovery-laboratories-inc-issued-by-beacon-equity/2009/</loc>
		<lastmod>2009-10-27T13:50:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3934: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-heads-for-tepid-open/2009/</loc>
		<lastmod>2009-10-27T13:16:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3947: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ligand-pharmaceuticals-metabasis-therapeutics-enter-into-merger-agreement-news-medical-net/2009/</loc>
		<lastmod>2009-10-27T12:33:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3935: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotechs-pursue-unorthodox-funding-san-diego-union-tribune/2009/</loc>
		<lastmod>2009-10-27T09:22:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3936: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotechs-pursue-unorthodox-funding-san-diego-union-tribune/2009/</loc>
		<lastmod>2009-10-27T09:22:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3933: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotage-interim-report-january-september-2009-business-wire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-10-27T07:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3932: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-10-27-0725-swiss-stocks-factors-to-watch-on-oct-27-interactive-investor/2009/</loc>
		<lastmod>2009-10-27T07:42:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3940: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/icagen-asthma-drug-senicapoc-trial-fails/2009/</loc>
		<lastmod>2009-10-27T02:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3931: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pa-jury-returns-verdict-in-prempro-cancer-case/2009/</loc>
		<lastmod>2009-10-27T01:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3938: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/longtime-arizona-newspaper-publisher-dies-at-84/2009/</loc>
		<lastmod>2009-10-27T01:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3928: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-schering-plough-merck-co-sanofi-aventis-google-and-ebay/2009/</loc>
		<lastmod>2009-10-27T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3897: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rises-off-14-month-low/2009/</loc>
		<lastmod>2009-10-26T22:33:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3900: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-falls-below-79/2009/</loc>
		<lastmod>2009-10-26T22:12:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3923: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nyba-board-members-sharon-mates-and-barbara-dalton-to-be-honored-at-the-winners-circle-awards-celebration-dinner-business-wire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-10-26T20:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3929: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/unusual-call-volume-in-merck-options/2009/</loc>
		<lastmod>2009-10-26T20:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3904: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-slump-as-dollar-spikes/2009/</loc>
		<lastmod>2009-10-26T20:24:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3926: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/for-tysabri-23-is-10-too-many/2009/</loc>
		<lastmod>2009-10-26T19:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3949: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/earnings-preview-glaxosmithkline-q3-earns-seen-up/2009/</loc>
		<lastmod>2009-10-26T19:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3915: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/this-trick-could-haunt-your-portfolio-forever/2009/</loc>
		<lastmod>2009-10-26T18:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3922: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-big-upgrade-for-electro-optical-sciences/2009/</loc>
		<lastmod>2009-10-26T18:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3918: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dole-ipo-takes-a-bruising/2009/</loc>
		<lastmod>2009-10-26T18:18:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3917: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-cancer-drug-study-suspended/2009/</loc>
		<lastmod>2009-10-26T18:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3913: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-pharma-flip/2009/</loc>
		<lastmod>2009-10-26T18:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3912: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-fall-as-record-auction-starts/2009/</loc>
		<lastmod>2009-10-26T18:12:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3914: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/astrazeneca-partners-with-mercy-primary-care-center-to-help-michigan-uninsured/2009/</loc>
		<lastmod>2009-10-26T16:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3909: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/earnings-preview-glaxosmithkline-q3-earns-seen-up-ap-via-yahoo-finance/2009/</loc>
		<lastmod>2009-10-26T16:39:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3908: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/deals-of-the-day-is-a-comcast-nbcu-tie-up-a-good-idea/2009/</loc>
		<lastmod>2009-10-26T16:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3911: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/finding-gold-in-little-miners/2009/</loc>
		<lastmod>2009-10-26T16:01:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3901: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/germanys-merck-says-q3-net-income-falls-28-pct/2009/</loc>
		<lastmod>2009-10-26T14:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3906: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/afx-uk-focus-2009-10-26-1409-factbox-emea-ipo-pipeline-interactive-investor/2009/</loc>
		<lastmod>2009-10-26T14:11:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3902: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/swine-flu-small-cap-jumps-on-fda-announcement-indie-research-via-yahoo-finance/2009/</loc>
		<lastmod>2009-10-26T13:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3899: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/singapore-bets-on-casino-gambling-businessweek-online-via-yahoo-uk-ireland-finance/2009/</loc>
		<lastmod>2009-10-26T12:24:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3898: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/anti-viral-drug-development-programs-progress-successfully-reports-nanoviricides-news-medical-net/2009/</loc>
		<lastmod>2009-10-26T11:46:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3896: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/s-korea-turn-down-disgraced-cloning-expert-the-star/2009/</loc>
		<lastmod>2009-10-26T10:06:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3893: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/s-korea-turn-down-disgraced-cloning-expert-pretoria-news/2009/</loc>
		<lastmod>2009-10-26T09:57:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3894: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-to-rebound/2009/</loc>
		<lastmod>2009-10-26T09:06:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3891: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dubais-dubiotech-partner-with-swiss-biotech-association-menafn/2009/</loc>
		<lastmod>2009-10-26T05:06:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3892: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dubais-dubiotech-partner-with-swiss-biotech-association-menafn/2009/</loc>
		<lastmod>2009-10-26T05:06:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3895: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/corporate-watch-2/2009/</loc>
		<lastmod>2009-10-26T00:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3890: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/business-in-brief-haaretz-daily/2009/</loc>
		<lastmod>2009-10-25T23:20:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3887: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-trying-to-recharge-the-rally/2009/</loc>
		<lastmod>2009-10-25T12:57:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3888: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/news-und-mein-neues-invest-stock-world/2009/</loc>
		<lastmod>2009-10-25T10:14:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3886: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/elder-law-sorting-through-misinformation-can-be-tough-chore-the-news-press/2009/</loc>
		<lastmod>2009-10-25T05:27:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3882: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-sitdown-with-eli-lilly-co-s-ceo-the-post-and-courier/2009/</loc>
		<lastmod>2009-10-25T04:13:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3881: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/from-motown-to-techtown-cbs-news/2009/</loc>
		<lastmod>2009-10-25T01:36:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3880: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/chinas-sweet-as-moment-stuff/2009/</loc>
		<lastmod>2009-10-25T00:40:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3889: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-king-of-catalyst-capture/2009/</loc>
		<lastmod>2009-10-24T12:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3907: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/resurrecting-those-old-merger-spirits/2009/</loc>
		<lastmod>2009-10-24T12:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3875: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-wal-mart-capital-one-merck-glaxosmithkline-and-schering-plough/2009/</loc>
		<lastmod>2009-10-24T00:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3903: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/h1n1-matches-seasonal-flu-peak-months-early-cdc/2009/</loc>
		<lastmod>2009-10-23T22:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3876: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-decoder-jobless-recovery/2009/</loc>
		<lastmod>2009-10-23T20:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3849: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rallies-against-the-pound/2009/</loc>
		<lastmod>2009-10-23T20:07:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3921: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/not-made-in-the-usa-the-gerber-baby/2009/</loc>
		<lastmod>2009-10-23T19:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3871: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/i-dont-need-no-massive-merger/2009/</loc>
		<lastmod>2009-10-23T19:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3873: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/swine-flu-doesnt-need-to-save-novartis/2009/</loc>
		<lastmod>2009-10-23T19:43:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3874: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dont-miss-this-cheap-stock-the-motley-fool/2009/</loc>
		<lastmod>2009-10-23T19:32:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3883: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/analysts-hate-this-stock/2009/</loc>
		<lastmod>2009-10-23T19:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3878: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-schering-doesnt-look-so-good/2009/</loc>
		<lastmod>2009-10-23T19:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3865: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/these-companies-could-be-takeover-targets/2009/</loc>
		<lastmod>2009-10-23T18:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3867: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/not-50-growth-but-well-take-it/2009/</loc>
		<lastmod>2009-10-23T18:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3855: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-slump-after-rally/2009/</loc>
		<lastmod>2009-10-23T18:23:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3859: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eu-mergers-and-takeovers-oct-23/2009/</loc>
		<lastmod>2009-10-23T18:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3869: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pharma-payments-to-mental-health-group-more-to-come/2009/</loc>
		<lastmod>2009-10-23T17:39:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3861: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-slip-ahead-of-record-auction/2009/</loc>
		<lastmod>2009-10-23T17:17:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3848: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-retreats-below-81/2009/</loc>
		<lastmod>2009-10-23T17:08:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3847: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eu-approves-merck-takeover-of-schering-plough/2009/</loc>
		<lastmod>2009-10-23T15:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3854: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/banks-showing-some-dividend-potential/2009/</loc>
		<lastmod>2009-10-23T15:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3839: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wall-street-ready-for-early-pop/2009/</loc>
		<lastmod>2009-10-23T12:57:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3843: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sec-charges-new-york-broker-for-manipulating-stock-prices-through-fake-press-releases-and-internet-postings-kansas-city-infozine/2009/</loc>
		<lastmod>2009-10-23T09:59:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3841: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/americas-most-generous-companies/2009/</loc>
		<lastmod>2009-10-23T04:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3835: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/in-pictures-americas-most-generous-companies/2009/</loc>
		<lastmod>2009-10-23T04:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3844: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-health-care-pick-for-a-shot-of-growth/2009/</loc>
		<lastmod>2009-10-23T01:23:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3836: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/genesis-partner-helps-fund-gene-research-stock-up-scoop-co-nz/2009/</loc>
		<lastmod>2009-10-23T01:12:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3795: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/earnings-cheer-pushes-up-djia/2009/</loc>
		<lastmod>2009-10-22T23:45:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3790: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-surges-past-10000-again/2009/</loc>
		<lastmod>2009-10-22T23:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3822: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drugmakers-mostly-post-higher-profits-muted-sales/2009/</loc>
		<lastmod>2009-10-22T23:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3831: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-declares-a-16-cent-fourth-quarter-2009-dividend/2009/</loc>
		<lastmod>2009-10-22T23:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3832: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-declares-a-16-cent-fourth-quarter-2009-dividend/2009/</loc>
		<lastmod>2009-10-22T23:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3813: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bond-prices-slip-as-stocks-rally/2009/</loc>
		<lastmod>2009-10-22T22:41:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3812: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bristol-myers-posts-higher-3q-sales-lower-profit/2009/</loc>
		<lastmod>2009-10-22T21:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3823: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-3-india-brazil-to-take-eu-to-court-in-generics-row/2009/</loc>
		<lastmod>2009-10-22T21:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3833: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/elans-headed-in-the-right-direction/2009/</loc>
		<lastmod>2009-10-22T20:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3834: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/beat-earnings-stock-down-rinse-and-repeat/2009/</loc>
		<lastmod>2009-10-22T20:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3819: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/nibbles-here-and-there-at-forest-labs/2009/</loc>
		<lastmod>2009-10-22T19:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3820: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-gift-that-keeps-on-giving/2009/</loc>
		<lastmod>2009-10-22T19:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3814: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-slides-on-jobs-data/2009/</loc>
		<lastmod>2009-10-22T19:55:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3793: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-rally-on-earnings-optimism/2009/</loc>
		<lastmod>2009-10-22T19:16:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3817: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/good-luck-in-2010-amgen/2009/</loc>
		<lastmod>2009-10-22T18:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3808: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/cost-cuts-at-big-pharma-fail-to-excite/2009/</loc>
		<lastmod>2009-10-22T18:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3816: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/eli-lilly-ceo-banking-on-new-drug-pipeline-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-10-22T18:33:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3803: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/swiss-etf-wont-budge/2009/</loc>
		<lastmod>2009-10-22T18:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3805: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sec-charges-new-york-broker-for-manipulating-stock-prices-through-fake-press-releases-and-internet-postings-u-s-securities-and-exchange-commission/2009/</loc>
		<lastmod>2009-10-22T17:42:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3797: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-tops-street-ahead-of-schering-merger/2009/</loc>
		<lastmod>2009-10-22T17:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3804: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/ericsson-china-drag-on-europe/2009/</loc>
		<lastmod>2009-10-22T17:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3860: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/att-3m-thursdays-headlines/2009/</loc>
		<lastmod>2009-10-22T16:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3799: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/critical-alerts-for-schlumberger-merck-deere-delta-and-autozone-released-by-seven-summits-research/2009/</loc>
		<lastmod>2009-10-22T16:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3806: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/traders-flock-to-calls-on-biotech-firm-ahead-of-earnings-schaeffers-research/2009/</loc>
		<lastmod>2009-10-22T16:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3788: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-beats-profit-forecasts-helped-by-cost-cuts/2009/</loc>
		<lastmod>2009-10-22T16:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2536: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-futures-point-to-lower-open/2009/</loc>
		<lastmod>2009-10-22T16:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3783: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/inside-the-7-billion-swine-flu-vaccine-industry/2009/</loc>
		<lastmod>2009-10-22T15:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3800: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/celgene-3q-profit-surges-on-cancer-drug-sales-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-10-22T15:01:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3778: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-posts-big-profit-jump-slight-rise-in-sales/2009/</loc>
		<lastmod>2009-10-22T14:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3779: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/schering-plough-posts-17-percent-drop-in-3q-profit/2009/</loc>
		<lastmod>2009-10-22T14:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3780: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-reports-profit-spike-on-asset-sale/2009/</loc>
		<lastmod>2009-10-22T14:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3781: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-announces-third-quarter-2009-financial-results/2009/</loc>
		<lastmod>2009-10-22T14:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3794: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-mixed-at-open/2009/</loc>
		<lastmod>2009-10-22T13:38:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3774: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-poised-for-a-weak-open/2009/</loc>
		<lastmod>2009-10-22T12:43:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3776: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rebounds-from-14-month-low/2009/</loc>
		<lastmod>2009-10-22T10:54:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3770: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biocons-second-quarter-net-at-13-85-million-dollars-new-kerala/2009/</loc>
		<lastmod>2009-10-22T08:52:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3777: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-ups-sales-forecast-as-profits-rise/2009/</loc>
		<lastmod>2009-10-22T08:37:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3775: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-reports-net-income-of-2-1-billion/2009/</loc>
		<lastmod>2009-10-22T08:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3771: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tips-for-an-investing-newbie/2009/</loc>
		<lastmod>2009-10-22T08:20:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3767: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/earnings-may-fail-to-lift-markets-again-forbes/2009/</loc>
		<lastmod>2009-10-22T04:47:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3749: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/djia-slides-back-under-10000/2009/</loc>
		<lastmod>2009-10-22T00:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3761: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mv-weather-report-late-day-hail-storm-buries-bulls/2009/</loc>
		<lastmod>2009-10-21T23:52:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3765: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/earnings-dark-pools-insurance-and-tips/2009/</loc>
		<lastmod>2009-10-21T23:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3760: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stock-wrap-the-real-story-october-21/2009/</loc>
		<lastmod>2009-10-21T23:42:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3762: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lilly-posts-3q-profit-analysts-doubt-future-sales-ap-via-yahoo-news/2009/</loc>
		<lastmod>2009-10-21T22:13:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3756: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-fall-as-fed-reports-modest-recovery/2009/</loc>
		<lastmod>2009-10-21T20:45:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3736: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-fall-from-one-year-highs/2009/</loc>
		<lastmod>2009-10-21T20:07:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3747: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/kass-the-earnings-season-racket/2009/</loc>
		<lastmod>2009-10-21T20:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3728: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-holds-1-year-high-above-81/2009/</loc>
		<lastmod>2009-10-21T19:51:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3746: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mrk-preview-lots-of-costs-to-cut/2009/</loc>
		<lastmod>2009-10-21T19:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3784: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/double-digit-growth-in-a-recession/2009/</loc>
		<lastmod>2009-10-21T18:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3785: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/double-digit-growth-in-a-recession/2009/</loc>
		<lastmod>2009-10-21T18:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3738: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lilly-profit-tops-street-view-but-shares-fall/2009/</loc>
		<lastmod>2009-10-21T18:46:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3809: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/heres-why-the-market-can-keep-going-up/2009/</loc>
		<lastmod>2009-10-21T17:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3739: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/lockheed-analysts-upgrades-downgrades/2009/</loc>
		<lastmod>2009-10-21T16:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3743: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/an-october-christmas-for-retail-stocks/2009/</loc>
		<lastmod>2009-10-21T16:03:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3768: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/upgrades-downgrades-lockheed-martin-gets-knocked-down/2009/</loc>
		<lastmod>2009-10-21T15:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3802: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/from-strong-earnings-to-actual-job-gains/2009/</loc>
		<lastmod>2009-10-21T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3737: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/euro-tops-1-50-at-14-month-high/2009/</loc>
		<lastmod>2009-10-21T14:37:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3733: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/complacency-rather-than-fear/2009/</loc>
		<lastmod>2009-10-21T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3734: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/earnings-preview-bristol-myers-3q-earnings-report/2009/</loc>
		<lastmod>2009-10-21T13:58:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3729: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/earnings-preview-merck-to-report-3q-earnings/2009/</loc>
		<lastmod>2009-10-21T13:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3735: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-ag-raised-to-outperform-at-cazenove/2009/</loc>
		<lastmod>2009-10-21T12:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3730: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/big-pharma-immune-to-obama-overhaul/2009/</loc>
		<lastmod>2009-10-21T12:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3726: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/using-buybacks-to-help-pick-stocks/2009/</loc>
		<lastmod>2009-10-21T09:21:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3725: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/weak-open-seen-for-stocks/2009/</loc>
		<lastmod>2009-10-21T09:17:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3722: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oncolytics-biotech-invests-in-private-company-british-canadian-biosciences-canadian-business/2009/</loc>
		<lastmod>2009-10-21T02:02:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3723: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oncolytics-biotech-invests-in-private-company-british-canadian-biosciences-the-canadian-press-via-yahoo-canada-news/2009/</loc>
		<lastmod>2009-10-21T01:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3731: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/a-shot-in-the-arm-for-the-pap-smear/2009/</loc>
		<lastmod>2009-10-21T01:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3721: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/quicker-rebound-for-exporters-to-china-india/2009/</loc>
		<lastmod>2009-10-21T01:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3716: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/top-takes-from-realmoney-2/2009/</loc>
		<lastmod>2009-10-21T01:08:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3681: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-slip-as-earnings-bar-rises/2009/</loc>
		<lastmod>2009-10-21T00:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3703: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/housing-ppi-data-sink-djia/2009/</loc>
		<lastmod>2009-10-20T23:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2716: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/treasurys-bounce-higher-on-housing-concerns/2009/</loc>
		<lastmod>2009-10-20T21:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3701: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-profit-jumps-despite-drop-in-sales/2009/</loc>
		<lastmod>2009-10-20T21:32:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3702: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/earnings-roundup-pfizer-state-street/2009/</loc>
		<lastmod>2009-10-20T21:18:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3713: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-biogen-idec-inc-facet-biotech-corporation-trubion-pharmaceuticals-bristol-myers-business-wire-via-yahoo-finance/2009/</loc>
		<lastmod>2009-10-20T21:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3711: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/galleons-biotech-stock-holdings-biobuzz-thestreet-com/2009/</loc>
		<lastmod>2009-10-20T20:56:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3712: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/running-with-the-energy-bulls/2009/</loc>
		<lastmod>2009-10-20T20:40:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3695: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-6-pfizer-3rd-quarter-profit-rises-tops-street-2/2009/</loc>
		<lastmod>2009-10-20T20:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3672: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-3q-profit-jumps-26-percent-on-cost-cutting/2009/</loc>
		<lastmod>2009-10-20T20:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3727: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/all-tysabri-all-the-time/2009/</loc>
		<lastmod>2009-10-20T19:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3715: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-heart-companys-disheartening-forecast/2009/</loc>
		<lastmod>2009-10-20T19:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3683: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-slide-but-dow-holds-10000/2009/</loc>
		<lastmod>2009-10-20T19:09:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3700: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-starts-the-blame-game/2009/</loc>
		<lastmod>2009-10-20T18:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3668: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-retreats-from-80/2009/</loc>
		<lastmod>2009-10-20T18:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3675: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-rises-on-european-support/2009/</loc>
		<lastmod>2009-10-20T18:02:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3706: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/update-1-astrazeneca-offers-buyouts-to-cut-u-s-sales-force/2009/</loc>
		<lastmod>2009-10-20T17:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3720: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/sell-pfizer-against-the-grain/2009/</loc>
		<lastmod>2009-10-20T17:21:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3690: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/forest-labs-2q-profit-slides-on-drug-costs/2009/</loc>
		<lastmod>2009-10-20T16:59:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3719: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/weekly-digests-investor-essentials-special-report-identifies-unique-investing-opportunities-in-the-h1n1-swine-flu-outbreak-2/2009/</loc>
		<lastmod>2009-10-20T16:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3684: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/did-your-doctor-get-paid-to-give-talks-for-merck/2009/</loc>
		<lastmod>2009-10-20T16:04:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3693: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/neurogenic-orthostatic-hypotension-treatment-should-pass-phase-iii-trials-catalyst-for-biotech-stock-says-wedbush-wall-street-transcript-via-yahoo-finance/2009/</loc>
		<lastmod>2009-10-20T16:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3740: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/early-movers-pump-up-the-volume-2/2009/</loc>
		<lastmod>2009-10-20T15:53:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3691: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-you-need-to-become-a-millionaire/2009/</loc>
		<lastmod>2009-10-20T15:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3741: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/how-many-jobs-has-pfizer-cut-this-year/2009/</loc>
		<lastmod>2009-10-20T15:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3688: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-approves-new-test-to-aid-in-the-diagnosis-of-rheumatoid-arthritis/2009/</loc>
		<lastmod>2009-10-20T15:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3748: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-abt-6/2009/</loc>
		<lastmod>2009-10-20T15:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3689: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/wedbush-morgan-biotech-analyst-sees-access-to-capital-increasing-again-for-small-cap-firms-wall-street-transcript-via-yahoo-finance/2009/</loc>
		<lastmod>2009-10-20T15:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3673: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfizer-reports-third-quarter-2009-results/2009/</loc>
		<lastmod>2009-10-20T14:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3677: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mondays-biggest-stock-stars-the-motley-fool-3/2009/</loc>
		<lastmod>2009-10-20T13:32:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3676: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biotech-mergers-and-acquisitions-will-accelerate-according-to-wedbush-morgan-expert-analyst-as-more-expensive-phase-wall-street-transcript-via-yahoo-finance/2009/</loc>
		<lastmod>2009-10-20T13:30:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3663: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/stocks-set-for-modest-gains-2/2009/</loc>
		<lastmod>2009-10-20T12:50:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3682: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/tuesdays-top-stories-in-two-minutes/2009/</loc>
		<lastmod>2009-10-20T12:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3685: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/swine-flu-shot-gets-mexican-test/2009/</loc>
		<lastmod>2009-10-20T12:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3670: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novavax-ge-avimex-set-mexico-h1n1-vaccine-trial-malaysianews-net/2009/</loc>
		<lastmod>2009-10-20T11:22:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3664: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/zacks-analyst-blog-highlights-biogen-idec-inc-facet-biotech-corporation-trubion-pharmaceuticals-bristol-myers-zacks-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-10-20T10:47:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3686: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/novartis-progress-with-leukemia-arthritis-drugs/2009/</loc>
		<lastmod>2009-10-20T09:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3661: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/world-stocks-soar-to-one-year-high/2009/</loc>
		<lastmod>2009-10-20T08:35:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3687: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/market-report-in-play-nvs-12/2009/</loc>
		<lastmod>2009-10-20T08:29:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3669: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/morgan-sells-van-kampen-fund-unit/2009/</loc>
		<lastmod>2009-10-20T08:17:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3679: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/boston-scientific-cuts-profit-outlook-shares-slide/2009/</loc>
		<lastmod>2009-10-20T04:02:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3659: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/boston-scientific-returns-to-profit-in-3rd-qtr/2009/</loc>
		<lastmod>2009-10-20T03:33:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3665: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/markets-set-to-digest-earnings/2009/</loc>
		<lastmod>2009-10-20T01:40:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3653: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/report-evidence-lacking-to-compare-viagra-levitra-and-cialis/2009/</loc>
		<lastmod>2009-10-20T00:24:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3644: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mv-weather-report-gusts-of-earnings-expected/2009/</loc>
		<lastmod>2009-10-19T23:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3616: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dollar-falls-against-rivals/2009/</loc>
		<lastmod>2009-10-19T22:53:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3615: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bonds-mixed-as-stocks-surge/2009/</loc>
		<lastmod>2009-10-19T22:51:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3680: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/drugmaker-astrazeneca-cutting-its-us-sales-force/2009/</loc>
		<lastmod>2009-10-19T22:47:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3612: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/dow-10000-stocks-at-one-year-highs/2009/</loc>
		<lastmod>2009-10-19T22:28:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3647: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/mylan-to-pay-121m-to-end-medicaid-generic-claims/2009/</loc>
		<lastmod>2009-10-19T22:28:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3645: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/merck-starts-revealing-payments-to-doctor-speakers/2009/</loc>
		<lastmod>2009-10-19T22:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3651: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/fda-delays-approval-for-amgens-osteoporosis-drug-ventura-county-star/2009/</loc>
		<lastmod>2009-10-19T22:06:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3658: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/growth-stock-swing-option-oct-19-2009-optionetics-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-10-19T21:20:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3646: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/new-pfizer-animal-health-is-unveiled-with-acquisition-of-wyeth/2009/</loc>
		<lastmod>2009-10-19T21:14:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3649: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/still-waiting-for-its-blockbuster/2009/</loc>
		<lastmod>2009-10-19T19:56:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3624: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/oil-ends-close-to-80-mark/2009/</loc>
		<lastmod>2009-10-19T19:22:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3635: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/pfe-preview-is-wyeth-a-game-changer/2009/</loc>
		<lastmod>2009-10-19T19:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3641: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/the-hpv-vaccine-wars-of-2010/2009/</loc>
		<lastmod>2009-10-19T19:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3642: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/foolish-forecast-a-last-look-at-mini-pfizer/2009/</loc>
		<lastmod>2009-10-19T19:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3636: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-your-index-fund-behaving-stupidly/2009/</loc>
		<lastmod>2009-10-19T17:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3634: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/biogen-extends-hostile-bid-zacks-com-via-yahoo-finance/2009/</loc>
		<lastmod>2009-10-19T17:40:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3638: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/why-you-should-buy-health-care-stocks-now/2009/</loc>
		<lastmod>2009-10-19T17:16:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3619: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/advanced-micro-devices-beat-is-still-a-loss/2009/</loc>
		<lastmod>2009-10-19T17:15:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3620: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/upgrades-downgrades-no-love-for-southwest-airlines/2009/</loc>
		<lastmod>2009-10-19T17:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3621: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/bofa-analysts-upgrades-downgrades/2009/</loc>
		<lastmod>2009-10-19T17:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3622: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/morning-playbook-dividend-com-6/2009/</loc>
		<lastmod>2009-10-19T16:38:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3639: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/is-the-market-rally-a-hoax/2009/</loc>
		<lastmod>2009-10-19T16:34:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3631: Comments: 0 of 0 = 0 points -->	<url>
		<loc>http://pubmeddy.com/stocks/newswatch-1987-crash-anniversary-has-much-to-teach-us-market-watch/2009/</loc>
		<lastmod>2009-10-19T16:11:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report